MG-132
Based on 2185 publication(s) in Google Scholar
MG-132 (Z-Leu-Leu-Leu-al) is a potent proteasome and calpain inhibitor with IC50s of 100 nM and 1.2 μM, respectively. MG-132 effectively blocks the proteolytic activity of the 26S proteasome complex. MG-132, a peptide aldehyde, also is an autophagy activator. MG-132 also induces apoptosis.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit: 99.90%
- CAS. Nr.: 133407-82-6
- Formel: C26H41N3O5
- Molecular Weight:475.62
-
Speicherung:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
Publications Citing Use of MedChemExpress (MCE) MG-132
More- Signal Transduct Target Ther. 2026 May 15;11(1):182. [Abstract]
- Signal Transduct Target Ther. 2026 Apr 8;11(1):125. [Abstract]
- Signal Transduct Target Ther. 2026 Feb 18;11(1):59. [Abstract]
- Signal Transduct Target Ther. 2025 Dec 26;10(1):420. [Abstract]
- Signal Transduct Target Ther. 2025 Dec 15;10(1):406. [Abstract]
- Signal Transduct Target Ther. 2025 Oct 15;10(1):346. [Abstract]
- Signal Transduct Target Ther. 2025 Apr 23;10(1):131. [Abstract]
- Signal Transduct Target Ther. 2024 Sep 26;9(1):254. [Abstract]
- Signal Transduct Target Ther. 2023 Jan 16;8(1):18. [Abstract]
- Signal Transduct Target Ther. 2022 Jan 24;7(1):21. [Abstract]
- Signal Transduct Target Ther. 2020 Dec 26;5(1):298. [Abstract]
- Nature. 2026 Apr;652(8112):1339-1348. [Abstract]
- Nature. 2026 Jan;649(8099):1273-1281. [Abstract]
- Nature. 2025 Jul;643(8073):1107-1116. [Abstract]
- Nature. 2025 May;641(8061):202-210. [Abstract]
- Nature. 2021 Nov;599(7885):491-496. [Abstract]
- Science. 2020 Dec 4;370(6521):eaay2002. [Abstract]
- Cancer Cell. 2026 Jun 11:S1535-6108(26)00257-6. [Abstract]
- Cancer Cell. 2025 Jul 25:S1535-6108(25)00310-1. [Abstract]
- Cancer Cell. 2023 Jun 12;41(6):1073-1090.e12. [Abstract]
- Cancer Cell. 2022 Oct 10;40(10):1190-1206.e9. [Abstract]
- Cell. 2026 Jun 11;189(12):3553-3570.e30. [Abstract]
- Cell. 2025 Feb 6;188(3):814-831.e21. [Abstract]
- Cell. 2023 Feb 16;186(4):803-820.e25. [Abstract]
- Nat Biotechnol. 2025 Sep 10. [Abstract]
- Nat Biotechnol. 2024 Dec 11. [Abstract]
- J Hematol Oncol. 2024 Sep 2;17(1):78. [Abstract]
- J Hematol Oncol. 2021 Jan 7;14(1):9. [Abstract]
- Circulation. 2024 Apr 23;149(17):1354-1371. [Abstract]
- Circulation. 2022 Mar;145(9):675-687. [Abstract]
- Nat Nanotechnol. 2025 Feb;20(2):296-302. [Abstract]
- Mol Cancer. 2026 Apr 2;25(1):130. [Abstract]
- Mol Cancer. 2025 Mar 17;24(1):82. [Abstract]
- Mol Cancer. 2024 Dec 19;23(1):274. [Abstract]
- Mol Cancer. 2024 Jul 9;23(1):141. [Abstract]
- Mol Cancer. 2024 Apr 29;23(1):86. [Abstract]
- Mol Cancer. 2024 Jan 24;23(1):23. [Abstract]
- Mol Cancer. 2023 May 20;22(1):86. [Abstract]
- Cell Metab. 2026 May 5;38(5):963-980.e12. [Abstract]
- Cell Metab. 2026 Jan 23:S1550-4131(25)00584-4. [Abstract]
- Cell Metab. 2026 Jan 9:S1550-4131(25)00546-7. [Abstract]
- Cell Metab. 2025 Oct 24:S1550-4131(25)00435-8. [Abstract]
- Cell Metab. 2024 Jan 2;36(1):159-175.e8. [Abstract]
- Cell Metab. 2023 Aug 8;35(8):1390-1405.e8. [Abstract]
- Cell Metab. 2021 May 4;33(5):971-987.e6. [Abstract]
- Nat Immunol. 2026 Mar 3. [Abstract]
- Nat Immunol. 2025 Jul;26(7):1036-1047. [Abstract]
- Nat Immunol. 2022 Aug;23(8):1193-1207. [Abstract]
- Adv Mater. 2025 May 16:e2501933. [Abstract]
- Immunity. 2025 Apr 8:S1074-7613(25)00128-1. [Abstract]
- Cell Res. 2023 Dec;33(12):904-922. [Abstract]
- Cell Res. 2021 Nov;31(11):1199-1211. [Abstract]
- Cell Res. 2021 Mar;31(3):291-311. [Abstract]
- Cancer Commun (Lond). 2025 Jul 24. [Abstract]
- Cancer Commun (Lond). 2023 May;43(5):582-612. [Abstract]
- Blood. 2021 Mar 18;137(11):1478-1490. [Abstract]
- Exploration. 2025 Dec 12;5(6):20240069. [Abstract]
- Drug Resist Updat. 2025 Dec 4:85:101339. [Abstract]
- Drug Resist Updat. 2025 Jul:81:101224. [Abstract]
- Drug Resist Updat. 2023 May:68:100933. [Abstract]
- Sci Bull. 2026 Mar 2:S2095-9273(26)00213-6. [Abstract]
- Nat Metab. 2022 Sep;4(9):1202-1213. [Abstract]
- Nat Neurosci. 2023 May;26(5):751-764. [Abstract]
- Cell Mol Immunol. 2026 Mar;23(3):284-300. [Abstract]
- Cell Mol Immunol. 2025 Sep;22(9):1032-1044. [Abstract]
- Cell Mol Immunol. 2022 Oct;19(10):1117-1129. [Abstract]
- Cell Mol Immunol. 2022 Jan;19(1):67-78. [Abstract]
- Cell Mol Immunol. 2020 May;17(5):496-506. [Abstract]
- Nat Cell Biol. 2025 Apr 14. [Abstract]
- Nat Cell Biol. 2021 Mar;23(3):257-267. [Abstract]
- Nat Cell Biol. 2024 May 23. [Abstract]
- Nat Cell Biol. 2022 Apr;24(4):497-512. [Abstract]
- Mol Neurodegener. 2025 Nov 21;20(1):121. [Abstract]
- Natl Sci Rev. 2021 Feb 10;8(7):nwab024. [Abstract]
- Cancer Res. 2026 Jul 2;86(13):3213-3232. [Abstract]
- Cancer Res. 2026 Jul 15;86(14):3436-3458. [Abstract]
- Mol Cell. 2026 Jun 4;86(11):2173-2190.e11. [Abstract]
- Cancer Res. 2025 Oct 9. [Abstract]
- Cancer Res. 2025 Aug 21. [Abstract]
- Mol Cell. 2025 Apr 4:S1097-2765(25)00260-6. [Abstract]
- Cancer Res. 2025 May 2;85(9):1628-1643. [Abstract]
- Mol Cell. 2024 Mar 21;84(6):1120-1138.e8. [Abstract]
- Mol Cell. 2020 Jan 2;77(1):95-107.e5. [Abstract]
- Mol Cell. 2023 Dec 7;83(23):4370-4385.e9. [Abstract]
- Mol Cell. 2022 Sep 15;82(18):3453-3467.e14. [Abstract]
- Mol Cell. 2022 May 19;82(10):1821-1835.e6. [Abstract]
- Mol Cell. 2021 Nov 4;81(21):4425-4439.e6. [Abstract]
- Mol Cell. 2020 Jul 16;79(2):304-319.e7. [Abstract]
- Mol Cell. 2020 Jul 16;79(2):320-331.e9. [Abstract]
- Cancer Res. 2019 May 1;79(9):2257-2270. [Abstract]
- Cancer Res. 2019 Feb 1;79(3):534-545. [Abstract]
- ACS Nano. 2025 Oct 7;19(39):34659-34676. [Abstract]
- ACS Nano. 2025 May 20;19(19):18708-18728. [Abstract]
- ACS Nano. 2025 Mar 18. [Abstract]
- ACS Nano. 2024 Jan 30;18(4):3733-3751. [Abstract]
- ACS Nano. 2023 Nov 28;17(22):22240-22258. [Abstract]
- Hepatology. 2023 Nov 1;78(5):1384-1401. [Abstract]
- Nat Commun. 2026 Jun 19. [Abstract]
- Nat Commun. 2026 May 11. [Abstract]
- Nat Commun. 2026 Apr 1;17(1):4718. [Abstract]
- Nat Commun. 2026 Feb 9;17(1):2544. [Abstract]
- Nat Commun. 2025 Dec 10. [Abstract]
- Nat Commun. 2025 Dec 12;16(1):11092. [Abstract]
- Nat Commun. 2025 Nov 26;16(1):10555. [Abstract]
- Nat Commun. 2025 Sep 30;16(1):8642. [Abstract]
- Nat Commun. 2025 Sep 16;16(1):8289. [Abstract]
- Nat Commun. 2025 Aug 4;16(1):7156. [Abstract]
- Nat Commun. 2025 Aug 22;16(1):7854. [Abstract]
- Nat Commun. 2025 Jul 1;16(1):5610. [Abstract]
- Nat Commun. 2025 Jul 23;16(1):6769. [Abstract]
- Nat Commun. 2025 Jul 24;16(1):6777. [Abstract]
- Nat Commun. 2025 Jun 2;16(1):5101. [Abstract]
- Nat Commun. 2025 Jun 25;16(1):5387. [Abstract]
- Nat Commun. 2025 May 23;16(1):4794. [Abstract]
- Nat Commun. 2025 May 30;16(1):5006. [Abstract]
- Nat Commun. 2025 May 10;16(1):4365. [Abstract]
- Nat Commun. 2025 Apr 16;16(1):3623. [Abstract]
- Nat Commun. 2025 Feb 21;16(1):1865. [Abstract]
- Nat Commun. 2025 Feb 25;16(1):1952. [Abstract]
- Nat Commun. 2024 Nov 6;15(1):9578. [Abstract]
- Nat Commun. 2025 Jan 20;16(1):867. [Abstract]
- Nat Commun. 2024 Dec 5;15(1):10594. [Abstract]
- Nat Commun. 2024 Sep 28;15(1):8425. [Abstract]
- Nat Commun. 2024 Sep 3;15(1):7654. [Abstract]
- Nat Commun. 2024 Jun 25;15(1):5392. [Abstract]
- Nat Commun. 2024 Jun 5;15(1):4790. [Abstract]
- Nat Commun. 2024 Mar 16;15(1):2377. [Abstract]
- Nat Commun. 2024 Jan 2;15(1):9. [Abstract]
- Nat Commun. 2023 Oct 10;14(1):6332. [Abstract]
- Nat Commun. 2023 Sep 21;14(1):5891. [Abstract]
- Nat Commun. 2023 Jul 14;14(1):4217. [Abstract]
- Nat Commun. 2023 May 19;14(1):2859. [Abstract]
- Nat Commun. 2023 May 5;14(1):2602. [Abstract]
- Nat Commun. 2023 Mar 18;14(1):1521. [Abstract]
- Nat Commun. 2023 Jan 4;14(1):61. [Abstract]
- Nat Commun. 2022 Sep 2;13(1):5173. [Abstract]
- Nat Commun. 2022 Sep 23;13(1):5594. [Abstract]
- Nat Commun. 2022 Jun 28;13(1):3706. [Abstract]
- Nat Commun. 2022 May 31;13(1):3034. [Abstract]
- Nat Commun. 2022 Apr 8;13(1):1923. [Abstract]
- Nat Commun. 2021 Aug 24;12(1):5106. [Abstract]
- Nat Commun. 2021 Jul 20;12(1):4413. [Abstract]
- Nat Commun. 2021 Jun 3;12(1):3319. [Abstract]
- Nat Commun. 2019 Sep 19;10(1):4266. [Abstract]
- Cell Death Differ. 2026 Jun 13. [Abstract]
- Cell Death Differ. 2026 Jun 24. [Abstract]
- Cell Death Differ. 2026 Jun 23. [Abstract]
- Cell Death Differ. 2026 May 22. [Abstract]
- Cell Death Differ. 2026 May 25. [Abstract]
- Cell Death Differ. 2026 Mar 23. [Abstract]
- Cell Death Differ. 2026 Jan 28. [Abstract]
- Cell Death Differ. 2025 Nov 17. [Abstract]
- Cell Death Differ. 2025 Jul 30. [Abstract]
- Cell Death Differ. 2025 Jul 11. [Abstract]
- Cell Death Differ. 2025 May 20. [Abstract]
- Cell Death Differ. 2025 Apr 8. [Abstract]
- Cell Death Differ. 2025 Apr 28. [Abstract]
- Cell Death Differ. 2025 Apr 16. [Abstract]
- Cell Death Differ. 2025 Apr 11. [Abstract]
- Cell Death Differ. 2025 Mar;32(3):488-505. [Abstract]
- Cell Death Differ. 2025 Jan;32(1):149-161. [Abstract]
- Cell Death Differ. 2024 May 18. [Abstract]
- Cell Death Differ. 2024 Feb;31(2):203-216. [Abstract]
- Cell Death Differ. 2023 Nov;30(11):2382-2392. [Abstract]
- Cell Death Differ. 2023 Jul;30(7):1811-1828. [Abstract]
- Cell Death Differ. 2023 Jul;30(7):1829-1848. [Abstract]
- Cell Death Differ. 2023 Feb;30(2):527-543. [Abstract]
- Cell Death Differ. 2023 Feb;30(2):327-340. [Abstract]
- Cell Death Differ. 2023 Mar;30(3):673-686. [Abstract]
- Cell Death Differ. 2023 Jan;30(1):137-151. [Abstract]
- Cell Death Differ. 2022 Dec;29(12):2417-2428. [Abstract]
- Cell Death Differ. 2022 May;29(5):988-1003. [Abstract]
- Cell Death Differ. 2022 Mar;29(3):642-656. [Abstract]
- Cell Death Differ. 2021 Aug;28(8):2367-2384. [Abstract]
- Cell Death Differ. 2021 Jul;28(7):2221-2237. [Abstract]
- Cell Death Differ. 2021 Jan;28(1):337-348. [Abstract]
- Cell Death Differ. 2020 Nov;27(11):3177-3195. [Abstract]
- Cell Death Differ. 2020 Jul;27(7):2048-2065. [Abstract]
- Cell Death Differ. 2020 Jun;27(6):1795-1806. [Abstract]
- Cell Death Differ. 2019 Nov;26(11):2400-2415. [Abstract]
- Neuron. 2026 Mar 11:S0896-6273(26)00086-3. [Abstract]
- Neuron. 2025 Aug 22:S0896-6273(25)00556-2. [Abstract]
- Bone Res. 2025 Jun 12;13(1):62. [Abstract]
- Bone Res. 2025 Jan 30;13(1):20. [Abstract]
- Acta Pharm Sin B. 2026 Jul;16(7):4410-4425. [Abstract]
- Acta Pharm Sin B. 2026 Mar 2.
- Acta Pharm Sin B. 2026 Feb 10.
- Acta Pharm Sin B. 2025 Nov 1.
- Acta Pharm Sin B. 2025 Nov;15(11):5817-5831. [Abstract]
- Acta Pharm Sin B. 2025 Oct;15(10):5261-5276. [Abstract]
- Acta Pharm Sin B. 2025 Jul 25.
- Acta Pharm Sin B. 2025 Mar;15(3):1535-1551. [Abstract]
- Acta Pharm Sin B. 2024 Oct;14(10):4312-4328. [Abstract]
- Acta Pharm Sin B. 2024 Mar;14(3):1222-1240. [Abstract]
- Acta Pharm Sin B. 2023 Feb;13(2):559-576. [Abstract]
- Acta Pharm Sin B. 2022 Mar;12(3):1225-1239. [Abstract]
- Acta Pharm Sin B. 2022 Mar;12(3):1339-1350. [Abstract]
- Acta Pharm Sin B. 2021 Nov;11(11):3567-3584. [Abstract]
- Acta Pharm Sin B. 2021 Oct;11(10):3178-3192. [Abstract]
- Acta Pharm Sin B. 2021 Jan;11(1):71-88. [Abstract]
- J Extracell Vesicles. 2025 Dec;14(12):e70182. [Abstract]
- J Extracell Vesicles. 2024 Jul;13(7):e12468. [Abstract]
- Autophagy. 2026 Jul;22(7):1639-1656. [Abstract]
- Autophagy. 2026 Jul;22(7):1679-1697. [Abstract]
- Autophagy. 2026 Jun 14:1-16. [Abstract]
- Autophagy. 2026 May 7:1-17. [Abstract]
- Autophagy. 2026 Mar 13:1-23. [Abstract]
- Autophagy. 2026 Apr;22(4):763-778. [Abstract]
- Autophagy. 2026 Feb 15:1-19. [Abstract]
- Autophagy. 2025 Nov 30:1-21. [Abstract]
- Autophagy. 2025 Oct 25. [Abstract]
- Autophagy. 2025 Sep 8:1-20. [Abstract]
- Autophagy. 2025 Jun 3:1-17. [Abstract]
- Autophagy. 2025 Jun 3:1-19. [Abstract]
- Autophagy. 2025 May 19:1-18. [Abstract]
- Autophagy. 2025 Apr 13. [Abstract]
- Autophagy. 2025 Aug;21(8):1644-1661. [Abstract]
- Autophagy. 2025 Jul;21(7):1473-1491. [Abstract]
- Autophagy. 2025 Mar 20. [Abstract]
- Autophagy. 2025 Jun;21(6):1228-1244. [Abstract]
- Autophagy. 2025 Apr;21(4):807-826. [Abstract]
- Autophagy. 2025 Mar;21(3):530-547. [Abstract]
- Autophagy. 2025 Feb;21(2):352-373. [Abstract]
- Autophagy. 2025 Jan;21(1):178-190. [Abstract]
- Autophagy. 2024 Oct;20(10):2221-2237. [Abstract]
- Autophagy. 2024 Aug;20(8):1762-1779. [Abstract]
- Autophagy. 2024 Apr;20(4):735-751. [Abstract]
- Autophagy. 2023 Oct;19(10):2702-2718. [Abstract]
- Autophagy. 2023 Jun;19(6):1745-1763. [Abstract]
- Autophagy. 2023 Feb;19(2):551-569. [Abstract]
- Autophagy. 2021 Jul;17(7):1684-1699. [Abstract]
- Adv Sci (Weinh). 2026 Jun 15:e76077. [Abstract]
- Adv Sci (Weinh). 2026 Jun 18:e76122. [Abstract]
- Adv Sci (Weinh). 2026 May 4:e75527. [Abstract]
- Adv Sci (Weinh). 2026 May 8:e75449. [Abstract]
- Adv Sci (Weinh). 2026 May 26:e23660. [Abstract]
- Adv Sci (Weinh). 2026 Mar 4:e21921. [Abstract]
- Adv Sci (Weinh). 2026 Mar 24:e15970. [Abstract]
- Adv Sci (Weinh). 2026 Apr;13(20):e16488. [Abstract]
- Adv Sci (Weinh). 2026 Feb 28:e21818. [Abstract]
- Adv Sci (Weinh). 2026 Apr;13(24):e20627. [Abstract]
- Adv Sci (Weinh). 2026 Apr;13(20):e15159. [Abstract]
- Adv Sci (Weinh). 2026 May;13(25):e19248. [Abstract]
- Adv Sci (Weinh). 2026 Mar;13(16):e13310. [Abstract]
- Adv Sci (Weinh). 2026 Apr;13(23):e15651. [Abstract]
- Adv Sci (Weinh). 2026 Jan 20:e16355. [Abstract]
- Adv Sci (Weinh). 2026 Jan 28:e19642. [Abstract]
- Adv Sci (Weinh). 2025 Nov 30:e14349. [Abstract]
- Adv Sci (Weinh). 2025 Nov 7:e18323. [Abstract]
- Adv Sci (Weinh). 2025 Nov 7:e11947. [Abstract]
- Adv Sci (Weinh). 2025 Oct 27:e10854. [Abstract]
- Adv Sci (Weinh). 2025 Oct 22:e07602. [Abstract]
- Adv Sci (Weinh). 2025 Oct 14:e10662. [Abstract]
- Adv Sci (Weinh). 2025 Oct 13:e08918. [Abstract]
- Adv Sci (Weinh). 2025 Sep 4:e06253. [Abstract]
- Adv Sci (Weinh). 2025 Sep 29:e12281. [Abstract]
- Adv Sci (Weinh). 2025 Sep 18:e01211. [Abstract]
- Adv Sci (Weinh). 2025 Sep 15:e06294. [Abstract]
- Adv Sci (Weinh). 2025 Sep 3:e05270. [Abstract]
- Adv Sci (Weinh). 2025 Aug 11:e11081. [Abstract]
- Adv Sci (Weinh). 2025 Aug 4:e03972. [Abstract]
- Adv Sci (Weinh). 2025 Aug 4:e04680. [Abstract]
- Adv Sci (Weinh). 2025 Aug 19:e04378. [Abstract]
- Adv Sci (Weinh). 2025 Jul 28:e17795. [Abstract]
- Adv Sci (Weinh). 2025 Jul 25:e15313. [Abstract]
- Adv Sci (Weinh). 2025 Jul 26:e08515. [Abstract]
- Adv Sci (Weinh). 2025 Jul 11:e00971. [Abstract]
- Adv Sci (Weinh). 2025 Jul 11:e05479. [Abstract]
- Adv Sci (Weinh). 2025 Jul 15:e03486. [Abstract]
- Adv Sci (Weinh). 2025 Jun 5:e06529. [Abstract]
- Adv Sci (Weinh). 2025 Jun 23:e03322. [Abstract]
- Adv Sci (Weinh). 2025 Jun 29:e09533. [Abstract]
- Adv Sci (Weinh). 2025 May 23:e04372. [Abstract]
- Adv Sci (Weinh). 2025 May 30:e14902. [Abstract]
- Adv Sci (Weinh). 2025 May 31:e14956. [Abstract]
- Adv Sci (Weinh). 2025 May 14:e2416419. [Abstract]
- Adv Sci (Weinh). 2025 May 20:e17128. [Abstract]
- Adv Sci (Weinh). 2025 Apr 24:e2501934. [Abstract]
- Adv Sci (Weinh). 2025 May;12(18):e2408724. [Abstract]
- Adv Sci (Weinh). 2025 Apr;12(14):e2412985. [Abstract]
- Adv Sci (Weinh). 2025 Mar 24:e2411980. [Abstract]
- Adv Sci (Weinh). 2025 Jan 31:e2413333. [Abstract]
- Adv Sci (Weinh). 2025 Feb 8:e2415229. [Abstract]
- Adv Sci (Weinh). 2024 Dec 25:e2409416. [Abstract]
- Adv Sci (Weinh). 2025 Jan 9:e2411675. [Abstract]
- Adv Sci (Weinh). 2025 Jan 21:e2413990. [Abstract]
- Adv Sci (Weinh). 2025 Jan 21:e2407942. [Abstract]
- Adv Sci (Weinh). 2024 Nov 11:e2405083. [Abstract]
- Adv Sci (Weinh). 2024 Dec 31:e2411943. [Abstract]
- Adv Sci (Weinh). 2024 Nov 5:e2410285. [Abstract]
- Adv Sci (Weinh). 2024 Dec 25:e2406700. [Abstract]
- Adv Sci (Weinh). 2024 Dec 25:e2413122. [Abstract]
- Adv Sci (Weinh). 2025 Jan 21:e2408753. [Abstract]
- Adv Sci (Weinh). 2024 Dec 16:e2411479. [Abstract]
- Adv Sci (Weinh). 2024 Dec 24:e2413514. [Abstract]
- Adv Sci (Weinh). 2024 Dec 18:e2414100. [Abstract]
- Adv Sci (Weinh). 2024 Oct 23:e2405153. [Abstract]
- Adv Sci (Weinh). 2024 Sep 19:e2403442. [Abstract]
- Adv Sci (Weinh). 2024 Sep 18:e2407132. [Abstract]
- Adv Sci (Weinh). 2024 Aug 9:e2402329. [Abstract]
- Adv Sci (Weinh). 2024 Aug 8:e2406633. [Abstract]
- Adv Sci (Weinh). 2023 Dec;10(36):e2303484. [Abstract]
- Adv Sci (Weinh). 2024 Jun;11(21):e2306486. [Abstract]
- Adv Sci (Weinh). 2024 Mar;11(11):e2305260. [Abstract]
- Adv Sci (Weinh). 2024 Feb;11(5):e2305374. [Abstract]
- Adv Sci (Weinh). 2024 Feb;11(7):e2305620. [Abstract]
- Adv Sci (Weinh). 2024 Jan;11(3):e2306535. [Abstract]
- Adv Sci (Weinh). 2023 Nov;10(33):e2302953. [Abstract]
- Adv Sci (Weinh). 2023 Dec;10(35):e2300698. [Abstract]
- Adv Sci (Weinh). 2023 Oct;10(28):e2302130. [Abstract]
- Adv Sci (Weinh). 2023 Sep;10(25):e2207549. [Abstract]
- Adv Sci (Weinh). 2023 Apr;10(11):e2206792. [Abstract]
- Adv Sci (Weinh). 2023 Feb;10(4):e2204018. [Abstract]
- Adv Sci (Weinh). 2020 Aug 5;7(19):2001041. [Abstract]
- Adv Sci (Weinh). 2019 Mar 25;6(10):1801862. [Abstract]
- Nat Chem Biol. 2023 Dec;19(12):1513-1523. [Abstract]
- Nat Chem Biol. 2022 Nov;18(11):1214-1223. [Abstract]
- J Clin Invest. 2026 Jan 2;136(1):e192599. [Abstract]
- Nat Plants. 2025 Sep 12. [Abstract]
- J Clin Invest. 2025 Feb 18;135(8):e186648. [Abstract]
- J Clin Invest. 2025 Feb 25;135(8):e179617. [Abstract]
- J Clin Invest. 2025 Feb 11:e175972. [Abstract]
- Nat Plants. 2023 Feb;9(2):228-237. [Abstract]
- J Clin Invest. 2022 Mar 1;132(5):e152170. [Abstract]
- Nat Plants. 2021 Feb;7(2):209-218. [Abstract]
- Exp Hematol Oncol. 2023 Dec 16;12(1):105. [Abstract]
- Leukemia. 2025 Sep;39(9):2181-2195. [Abstract]
- Neuro Oncol. 2023 Oct 3;25(10):1788-1801. [Abstract]
- Neuro Oncol. 2023 Jan 5;25(1):82-96. [Abstract]
- Theranostics. 2024 Jul 22;14(11):4481-4498. [Abstract]
- Theranostics. 2024 Jul 1;14(10):3984-3996. [Abstract]
- Theranostics. 2023 Sep 4;13(14):4919-4935. [Abstract]
- Theranostics. 2022 Jan 24;12(4):1904-1920. [Abstract]
- Theranostics. 2021 Jun 11;11(16):7640-7657. [Abstract]
- Theranostics. 2021 Mar 11;11(11):5279-5295. [Abstract]
- Theranostics. 2021 Mar 4;11(10):4616-4636. [Abstract]
- Theranostics. 2021 Jan 1;11(2):841-860. [Abstract]
- Theranostics. 2021 Jan 1;11(3):1473-1492. [Abstract]
- Theranostics. 2021 Jan 1;11(2):861-877. [Abstract]
- Theranostics. 2020 Aug 13;10(24):11110-11126. [Abstract]
- Theranostics. 2020 May 16;10(14):6483-6499. [Abstract]
- Theranostics. 2020 Jul 9;10(19):8573-8590. [Abstract]
- Theranostics. 2019 Aug 14;9(21):6334-6353. [Abstract]
- Theranostics. 2019 Aug 12;9(20):5769-5783. [Abstract]
- Theranostics. 2019 Apr 13;9(9):2424-2438. [Abstract]
- Chem Eng J. 2025 May 1.
- Chem Eng J. 2023 Nov 1, 475, 146449.
- Nucleic Acids Res. 2024 Feb 9;52(3):1156-1172. [Abstract]
- Nucleic Acids Res. 2018 Apr 20;46(7):3284-3297. [Abstract]
- J Adv Res. 2026 Jul 1:S2090-1232(26)00516-3. [Abstract]
- J Adv Res. 2026 May 3:S2090-1232(26)00381-4. [Abstract]
- J Adv Res. 2026 Apr 6:S2090-1232(26)00296-1. [Abstract]
- J Adv Res. 2026 Jan 2:S2090-1232(26)00003-2. [Abstract]
- J Adv Res. 2025 Dec 27:S2090-1232(25)01027-6. [Abstract]
- J Adv Res. 2024 Nov 5:S2090-1232(24)00496-X. [Abstract]
- J Adv Res. 2025 Jan 2:S2090-1232(24)00623-4. [Abstract]
- J Adv Res. 2025 Jan:67:217-229. [Abstract]
- J Adv Res. 2024 Aug:62:143-154. [Abstract]
- J Adv Res. 2024 Jan:55:45-60. [Abstract]
- Biomaterials. 2026 Jul:330:124045. [Abstract]
- Biomaterials. 2025 May 7:322:123387. [Abstract]
- Exp Mol Med. 2023 Jan;55(1):183-195. [Abstract]
- Exp Mol Med. 2022 Sep;54(9):1549-1562. [Abstract]
- J Exp Clin Cancer Res. 2026 Jun 6. [Abstract]
- J Exp Clin Cancer Res. 2025 Dec 29;44(1):329. [Abstract]
- J Exp Clin Cancer Res. 2025 Oct 8;44(1):285. [Abstract]
- J Exp Clin Cancer Res. 2025 Aug 9;44(1):232. [Abstract]
- J Exp Clin Cancer Res. 2025 Aug 19;44(1):245. [Abstract]
- J Exp Clin Cancer Res. 2024 Jul 27;43(1):208. [Abstract]
- J Exp Clin Cancer Res. 2024 Jun 20;43(1):173. [Abstract]
- Protein Cell. 2024 May 9:pwae023. [Abstract]
- J Exp Clin Cancer Res. 2024 May 14;43(1):143. [Abstract]
- J Exp Clin Cancer Res. 2024 Jan 2;43(1):7. [Abstract]
- J Exp Clin Cancer Res. 2024 Feb 2;43(1):39. [Abstract]
- J Exp Clin Cancer Res. 2023 Oct 7;42(1):261. [Abstract]
- J Exp Clin Cancer Res. 2023 Aug 24;42(1):219. [Abstract]
- J Exp Clin Cancer Res. 2022 Dec 29;41(1):364. [Abstract]
- Protein Cell. 2023 Mar 16;14(2):123-136. [Abstract]
- J Exp Clin Cancer Res. 2022 Mar 28;41(1):111. [Abstract]
- J Exp Clin Cancer Res. 2022 Jan 24;41(1):33. [Abstract]
- J Exp Clin Cancer Res. 2021 May 7;40(1):158. [Abstract]
- J Exp Clin Cancer Res. 2021 Apr 8;40(1):122. [Abstract]
- J Exp Clin Cancer Res. 2020 Sep 16;39(1):190. [Abstract]
- Protein Cell. 2021 Feb;12(2):107-127. [Abstract]
- J Exp Clin Cancer Res. 2019 Feb 26;38(1):101. [Abstract]
- J Exp Clin Cancer Res. 2018 Nov 27;37(1):287. [Abstract]
- J Exp Clin Cancer Res. 2018 Oct 3;37(1):240. [Abstract]
- J Exp Clin Cancer Res. 2018 Aug 15;37(1):193. [Abstract]
- Sci Adv. 2026 Feb 20;12(8):eadz2439. [Abstract]
- Cell Discov. 2026 Feb 24;12(1):13. [Abstract]
- Sci Adv. 2025 Nov 28;11(48):eadz1243. [Abstract]
- Sci Adv. 2025 Oct 10;11(41):eadw7989. [Abstract]
- Sci Adv. 2025 Sep 12;11(37):eadx4511. [Abstract]
- Sci Adv. 2025 Sep 5;11(36):eady1949. [Abstract]
- Sci Adv. 2025 Jun 13;11(24):eadt2842. [Abstract]
- Sci Adv. Sci Adv. 2025 Apr 25;11(17):eadu0847. [Abstract]
- Sci Adv. 2025 Mar 21;11(12):eadq9111. [Abstract]
- Cell Discov. 2024 Sep 17;10(1):96. [Abstract]
- Cell Discov. 2023 Jul 25;9(1):76. [Abstract]
- Cell Discov. 2023 Mar 7;9(1):26. [Abstract]
- Sci Adv. 2022 Aug 26;8(34):eabq4722. [Abstract]
- Sci Adv. 2021 Jan 1;7(1):eabe1340. [Abstract]
- Int J Oral Sci. 2026 Jan 16;18(1):10. [Abstract]
- J Biomed Sci. 2021 Jul 23;28(1):55. [Abstract]
- Mol Ther. 2025 Aug 5:S1525-0016(25)00628-8. [Abstract]
- Mol Ther. 2025 Mar 5;33(3):1073-1090. [Abstract]
- Redox Biol. 2026 Jun 21:95:104271. [Abstract]
- Metabolism. 2026 May 20:182:156651. [Abstract]
- Redox Biol. 2026 May:92:104114. [Abstract]
- Metabolism. 2026 May:178:156553. [Abstract]
- Redox Biol. 2026 May:92:104086. [Abstract]
- Redox Biol. 2026 May:92:104102. [Abstract]
- Redox Biol. 2026 Mar:90:104058. [Abstract]
- Redox Biol. 2026 Mar:90:104039. [Abstract]
- Redox Biol. 2026 Mar:90:104043. [Abstract]
- Redox Biol. 2025 Dec:88:103949. [Abstract]
- Redox Biol. 2025 Sep:85:103751. [Abstract]
- Redox Biol. 2025 Jun 21:85:103737. [Abstract]
- Metabolism. 2025 Apr 23:169:156271. [Abstract]
- Redox Biol. 2025 Apr:81:103557. [Abstract]
- Redox Biol. 2024 Dec 5:79:103460. [Abstract]
- Redox Biol. 2024 Nov:77:103397. [Abstract]
- Redox Biol. 2024 Nov:77:103388. [Abstract]
- Redox Biol. 2024 Aug 26:76:103328. [Abstract]
- Redox Biol. 2024 May:71:103100. [Abstract]
- Metabolism. 2024 Mar:152:155769. [Abstract]
- Redox Biol. 2023 Nov:67:102931. [Abstract]
- Redox Biol. 2023 Nov:67:102896. [Abstract]
- Redox Biol. 2023 Jun:62:102705. [Abstract]
- Redox Biol. 2023 Jun:62:102682. [Abstract]
- Redox Biol. 2022 Oct:56:102437. [Abstract]
- Redox Biol. 2022 Oct;56:102435. [Abstract]
- Redox Biol. 2020 Nov 1;38:101771. [Abstract]
- Redox Biol. 2020 Jul;34:101559. [Abstract]
- Plant Cell. 2025 Oct 24:koaf258. [Abstract]
- Blood Cancer J. 2024 Nov 26;14(1):207. [Abstract]
- Plant Cell. 2024 May 29;36(6):2103-2116. [Abstract]
- J Control Release. 2026 Jul 10:395:114937. [Abstract]
- J Control Release. 2026 May 10:393:114828. [Abstract]
- J Control Release. 2025 Dec 30:114591. [Abstract]
- Biomark Res. 2025 Apr 7;13(1):57. [Abstract]
- Biomark Res. 2025 Jan 23;13(1):17. [Abstract]
- J Hazard Mater. 2026 Mar 1:505:141552. [Abstract]
- J Hazard Mater. 2025 Jun 6:495:138854. [Abstract]
- J Hazard Mater. 2024 Jun 18:476:134969. [Abstract]
- J Hazard Mater. 2024 May 8:473:134560. [Abstract]
- J Hazard Mater. 2024 May 15:470:134142. [Abstract]
- J Hazard Mater. 2024 Mar 5:465:133038. [Abstract]
- J Hazard Mater. 2023 Sep 5:457:131750. [Abstract]
- J Hazard Mater. 2022 Feb 15;424(Pt A):127268. [Abstract]
- Gut Microbes. 2026 Dec 31;18(1):2612620. [Abstract]
- Gut Microbes. 2024 Jan-Dec;16(1):2348441. [Abstract]
- EBioMedicine. 2025 Aug 15:119:105879. [Abstract]
- EBioMedicine. 2023 Feb:88:104444. [Abstract]
- EBioMedicine. 2022 Aug:82:104181. [Abstract]
- EBioMedicine. 2018 Aug:34:243-255. [Abstract]
- MedComm (2020). 2026 Mar 4;7(3):e70662. [Abstract]
- MedComm (2020). 2025 Nov 23;6(12):e70488. [Abstract]
- MedComm (2020). 2025 Aug 29;6(9):e70345. [Abstract]
- Research (Wash D C). 2025 May 23:8:0708. [Abstract]
- Research (Wash D C). 2025 Apr 3:8:0649. [Abstract]
- MedComm (2020). 2025 Feb 18;6(3):e70107. [Abstract]
- Research (Wash D C). 2024 Oct 24:7:0511. [Abstract]
- MedComm (2020). 2024 Aug 12;5(8):e684. [Abstract]
- MedComm (2020). 2024 Jun 27;5(7):e611. [Abstract]
- MedComm. 2024 Apr 13;5(4):e537. [Abstract]
- Cell Rep Med. 2026 May 19;7(5):102763. [Abstract]
- Cell Rep Med. 2026 Apr 21;7(4):102724. [Abstract]
- J Immunother Cancer. 2025 Nov 28;13(11):e011976. [Abstract]
- Cell Rep Med. 2025 Oct 27:102424. [Abstract]
- Cell Rep Med. 2025 Jul 15;6(7):102208. [Abstract]
- Cell Rep Med. 2025 Jan 27:101928. [Abstract]
- Cell Rep Med. 2024 Feb 20;5(2):101357. [Abstract]
- J Immunother Cancer. 2022 Dec;10(12):e005668. [Abstract]
- Plant Biotechnol J. 2025 Dec 17. [Abstract]
- Pharmacol Res. 2025 Dec 31:108081. [Abstract]
- Pharmacol Res. 2025 Dec:222:108027. [Abstract]
- Plant Biotechnol J. 2025 Aug;23(8):3363-3381. [Abstract]
- Pharmacol Res. 2025 Apr 16:107739. [Abstract]
- Pharmacol Res. 2024 Nov:209:107471. [Abstract]
- Pharmacol Res. 2023 Dec:198:106995. [Abstract]
- Pharmacol Res. 2023 Nov:197:106964. [Abstract]
- Pharmacol Res. 2023 Mar:189:106704. [Abstract]
- Pharmacol Res. 2023 Jan:187:106613. [Abstract]
- Pharmacol Res. 2022 Jun;180:106244. [Abstract]
- Pharmacol Res. 2022 May 13;181:106259. [Abstract]
- Pharmacol Res. 2022 Feb:176:106059. [Abstract]
- Pharmacol Res. 2020 Jul;157:104845. [Abstract]
- ACS Cent Sci. 2024 Apr 23;10(5):1065-1083. [Abstract]
- ACS Cent Sci. 2022 Feb 23;8(2):192-204. [Abstract]
- Cell Mol Biol Lett. 2025 Oct 2;30(1):109. [Abstract]
- Clin Cancer Res. 2025 Jul 8. [Abstract]
- Cell Mol Biol Lett. 2025 May 31;30(1):65. [Abstract]
- Cell Mol Biol Lett. 2025 May 14;30(1):59. [Abstract]
- Mater Today Bio. 2025 Feb 14:31:101569. [Abstract]
- Mater Today Bio. 2025 Feb 27:31:101606. [Abstract]
- Cell Mol Biol Lett. 2021 Nov 10;26(1):45. [Abstract]
- Diabetologia. 2020 Apr;63(4):811-824. [Abstract]
- Cancer Lett. 2026 Sep 1:655:218557. [Abstract]
- Mol Biomed. 2026 Apr 8;7(1):47. [Abstract]
- Cancer Lett. 2026 May 1:645:218395. [Abstract]
- Cancer Lett. 2026 May 1:645:218337. [Abstract]
- Cancer Lett. 2026 Apr 1:642:218277. [Abstract]
- Mol Biomed. 2025 Nov 17;6(1):112. [Abstract]
- Mol Biomed. 2025 Nov 27;6(1):122. [Abstract]
- Cancer Lett. 2026 Jan 28:638:218156. [Abstract]
- J Neuroinflammation. 2025 Oct 31;22(1):253. [Abstract]
- Mol Biomed. 2025 Nov 24;6(1):116. [Abstract]
- Cancer Lett. 2025 Oct 2:218073. [Abstract]
- Cancer Lett. 2025 Apr 16:217726. [Abstract]
- Nat Struct Mol Biol. 2025 May;32(5):853-863. [Abstract]
- Int J Surg. 2025 Feb 1;111(2):1801-1813. [Abstract]
- Cancer Lett. 2024 Jun 28:217092. [Abstract]
- Cancer Lett. 2024 Aug 1:596:217004. [Abstract]
- Cancer Lett. 2024 Jun 14:597:217005. [Abstract]
- Cancer Lett. 2024 May 1:589:216832. [Abstract]
- Nat Struct Mol Biol. 2024 May 20. [Abstract]
- Cancer Lett. 2024 May 28:590:216844. [Abstract]
- Cancer Lett. 2024 May 1:589:216811. [Abstract]
- Cancer Lett. 2024 Apr 10:587:216732. [Abstract]
- Cancer Lett. 2024 Apr 10:587:216703. [Abstract]
- Cancer Lett. 2024 Apr 10:587:216733. [Abstract]
- Cancer Lett. 2023 Nov 28:577:216439. [Abstract]
- Cancer Lett. 2023 Aug 1:568:216288. [Abstract]
- Nat Struct Mol Biol. 2023 Jun;30(6):785-799. [Abstract]
- Cancer Lett. 2023 May 28:562:216158. [Abstract]
- Cancer Lett. 2022 Nov 28:549:215911. [Abstract]
- Cancer Lett. 2022 Oct 28:547:215862. [Abstract]
- Cancer Lett. 2022 Nov 28:549:215837. [Abstract]
- Cancer Lett. 2022 Apr 28:532:215586. [Abstract]
- Cancer Lett. 2022 Apr 28:532:215588. [Abstract]
- Cancer Lett. 2021 Oct 10:518:266-277. [Abstract]
- Cancer Lett. 2021 Oct 28:519:237-249. [Abstract]
- Cancer Lett. 2021 Aug 10:513:75-89. [Abstract]
- Cancer Lett. 2020 Mar 31;473:130-138. [Abstract]
- Cancer Lett. 2017 Dec 1:410:112-123. [Abstract]
- Int J Biol Sci. 2026 May 18;22(10):5385-5398. [Abstract]
- Int J Biol Sci. 2026 Apr 23;22(9):4724-4746. [Abstract]
- Int J Biol Sci. 2025 Jun 9;21(9):3852-3866. [Abstract]
- Int J Biol Sci. 2023 Oct 24;19(16):5319-5336. [Abstract]
- Int J Biol Sci. 2024 Jan 12;20(3):953-967. [Abstract]
- Int J Biol Sci. 2023 Jun 26;19(11):3324-3340. [Abstract]
- Int J Biol Sci. 2023 May 8;19(8):2531-2550. [Abstract]
- Int J Biol Sci. 2023 Feb 27;19(5):1471-1489. [Abstract]
- Int J Biol Sci. 2022 Aug 29;18(14):5459-5474. [Abstract]
- Int J Biol Sci. 2022 Jul 18;18(13):4824-4836. [Abstract]
- Int J Biol Sci. 2022 Jun 27;18(10):4245-4259. [Abstract]
- Int J Biol Sci. 2022 Jun 21;18(10):4135-4150. [Abstract]
- Int J Biol Sci. 2022 Jun 6;18(9):3888-3907. [Abstract]
- Int J Biol Sci. 2022 May 1;18(8):3122-3136. [Abstract]
- Int J Biol Sci. 2022 May 16;18(8):3544-3561. [Abstract]
- Int J Biol Sci. 2022 Apr 11;18(7):2932-2948. [Abstract]
- Int J Biol Sci. 2021 Jul 13;17(12):3013-3023. [Abstract]
- Environ Int. 2026 Apr:210:110254. [Abstract]
- Cell Death Dis. 2026 Jun 25. [Abstract]
- Cell Death Dis. 2026 Jun 1. [Abstract]
- Cell Death Dis. 2026 Jun 3. [Abstract]
- Cell Death Dis. 2026 Jun 13. [Abstract]
- Cell Death Dis. 2026 Jun 3. [Abstract]
- Cell Death Dis. 2026 May 19;17(1):635. [Abstract]
- Cell Death Dis. 2026 Apr 24;17(1):541. [Abstract]
- Biomater Res. 2026 Apr 29.
- Cell Death Dis. 2026 Apr 10;17(1):465. [Abstract]
- Cell Death Dis. 2026 Mar 2;17(1):288. [Abstract]
- Cell Death Dis. 2026 Feb 14;17(1):225. [Abstract]
- Cell Death Dis. 2026 Feb 23;17(1):247. [Abstract]
- Cell Death Dis. 2026 Feb 19;17(1):233. [Abstract]
- Cell Death Dis. 2026 Jan 9;17(1):17. [Abstract]
- Cell Death Dis. 2026 Jan 24;17(1):165. [Abstract]
- Cell Death Dis. 2025 Dec 23. [Abstract]
- Burns Trauma. 2025.
- Cell Death Dis. 2025 Dec 10;16(1):889. [Abstract]
- Cell Death Dis. 2025 Nov 17;16(1):843. [Abstract]
- Cell Death Dis. 2025 Nov 24;16(1):856. [Abstract]
- Cell Death Dis. 2025 Oct 7;16(1):715. [Abstract]
- Cell Death Dis. 2025 Oct 27;16(1):763. [Abstract]
- Cell Death Dis. 2025 Oct 21;16(1):743. [Abstract]
- Cell Death Dis. 2025 Sep 1;16(1):589. [Abstract]
- Cell Death Dis. 2025 Aug 28;16(1):655. [Abstract]
- Cell Death Dis. 2025 Aug 28;16(1):654. [Abstract]
- Cell Death Dis. 2025 Aug 29;16(1):657. [Abstract]
- Cell Death Dis. 2025 Jul 23;16(1):551. [Abstract]
- Cell Death Dis. 2025 Jul 2;16(1):485. [Abstract]
- Cell Death Dis. 2025 May 2;16(1):356. [Abstract]
- Adv Healthc Mater. 2025 May 16:e2500941. [Abstract]
- Cell Death Dis. 2025 May 28;16(1):422. [Abstract]
- Cell Death Dis. 2025 May 22;16(1):409. [Abstract]
- Cell Death Dis. 2025 Mar 31;16(1):228. [Abstract]
- Cell Death Dis. 2025 Apr 15;16(1):301. [Abstract]
- Cell Death Dis. 2025 Apr 13;16(1):287. [Abstract]
- Cell Death Dis. 2025 Apr 9;16(1):266. [Abstract]
- Cell Death Dis. 2025 Apr 6;16(1):257. [Abstract]
- Cell Death Dis. 2025 Mar 6;16(1):160. [Abstract]
- Cell Death Dis. 2025 Mar 12;16(1):170. [Abstract]
- Cell Death Dis. 2025 Feb 28;16(1):144. [Abstract]
- Cell Death Dis. 2025 Feb 6;16(1):71. [Abstract]
- Cell Death Dis. 2025 Feb 3;16(1):64. [Abstract]
- Cell Death Dis. 2025 Jan 14;16(1):17. [Abstract]
- Cell Death Dis. 2024 Nov 1;15(11):786. [Abstract]
- Cell Death Dis. 2024 Nov 14;15(11):825. [Abstract]
- Cell Death Dis. 2024 Dec 1;15(12):873. [Abstract]
- Cell Death Dis. 2024 Oct 18;15(10):758. [Abstract]
- Cell Death Dis. 2024 Sep 8;15(9):658. [Abstract]
- Cell Death Dis. 2024 Sep 11;15(9):665. [Abstract]
- Cell Death Dis. 2024 Jul 31;15(7):545. [Abstract]
- Cell Death Dis. 2024 Jul 20;15(7):519. [Abstract]
- Cell Death Dis. 2024 Jun 17;15(6):422. [Abstract]
- Cell Death Dis. 2024 Apr 26;15(4):297. [Abstract]
- Cell Death Dis. 2024 May 20;15(5):347. [Abstract]
- Cell Death Dis. 2023 Nov 29;14(11):782. [Abstract]
- Cell Death Dis. 2023 Nov 25;14(11):765. [Abstract]
- Cell Death Dis. 2023 Sep 13;14(9):604. [Abstract]
- Cell Death Dis. 2023 Sep 19;14(9):614. [Abstract]
- Cell Death Dis. 2023 Aug 3;14(8):494. [Abstract]
- Cell Death Dis. 2023 Aug 25;14(8):558. [Abstract]
- Cell Death Dis. 2023 Jun 14;14(6):361. [Abstract]
- Cell Death Dis. 2023 Jun 13;14(6):360. [Abstract]
- Cell Death Dis. 2023 Mar 4;14(3):178. [Abstract]
- Cell Death Dis. 2023 Mar 11;14(3):193. [Abstract]
- Cell Death Dis. 2023 Mar 25;14(3):211. [Abstract]
- Cell Death Dis. 2023 Feb 10;14(2):100. [Abstract]
- Cell Death Dis. 2023 Jan 5;14(1):6. [Abstract]
- Cell Death Dis. 2023 Jan 3;14(1):2. [Abstract]
- Cell Death Dis. 2022 Dec 12;13(12):1034. [Abstract]
- Cell Death Dis. 2022 Dec 5;13(12):1021. [Abstract]
- Cell Death Dis. 2022 Nov 28;13(11):1007. [Abstract]
- Cell Death Dis. 2022 Dec 27;13(12):1075. [Abstract]
- Cell Death Dis. 2022 Sep 26;13(9):824. [Abstract]
- Cell Death Dis. 2022 Sep 20;13(9):805. [Abstract]
- Cell Death Dis. 2022 Aug 29;13(8):742. [Abstract]
- Cell Death Dis. 2022 Aug 25;13(8):734. [Abstract]
- Cell Death Dis. 2022 Jul 13;13(7):606. [Abstract]
- Cell Death Dis. 2022 Apr 25;13(4):403. [Abstract]
- Cell Death Dis. 2022 Apr 9;13(4):326. [Abstract]
- Cell Death Dis. 2022 May 12;13(5):451. [Abstract]
- Cell Death Dis. 2022 May 17;13(5):465. [Abstract]
- Cell Death Dis. 2022 May 3;13(5):427. [Abstract]
- Cell Death Dis. 2022 Apr 22;13(4):396. [Abstract]
- Cell Death Dis. 2022 Apr 2;13(4):294. [Abstract]
- Cell Death Dis. 2022 Jan 13;13(1):55. [Abstract]
- Cell Death Dis. 2022 Jan 10;13(1):42. [Abstract]
- Cell Death Dis. 2021 Oct 1;12(10):899. [Abstract]
- Cell Death Dis. 2021 Sep 25;12(10):876. [Abstract]
- Cell Death Dis. 2021 Sep 25;12(10):878. [Abstract]
- Cell Death Dis. 2021 Oct 20;12(11):968. [Abstract]
- Cell Death Dis. 2021 Jun 23;12(7):642. [Abstract]
- Cell Death Dis. 2021 May 25;12(6):534. [Abstract]
- Cell Death Dis. 2021 Apr 12;12(4):388. [Abstract]
- Cell Death Dis. 2021 Jan 12;12(1):77. [Abstract]
- Cell Death Dis. 2021 Jan 7;12(1):42. [Abstract]
- Cell Death Dis. 2020 Nov 26;11(11):1014. [Abstract]
- Cell Death Dis. 2020 Oct 13;11(10):852. [Abstract]
- Cell Death Dis. 2019 Aug 8;10(8):599. [Abstract]
- Cell Death Dis. 2018 May 22;9(6):604. [Abstract]
- Sci China Life Sci. 2025 Aug;68(8):2348-2362. [Abstract]
- Sci China Life Sci. 2024 Nov;67(11):2411-2425. [Abstract]
- Genes Dis. 2026 Mar 17.
- Genes Dis. 2024 Jul 24;12(3):101382. [Abstract]
- Gene Dis. 2019 May 25;7(3):401-407. [Abstract]
- J Integr Plant Biol. 2025 Aug 19. [Abstract]
- Proc Natl Acad Sci U S A. 2026 May 26;123(21):e2528760123. [Abstract]
- J Cachexia Sarcopenia Muscle. 2025 Aug;16(4):e70044. [Abstract]
- Proc Natl Acad Sci U S A. 2025 May 20;122(20):e2425812122. [Abstract]
- Proc Natl Acad Sci U S A. 2025 Jan 28;122(4):e2404445122. [Abstract]
- Proc Natl Acad Sci U S A. 2023 Dec 5;120(49):e2314392120. [Abstract]
- Proc Natl Acad Sci U S A. 2023 Apr 11;120(15):e2209435120. [Abstract]
- Proc Natl Acad Sci U S A. 2023 Jan 31;120(5):e2213777120. [Abstract]
- Proc Natl Acad Sci U S A. 2022 Apr 19;119(16):e2202970119. [Abstract]
- Proc Natl Acad Sci U S A. 2022 Mar 1;119(9):e2119995119. [Abstract]
- Bioresour Technol. 2025 Jun:425:132336. [Abstract]
- J Pharm Anal. 2026 Jun 8.
- Cell Commun Signal. 2026 May 15;24(1):395. [Abstract]
- Cell Commun Signal. 2026 Mar 24;24(1):262. [Abstract]
- J Pharm Anal. 2026 Mar 10.
- Cell Commun Signal. 2026 Feb 17;24(1):191. [Abstract]
- Cell Commun Signal. 2026 Feb 9;24(1):168. [Abstract]
- J Pharm Anal. 2025 Dec 10.
- Cell Commun Signal. 2025 Nov 21;23(1):502. [Abstract]
- Cell Commun Signal. 2025 Apr 2;23(1):162. [Abstract]
- J Pharm Anal. 2025 Dec;15(12):101307. [Abstract]
- J Pharm Anal. 2025 Jul;15(7):101246. [Abstract]
- J Pharm Anal. 2025 Nov;15(11):101219. [Abstract]
- Cell Commun Signal. 2024 Nov 11;22(1):539. [Abstract]
- Cell Commun Signal. 2024 Oct 11;22(1):488. [Abstract]
- Cell Commun Signal. 2024 Oct 24;22(1):516. [Abstract]
- Cell Commun Signal. 2024 May 3;22(1):254. [Abstract]
- Cell Commun Signal. 2024 Mar 7;22(1):168. [Abstract]
- Cell Commun Signal. 2023 Dec 15;21(1):356. [Abstract]
- Cell Commun Signal. 2023 Sep 18;21(1):242. [Abstract]
- Cell Commun Signal. 2023 Aug 9;21(1):198. [Abstract]
- Cell Commun Signal. 2023 Jun 22;21(1):152. [Abstract]
- Cell Commun Signal. 2022 Aug 15;20(1):121. [Abstract]
- Cell Commun Signal. 2022 Jun 15;20(1):87. [Abstract]
- Cell Commun Signal. 2021 Mar 15;19(1):33. [Abstract]
- Dev Cell. 2026 Apr 29:S1534-5807(26)00150-4. [Abstract]
- Dev Cell. 2025 Sep 3:S1534-5807(25)00530-1. [Abstract]
- Dev Cell. 2025 Jul 9:S1534-5807(25)00402-2. [Abstract]
- Dev Cell. 2025 May 27:S1534-5807(25)00296-5. [Abstract]
- Dev Cell. 2025 May 5;60(9):1336-1347.e5. [Abstract]
- Dev Cell. 2023 Nov 6;58(21):2326-2337.e5. [Abstract]
- Dev Cell. 2023 Feb 27;58(4):278-288.e5. [Abstract]
- Int J Biol Macromol. 2026 Jun 22:153160. [Abstract]
- Int J Biol Macromol. 2026 May:362:152113. [Abstract]
- Hortic Res. 2026 Mar 3.
- Int J Biol Macromol. 2026 Mar 11.
- Int J Biol Macromol. 2026 Mar:349:150861. [Abstract]
- Int J Biol Macromol. 2026 Apr:354:151391. [Abstract]
- Int J Biol Macromol. 2026 Jan 7;340:150099.
- Int J Biol Macromol. 2025 Dec 15:149611. [Abstract]
- Int J Biol Macromol. 2025 Dec 15:149690. [Abstract]
- Int J Biol Macromol. 2025 Dec 28;339(Pt 2):149970. [Abstract]
- Int J Biol Macromol. 2025 Dec;334(Pt 2):149085. [Abstract]
- Int J Biol Macromol. 2026 Jan:336:149150. [Abstract]
- Int J Biol Macromol. 2025 Oct 13;330(Pt 4):148292. [Abstract]
- Int J Biol Macromol. 2025 Oct 15;331(Pt 1):148341. [Abstract]
- Int J Biol Macromol. 2025 Oct 7;330(Pt 4):148112. [Abstract]
- Int J Biol Macromol. 2025 Sep 1;327(Pt 1):147275. [Abstract]
- Int J Biol Macromol. 2025 Sep;321(Pt 2):146064. [Abstract]
- Int J Biol Macromol. 2025 Jul 3;320(Pt 1):145732. [Abstract]
- Int J Biol Macromol. 2025 May 29:144742. [Abstract]
- Int J Biol Macromol. 2025 May 1:143885. [Abstract]
- Int J Biol Macromol. 2025 May 11:312:144142. [Abstract]
- Int J Biol Macromol. 2025 May 30:144816. [Abstract]
- Int J Biol Macromol. 2025 May 19:144398. [Abstract]
- Int J Biol Macromol. 2025 Feb 15;305(Pt 1):141055. [Abstract]
- Int J Biol Macromol. 2025 Feb 3:303:140664. [Abstract]
- Int J Biol Macromol. 2025 Jan 28:301:140445. [Abstract]
- Int J Biol Macromol. 2024 Sep 17:135764. [Abstract]
- Int J Biol Macromol. 2024 May;266(Pt 2):131151. [Abstract]
- Int J Biol Macromol. 2024 Feb 6;262(Pt 1):130037. [Abstract]
- Int J Biol Macromol. 2024 Jan;256(Pt 2):128451. [Abstract]
- Int J Biol Macromol. 2023 Aug 30:247:125670. [Abstract]
- Int J Biol Macromol. 2023 Mar 1:230:123191. [Abstract]
- Int J Biol Macromol. 2023 Jan 31:226:996-1009. [Abstract]
- Int J Biol Macromol. 2021 Jun 30:181:1081-1091. [Abstract]
- Acta Pharmacol Sin. 2026 May 18. [Abstract]
- Acta Pharmacol Sin. 2026 Apr 30. [Abstract]
- Acta Pharmacol Sin. 2026 Apr 27. [Abstract]
- Acta Pharmacol Sin. 2026 Feb 19. [Abstract]
- Acta Pharmacol Sin. 2026 Jan 1. [Abstract]
- Acta Pharmacol Sin. 2025 Jun 20. [Abstract]
- Acta Pharmacol Sin. 2025 May 20. [Abstract]
- Acta Pharmacol Sin. 2025 Aug;46(8):2136-2150. [Abstract]
- Acta Pharmacol Sin. 2025 Jan;46(1):184-195. [Abstract]
- Acta Pharmacol Sin. 2024 Oct;45(10):2174-2185. [Abstract]
- Acta Pharmacol Sin. 2023 Sep;44(9):1920-1931. [Abstract]
- Acta Pharmacol Sin. 2021 Nov;42(11):1834-1846. [Abstract]
- Acta Pharmacol Sin. 2021 May;42(5):767-779. [Abstract]
- Phytomedicine. 2026 Jun:155:158158. [Abstract]
- Phytomedicine. 2026 Jun:155:158166. [Abstract]
- Phytomedicine. 2026 Jun 17:159:158446. [Abstract]
- Phytomedicine. 2026 Jun 11:159:158429. [Abstract]
- Phytomedicine. 2026 May 14:157:158290. [Abstract]
- Phytomedicine. 2026 May:154:158057. [Abstract]
- Phytomedicine. 2026 May:154:158028. [Abstract]
- Phytomedicine. 2026 Apr:153:157913. [Abstract]
- Phytomedicine. 2026 Jan 28:153:157894. [Abstract]
- Phytomedicine. 2025 Nov 26:150:157623. [Abstract]
- EMBO J. 2025 Sep 16. [Abstract]
- Phytomedicine. 2025 Nov:147:157236. [Abstract]
- Phytomedicine. 2025 Aug 16:147:157171. [Abstract]
- Phytomedicine. 2025 Aug:144:156952. [Abstract]
- Phytomedicine. 2025 May 29:144:156929. [Abstract]
- Phytomedicine. 2025 May 10:143:156840. [Abstract]
- Phytomedicine. 2025 Apr 1:141:156692. [Abstract]
- EMBO Mol Med. 2025 Apr;17(4):679-695. [Abstract]
- EMBO J. 2025 Mar;44(6):1641-1662. [Abstract]
- EMBO J. 2025 Mar;44(5):1414-1441. [Abstract]
- Phytomedicine. 2025 Apr:139:156468. [Abstract]
- Phytomedicine. 2024 Nov 9:135:156245. [Abstract]
- EMBO Mol Med. 2024 Nov;16(11):2856-2881. [Abstract]
- Phytomedicine. 2024 Oct 5:135:156119. [Abstract]
- Phytomedicine. 2024 May 8:129:155690. [Abstract]
- Phytomedicine. 2024 Jul:129:155675. [Abstract]
- Phytomedicine. 2024 Jul:129:155570. [Abstract]
- Phytomedicine. 2024 Jul 25:130:155556. [Abstract]
- Phytomedicine. 2024 Jun:128:155527. [Abstract]
- Phytomedicine. 2021 Oct:91:153692. [Abstract]
- EMBO J. 2023 Dec 1;42(23):e114558. [Abstract]
- Phytomedicine. 2024 Jan:122:155156. [Abstract]
- BMC Med. 2023 Sep 25;21(1):366. [Abstract]
- Phytomedicine. 2023 Aug:117:154921. [Abstract]
- Phytomedicine. 2023 Jul 25:116:154876. [Abstract]
- EMBO J. 2023 May 15;42(10):e111980. [Abstract]
- EMBO Mol Med. 2022 Jul 7;14(7):e15373. [Abstract]
- Phytomedicine. 2022 Jan:95:153861. [Abstract]
- Phytomedicine. 2021 Jul:87:153578. [Abstract]
- Phytomedicine. 2021 Apr:84:153503. [Abstract]
- Phytomedicine. 2021 Jan;80:153383. [Abstract]
- EMBO J. 2019 Mar 15;38(6):e100376. [Abstract]
- Free Radic Biol Med. 2026 Sep:253:561-577. [Abstract]
- NPJ Parkinsons Dis. 2026 Jun 6. [Abstract]
- Free Radic Biol Med. 2026 Jun 6:254:46-61. [Abstract]
- Free Radic Biol Med. 2026 Jun 27:S0891-5849(26)00907-X. [Abstract]
- ACS Appl Mater Interfaces. 2026 Mar 18;18(10):14540-14557. [Abstract]
- Free Radic Biol Med. 2026 Apr:247:378-392. [Abstract]
- Free Radic Biol Med. 2026 May:248:320-332. [Abstract]
- Free Radic Biol Med. 2026 Mar 16:246:35-50. [Abstract]
- Free Radic Biol Med. 2026 Mar 16:246:80-92. [Abstract]
- Free Radic Biol Med. 2026 Mar 16:246:614-626. [Abstract]
- Free Radic Biol Med. 2025 Nov 8:243:414-433. [Abstract]
- Cancer Immunol Res. 2025 Nov 11. [Abstract]
- ACS Appl Mater Interfaces. 2025 Jul 23;17(29):41781-41791. [Abstract]
- Free Radic Biol Med. 2025 Jun 14:237:585-599. [Abstract]
- Free Radic Biol Med. 2025 Sep:237:503-514. [Abstract]
- Free Radic Biol Med. 2025 Apr 11:S0891-5849(25)00228-X. [Abstract]
- Free Radic Biol Med. 2025 Aug 1:235:231-247. [Abstract]
- Free Radic Biol Med. 2025 Aug 1:235:317-334. [Abstract]
- Free Radic Biol Med. 2024 Nov 8:226:29-42. [Abstract]
- Free Radic Biol Med. 2024 Aug 6:S0891-5849(24)00591-4. [Abstract]
- Free Radic Biol Med. 2024 Aug 10:S0891-5849(24)00582-3. [Abstract]
- Free Radic Biol Med. 2024 May 13:S0891-5849(24)00460-X. [Abstract]
- Free Radic Biol Med. 2024 Feb 20:212:162-173. [Abstract]
- Free Radic Biol Med. 2023 Aug 20:205:291-304. [Abstract]
- Free Radic Biol Med. 2023 Aug 20:205:13-24. [Abstract]
- Free Radic Biol Med. 2023 Jul:203:86-101. [Abstract]
- Free Radic Biol Med. 2023 May 20:201:89-97. [Abstract]
- Free Radic Biol Med. 2022 Nov 20;193(Pt 2):579-594. [Abstract]
- Free Radic Biol Med. 2022 Sep:190:62-74. [Abstract]
- Free Radic Biol Med. 2022 Mar:182:246-259. [Abstract]
- Free Radic Biol Med. 2022 Feb 20:180:75-84. [Abstract]
- Free Radic Biol Med. 2022 Feb 20:180:95-107. [Abstract]
- Free Radic Biol Med. 2021 Jun:169:271-282. [Abstract]
- Free Radic Biol Med. 2021 Jun:169:361-381. [Abstract]
- Free Radical Bio Med. 2020 Nov 1;159:164-176. [Abstract]
- Free Radic Biol Med. 2020 Nov 20;160:303-318. [Abstract]
- Free Radic Biol Med. 2020 May 20;152:525-539. [Abstract]
- Apoptosis. 2026 Jan 12;31(1):41. [Abstract]
- Apoptosis. 2026 Jan 10;31(1):37. [Abstract]
- Apoptosis. 2025 Sep 9. [Abstract]
- New Phytol. 2025 Oct;248(1):193-210. [Abstract]
- Apoptosis. 2025 Feb;30(1-2):16-34. [Abstract]
- Apoptosis. 2024 May 14. [Abstract]
- Apoptosis. 2023 Aug;28(7-8):1154-1167. [Abstract]
- Apoptosis. 2023 Apr;28(3-4):576-593. [Abstract]
- Apoptosis. 2023 Apr;28(3-4):397-413. [Abstract]
- New Phytol. 2021 Sep;231(5):2050-2064. [Abstract]
- Chemosphere. 2021 Feb;264(Pt 1):128440. [Abstract]
- NPJ Precis Oncol. 2025 Nov 4;9(1):338. [Abstract]
- NPJ Precis Oncol. 2025 Jul 10;9(1):234. [Abstract]
- NPJ Precis Oncol. 2025 Jun 5;9(1):163. [Abstract]
- NPJ Precis Oncol. 2025 May 16;9(1):143. [Abstract]
- Food Res Int. 2024 Aug:190:114581. [Abstract]
- NPJ Precis Oncol. 2021 Mar 2;5(1):14. [Abstract]
- Br J Pharmacol. 2026 May 10. [Abstract]
- Br J Pharmacol. 2026 Mar 10. [Abstract]
- Br J Pharmacol. 2026 Jun;183(11):2675-2694. [Abstract]
- Neoplasia. 2026 Mar:73:101285. [Abstract]
- Neoplasia. 2026 Mar:73:101270. [Abstract]
- Br J Pharmacol. 2025 Nov 7. [Abstract]
- Br J Pharmacol. 2025 Oct 8. [Abstract]
- Br J Pharmacol. 2025 Jul 21. [Abstract]
- Br J Pharmacol. 2025 Jun;182(12):2662-2681. [Abstract]
- Neoplasia. 2025 Feb 4:61:101123. [Abstract]
- Br J Pharmacol. 2025 Apr;182(8):1856-1875. [Abstract]
- Br J Pharmacol. 2024 Oct 22. [Abstract]
- Br J Pharmacol. 2024 Dec;181(23):4822-4844. [Abstract]
- Br J Pharmacol. 2024 Oct;181(20):3886-3907. [Abstract]
- Environ Res. 2024 Jun 4:257:119325. [Abstract]
- Neoplasia. 2024 May 10:53:101004. [Abstract]
- Br J Pharmacol. 2023 Aug;180(15):1930-1948. [Abstract]
- Neoplasia. 2022 Dec:34:100839. [Abstract]
- Neoplasia. 2022 Nov;33:100835. [Abstract]
- Br J Pharmacol. 2022 Sep;179(18):4516-4533. [Abstract]
- Neoplasia. 2021 Dec;23(12):1227-1239. [Abstract]
- Br J Pharmacol. 2022 Mar;179(6):1237-1250. [Abstract]
- Mov Disord. 2025 Dec 17. [Abstract]
- Brain Behav Immun. 2019 Jul:79:244-255. [Abstract]
- Emerg Microbes Infect. 2026 Dec;15(1):2627066. [Abstract]
- Arch Pharm Res. 2026 Feb;49(2):223-241. [Abstract]
- J Transl Med. 2025 Nov 10;23(1):1252. [Abstract]
- J Transl Med. 2025 Aug 19;23(1):939. [Abstract]
- J Transl Med. 2025 Jul 2;23(1):729. [Abstract]
- J Transl Med. 2025 Jun 5;23(1):631. [Abstract]
- J Transl Med. 2025 May 7;23(1):514. [Abstract]
- J Transl Med. 2025 Apr 11;23(1):435. [Abstract]
- J Transl Med. 2025 Apr 10;23(1):415. [Abstract]
- J Transl Med. 2025 Feb 21;23(1):220. [Abstract]
- J Transl Med. 2025 Jan 16;23(1):74. [Abstract]
- J Transl Med. 2024 Dec 27;22(1):1153. [Abstract]
- J Transl Med. 2024 Dec 20;22(1):1135. [Abstract]
- J Transl Med. 2024 Sep 27;22(1):867. [Abstract]
- J Transl Med. 2024 Aug 22;22(1):785. [Abstract]
- Biomed Pharmacother. 2024 Aug 15:179:117309. [Abstract]
- J Transl Med. 2024 May 27;22(1):507. [Abstract]
- Biomed Pharmacother. 2024 May 12:175:116736. [Abstract]
- Biomed Pharmacother. 2024 May:174:116447. [Abstract]
- J Transl Med. 2023 Nov 21;21(1):838. [Abstract]
- J Transl Med. 2023 Jun 20;21(1):402. [Abstract]
- J Transl Med. 2023 May 5;21(1):306. [Abstract]
- Biomed Pharmacother. 2023 May:161:114560. [Abstract]
- Emerg Microbes Infect. 2022 Dec;11(1):2486-2501. [Abstract]
- J Transl Med. 2022 May 4;20(1):191. [Abstract]
- Diabetes. 2021 Oct 21:db210240. [Abstract]
- Diabetes. 2021 May;70(5):1170-1184. [Abstract]
- Biomed Pharmacother. 2020 Dec;132:110856. [Abstract]
- Biomed Pharmacother. 2020 Aug;128:110221. [Abstract]
- Redox Rep. 2025 Dec;30(1):2588086. [Abstract]
- J Transl Int Med. 2025 Jun 20;13(3):281-294. [Abstract]
- Cell Mol Gastroenterol Hepatol. 2024;17(4):539-551. [Abstract]
- Oncogene. 2026 Jul;45(28):2851-2864. [Abstract]
- Oncogene. 2026 Jun;45(20):1930-1940. [Abstract]
- Oncogene. 2026 Jun;45(22):2098-2110. [Abstract]
- Oncogene. 2026 Apr;45(15):1386-1397. [Abstract]
- Oncogene. 2026 Feb;45(6):703-714. [Abstract]
- Oncogene. 2025 Dec;44(50):4868-4877. [Abstract]
- Oncogene. 2025 Nov 28. [Abstract]
- Oncogene. 2025 Sep 19. [Abstract]
- Oncogene. 2025 Sep 18. [Abstract]
- Environ Pollut. 2025 Aug 8:384:126969. [Abstract]
- Oncogene. 2025 Sep;44(35):3183-3198. [Abstract]
- Stem Cell Res Ther. 2025 Apr 29;16(1):213. [Abstract]
- Oncogene. 2025 Jun;44(22):1678-1693. [Abstract]
- Oncogene. 2025 May;44(16):1078-1092. [Abstract]
- Oncogene. 2024 Nov;43(49):3570-3585. [Abstract]
- Oncogene. 2024 Oct;43(44):3215-3226. [Abstract]
- Oncogene. 2024 Oct;43(43):3170-3183. [Abstract]
- Oncogene. 2024 Jun;43(25):1885-1899. [Abstract]
- Oncogene. 2023 Nov;42(47):3503-3513. [Abstract]
- Oncogene. 2023 Jul;42(29):2249-2262. [Abstract]
- Oncogene. 2023 Apr;42(16):1308-1320. [Abstract]
- Oncogene. 2023 Mar;42(10):725-736. [Abstract]
- Oncogene. 2022 Dec;41(50):5397-5410. [Abstract]
- Oncogene. 2022 Sep;41(40):4524-4536. [Abstract]
- Oncogene. 2022 Jul;41(31):3846-3858. [Abstract]
- Environ Pollut. 2022 Aug 15:307:119484. [Abstract]
- Oncogene. 2022 Mar;41(13):1851-1865. [Abstract]
- Oncogene. 2021 Nov;40(44):6273-6283. [Abstract]
- Oncogene. 2021 Jan;40(1):163-176. [Abstract]
- Cell Chem Biol. 2026 Jun 8:S2451-9456(26)00156-X. [Abstract]
- Cell Chem Biol. 2026 Apr 16;33(4):523-537.e7. [Abstract]
- Cell Chem Biol. 2024 Feb 15;31(2):326-337.e11. [Abstract]
- PLoS Biol. 2022 Apr 27;20(4):e3001619 [Abstract]
- Cell Chem Biol. 2020 Nov 19;27(11):1359-1370.e8. [Abstract]
- Aging Cell. 2026 Jul;25(7):e70603. [Abstract]
- Aging Cell. 2026 Feb;25(2):e70377. [Abstract]
- J Genet Genomics. 2025 Oct 7:S1673-8527(25)00277-2. [Abstract]
- J Genet Genomics. 2025 Jul 5:S1673-8527(25)00193-6. [Abstract]
- Eur J Cancer. 2024 Aug 10:210:114278. [Abstract]
- J Genet Genomics. 2024 Oct;51(10):1020-1029. [Abstract]
- Eur J Cancer. 2023 Jul:188:49-63. [Abstract]
- Aging Cell. 2022 Mar;21(3):e13573. [Abstract]
- Aging Cell. 2020 Jul;19(7):e13171. [Abstract]
- Blood Adv. 2017 Sep 8;1(20):1773-1785. [Abstract]
- Cell Death Discov. 2026 Jun 20. [Abstract]
- Cell Death Discov. 2026 May 20;12(1):300. [Abstract]
- Cell Death Discov. 2026 Apr 9;12(1):240. [Abstract]
- Cell Death Discov. 2026 Apr 1;12(1):215. [Abstract]
- Cell Death Discov. 2026 Apr 9;12(1):242. [Abstract]
- Cell Death Discov. 2026 Mar 19;12(1):156. [Abstract]
- Cell Death Discov. 2026 Mar 23;12(1):168. [Abstract]
- Cell Death Discov. 2025 Oct 27;11(1):492. [Abstract]
- Cell Death Discov. 2025 Jul 24;11(1):339. [Abstract]
- Cell Death Discov. 2025 Apr 25;11(1):197. [Abstract]
- Cell Death Discov. 2025 Apr 4;11(1):139. [Abstract]
- Cell Death Discov. 2025 Mar 12;11(1):99. [Abstract]
- Cell Death Discov. 2024 Oct 26;10(1):453. [Abstract]
- Cell Death Discov. 2024 Jun 22;10(1):298. [Abstract]
- Cell Death Discov. 2023 Nov 28;9(1):427. [Abstract]
- Cell Death Discov. 2023 Nov 22;9(1):421. [Abstract]
- Cell Death Discov. 2023 Nov 2;9(1):406. [Abstract]
- Cell Death Discov. 2023 Aug 28;9(1):319. [Abstract]
- Cell Death Discov. 2023 Jun 29;9(1):199. [Abstract]
- Cell Death Discov. 2022 Sep 16;8(1):386. [Abstract]
- Cell Death Discov. 2022 May 17;8(1):265. [Abstract]
- Cell Death Discov. 2022 Mar 9;8(1):107. [Abstract]
- Cell Death Discov. 2022 Feb 11;8(1):59. [Abstract]
- Cell Death Discov. 2021 Dec 14;7(1):389. [Abstract]
- Cell Death Discov. 2021 Dec 8;7(1):379. [Abstract]
- Cell Rep. 2026 Jun 25;45(7):117606. [Abstract]
- Cell Rep. 2026 Jun 3;45(6):117495. [Abstract]
- Cell Rep. 2026 Jun 25;45(7):117613. [Abstract]
- Cell Rep. 2026 May 4;45(5):117338. [Abstract]
- Cell Rep. 2026 Apr 25;45(5):117297. [Abstract]
- Cell Rep. 2026 Apr 28;45(5):117328. [Abstract]
- Cell Rep. 2026 Mar 13;45(3):117106. [Abstract]
- Cell Rep. 2026 Mar 24;45(3):117086. [Abstract]
- Cell Rep. 2026 Feb 24;45(2):116914. [Abstract]
- Cell Rep. 2026 Feb 23;45(3):117034. [Abstract]
- Cell Rep. 2026 Jan 22;45(2):116859. [Abstract]
- Cell Rep. 2025 Dec 26;45(1):116774. [Abstract]
- Cell Rep. 2025 Dec 16;45(1):116722. [Abstract]
- Cell Rep. 2025 Dec 24;45(1):116797.
- Cell Rep. 2025 Nov 25;44(11):116476. [Abstract]
- Cell Rep. 2025 Nov 18;44(12):116581. [Abstract]
- Cell Rep. 2025 Nov 25;44(12):116602. [Abstract]
- Cell Rep. 2025 Oct 15;44(10):116433. [Abstract]
- Cell Rep. 2025 Sep 1;44(9):116139. [Abstract]
- Aging Dis. 2025 Aug 6. [Abstract]
- Cell Rep. 2025 Jul 23;44(8):116018. [Abstract]
- Cell Rep. 2025 Jul 30;44(8):116091. [Abstract]
- Cell Rep. 2025 Jun 27;44(7):115931. [Abstract]
- Cell Rep. 2025 Jun 25;44(7):115919. [Abstract]
- Cell Rep. 2024 Dec 21;44(1):115094. [Abstract]
- Cell Rep. 2024 Nov 9;43(11):114962. [Abstract]
- Cell Rep. 2024 Oct 8;43(10):114812. [Abstract]
- Cell Rep. 2024 Oct 8;43(10):114792. [Abstract]
- Cell Rep. 2024 Sep 25;43(10):114756. [Abstract]
- Cell Rep. 2024 Oct 24;43(11):114885. [Abstract]
- Cell Rep. 2024 Sep 13;43(9):114751. [Abstract]
- Cell Rep. 2024 Sep 12;43(9):114727. [Abstract]
- Cell Rep. 2024 Sep 3;43(9):114691. [Abstract]
- Cell Rep. 2024 Jul 13;43(7):114507. [Abstract]
- Cell Rep. 2024 Jun 27;43(7):114402. [Abstract]
- Cell Rep. 2024 Jul 11;43(7):114487. [Abstract]
- Cell Rep. 2024 Apr 23;43(4):114111. [Abstract]
- Cell Rep. 2024 Mar 1;43(3):113886. [Abstract]
- Cell Rep. 2023 Aug 29;42(8):112851. [Abstract]
- Cell Rep. 2024 Feb 21;43(3):113838. [Abstract]
- Cell Rep. 2023 Nov 23;42(12):113479. [Abstract]
- Cell Rep. 2023 Nov 14;42(11):113426. [Abstract]
- Cell Rep. 2023 Oct 13;42(10):113264. [Abstract]
- Cell Rep. 2023 Sep 7;42(9):113110. [Abstract]
- Cell Rep. 2023 Aug 13;42(8):112968. [Abstract]
- Cell Rep. 2023 Aug 11;42(8):112975. [Abstract]
- Plant Physiol. 2023 Jul 3;192(3):2507-2522. [Abstract]
- Cell Rep. 2023 Mar 25;42(4):112309. [Abstract]
- Cell Rep. 2023 Jan 30;42(2):112033. [Abstract]
- Cell Rep. 2023 Jan 31;42(1):112002. [Abstract]
- Cell Rep. 2022 Oct 25;41(4):111530. [Abstract]
- Cell Rep. 2022 Aug 16;40(7):111194. [Abstract]
- Cell Rep. 2022 Apr 12;39(2):110656. [Abstract]
- Cell Rep. 2022 Apr 12;39(2):110635. [Abstract]
- Cell Rep. 2021 Nov 2;37(5):109949. [Abstract]
- Cell Rep. 2021 Sep 21;36(12):109739. [Abstract]
- Cell Rep. 2021 Jul 13;36(2):109384. [Abstract]
- Cell Rep. 2020 Aug 4;32(5):107990. [Abstract]
- Cell Rep. 2020 Jul 21;32(3):107936. [Abstract]
- Cell Rep. 2020 Jul 14;32(2):107877. [Abstract]
- Plant Physiol. 2020 May;183(1):358-370. [Abstract]
- Cell Rep. 2019 May.
- Cell Rep. 2018 Sep 25;24(13):3513-3527.e7. [Abstract]
- Clin Transl Med. 2026 Jul;16(7):e70718. [Abstract]
- J Med Chem. 2026 Jun 11;69(11):13141-13164. [Abstract]
- Clin Transl Med. 2026 May;16(5):e70681. [Abstract]
- J Med Chem. 2026 Apr 9;69(7):8417-8432. [Abstract]
- J Med Chem. 2026 Apr 9;69(7):8237-8254. [Abstract]
- Clin Transl Med. 2025 Dec;15(12):e70550. [Abstract]
- J Med Chem. 2025 Dec 31. [Abstract]
- Br J Cancer. 2025 Nov 26. [Abstract]
- J Med Chem. 2025 Oct 29. [Abstract]
- J Med Chem. 2025 Jul 24;68(14):14333-14356. [Abstract]
- Br J Cancer. 2025 Jul 15. [Abstract]
- Clin Transl Med. 2025 Mar;15(3):e70257. [Abstract]
- J Med Chem. 2025 Mar 13;68(5):5275-5291. [Abstract]
- Clin Transl Med. 2025 Jan;15(1):e70191. [Abstract]
- Clin Transl Med. 2024 Oct;14(10):e70038. [Abstract]
- Clin Transl Med. 2024 Oct;14(10):e70039. [Abstract]
- J Med Chem. 2024 Oct 24;67(20):18247-18264. [Abstract]
- J Med Chem. 2024 Nov 14;67(21):19874-19888. [Abstract]
- J Med Chem. 2024 Aug 8;67(15):12521-12533. [Abstract]
- J Med Chem. 2024 Aug 22;67(16):13666-13680. [Abstract]
- Clin Transl Med. 2024 Jun;14(6):e1725. [Abstract]
- J Med Chem. 2024 Apr 25;67(8):6658-6672. [Abstract]
- Br J Cancer. 2024 Mar;130(5):755-768. [Abstract]
- J Med Chem. 2023 Sep 14;66(17):12614-12628. [Abstract]
- J Med Chem. 2023 Jul 13;66(13):9184-9200. [Abstract]
- Clin Transl Med. 2023 Jun;13(6):e1300. [Abstract]
- J Med Chem. 2023 May 11;66(9):6070-6081. [Abstract]
- Clin Transl Med. 2022 Nov;12(11):e1113. [Abstract]
- Clin Transl Med. 2022 Aug;12(8):e1003. [Abstract]
- Clin Transl Med. 2022 Apr;12(4):e797. [Abstract]
- Clin Transl Med. 2021 Sep;11(9):e464. [Abstract]
- Clin Transl Med. 2021 Apr;11(4):e395. [Abstract]
- Clin Transl Med. 2020 Dec;10(8):e240. [Abstract]
- Neural Regen Res. 2025 Sep 3. [Abstract]
- Anal Chem. 2025 Jul 29;97(29):15687-15697. [Abstract]
- Neural Regen Res. 2026 Apr 1;21(4):1641-1651. [Abstract]
- Antioxidants (Basel). 2026 Mar 25;15(4):413. [Abstract]
- Sci Signal. 2025 Jul 29;18(897):eadr3411. [Abstract]
- Sci Signal. 2025 Mar 18;18(878):eadi5174. [Abstract]
- Sci Signal. 2024 Jan 2;17(817):eadf7318. [Abstract]
- Antioxidants (Basel). 2022 Dec 29;12(1):74. [Abstract]
- Sci Signal. 2022 Dec 20;15(765):eabo4356. [Abstract]
- Int J Nanomedicine. 2023 Nov 1:18:6199-6212. [Abstract]
- Oncogenesis. 2026 May 27. [Abstract]
- Oncogenesis. 2025 Nov 28;14(1):46. [Abstract]
- J Cell Biol. 2025 Oct 6;224(10):e202412224. [Abstract]
- J Cell Biol. 2025 May 5;224(5):e202405142. [Abstract]
- Mol Med. 2025 Jan 23;31(1):21. [Abstract]
- Mol Med. 2024 Oct 18;30(1):180. [Abstract]
- Oncogenesis. 2024 Jun 21;13(1):23. [Abstract]
- Mol Med. 2024 May 23;30(1):69. [Abstract]
- Mol Med. 2024 Apr 15;30(1):50. [Abstract]
- Mol Med. 2023 Oct 20;29(1):139. [Abstract]
- Mol Med. 2023 Jul 6;29(1):91. [Abstract]
- J Cell Biol. 2023 May 1;222(5):e202103098. [Abstract]
- Oncogenesis. 2023 Feb 4;12(1):3. [Abstract]
- Elife. 2022 Oct 7;11:e80760. [Abstract]
- Elife. 2020 Jun 2;9:e54954. [Abstract]
- Oncogenesis. 2020 Apr 29;9(4):42. [Abstract]
- Oncogenesis. 2020 Mar 12;9(3):34. [Abstract]
- Phytother Res. 2026 Apr;40(4):1935-1950. [Abstract]
- Phytother Res. 2025 Dec 12. [Abstract]
- Phytother Res. 2025 Nov 20. [Abstract]
- Phytother Res. 2025 Aug 6. [Abstract]
- Commun Med (Lond). 2025 Apr 26;5(1):140. [Abstract]
- Plant Cell Environ. 2025 Mar;48(3):2343-2356. [Abstract]
- Phytother Res. 2022 Feb;36(2):938-950. [Abstract]
- Phytother Res. 2022 Apr;36(4):1692-1707. [Abstract]
- Cell Mol Life Sci. 2026 Jun 6. [Abstract]
- Cell Mol Life Sci. 2026 May 22. [Abstract]
- J Agric Food Chem. 2026 Apr 8;74(13):11079-11091. [Abstract]
- Ind Crops Prod. 2026 Mar 16.
- Cell Mol Life Sci. 2025 Nov 19;82(1):408. [Abstract]
- J Agric Food Chem. 2025 Oct 15;73(41):26060-26072. [Abstract]
- J Agric Food Chem. 2025 Jul 23;73(29):18437-18447. [Abstract]
- EMBO Rep. 2025 Aug;26(16):4100-4123. [Abstract]
- Cell Biosci. 2025 Feb 5;15(1):14. [Abstract]
- Cell Mol Life Sci. 2025 Feb 3;82(1):69. [Abstract]
- Cell Mol Life Sci. 2024 Nov 16;81(1):456. [Abstract]
- EMBO Rep. 2024 Oct;25(10):4594-4624. [Abstract]
- EMBO Rep. 2024 Oct;25(10):4337-4357. [Abstract]
- J Agric Food Chem. 2024 Mar 27;72(12):6178-6188. [Abstract]
- Cell Mol Life Sci. 2023 Oct 13;80(11):325. [Abstract]
- EMBO Rep. 2023 Nov 6;24(11):e56614. [Abstract]
- EMBO Rep. 2023 Aug 3;24(8):e56437. [Abstract]
- Cell Biosci. 2023 Feb 21;13(1):37. [Abstract]
- Cell Biosci. 2022 Dec 19;12(1):203. [Abstract]
- Cell Biosci. 2022 Oct 8;12(1):169. [Abstract]
- Cell Biosci. 2020 Dec 22;10(1):146. [Abstract]
- Cell Biosci. 2020 Nov 27;10(1):139. [Abstract]
- JCI Insight. 2025 Dec 16:e193221. [Abstract]
- Ecotoxicol Environ Saf. 2025 Dec 13:309:119560. [Abstract]
- Antioxid Redox Signal. 2025 Oct 13. [Abstract]
- JCI Insight. 2025 Aug 22;10(16):e191347. [Abstract]
- Ecotoxicol Environ Saf. 2025 Aug 25:303:118932. [Abstract]
- Antioxid Redox Signal. 2025 Aug 1. [Abstract]
- Hepatol Int. 2025 Jul 28. [Abstract]
- JCI Insight. 2025 Apr 29:e190838. [Abstract]
- Antioxid Redox Signal. 2025 Jun;42(16-18):933-953. [Abstract]
- Hepatol Int. 2025 Jun;19(3):529-546. [Abstract]
- Antioxid Redox Signal. 2023 Jan;38(1-3):115-136. [Abstract]
- Ecotoxicol Environ Saf. 25 December 2021, 113028.
- Mol Ther Nucleic Acids. 2021 Jan 26:24:711-727. [Abstract]
- Ecotoxicol Environ Saf. 2020 Sep 15;201:110831. [Abstract]
- Mol Ther Nucleic Acids. 2020 Mar 6;19:974-985. [Abstract]
- Antioxid Redox Signal. 2019 May 20;30(15):1831-1848. [Abstract]
- JCI Insight. 2019 Feb 21;4(4). pii: 121582. [Abstract]
- Cancer Cell Int. 2025 Nov 14;25(1):403. [Abstract]
- Cancer Cell Int. 2025 May 17;25(1):180. [Abstract]
- Cancer Cell Int. 2024 Jul 7;24(1):238. [Abstract]
- Cancer Cell Int. 2024 Jun 10;24(1):204. [Abstract]
- Cancer Cell Int. 2024 May 23;24(1):179. [Abstract]
- Cancer Cell Int. 2023 Nov 21;23(1):286. [Abstract]
- Cancer Cell Int. 2022 Jan 6;22(1):7. [Abstract]
- Cancer Cell Int. 2021 Nov 27;21(1):631. [Abstract]
- Cancer Cell Int. 2020 Dec 7;20(1):587. [Abstract]
- J Mol Cell Biol. 2025 Dec 18:mjaf049. [Abstract]
- J Mol Cell Biol. 2025 Dec 2:mjaf048. [Abstract]
- Cell Biol Toxicol. 2025 Jul 16;41(1):117. [Abstract]
- Eur J Med Chem. 2025 Jun 14:296:117871. [Abstract]
- Cell Biol Toxicol. 2025 May 28;41(1):91. [Abstract]
- Cell Biol Toxicol. 2025 Mar 5;41(1):55. [Abstract]
- Cell Biol Toxicol. 2024 Nov 6;40(1):94. [Abstract]
- Cell Biol Toxicol. 2024 Dec 20;41(1):2. [Abstract]
- Cell Biol Toxicol. 2024 Nov 28;40(1):105. [Abstract]
- Cell Biol Toxicol. 2024 Oct 30;40(1):93. [Abstract]
- Eur J Med Chem. 2024 Dec 15:280:116978. [Abstract]
- Food Biosci. 2024 Oct.
- Cell Biol Toxicol. 2024 Jul 29;40(1):60. [Abstract]
- Cell Biol Toxicol. 2024 Jun 4;40(1):41. [Abstract]
- Transl Res. 2024 Oct:272:162-176. [Abstract]
- J Mol Cell Biol. 2023 Aug 3;15(3):mjad019. [Abstract]
- Eur J Med Chem. 2020 Nov 15;206:112708. [Abstract]
- Eur J Med Chem. 2018 Feb 25:146:251-259. [Abstract]
- Stress Biol. 2026 May 6;6(1):35. [Abstract]
- Int J Mol Med. 2026 Jun;57(6):141. [Abstract]
- Stress Biol. 2026 Jan 4;6(1):1. [Abstract]
- Int J Mol Med. 2026 Feb;57(2):36. [Abstract]
- Neurosci Bull. 2025 Oct 3. [Abstract]
- Int J Mol Med. 2025 Oct;56(4):154. [Abstract]
- Int J Mol Med. 2021 Oct;48(4):193. [Abstract]
- Chin Med. 2025 May 26;20(1):71. [Abstract]
- Plant J. 2024 Jul;119(2):746-761. [Abstract]
- J Invest Dermatol. 2020 Oct;140(10):2009-2022.e4. [Abstract]
- J Exp Bot. 2019 Sep 24;70(18):4749-4762. [Abstract]
- Acta Neuropathol Commun. 2017 Sep 6;5(1):67. [Abstract]
- Biochem Pharmacol. 2026 Jun 12;251(Pt 2):118163. [Abstract]
- Acta Physiol. 2026 Jun;242(6):e70236. [Abstract]
- Biochem Pharmacol. 2026 Mar 28;250(Pt 1):117939. [Abstract]
- Biochem Pharmacol. 2026 Mar 27;250(Pt 1):117936. [Abstract]
- Biochem Pharmacol. 2026 Jun:248:117862. [Abstract]
- Biochem Pharmacol. 2026 May:247:117761. [Abstract]
- Acta Physiol. 2026 Feb;242(2):e70163. [Abstract]
- Biochem Pharmacol. 2026 Apr:246:117721. [Abstract]
- Biochem Pharmacol. 2026 Feb:244:117591. [Abstract]
- Biochem Pharmacol. 2026 Jan;243(Pt 2):117543. [Abstract]
- Biochem Pharmacol. 2026 Jan;243(Pt 2):117554. [Abstract]
- Biochem Pharmacol. 2025 Dec;242(Pt 4):117377. [Abstract]
- Biochem Pharmacol. 2025 Oct 21;242(Pt 4):117450. [Abstract]
- Neurobiol Dis. 2025 Oct 15:215:107090. [Abstract]
- Biochem Pharmacol. 2025 Aug 7;242(Pt 3):117212. [Abstract]
- Breast Cancer Res. 2025 Jul 9;27(1):128. [Abstract]
- Biochem Pharmacol. 2025 Jul 30;242(Pt 2):117200. [Abstract]
- Biochem Pharmacol. 2025 Jul 12:241:117159. [Abstract]
- Biochem Pharmacol. 2025 Jul 26:241:117191. [Abstract]
- Biochem Pharmacol. 2025 Jul 12:241:117166. [Abstract]
- Biochem Pharmacol. 2025 Jul 16:241:117172. [Abstract]
- Biochem Pharmacol. 2025 Jul 12:241:117158. [Abstract]
- Biochem Pharmacol. 2025 Jun 23:117078. [Abstract]
- Biochem Pharmacol. 2025 Jun 19:117053. [Abstract]
- Biochem Pharmacol. 2025 Jun 23:117073. [Abstract]
- Biochem Pharmacol. 2025 May 24:239:116998. [Abstract]
- Biochem Pharmacol. 2025 Mar 28:116904. [Abstract]
- Biochem Pharmacol. 2025 Apr 6:116925. [Abstract]
- Biochem Pharmacol. 2025 May:235:116843. [Abstract]
- Biochem Pharmacol. 2025 Jan 29:116788. [Abstract]
- Biochem Pharmacol. 2025 Jan 31:116790. [Abstract]
- Cell Prolif. 2024 Oct 30:e13759. [Abstract]
- Biochem Pharmacol. 2024 Dec 19:116720. [Abstract]
- Biochem Pharmacol. 2024 Sep 3:116519. [Abstract]
- Biochem Pharmacol. 2024 Jun 27:116398. [Abstract]
- Cell Prolif. 2024 Jun 26:e13700. [Abstract]
- Biochem Pharmacol. 2024 Jul 10:116418. [Abstract]
- Biochem Pharmacol.2024 May 25:116319. [Abstract]
- Breast Cancer Res. 2024 Mar 19;26(1):48. [Abstract]
- Breast Cancer Res. 2024 Mar 11;26(1):44. [Abstract]
- Biochem Pharmacol. 2024 Mar:221:116040. [Abstract]
- Breast Cancer Res. 2024 Jan 2;26(1):1. [Abstract]
- Immun Ageing. 2023 Nov 21;20(1):66. [Abstract]
- Biochem Pharmacol. 2023 Nov:217:115834. [Abstract]
- Biochem Pharmacol. 2023 Jun:212:115581. [Abstract]
- Breast Cancer Res. 2023 May 22;25(1):55. [Abstract]
- Biochem Pharmacol. 2023 Apr:210:115489. [Abstract]
- Biochem Pharmacol. 2023 Jan:207:115355. [Abstract]
- Cell Prolif. 2023 Feb;56(2):e13349. [Abstract]
- Biochem Pharmacol. 2022 Dec:206:115326. [Abstract]
- Biochem Pharmacol. 2022 Aug:202:115107. [Abstract]
- Biochem Pharmacol. 2022 Apr:198:114975. [Abstract]
- Breast Cancer Res. 2021 Dec 18;23(1):116. [Abstract]
- Biochem Pharmacol. 2020 May;175:113856. [Abstract]
- Biochem Pharmacol. 2020 Jan;171:113715. [Abstract]
- Cell Prolif. 2019 Nov;52(6):e12689. [Abstract]
- Cell Prolif. 2019 May;52(3):e12606. [Abstract]
- Biochem Pharmacol. 2018 Oct:156:511-523. [Abstract]
- Cell Prolif. 2018 Aug;51(4):e12451. [Abstract]
- Biochem Pharmacol. 2018 Apr:150:280-292. [Abstract]
- J Gastroenterol. 2026 May 27. [Abstract]
- Am J Chin Med. 2026;54(1):329-348. [Abstract]
- Pharmaceutics. 2025 Nov 27;17(12):1524. [Abstract]
- Pharmaceutics. 2024 Dec 21;16(12):1620. [Abstract]
- Mol Cell Proteomics. 2023 Aug;22(8):100593. [Abstract]
- Mol Cancer Ther. 2020 Jan;19(1):221-230. [Abstract]
- Chem Biol Interact. 2026 Aug 1:436:112210. [Abstract]
- Chem Biol Interact. 2026 Jun 25:433:112083. [Abstract]
- J Ethnopharmacol. 2026 May 27:121893. [Abstract]
- Virulence. 2026 Dec;17(1):2645908. [Abstract]
- Chem Biol Interact. 2026 Jan 5:423:111838. [Abstract]
- J Ethnopharmacol. 2025 Oct 23:356:120777. [Abstract]
- Chem Biol Interact. 2025 Sep 19:111750. [Abstract]
- Chem Biol Interact. 2025 Oct 22:420:111697. [Abstract]
- Food Funct. 2025 Jul 1;16(13):5543-5555. [Abstract]
- Chem Biol Interact. 2025 May 17:111559. [Abstract]
- Virulence. 2025 Dec;16(1):2458681. [Abstract]
- J Ethnopharmacol. 2024 Dec 23:340:119277. [Abstract]
- J Ethnopharmacol. 2024 Aug 18:118709. [Abstract]
- Chem Biol Interact. 2024 May 25:395:110999. [Abstract]
- Virulence. 2024 Dec;15(1):2289764. [Abstract]
- J Ethnopharmacol. 2023 May 10:307:116243. [Abstract]
- Chem Biol Interact. 2023 Apr 1:374:110408. [Abstract]
- Chem Biol Interact. 2022 Aug 1:362:109999. [Abstract]
- Virulence. 2022 Dec;13(1):514-529. [Abstract]
- Chem Biol Interact. 2022 Feb 25:354:109798. [Abstract]
- Chem Biol Interact. 2022 Jan 5:351:109729. [Abstract]
- J Ethnopharmacol. 2022 Jan 30:283:114694. [Abstract]
- Mar Drugs. 2021 Jan 31;19(2):79. [Abstract]
- Mol Ther Oncolytics. 2022 Aug 25:26:413-428. [Abstract]
- Mol Ther Oncolytics. 2021 Aug 28:23:107-123. [Abstract]
- Cells. 2026 May 18;15(10):917. [Abstract]
- J Pathol. 2025 Jul 21. [Abstract]
- Liver Int. 2022 Aug;42(8):1793-1802. [Abstract]
- J Pathol. 2021 Jun;254(2):185-198. [Abstract]
- Commun Biol. 2026 Feb 7;9(1):373. [Abstract]
- Commun Biol. 2026 Jan 16;9(1):260. [Abstract]
- Commun Biol. 2025 Dec 18. [Abstract]
- Commun Biol. 2025 Nov 23. [Abstract]
- Commun Biol. 2025 Oct 14;8(1):1470. [Abstract]
- Cancer Immunol Immunother. 2025 Sep 11;74(10):300. [Abstract]
- Cancer Immunol Immunother. 2025 Aug 25;74(9):293. [Abstract]
- Commun Biol. 2025 Aug 27;8(1):1291. [Abstract]
- Glia. 2025 Aug 8. [Abstract]
- Commun Biol. 2025 Aug 29;8(1):1308. [Abstract]
- Commun Biol. 2025 Jul 29;8(1):1127. [Abstract]
- Life Sci. 2025 May 30:123780. [Abstract]
- Commun Biol. 2025 Apr 10;8(1):596. [Abstract]
- Life Sci. 2024 Nov 13:359:123240. [Abstract]
- Commun Biol. 2024 Nov 5;7(1):1438. [Abstract]
- Commun Biol. 2024 Oct 8;7(1):1279. [Abstract]
- Commun Biol. 2024 Jul 17;7(1):872. [Abstract]
- Life Sci. 2023 May 15:321:121594. [Abstract]
- Life Sci. 2023 May 15:321:121608. [Abstract]
- Mech Ageing Dev. 2023 Mar:210:111760. [Abstract]
- Commun Biol. 2022 Mar 1;5(1):182. [Abstract]
- Commun Biol. 2021 Dec 13;4(1):1391. [Abstract]
- Life Sci. 2021 Dec 16;289:120231. [Abstract]
- Life Sci. 2022 Mar 1:292:119552. [Abstract]
- Life Sci. 2020 Sep 15;257:118021. [Abstract]
- Life Sci. 2020 Sep 1;256:117983. [Abstract]
- Life Sci. 2020 Apr 1;246:117419. [Abstract]
- Respir Res. 2026 May 9. [Abstract]
- Inflammation. 2026 May 16. [Abstract]
- Respir Res. 2026 Apr 6;27(1):222. [Abstract]
- Cancer Gene Ther. 2025 Dec;32(12):1414-1427. [Abstract]
- Cancer Gene Ther. 2025 Oct 2. [Abstract]
- Respir Res. 2025 Jul 10;26(1):238. [Abstract]
- Respir Res. 2025 Apr 9;26(1):128. [Abstract]
- Biofactors. 2025 Jan-Feb;51(1):e2158. [Abstract]
- Inflammation. 2025 Jun;48(3):1484-1498. [Abstract]
- CNS Neurosci Ther. 2024 Mar;30(3):e14432. [Abstract]
- Cancer Gene Ther. 2023 Jul;30(7):985-996. [Abstract]
- Nutrients. 2022 Nov 27;14(23):5044. [Abstract]
- Cancer Gene Ther. 2022 Dec;29(12):1939-1950. [Abstract]
- Inflammation. 2022 Dec;45(6):2309-2324. [Abstract]
- Inflammation. 2022 Jun;45(3):1089-1100. [Abstract]
- Cancer Gene Ther. 2022 Jan;29(1):87-100. [Abstract]
- Int J Mol Sci. 2026 Jun 5;27(11):5116. [Abstract]
- PLoS Pathog. 2026 Jun 24;22(6):e1014371. [Abstract]
- PLoS Pathog. 2026 Apr 24;22(4):e1014174. [Abstract]
- PLoS Pathog. 2026 Apr 24;22(4):e1014170. [Abstract]
- PLoS Pathog. 2026 Mar 23;22(3):e1014078. [Abstract]
- PLoS Pathog. 2026 Feb 5;22(2):e1013932. [Abstract]
- Int J Mol Sci. 2026 Jan 22;27(2):1119. [Abstract]
- Int J Mol Sci. 2026 Jan;27(11):4744.
- PLoS Pathog. 2025 Dec 3;21(12):e1013731. [Abstract]
- PLoS Pathog. 2025 Oct 14;21(10):e1013593. [Abstract]
- Biol Direct. 2025 Oct 1;20(1):100. [Abstract]
- PLoS Pathog. 2025 Oct 17;21(10):e1013581. [Abstract]
- PLoS Pathog. 2025 Sep 8;21(9):e1013472. [Abstract]
- Mol Plant Pathol. 2025 Sep;26(9):e70147. [Abstract]
- Int J Mol Sci. 2025 Aug 23;26(17):8201. [Abstract]
- Int J Mol Sci. 2025 Aug 18;26(16):7962. [Abstract]
- Int J Mol Sci. 2025 Jul 27;26(15):7252. [Abstract]
- PLoS Pathog. 2025 Jul 16;21(7):e1013344. [Abstract]
- Int J Mol Sci. 2025 Jun 4;26(11):5391. [Abstract]
- PLoS Pathog. 2025 Apr 8;21(4):e1013060. [Abstract]
- Biol Direct. 2025 Apr 7;20(1):47. [Abstract]
- Biol Direct. 2024 Dec 22;19(1):133. [Abstract]
- PLoS Pathog. 2024 Oct 28;20(10):e1012670. [Abstract]
- PLoS Pathog. 2024 Sep 10;20(9):e1012535. [Abstract]
- PLoS Pathog. 2024 Jun 20;20(6):e1012329. [Abstract]
- Biol Direct. 2024 Apr 24;19(1):31. [Abstract]
- Biol Direct. 2024 Apr 3;19(1):25. [Abstract]
- Int J Mol Sci. 2024 Apr 29;25(9):4853. [Abstract]
- PLoS Pathog. 2024 Apr 16;20(4):e1012141. [Abstract]
- PLoS Pathog. 2024 Mar 20;20(3):e1012112. [Abstract]
- PLoS Pathog. 2023 Jul 13;19(7):e1010986. [Abstract]
- PLoS Pathog. 2024 Feb 14;20(2):e1011981. [Abstract]
- PLoS Pathog. 2024 Jan 12;20(1):e1011943. [Abstract]
- Int J Mol Sci. 2023 Sep 26;24(19):14530. [Abstract]
- PLoS Pathog. 2023 Jul 27;19(7):e1011550. [Abstract]
- Int J Mol Sci. 2023 Aug 13;24(16):12740. [Abstract]
- Int J Oncol. 2023 Aug;63(2):98. [Abstract]
- Int J Mol Sci. 2023 Apr 6;24(7):6826. [Abstract]
- J Nutr Biochem. 2023 Jul:117:109337. [Abstract]
- Int J Mol Sci. 2023 Feb 3;24(3):2960. [Abstract]
- Int J Oncol. 2023 Mar;62(3):40. [Abstract]
- Int J Mol Sci. 2022 Sep 21;23(19):11048. [Abstract]
- Int J Mol Sci. 2022 Sep 5;23(17):10161. [Abstract]
- PLoS Pathog. 2021 Sep 13;17(9):e1009900. [Abstract]
- PLoS Pathog. 2021 Jun 2;17(6):e1009645. [Abstract]
- PLoS Pathog. 2021 Mar 4;17(3):e1009370. [Abstract]
- J Zhejiang Univ Sci B. 2020 Jul;21(7):560-570. [Abstract]
- Int J Oncol. 2020 Jan;56(1):232-242. [Abstract]
- Mol Plant Pathol. 2018 Dec;19(12):2623-2634. [Abstract]
- Pharm Biol. 2026 Dec;64(1):764-782. [Abstract]
- Cell Oncol (Dordr). 2026 Apr 29;49(3):82. [Abstract]
- Biomolecules. 2025 Dec 18;15(12):1749. [Abstract]
- Cell Oncol (Dordr). 2025 Dec 30;49(1):11. [Abstract]
- Pharmaceuticals (Basel). 2025 Sep 24;18(10):1431. [Abstract]
- Pharmaceuticals (Basel). 2025 Aug 10;18(8):1180. [Abstract]
- Cell Oncol (Dordr). 2025 Jun;48(3):675-692. [Abstract]
- Cell Oncol (Dordr). 2024 Dec;47(6):2427-2438. [Abstract]
- Front Cell Infect Microbiol. 2024 Nov 29:14:1502770. [Abstract]
- Biomolecules. 2024 May 23;14(6):613. [Abstract]
- Front Pharmacol. 2023 Apr 18:14:1148611. [Abstract]
- Cell Oncol (Dordr). 2022 Dec;45(6):1421-1434. [Abstract]
- Front Pharmacol. 2022 Aug 17:13:942769. [Abstract]
- Front Pharmacol. 2022 May 20;13:911945. [Abstract]
- Front Pharmacol. 2021 Oct 18;12:709526. [Abstract]
- Front Pharmacol. 2021 Mar 22;12:572463. [Abstract]
- Front Cell Infect Microbiol. 2021 Aug 12;11:662404. [Abstract]
- Cell Oncol (Dordr). 2021 Apr;44(2):329-343. [Abstract]
- Front Pharmacol. 2020 May 8:11:668. [Abstract]
- Front Pharmacol. 2018 Apr 19:9:377. [Abstract]
- Bioorg Chem. 2026 Jun 18:180:110129. [Abstract]
- Int Immunopharmacol. 2026 Jun 26:186:117064. [Abstract]
- Int Immunopharmacol. 2026 Apr 15:175:116446. [Abstract]
- Bioorg Chem. 2026 Jul 5:175:109788. [Abstract]
- Int Immunopharmacol. 2026 Apr 15:175:116421. [Abstract]
- Int Immunopharmacol. 2026 Apr 15:175:116423. [Abstract]
- Int Immunopharmacol. 2026 Mar 15:173:116250. [Abstract]
- Bioorg Chem. 2026 Mar:170:109509. [Abstract]
- Eur J Pharmacol. 2026 Jan 12:1011:178440. [Abstract]
- Int Immunopharmacol. 2025 Dec 27:170:116081. [Abstract]
- Int Immunopharmacol. 2026 Jan 1;168(Pt 2):115929. [Abstract]
- Int Immunopharmacol. 2025 Nov 20;168(Pt 2):115904. [Abstract]
- Int Immunopharmacol. 2026 Jan 1;168(Pt 1):115747. [Abstract]
- Eur J Pharmacol. 2025 Oct 21:1007:178274. [Abstract]
- Int Immunopharmacol. 2025 Sep 6:165:115445. [Abstract]
- Int Immunopharmacol. 2025 Jul 23:163:115262. [Abstract]
- Eur J Pharmacol. 2025 Sep 15:1003:177942. [Abstract]
- Int Immunopharmacol. 2025 Jun 17:161:115065. [Abstract]
- Int Immunopharmacol. 2025 Jun 8:161:115033. [Abstract]
- Int Immunopharmacol. 2025 Mar 29:154:114490. [Abstract]
- Bioorg Chem. 2025 Apr 8:160:108453. [Abstract]
- Int Immunopharmacol. 2025 Feb 3:149:114190. [Abstract]
- Int Immunopharmacol. 2024 Dec 9:145:113781. [Abstract]
- Mol Cancer Res. 2025 Mar 3;23(3):202-218. [Abstract]
- Int Immunopharmacol. 2024 Dec 4:145:113727. [Abstract]
- Int Immunopharmacol. 2024 Nov 16;143(Pt 3):113622. [Abstract]
- Int Immunopharmacol. 2024 Sep 18;142(Pt B):113186. [Abstract]
- Noncoding RNA Res. 2024 Aug 9:10:140-152. [Abstract]
- Eur J Pharmacol. 2024 Jul 31:980:176828. [Abstract]
- mBio. 2024 Mar 13;15(3):e0343323. [Abstract]
- mBio. 2023 Dec 19;14(6):e0168823. [Abstract]
- mBio. 2023 Oct 31;14(5):e0211023. [Abstract]
- Eur J Pharmacol. 2023 Jan 5:938:175411. [Abstract]
- mBio. 2022 Oct 26;13(5):e0143422. [Abstract]
- Eur J Pharmacol. 2022 Apr 5:920:174822. [Abstract]
- mBio. 2022 Feb 22;13(1):e0233021. [Abstract]
- Int Immunopharmacol. 2021 Aug:97:107688. [Abstract]
- Mol Cancer Res. 2020 Feb;18(2):204-215. [Abstract]
- Int J Cancer. 2020 Apr 1;146(7):1963-1978. [Abstract]
- Molecules. 2026 Mar 16;31(6):997. [Abstract]
- Toxicology. 2026 Jun:523:154429. [Abstract]
- Neuropharmacology. 2025 Nov 15:279:110638. [Abstract]
- Cancer Biol Ther. 2025 Dec;26(1):2478670. [Abstract]
- Toxicology. 2024 Dec:509:153982. [Abstract]
- J Med Virol. 2024 Oct;96(10):e29945. [Abstract]
- J Med Virol. 2024 Oct;96(10):e29955. [Abstract]
- J Med Virol. 2024 Sep;96(9):e29891. [Abstract]
- Toxicology. 2024 Mar:503:153742. [Abstract]
- Cancer Biol Ther. 2023 Dec 31;24(1):2230641. [Abstract]
- J Med Virol. 2023 Jan;95(1):e28203. [Abstract]
- Arthritis Res Ther. 2020 Nov 16;22(1):269. [Abstract]
- J Med Virol. 2020 Dec;92(12):3057-3066. [Abstract]
- Molecules. 2019 Jan 22;24(3):393. [Abstract]
- BMC Biol. 2025 May 28;23(1):143. [Abstract]
- Front Aging Neurosci. 2025 Mar 20:17:1516190. [Abstract]
- BMC Biol. 2024 Mar 25;22(1):71. [Abstract]
- Mol Oncol. 2022 Mar;16(5):1200-1217. [Abstract]
- Mol Oncol. 2023 Feb;17(2):344-364. [Abstract]
- Gene Ther. 2022 Jun;29(6):379-389. [Abstract]
- Front Microbiol. 2020 May 20;11:987. [Abstract]
- Front Microbiol. 2020 Jan 8;10:3040. [Abstract]
- Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):2882-2890. [Abstract]
- Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):2343-2351. [Abstract]
- J Integr Agric. 2026 Apr 7.
- Cancers (Basel). 2026 Apr 22;18(9):1327. [Abstract]
- J Dairy Sci. 2025 Sep;108(9):10151-10172. [Abstract]
- J Physiol. 2024 Oct;602(19):4959-4985. [Abstract]
- Cancers (Basel). 2023 Oct 18;15(20):5033. [Abstract]
- Cancers (Basel). 2023 Sep 1;15(17):4385. [Abstract]
- Clin Epigenetics. 2023 May 5;15(1):77. [Abstract]
- Cancers (Basel). 2022 Dec 16;14(24):6218. [Abstract]
- Cancers (Basel). 2021 Jul 11;13(14):3467. [Abstract]
- ACS Omega. 2026 Feb 2;11(6):9098-9106. [Abstract]
- ACS Omega. 2024 Dec 3;9(50):49739-49748. [Abstract]
- J Physiol Biochem. 2024 Aug;80(3):523-539. [Abstract]
- Front Cell Dev Biol. 2021 Dec 24;9:781792. [Abstract]
- Front Cell Dev Biol. 2021 Feb 5:8:621509. [Abstract]
- Front Cell Dev Biol. 2021 Mar 30:9:633259. [Abstract]
- Mol Neurobiol. 2021 May;58(5):1990-2004. [Abstract]
- Front Cell Dev Biol. 2020 May 7:8:287. [Abstract]
- Biochim Biophys Acta Mol Basis Dis. 2026 Aug;1872(6):168257. [Abstract]
- Biochim Biophys Acta Mol Basis Dis. 2026 Aug;1872(6):168237. [Abstract]
- FASEB J. 2026 Jun 30;40(12):e72071. [Abstract]
- FASEB J. 2026 Jun 15;40(11):e72019. [Abstract]
- FASEB J. 2026 May 31;40(10):e71905. [Abstract]
- FASEB J. 2026 Apr 15;40(7):e71743. [Abstract]
- FASEB J. 2026 Apr 15;40(7):e71755. [Abstract]
- Biochim Biophys Acta Mol Basis Dis. 2026 Apr 1;1872(5):168232. [Abstract]
- FASEB J. 2026 Mar 31;40(6):e71712. [Abstract]
- FEBS J. 2026 Mar 20. [Abstract]
- Poult Sci. 2026 Mar 17;105(6):106808. [Abstract]
- J Cell Mol Med. 2026 Jan;30(1):e71000. [Abstract]
- FASEB J. 2026 Jan 15;40(1):e71285. [Abstract]
- FASEB J. 2025 Dec 31;39(24):e71337. [Abstract]
- Mediators Inflamm. 2025 Nov 12:2025:8862449. [Abstract]
- J Cell Mol Med. 2025 Nov;29(21):e70928. [Abstract]
- FASEB J. 2025 Oct 31;39(20):e71096. [Abstract]
- FASEB J. 2025 Aug 31;39(16):e70945. [Abstract]
- Biochim Biophys Acta Mol Basis Dis. 2025 Jul 29;1871(8):167994. [Abstract]
- Biochim Biophys Acta Mol Basis Dis. 2025 Jun 9;1871(7):167947. [Abstract]
- FASEB J. 2025 May 31;39(10):e70670. [Abstract]
- Exp Neurol. 2025 Apr 26:115273. [Abstract]
- J Cell Mol Med. 2024 Nov;28(21):e70203. [Abstract]
- J Cell Mol Med. 2024 Sep;28(18):e70062. [Abstract]
- Drug Dev Res. 2024 Nov;85(7):e22263. [Abstract]
- FEBS J. 2025 Mar;292(5):1052-1069. [Abstract]
- Poult Sci. 2024 Dec;103(12):104238. [Abstract]
- Biochim Biophys Acta Mol Basis Dis. 2024 Jul 24:167440. [Abstract]
- Biochim Biophys Acta Mol Basis Dis. 2024 Mar;1870(3):167011. [Abstract]
- Chem Commun. 2024 Jan 16;60(6):686-689. [Abstract]
- J Ovarian Res. 2023 Nov 25;16(1):229. [Abstract]
- Mol Nutr Food Res. 2023 Dec;67(24):e2300444. [Abstract]
- Poult Sci. 2023 Nov;102(11):103026. [Abstract]
- FASEB J. 2023 Aug;37(8):e23083. [Abstract]
- J Cell Mol Med. 2024 Mar;28(5):e17856. [Abstract]
- FASEB J. 2023 Apr;37(4):e22848. [Abstract]
- FASEB J. 2023 Mar;37(3):e22832. [Abstract]
- J Cell Mol Med. 2022 Oct;26(19):5078-5094. [Abstract]
- J Cell Mol Med. 2022 Apr;26(8):2417-2427. [Abstract]
- Lab Invest. 2022 Jul;102(7):691-701. [Abstract]
- Lab Invest. 2022 Jun;102(6):613-620. [Abstract]
- J Cell Mol Med. 2022 Feb;26(3):893-912. [Abstract]
- Lab Invest. 2022 Apr;102(4):411-421. [Abstract]
- Bioengineered. 2022 Feb;13(2):3620-3633. [Abstract]
- Mol Nutr Food Res. 2021 Oct;65(19):e2100367. [Abstract]
- Biochim Biophys Acta Mol Basis Dis. 2021 Nov 1;1867(11):166213. [Abstract]
- J Cell Mol Med. 2021 Aug;25(16):7796-7808. [Abstract]
- J Cell Mol Med. 2021 Jun;25(12):5457-5469. [Abstract]
- FEBS J. 2021 Jul;288(14):4364-4381. [Abstract]
- J Cell Mol Med. 2020 Dec;24(23):14039-14049. [Abstract]
- Drug Dev Res. 2021 May;82(3):422-429. [Abstract]
- J Cell Mol Med. 2020 Dec;24(24):14171-14183. [Abstract]
- J Cell Mol Med. 2020 Oct;24(19):11512-11523. [Abstract]
- J Cell Mol Med. 2020 Nov;24(22):12994-13009. [Abstract]
- FASEB J. 2020 Aug;34(8):10966-10983. [Abstract]
- FASEB J. 2020 Jun;34(6):7631-7643. [Abstract]
- Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3322-3338. [Abstract]
- iScience. 2026 Jun 11;29(6):116226. [Abstract]
- Plants. 2026 May 11;15(10):1463. [Abstract]
- iScience. 2026 Apr 15;29(5):115739. [Abstract]
- iScience. 2026 Apr 17;29(5):115808. [Abstract]
- iScience. 2026 Mar 4;29(4):115223. [Abstract]
- iScience. 2026 Feb 5;29(3):114916. [Abstract]
- iScience. 2026 Jan 29;29(3):114840. [Abstract]
- J Inflamm (Lond). 2025 Dec 29;22(1):53. [Abstract]
- Oncol Res. 2025 Oct 22;33(11):3583-3603. [Abstract]
- iScience. 2025 Oct 27;28(11):113853. [Abstract]
- iScience. 2025 Oct 15;28(11):113775. [Abstract]
- Transl Oncol. 2025 Sep 29:62:102549. [Abstract]
- Transl Oncol. 2025 Sep 30:62:102553. [Abstract]
- iScience. 2025 Jul 7;28(8):113067. [Abstract]
- J Neuroendocrinol. 2024 Dec;36(12):e13448. [Abstract]
- J Lipid Res. 2024 Aug 20:100626. [Abstract]
- iScience. 2024 Aug 20;27(9):110757. [Abstract]
- iScience. 2024 Jun 4;27(7):110144. [Abstract]
- iScience. 2024 May 14;27(6):109974. [Abstract]
- iScience. 2024 Mar 29;27(6):109625. [Abstract]
- iScience. 2024 Mar 12;27(4):109497. [Abstract]
- iScience. 2024 Feb 16;27(3):109252. [Abstract]
- iScience. 2024 Jan 20;27(2):108982. [Abstract]
- iScience. 2023 Nov 20;26(12):108485. [Abstract]
- iScience. 2023 Jun 25;26(7):107206. [Abstract]
- iScience. 2023 May 9;26(6):106852. [Abstract]
- Tissue Eng Regen Med. 2023 Aug;20(5):705-723. [Abstract]
- iScience. 2023 Feb 27;26(3):106271. [Abstract]
- J Lipid Res. 2023 Mar;64(3):100342. [Abstract]
- Toxicol Sci. 2023 Feb 17;191(2):276-284. [Abstract]
- iScience. 2022 Jul 20;25(8):104773. [Abstract]
- iScience. 2022 Jun 7;25(7):104544. [Abstract]
- iScience. 2022 May 18;25(6):104416. [Abstract]
- Transl Oncol. 2022 Apr;18:101362. [Abstract]
- Transl Oncol. 2021 Sep;14(9):101148. [Abstract]
- Drug Metab Dispos. 2026 Apr;54(4):100274. [Abstract]
- Virol Sin. 2025 Aug;40(4):658-668. [Abstract]
- J Integr Med. 2025 Apr 22:S2095-4964(25)00050-0. [Abstract]
- J Funct Foods. 2025 Apr.
- J Cell Physiol. 2024 Aug 11:e31364. [Abstract]
- J Cell Physiol. 2024 Jul 9:e31368. [Abstract]
- Virol Sin. 2024 Jun 28:S1995-820X(24)00108-1. [Abstract]
- J Cell Physiol. 2024 Jun;239(6):e31259. [Abstract]
- Virol Sin. 2024 Apr;39(2):264-276. [Abstract]
- Virol Sin. 2023 Dec;38(6):900-910. [Abstract]
- J Cell Physiol. 2023 Sep;238(9):2147-2160. [Abstract]
- Antiviral Res. 2023 Jul:215:105621. [Abstract]
- Antiviral Res. 2023 Jul:215:105641. [Abstract]
- J Neurosci. 2023 Mar 1;43(9):1456-1474. [Abstract]
- J Neurosci. 2022 Jun 22;42(25):4958-4979. [Abstract]
- Front Mol Biosci. 2022 Jul 22:9:952608. [Abstract]
- Front Cell Neurosci. 2021 Mar 18;15:569424. [Abstract]
- J Cell Physiol. 2020 Dec;235(12):9538-9556. [Abstract]
- J Cell Physiol. 2020 Nov;235(11):8546-8557. [Abstract]
- J Cell Commun Signal. 2026 Jun 17;20(2):e70085. [Abstract]
- Neuromolecular Med. 2026 Jun 17;28(1):37. [Abstract]
- Sci Rep. 2026 Mar 31. [Abstract]
- Sci Rep. 2026 Feb 26;16(1):11190. [Abstract]
- J Biol Chem. 2026 Jan 20:111182. [Abstract]
- Fish Shellfish Immunol. 2026 Mar:170:111129. [Abstract]
- Sci Rep. 2025 Oct 14;15(1):35910. [Abstract]
- Sci Rep. 2025 Jun 6;15(1):19979. [Abstract]
- Sci Rep. 2025 Jun 4;15(1):19590. [Abstract]
- Sci Rep. 2025 Apr 27;15(1):14731. [Abstract]
- Neurotoxicology. 2025 Jul:109:1-10. [Abstract]
- Sci Rep. 2025 Feb 20;15(1):6160. [Abstract]
- Sci Rep. 2025 Mar 4;15(1):7553. [Abstract]
- J Biol Chem. 2025 Jan 8:108167. [Abstract]
- J Biol Chem. 2024 Jul 18:107592. [Abstract]
- Sci Rep. 2024 May 3;14(1):10160. [Abstract]
- J Biol Chem. 2024 May;300(5):107270. [Abstract]
- J Biol Chem. 2024 Apr;300(4):107152. [Abstract]
- J Biol Chem. 2024 Mar;300(3):105673. [Abstract]
- Fish Shellfish Immunol. 2023 Nov:142:109145. [Abstract]
- J Biol Chem. 2023 Oct;299(10):105215. [Abstract]
- J Biol Chem. 2023 Aug;299(8):104994. [Abstract]
- Fish Shellfish Immunol. 2023 Sep:140:108965. [Abstract]
- J Biol Chem. 2023 Jun;299(6):104829. [Abstract]
- J Biol Chem. 2023 Jun;299(6):104814. [Abstract]
- J Biol Chem. 2023 Jun;299(6):104723. [Abstract]
- J Biol Chem. 2023 May;299(5):104621. [Abstract]
- J Biol Chem. 2023 Mar;299(3):102990. [Abstract]
- Neurotoxicology. 2022 Jan:88:231-240. [Abstract]
- Oncol Rep. 2021 Dec;46(6):253. [Abstract]
- J Biol Chem. 2021 Nov;297(5):101307. [Abstract]
- Aging (Albany NY). 2021 Sep 8;13(17):21547-21570. [Abstract]
- J Biol Chem. 2021 Jan-Jun:296:100616. [Abstract]
- ACS Chem Neurosci. 2021 Apr 21;12(8):1343-1350. [Abstract]
- Oncol Rep. 2021 Apr;45(4):16. [Abstract]
- Aging. 2020 Oct 25;12(20):20047-20068. [Abstract]
- J Biol Chem. 2020 Dec 4;295(49):16826-16839. [Abstract]
- J Biol Chem. 2020 Oct 2;295(40):13798-13811. [Abstract]
- J Biol Chem. 2019 Nov 29;294(48):18504-18515. [Abstract]
- J Biol Chem. 2019 Jul 19;294(29):11119-11130. [Abstract]
- Aging (Albany NY). 2018 Oct 18;10(10):2783-2799. [Abstract]
- Sci Rep. 2017 Jul 5;7(1):4738. [Abstract]
- Sci Rep. 2017 Jun 7;7(1):2929. [Abstract]
- J Virol. 2026 Jun 10:e0047926. [Abstract]
- J Virol. 2026 Jun 23;100(6):e0206125. [Abstract]
- J Virol. 2026 Jun 15:e0048126. [Abstract]
- Microbiol Spectr. 2026 Jun 2;14(6):e0160825. [Abstract]
- J Virol. 2026 Apr 21;100(4):e0215625. [Abstract]
- J Virol. 2026 Apr 27:e0149525. [Abstract]
- J Virol. 2026 Apr 21;100(4):e0179325. [Abstract]
- Neurochem Res. 2026 Mar 25;51(2):124. [Abstract]
- J Virol. 2026 Apr 21;100(4):e0173925. [Abstract]
- J Virol. 2026 Mar 24;100(3):e0212125. [Abstract]
- J Virol. 2026 Mar 24;100(3):e0195225. [Abstract]
- J Virol. 2025 Dec 23;99(12):e0161625. [Abstract]
- Mol Divers. 2025 Nov 12. [Abstract]
- J Virol. 2025 Nov 25:e0164825. [Abstract]
- J Virol. 2025 Oct 15:e0108325. [Abstract]
- Microbiol Spectr. 2025 Oct 7;13(10):e0136225. [Abstract]
- J Virol. 2025 Sep 8:e0086825. [Abstract]
- J Virol. 2025 Aug 11:e0077125. [Abstract]
- Food Sci Nutr. 2025 Jul 13;13(7):e70632. [Abstract]
- J Virol. 2025 Aug 19;99(8):e0049825. [Abstract]
- Microbiol Spectr. 2025 Aug 5;13(8):e0018825. [Abstract]
- ACS Chem Biol. 2025 Jul 18;20(7):1646-1659. [Abstract]
- J Virol. 2025 Jun 23:e0009825. [Abstract]
- J Virol. 2025 Jun 24:e0007425. [Abstract]
- J Virol. 2025 May 21:e0035425. [Abstract]
- Neurochem Res. 2025 May 23;50(3):170. [Abstract]
- J Virol. 2025 Apr 25:e0230924. [Abstract]
- J Virol. 2025 Mar 31:e0016825. [Abstract]
- J Virol. 2025 Mar 27:e0013325. [Abstract]
- J Virol. 2025 Mar 18;99(3):e0198024. [Abstract]
- J Virol. 2024 Dec 6:e0144924. [Abstract]
- J Virol. 2024 Nov 27:e0127724. [Abstract]
- ACS Chem Biol. 2022 Dec 16;17(12):3389-3406. [Abstract]
- J Virol. 2024 Aug 30:e0133524. [Abstract]
- J Virol. 2024 Aug 28:e0078424. [Abstract]
- J Virol. 2024 Feb 20;98(2):e0190923. [Abstract]
- Microbiol Spectr. 2024 Jan 11;12(1):e0312423. [Abstract]
- J Virol. 2023 Aug 31;97(8):e0018123. [Abstract]
- J Virol. 2023 Jun 29;97(6):e0038223. [Abstract]
- J Virol. 2023 Apr 27;97(4):e0026423. [Abstract]
- J Virol. 2023 Mar 30;97(3):e0198422. [Abstract]
- J Virol. 2023 Feb 28;97(2):e0133822. [Abstract]
- Clin Immunol. 2023 Feb:247:109238. [Abstract]
- ACS Chem Biol. 2022 Oct 21;17(10):2734-2743. [Abstract]
- J Virol. 2022 Sep 14;96(17):e0094422. [Abstract]
- J Virol. 2022 Aug 10;96(15):e0080722. [Abstract]
- Cell Signal. 2026 Oct:146:112664. [Abstract]
- Cell Signal. 2026 Jul:143:112498. [Abstract]
- Biochim Biophys Acta Mol Cell Res. 2026 Apr;1873(4):120125. [Abstract]
- Cell Signal. 2026 Jun:142:112402. [Abstract]
- Cell Signal. 2025 Dec 26:139:112343. [Abstract]
- Mol Cell Biochem. 2025 Dec 1. [Abstract]
- Cell Signal. 2025 Dec 19:139:112333. [Abstract]
- Cytokine. 2025 Dec 6:198:157079. [Abstract]
- Cell Signal. 2025 Dec 26:139:112344. [Abstract]
- J Photochem Photobiol B. 2025 Dec 16:274:113343. [Abstract]
- Cell Signal. 2026 Feb:138:112246. [Abstract]
- Brain Res Bull. 2025 Nov:232:111619. [Abstract]
- Biochim Biophys Acta Mol Cell Res. 2025 Oct 30:120080. [Abstract]
- Biochim Biophys Acta Mol Cell Res. 2025 Sep 24;1873(1):120064. [Abstract]
- Cell Signal. 2025 Nov:135:112024. [Abstract]
- PLoS Genet. 2025 Jul 10;21(7):e1011794. [Abstract]
- Cell Signal. 2025 Nov:135:112016. [Abstract]
- Cell Signal. 2025 Jun 25:111962. [Abstract]
- Biochim Biophys Acta Mol Cell Res. 2025 May 12;1872(6):119988. [Abstract]
- Cell Signal. 2025 Apr 23:132:111834. [Abstract]
- Cell Signal. 2025 Jul:131:111735. [Abstract]
- Cell Signal. 2025 Jun:130:111669. [Abstract]
- Biochim Biophys Acta Mol Cell Res. 2025 Jan 27:119911. [Abstract]
- Cell Signal. 2025 Jan 21:127:111614. [Abstract]
- Cell Signal. 2025 Jan 5:111589. [Abstract]
- Cell Signal. 2024 Dec 8:127:111560. [Abstract]
- Cell Signal. 2024 Sep 7:111387. [Abstract]
- Mol Cell Biochem. 2025 Mar;480(3):1595-1610. [Abstract]
- Cell Signal. 2024 Sep:121:111235. [Abstract]
- Cell Signal. 2024 Jun 17:121:111264. [Abstract]
- Circ J. 2024 Sep 25;88(10):1697-1708. [Abstract]
- AAPS J. 2024 Apr 15;26(3):47. [Abstract]
- Cell Signal. 2024 May:117:111070. [Abstract]
- ACS Pharmacol Transl Sci. 2023 Sep 1;6(10):1347-1356. [Abstract]
- Biochim Biophys Acta Mol Cell Res. 2023 Dec;1870(8):119556. [Abstract]
- Biochim Biophys Acta Mol Cell Res. 2023 Oct;1870(7):119527. [Abstract]
- Cell Signal. 2023 Sep:109:110739. [Abstract]
- Cell Signal. 2023 Sep:109:110744. [Abstract]
- Biochim Biophys Acta Mol Cell Res. 2023 Jan 24;1870(3):119433. [Abstract]
- Cytokine. 2022 Mar:151:155789. [Abstract]
- Cell Signal. 2021 Jul:83:110002. [Abstract]
- Cell Signal. 2020 Aug;72:109654. [Abstract]
- Cell Signal. 2019 Feb:54:17-26. [Abstract]
- Bone. 2026 Mar 28:208:117869. [Abstract]
- Digestion. 2025 Jul 31:1-20. [Abstract]
- J Cell Sci. 2024 May 1;137(9):jcs261744. [Abstract]
- Heliyon. 2024 Apr 23;10(9):e29682. [Abstract]
- J Cell Sci. 2024 May 1;137(9):jcs261241. [Abstract]
- Heliyon. 2024 Apr 9;10(8):e29367. [Abstract]
- Heliyon. 2023 Jun 8;9(6):e17103. [Abstract]
- J Proteome Res. 2023 Jul 7;22(7):2352-2363. [Abstract]
- Am J Pathol. 2023 Sep;193(9):1248-1266. [Abstract]
- J Cell Sci. 2022 Jan 1;135(1):jcs258910. [Abstract]
- Am J Pathol. 2020 Dec;190(12):2464-2477. [Abstract]
- Bone. 2020 Jun;135:115326. [Abstract]
- J Nat Prod. 2020 Apr 24;83(4):1217-1228. [Abstract]
- J Cell Sci. 2018 Jun 11;131(11). pii: jcs216598. [Abstract]
- Exp Cell Res. 2026 Jun 15;459(2):115024. [Abstract]
- Viruses. 2026 May 18;18(5):567. [Abstract]
- MedScience. 2026 Mar 31. [Abstract]
- Exp Cell Res. 2026 Apr 15;457(2):114942. [Abstract]
- Vet Res. 2025 Sep 25;56(1):182. [Abstract]
- Exp Cell Res. 2025 Sep 1;452(1):114744. [Abstract]
- Viruses. 2025 Jul 22;17(8):1025. [Abstract]
- Vet Res. 2025 Jul 1;56(1):126. [Abstract]
- Vet Res. 2025 Jun 20;56(1):121. [Abstract]
- Exp Cell Res. 2025 May 28:114613. [Abstract]
- J Neuroimmune Pharmacol. 2025 May 8;20(1):52. [Abstract]
- Vet Res. 2025 May 21;56(1):104. [Abstract]
- Vet Res. 2025 Apr 30;56(1):94. [Abstract]
- Med Oncol. 2024 Nov 2;41(12):305. [Abstract]
- Viruses. 2024 Apr 20;16(4):643. [Abstract]
- Exp Cell Res. 2024 Mar 1;436(1):113956. [Abstract]
- Exp Cell Res. 2023 Dec 1;433(1):113805. [Abstract]
- Viruses. 2023 Jul 28;15(8):1644. [Abstract]
- Exp Cell Res. 2023 Aug 1;429(1):113644. [Abstract]
- Exp Cell Res. 2023 Jun 15;427(2):113587. [Abstract]
- Vet Res. 2023 Apr 2;54(1):30. [Abstract]
- Exp Cell Res. 2023 Apr 11;427(1):113601. [Abstract]
- Med Oncol. 2022 Dec 28;40(1):63. [Abstract]
- Vet Res. 2022 Jul 8;53(1):55. [Abstract]
- Metab Brain Dis. 2022 Feb;37(2):329-341. [Abstract]
- Food Chem Toxicol. 2022 Feb:160:112771. [Abstract]
- Exp Cell Res. 2022 Jan 1;410(1):112955. [Abstract]
- Exp Cell Res. 2021 Nov 15;408(2):112868. [Abstract]
- Exp Cell Res. 2021 Oct 1;407(1):112799. [Abstract]
- Mol Med Rep. 2021 Sep;24(3):629. [Abstract]
- Exp Cell Res. 2021 May 1;402(1):112552. [Abstract]
- Microb Pathog. 2021 Apr:153:104788. [Abstract]
- Med Oncol. 2020 Nov 19;37(12):116. [Abstract]
- Food Chem Toxicol. 2020 Jun;140:111329. [Abstract]
- Viruses. 2019 Dec 30;12(1):43. [Abstract]
- Viruses. 2019 Nov 30;11(12):1112. [Abstract]
- Cell Cycle. 2026 Dec;25(1):1-15. [Abstract]
- Acta Biochim Biophys Sin (Shanghai). 2026 Apr 30;Vol.(1):fpage-lpage. [Abstract]
- Andrology. 2025 Jul 2. [Abstract]
- Toxicol Appl Pharmacol. 2025 May 31:502:117424. [Abstract]
- J Immunol. 2025 May 20:vkaf089. [Abstract]
- J Immunol. 2024 Nov 15;213(10):1467-1478. [Abstract]
- Am J Physiol Renal Physiol. 2024 Aug 1;327(2):F290-F303. [Abstract]
- Biologics. 2024 Jul 4:18:181-193. [Abstract]
- J Hepatocell Carcinoma. 2023 Aug 3:10:1281-1293. [Abstract]
- Toxicol Appl Pharmacol. 2023 Jul 15:471:116568. [Abstract]
- J Neurosci Res. 2023 Jun;101(6):930-951. [Abstract]
- J Immunol. 2023 Mar 15;210(6):786-794. [Abstract]
- Pathol Int. 2023 Mar;73(3):109-119. [Abstract]
- BMC Cancer. 2021 Nov 5;21(1):1181. [Abstract]
- BMC Cancer. 2021 Oct 13;21(1):1101. [Abstract]
- Front Physiol. 2021 Feb 19;12:609674. [Abstract]
- Toxicol Appl Pharmacol. 2019 Oct 1:380:114696. [Abstract]
- PLoS Negl Trop Dis. 2019 Aug 20;13(8):e0007681. [Abstract]
- Cell Cycle. 2018;17(13):1591-1601. [Abstract]
- Appl Biochem Biotechnol. 2026 Jul;198(7):5045-5066. [Abstract]
- Chem Biol Drug Des. 2026 Apr;107(4):e70284. [Abstract]
- Appl Biochem Biotechnol. 2026 Mar 24. [Abstract]
- Cancer Res Commun. 2026 Mar 1;6(3):616-629. [Abstract]
- Appl Biochem Biotechnol. 2025 Jul 18. [Abstract]
- Chem Biol Drug Des. 2025 May;105(5):e70116. [Abstract]
- Biochim Biophys Acta Mol Cell Biol Lipids. 2025 Apr 26:159618. [Abstract]
- Appl Biochem Biotechnol. 2025 Jun;197(6):3871-3889. [Abstract]
- Chem Biol Drug Des. 2024 Aug;104(2):e14560. [Abstract]
- Chem Asian J. 2024 Sep 2:e202400824. [Abstract]
- Front Oncol. 2022 Sep 23;12:868866. [Abstract]
- Stem Cells Int. 2022 Sep 30:2022:3705637. [Abstract]
- Appl Biochem Biotechnol. 2022 Apr;194(4):1621-1635. [Abstract]
- Front Oncol. 2021 Feb 23;11:615568. [Abstract]
- IUBMB Life. 2026 Mar;78(3):e70094. [Abstract]
- Pathol Res Pract. 2026 May:281:156400. [Abstract]
- Mol Carcinog. 2026 Apr;65(4):407-421. [Abstract]
- Pathol Res Pract. 2026 Mar:279:156366. [Abstract]
- Pathol Res Pract. 2026 Apr:280:156375. [Abstract]
- Mol Carcinog. 2025 Oct 27. [Abstract]
- Pathol Res Pract. 2026 Jan:277:156297. [Abstract]
- Mol Carcinog. 2025 Jan;64(1):192-208. [Abstract]
- Mol Carcinog. 2024 Sep;63(9):1750-1767. [Abstract]
- Mol Carcinog. 2024 Jan;63(1):61-74. [Abstract]
- J Pharm Pharmacol. 2023 Jun 5;75(6):784-805. [Abstract]
- Clin Exp Metastasis. 2023 Feb;40(1):79-93. [Abstract]
- J Cancer. 2022 Mar 28;13(7):2061-2073. [Abstract]
- Int J Med Sci. 2022 Mar 6;19(3):525-536. [Abstract]
- Int J Med Sci. 2022 Jan 1;19(2):274-285. [Abstract]
- Hum Mol Genet. 2022 Jun 22;31(12):2035-2048. [Abstract]
- Environ Toxicol. 2022 Mar;37(3):603-611. [Abstract]
- J Cancer. 2022; 13(2):641-652.
- Hum Exp Toxicol. 2021 Nov;40(11):1985-1997. [Abstract]
- Int J Med Sci. 2021 Jan 1;18(1):245-255. [Abstract]
- Int J Med Sci. 2020 Jun 29;17(11):1652-1664. [Abstract]
- J Inorg Biochem. 2017 Oct:175:92-100. [Abstract]
- Cancer Med. 2026 Jun;15(6):e71772. [Abstract]
- Hum Cell. 2025 Oct 14;38(6):178. [Abstract]
- Naunyn Schmiedebergs Arch Pharmacol. 2025 Oct 31. [Abstract]
- Cell Biol Int. 2025 Aug 27. [Abstract]
- Cell Biol Int. 2025 Mar 24. [Abstract]
- J Alzheimers Dis. 2025 Jan 15:13872877241303949. [Abstract]
- Front Biosci (Landmark Ed). 2025 Jan 21;30(1):26426. [Abstract]
- Funct Integr Genomics. 2024 Sep 30;24(5):178. [Abstract]
- Glycoconj J. 2024 Oct;41(4-5):229-240. [Abstract]
- Kaohsiung J Med Sci. 2024 Oct;40(10):890-902. [Abstract]
- Immunol Res. 2024 Aug;72(4):741-753. [Abstract]
- Kaohsiung J Med Sci. 2024 Mar;40(3):255-268. [Abstract]
- Kaohsiung J Med Sci. 2024 Feb;40(2):161-174. [Abstract]
- Cell Biol Int. 2023 Jul;47(7):1209-1221. [Abstract]
- Cancer Med. 2022 May 2. [Abstract]
- Clin Oral Investig. 2021 May;25(5):2915-2923. [Abstract]
- J Alzheimers Dis. 2020;76(2):623-641. [Abstract]
- J Alzheimers Dis. 2020;76(2):491-504. [Abstract]
- Ren Fail. 2026 Dec;48(1):2668134. [Abstract]
- Biol Reprod. 2026 May 11:ioag090. [Abstract]
- Mol Immunol. 2026 Apr:192:32-44. [Abstract]
- Biol Reprod. 2025 Apr 14:ioaf088. [Abstract]
- J Tradit Complement Med. 2025 Feb 7;15(4):434-445. [Abstract]
- Mol Pharmacol. 2025 Mar;107(3):100021. [Abstract]
- J Tradit Complement Med. 2024 Aug 21;15(2):170-181. [Abstract]
- Arch Biochem Biophys. 2023 Jul 1:742:109640. [Abstract]
- Arch Biochem Biophys. 2023 Jul 15:743:109642. [Abstract]
- J Innate Immun. 2023;15(1):204-221. [Abstract]
- Arch Biochem Biophys. 2022 May 30;721:109194. [Abstract]
- Arch Biochem Biophys. 2022 Aug 15:725:109299. [Abstract]
- FEBS Lett. 2022 Apr;596(7):924-937. [Abstract]
- FEBS Lett. 2021 Jan;595(2):169-182. [Abstract]
- FEBS Lett. 2020 Feb;594(3):497-508. [Abstract]
- Mol Immunol. 2018 Dec:104:69-78. [Abstract]
- Discov Oncol. 2025 Jul 2;16(1):1253. [Abstract]
- Free Radic Res. 2025 Mar;59(3):215-225. [Abstract]
- Carcinogenesis. 2024 Sep 5:bgae060. [Abstract]
- J Anim Sci. 2024 Aug 19:skae239. [Abstract]
- Am J Cancer Res. 2024 Feb 15;14(2):727-743. [Abstract]
- Oral Dis. 2024 Oct;30(7):4255-4265. [Abstract]
- Am J Cancer Res. 2023 Aug 15;13(8):3705-3720. [Abstract]
- Discov Oncol. 2023 May 27;14(1):83. [Abstract]
- Insects. 2023 Mar 23;14(4):309. [Abstract]
- Am J Cancer Res. 2022 Mar 15;12(3):1069-1087. [Abstract]
- Am J Cancer Res. 2021 May 15;11(5):2238-2251. [Abstract]
- J Pharmacol Sci. 2021 Aug;146(4):249-258. [Abstract]
- Am J Cancer Res. 2020 Oct 1;10(10):3440-3457. [Abstract]
- Front Genet. 2025 Oct 27:16:1692704. [Abstract]
- J Appl Toxicol. 2025 Aug 11. [Abstract]
- J Orthop Surg Res. 2025 May 26;20(1):517. [Abstract]
- J Biochem Mol Toxicol. 2024 Jun;38(6):e23743. [Abstract]
- J Cancer Res Clin Oncol. 2024 Jun 6;150(6):294. [Abstract]
- Neuroscience. 2024 May 10:549:101-109. [Abstract]
- Neuroscience. 2023 Oct 15:530:144-157. [Abstract]
- BMC Pulm Med. 2021 Nov 22;21(1):379. [Abstract]
- Int J Biochem Cell Biol. 2020 Jan;118:105644. [Abstract]
- Vet Microbiol. 2026 Aug:319:111066. [Abstract]
- Vet Microbiol. 2026 May:316:110993. [Abstract]
- Vet Microbiol. 2026 May:316:111004. [Abstract]
- Immun Inflamm Dis. 2026 Feb;14(2):e70353. [Abstract]
- Virus Res. 2026 Mar:365:199699. [Abstract]
- Vet Microbiol. 2026 Feb:313:110875. [Abstract]
- Vet Microbiol. 2025 Dec 31:313:110865. [Abstract]
- Vet Microbiol. 2025 Dec 10:312:110836. [Abstract]
- Vet Microbiol. 2025 Nov 10:312:110791. [Abstract]
- Vet Microbiol. 2025 Sep 6:310:110721. [Abstract]
- Vet Microbiol. 2025 Sep:308:110658. [Abstract]
- Invest New Drugs. 2025 Aug 4. [Abstract]
- Vet Microbiol. 2025 May 13:306:110562. [Abstract]
- Vet Microbiol. 2025 Apr:303:110444. [Abstract]
- Vet Microbiol. 2025 May:304:110456. [Abstract]
- Vet Microbiol. 2025 Jan 13:302:110393. [Abstract]
- Toxicol In Vitro. 2025 Jan 27:106014. [Abstract]
- Vet Microbiol. 2024 Nov:298:110290. [Abstract]
- Vet Microbiol. 2024 Aug 15:298:110219. [Abstract]
- Toxicol In Vitro. 2024 Jun 8:105875. [Abstract]
- Vet Microbiol. 2023 Jul:282:109767. [Abstract]
- Anal Cell Pathol. 2023 Mar 28:2023:5617875. [Abstract]
- Vet Microbiol. 2023 Apr:279:109666. [Abstract]
- Virus Res. 2021 Jan 2;291:198220. [Abstract]
- Toxicol In Vitro. 2020 Dec;69:104971. [Abstract]
- Vet Microbiol. 2019 Dec;239:108456. [Abstract]
- Exp Eye Res. 2019 Nov;188:107782. [Abstract]
- Brain Res. 2026 Mar 1:1874:150163. [Abstract]
- PLoS One. 2025 Oct 8;20(10):e0332761. [Abstract]
- PLoS One. 2025 Jan 7;20(1):e0316912. [Abstract]
- PLoS One. 2023 Feb 7;18(2):e0281536. [Abstract]
- Adv Ther (Weinh). 2200160.
- Cancer Manag Res. 2020 Nov 6;12:11371-11382. [Abstract]
- Tissue Cell. 2026 Jun 17:103:103703. [Abstract]
- Tissue Cell. 2026 Jun:100:103359. [Abstract]
- J Steroid Biochem Mol Biol. 2026 Jan 29:259:106948. [Abstract]
- Tissue Cell. 2025 Dec 21:99:103291. [Abstract]
- Theriogenology. 2025 Dec 24:254:117795. [Abstract]
- Reprod Sci. 2025 Dec 29. [Abstract]
- Tissue Cell. 2025 Nov 27:99:103253. [Abstract]
- Clin Exp Pharmacol Physiol. 2025 Nov;52(11):e70077. [Abstract]
- Mol Biotechnol. 2025 Feb 7. [Abstract]
- J Steroid Biochem Mol Biol. 2025 Jan 9:106673. [Abstract]
- J Steroid Biochem Mol Biol. 2024 Aug 13:106599. [Abstract]
- Clin Transl Oncol. 2023 Jan;25(1):243-255. [Abstract]
- Prostate. 2022 Jun;82(8):917-932. [Abstract]
- J Cardiovasc Transl Res. 2022 Aug;15(4):740-753. [Abstract]
- Immunol Invest. 2026 Jun 22:1-21. [Abstract]
- Purinergic Signal. 2026 Mar 24;22(2):31. [Abstract]
- Toxicon. 2026 Apr 1:273:109018. [Abstract]
- Gene. 2025 Nov 20:972:149817. [Abstract]
- Virology. 2025 Sep:610:110626. [Abstract]
- Gene. 2025 Apr 10:149483. [Abstract]
- Gene. 2024 Mar 1:897:148085. [Abstract]
- Ann Hematol. 2023 Nov;102(11):3153-3165. [Abstract]
- Am J Reprod Immunol. 2023 Mar;89(3):e13659. [Abstract]
- Eur J Neurosci. 2023 Jan;57(2):217-232. [Abstract]
- Gene. 2022 Jul 20;832:146559. [Abstract]
- Vet Sci. 2025 May 19;12(5):490. [Abstract]
- Thorac Cancer. 2024 May 8. [Abstract]
- Exp Ther Med. 2024 Apr 17;27(6):255. [Abstract]
- Exp Ther Med. 2023 Mar 30;25(5):224. [Abstract]
- J Oral Pathol Med. 2023 May;52(5):448-455. [Abstract]
- J Recept Signal Transduct Res. 2022 Dec;42(6):588-598. [Abstract]
- FEBS Open Bio. 2021 Feb;11(2):456-467. [Abstract]
- Exp Ther Med. 2020 Dec;20(6):249. [Abstract]
- Insect Mol Biol. 2020 Feb;29(1):104-111. [Abstract]
- Cell Div. 2026 May 18;21(1):15. [Abstract]
- Biochemistry (Mosc). 2026 May;91(5):789-799. [Abstract]
- Curr Protoc. 2025 Dec 13.
- Biochem Biophys Res Commun. 2025 Nov 25:794:153046. [Abstract]
- J Gene Med. 2025 Aug;27(8):e70032. [Abstract]
- J Mol Histol. 2025 Jul 23;56(4):235. [Abstract]
- J Mol Histol. 2025 Jul 31;56(4):245. [Abstract]
- Biochem Biophys Res Commun. 2025 Jun 21:777:152244. [Abstract]
- Biochem Biophys Res Commun. 2025 Jan 20:749:151370. [Abstract]
- Bioorg Med Chem Lett. 2024 Dec 5:130058. [Abstract]
- Biochem Biophys Res Commun. 2024 May 14:708:149798. [Abstract]
- Oncol Lett. 2024 Jan 5;27(2):83. [Abstract]
- Biochem Biophys Res Commun. 2024 Jan 22:693:149324. [Abstract]
- Biochem Biophys Res Commun. 2023 Feb 12:644:112-121. [Abstract]
- Biochem Biophys Res Commun. 2022 Nov 5:628:76-83. [Abstract]
- Biochem Biophys Res Commun. 2022 Feb 19:593:122-128. [Abstract]
- Biochem Biophys Res Commun. 2020 Feb 18;S0006-291X(20)30325-9. [Abstract]
- Biochem Biophys Res Commun. 2020 Apr 2;524(2):280-287. [Abstract]
- Biochem Biophys Res Commun. 2019 Sep 17;517(2):376-382. [Abstract]
- Biochem Biophys Res Commun. 2019 Feb 12;509(3):797-802. [Abstract]
- Oncol Lett. 2018 Nov;16(5):5900-5906. [Abstract]
- Biochem Biophys Res Commun. 2017 Sep 2;490(4):1168-1175. [Abstract]
- Biochem Biophys Res Commun. 2016 Apr 29;473(2):396-402. [Abstract]
- J Diabetes Metab Disord. 2026 May 25;25(1):142. [Abstract]
- Genet Res (Camb). 2025 Dec 8:2025:3061843. [Abstract]
- Biochem Cell Biol. 2025 Jul 7. [Abstract]
- Arch Dermatol Res. 2024 Jun 1;316(6):323. [Abstract]
- FASEB Bioadv. 2024 Sep 9;6(11):555-564. [Abstract]
- BMC Med Genomics. 2024 Jan 26;17(1):36. [Abstract]
- J Gastrointest Oncol. 2020 Dec;11(6):1200-1213. [Abstract]
- J Thorac Dis. 2026 Mar 31;18(3):243. [Abstract]
- J Thorac Dis. 2025 Aug 31;17(8):6127-6150. [Abstract]
- Arch Insect Biochem Physiol. 2021 Jul;107(3):e21823. [Abstract]
- Biol Open. 2026 Jan 1;15(1):bio062179. [Abstract]
- Cell J. 2023 Feb 1;25(2):118-125. [Abstract]
- Transl Cancer Res. 2024 Jan 31;13(1):112-136. [Abstract]
- Psychogeriatrics. 2023 Jan;23(1):32-44. [Abstract]
- Transl Cancer Res. 2019 Oct;8(6):2449-2460. [Abstract]
- Asian Pac J Trop Bio. 2020;10:224-31.
- Am J Transl Res. 2026 May 15;18(5):4474-4491. [Abstract]
- Biochem Genet. 2026 Feb 21. [Abstract]
- Biochem Genet. 2026 Jan 3. [Abstract]
- Biochem Genet. 2025 Aug;63(4):3206-3219. [Abstract]
- Biochem Genet. 2024 Aug;62(4):3245-3259. [Abstract]
- Neurol Res. 2024 Jul 15:1-10. [Abstract]
- J Cardiothorac Surg. 2023 Mar 24;18(1):92. [Abstract]
- Mol Cell Toxicol. 2025 Nov 6.
- Biosci Biotechnol Biochem. 2024 Nov 22;88(12):1432-1441. [Abstract]
- Can J Physiol Pharmacol. 2017 May;95(5):481-491. [Abstract]
- Protein Pept Lett. 2026 Mar 2. [Abstract]
- bioRxiv. 2026 Jun 19.
- Res Sq. 2026 Jun 22.
- Autophagy Rep. 2026 Jun 12;5(1):2685472. [Abstract]
- Res Sq. 2026 Jun 16.
- bioRxiv. 2026 Jun 10.
- Res Sq. 2026 Jun 17.
- Lehigh University. 2026.
- University of Georgia. 2026.
- bioRxiv. 2026 Jun 23.
- bioRxiv. 2026 Jun 19.
- bioRxiv. 2026 May 2.
- bioRxiv. 2026 May 18:2026.05.16.725645. [Abstract]
- Res Sq. 2026 May 18.
- Res Sq. 2026 May 20.
- bioRxiv. 2026 May 14:2026.05.12.724395. [Abstract]
- Res Sq. 2026 May 21.
- Res Sq. 2026 May 18.
- bioRxiv. 2026 May 26.
- SSRN. 2026 Apr 21.
- Res Sq. 2026 Apr 21.
- Translational Dental Research. 2026 Apr 15.
- Res Sq. 2026 Apr 20.
- Res Sq. 2026 Apr 28.
- Res Sq. 2026 Apr 1.
- Res Sq. 2026 Apr 29.
- bioRxiv. 2026 Apr 19.
- Complutense University of Madrid. 2026.
- bioRxiv. 2026 Mar 17:2026.03.13.711603. [Abstract]
- Res Sq. 2026 Mar 5.
- bioRxiv. 2026 Mar 18.
- bioRxiv. 2026 Mar 26.
- SSRN. 2026 Mar 6.
- bioRxiv. 2026 Mar 29.
- Res Sq. 2026 Feb 23.
- bioRxiv. 2026 Feb 11.
- Res Sq. 2026 Feb 12.
- bioRxiv. 2026 Jan 13.
- bioRxiv. 2026 Jan 10.
- bioRxiv. 2026 Jan 2.
- bioRxiv. 2026 Jan 29.
- SSRN. 2026 Jan 7.
- bioRxiv. 2025 Dec 18:2025.12.18.695067. [Abstract]
- Res Sq. 2025 Dec 18.
- bioRxiv. 2025 Dec 25.
- Res Sq. 2025 Dec 3.
- bioRxiv. 2025 Dec 25.
- bioRxiv. 2025 Dec 27.
- Res Sq. 2025 Nov 10.
- SSRN. 2025 Nov 15.
- bioRxiv. 2025 Oct 24.
- bioRxiv. 2025 Oct 22.
- bioRxiv. 2025 Sep 4.
- bioRxiv. 2025 Sep 2.
- Patent. US20250276069A1.
- bioRxiv. 2025 Aug 20:2025.08.19.671158. [Abstract]
- Hong Kong Polytechnic University. 2025.
- SSRN. 2025 Aug 13.
- Res Sq. 2025 Aug 05.
- SSRN. 2025 Aug 6.
- bioRxiv. 2025 July 03.
- Washington State University. 2025.
- SSRN. 2025 Jul 2.
- bioRxiv. 2025 Jun 19.
- bioRxiv. 2025 May 09.
- bioRxiv. 2025 May 05.
- University of Pittsburgh. 2025.
- Res Sq. 2025 May 07.
- Phytomed Plus. 2025 Aug.
- Res Sq. 2025 May 29.
- Res Sq. 2025 May 05.
- Res Sq. 2025 May 21.
- SSRN. 2025 Apr 10.
- Res Sq. 2025 Mar 26.
- University of Washington. 2025.
- bioRxiv. 2025 April 03.
- bioRxiv. 2025 April 01.
- Res Sq. 2025 Feb 25.
- bioRxiv. 2025 March 03.
- bioRxiv. 2025 March 16.
- SSRN. 2025 Mar 20.
- SSRN. 2025 Feb 19.
- bioRxiv. 2025 March 25.
- bioRxiv. 2025 January 07.
- Comparative Immunology Reports. 2025 Jun.
- Research Square Preprint. 2024 Dec 31.
- Authorea. 2025 Jan 18.
- Research Square Preprint. 2025 Jan 08.
- SSRN. 2025 Jan 27.
- Research Square Preprint. 2024 Dec 18.
- SSRN. 2024 Nov 5.
- bioRxiv. 2024 November 19.
- Res Sq. 2024 Nov 18.
- bioRxiv. 2024 September 24.
- Res Sq. 2024 Nov 10.
- SSRN. 2024 Oct 30.
- University of Liege. 2024.
- Res Sq. 2024 Nov 15.
- bioRxiv. 2024 October 19.
- Res Sq. 2024 Nov 25.
- bioRxiv. 2024 Dec 5:2024.12.05.627000. [Abstract]
- bioRxiv. 2024 September 26.
- bioRxiv. 2024 Oct 23:2024.10.20.619300. [Abstract]
- bioRxiv. 2024 Sep 27:2024.09.25.615094. [Abstract]
- bioRxiv. 2024 July 27.
- bioRxiv. 2024 August 30.
- bioRxiv. 2024 September 10.
- SSRN. 2024 Sep 20.
- Res Sq. 2024 Jul 12.
- bioRxiv. 2024 June 12.
- Res Sq. 2024 Jun 13.
- Res Sq. 2024 Jun 28.
- SSRN. 2024 Jun 18.
- Res Sq. 2024 Jun 25.
- Res Sq. 2024 May 22.
- J Tradit Chinese Medical Sci. 2024 Jun 5.
- Res Sq. 2024 Jun 04.
- Research Square Preprint. 2024 May 2.
- SSRN. 2024 Apr 19.
- bioRxiv. 2024 Mar 29.
- bioRxiv. 2025 Apr 28:2024.04.18.590103. [Abstract]
- bioRxiv. 2024 Apr 10.
- Research Square Preprint. 2024 Mar 19.
- Research Square Preprint. 2024 Mar 19.
- bioRxiv. 2024 Feb 7.
- Research Square Preprint. 2024 Jan 2.
- Research Square Preprint. 2023 Dec 29.
- bioRxiv. 2023 Dec 20.
- Research Square Preprint. 2023 Oct 31.
- bioRxiv. 2023 Sep 28:2023.09.28.559973. [Abstract]
- bioRxiv. 2023 Oct 4.
- Research Square Preprint. 2023 Oct 3.
- SSRN. 2023 Oct 12.
- SSRN. 2023 Sep 5.
- Research Square Preprint. 2023 Sep 11.
- SSRN. 2023 Sep 18.
- SSRN. 2023 Sep 27.
- Research Square Preprint. 2023 Aug 1.
- Research Square Preprint. 2023 Aug 4.
- SSRN. 2023 Aug 4.
- Research Square Preprint. 2023 Aug 28.
- Research Square Preprint. 2023 Jul 31.
- SSRN. 2023 Aug 1.
- Research Square Preprint. 2023 Jun 26.
- SSRN. 2023 Jul 28.
- SSRN. 2023 Jun 22.
- Research Square Preprint. 2023 Jun 1.
- Research Square Preprint. 2023 Jun 22.
- bioRxiv. 2023 Jun 5.
- Research Square Preprint. 2023 May 22.
- Research Square Preprint. 2023 May 4.
- Research Square Preprint. 2023 May 24.
- Research Square Preprint. 2023 May 8.
- bioRxiv. 2023 May 1.
- Research Square Preprint. 2023 May 26.
- Research Square Preprint. 2023 Apr 11.
- Research Square Preprint. 2023 Apr 11.
- Research Square Print. 2023 Mar 24.
- Research Square Print. 2023 Mar 17.
- Research Square Print. 2023 Mar 24.
- bioRxiv. 2023 Mar 18.
- Research Square Print. 2023 Feb 3.
- Research Square Print. 2023 Feb 9th.
- Research Square Print. 2023 Feb 21.
- Research Square Print. 2023 Jan 24.
- Research Square Print. 2023 Jan 24.
- J Oncol. 2023 Jan 4:2023:8483325. [Abstract]
- Research Square Print. 2023 Jan 9.
- Research Square Print. November 29th, 2022.
- Research Square Print. December 1st, 2022.
- Research Square Print. November 30th, 2022.
- Research Square Print. 2022.
- Research Square Print. November 29th, 2022.
- SSRN. 7 Nov 2022
- Research Square Print. October 10th, 2022.
- Research Square Print. October 13th, 2022.
- Research Square Print. October 25th, 2022.
- Research Square Print. September 9th, 2022.
- Research Square Print. 2022 Aug.
- Research Square Print. 2022 Jul.
- Research Square Preprint. 2022 May.
- Research Square Preprint. 2022 Feb.
- Chemrxiv. Feb 03, 2022.
- Research Square Preprint. 2022 Jan.
- University of Coruña. 2022 Jan.
- Research Square Preprint. 2021 Aug.
- Research Square Preprint. 2021 Aug.
- Research Square Preprint. 2021 Jul.
- Research Square Preprint. 2021 May.
- Research Square Preprint. 2021 May.
- Research Square Preprint. 2021 Jan.
- Research Square Preprint. 2020 Nov.
- Ann Transl Med. 2020 Oct;8(20):1304. [Abstract]
- bioRxiv. 2020 Jul.
- bioRxiv. 2020 Jul.
- bioRxiv. 2020 Jun.
- bioRxiv. 2020 Jan.
- University Regensburg. 2018 Jun.
- Université de Montréal. Octobre 2017.
- Oncotarget. 2016 May 10;7(19):27176-84. [Abstract]
-
Cell Proliferation/Viability Assay
-
WB
-
WB
-
WB
-
WB
Biologische Aktivität
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| COS-7 | IC50 |
<10 μM
Compound: MG132
|
Cytotoxicity against african green monkey COS7 cells by XTT method
Cytotoxicity against african green monkey COS7 cells by XTT method
|
[PMID: 18088097] |
| HCT-116 | IC50 |
0.82 μM
Compound: MG132
|
Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 31312413] |
| HEK293 | IC50 |
0.009 μM
Compound: MG132
|
Inhibition of chymotrypsin-like activity of proteasome beta-5 subunit in HEK293 cells using Suc-LLVY-Glo as substrate incubated for 2 hrs prior to substrate addition measured after 10 mins by cell-based proteasome-Glo beta5 assay
Inhibition of chymotrypsin-like activity of proteasome beta-5 subunit in HEK293 cells using Suc-LLVY-Glo as substrate incubated for 2 hrs prior to substrate addition measured after 10 mins by cell-based proteasome-Glo beta5 assay
|
[PMID: 23540790] |
| HEK293 | IC50 |
0.6 μM
Compound: MG132
|
Inhibition of postacid activity of 20s proteasome beta-1 subunit in HEK293 cells using Z-nLPnLD-Glo as substrate incubated for 2 hrs prior to substrate addition measured after 10 mins by cell-based proteasome-Glo beta1 assay
Inhibition of postacid activity of 20s proteasome beta-1 subunit in HEK293 cells using Z-nLPnLD-Glo as substrate incubated for 2 hrs prior to substrate addition measured after 10 mins by cell-based proteasome-Glo beta1 assay
|
[PMID: 23540790] |
| HL-60 | IC50 |
0.068 μM
Compound: MG132
|
Inhibitory concentration to inhibit chymotrypsin-like activity of 20S proteasome prepared from human leukemia HL-60 cells was determined
Inhibitory concentration to inhibit chymotrypsin-like activity of 20S proteasome prepared from human leukemia HL-60 cells was determined
|
[PMID: 15780623] |
| HL-60 | IC50 |
1.4 μM
Compound: MG132
|
Inhibitory concentration to inhibit the PGPH activity of 20S proteasome prepared from human leukemia HL-60 cells was determined
Inhibitory concentration to inhibit the PGPH activity of 20S proteasome prepared from human leukemia HL-60 cells was determined
|
[PMID: 15780623] |
| HL-60 | IC50 |
4.5 μM
Compound: MG132
|
Inhibitory concentration to inhibit trypsin-like activity of 20S proteasome from human leukemia HL-60 cells was determined
Inhibitory concentration to inhibit trypsin-like activity of 20S proteasome from human leukemia HL-60 cells was determined
|
[PMID: 15780623] |
| Huh-7 | IC50 |
<10 μM
Compound: MG132
|
Cytotoxicity against human HuH7 cells by XTT method
Cytotoxicity against human HuH7 cells by XTT method
|
[PMID: 18088097] |
| HUVEC | IC50 |
0.6 μM
Compound: 1, MG-132
|
Inhibition of TNFalpha stimulated human NF-kappaB-mediated beta lactamase gene expression in HUVEC
Inhibition of TNFalpha stimulated human NF-kappaB-mediated beta lactamase gene expression in HUVEC
|
[PMID: 18024113] |
| MCF-10A | IC50 |
0.29 μM
Compound: MG-132
|
Growth inhibition of human MCF10A cells after 72 hrs by CellTiter-Blue assay
Growth inhibition of human MCF10A cells after 72 hrs by CellTiter-Blue assay
|
[PMID: 24153206] |
| MCF7 | IC50 |
0.13 μM
Compound: MG-132
|
Growth inhibition of human MCF7 cells after 72 hrs by CellTiter-Blue assay
Growth inhibition of human MCF7 cells after 72 hrs by CellTiter-Blue assay
|
[PMID: 24153206] |
| MCF7 | IC50 |
0.3 μM
Compound: MG-132
|
Cytotoxicity against human MCF7 cells
Cytotoxicity against human MCF7 cells
|
[PMID: 18598018] |
| MDA-MB-231 | IC50 |
0.18 μM
Compound: MG-132
|
Growth inhibition of human MDA-MB-231 cells after 72 hrs by CellTiter-Blue assay
Growth inhibition of human MDA-MB-231 cells after 72 hrs by CellTiter-Blue assay
|
[PMID: 24153206] |
| MDA-MB-231 | IC50 |
0.25 μM
Compound: MG-132
|
Cytotoxicity against human MDA-MB-231 cells
Cytotoxicity against human MDA-MB-231 cells
|
[PMID: 18598018] |
| NCI-H23 | IC50 |
0.48 μM
Compound: MG-132
|
Cytotoxicity against human NCI-H23 cells after 72 hrs by CellTiter 96 AQueous one solution cell proliferation assay
Cytotoxicity against human NCI-H23 cells after 72 hrs by CellTiter 96 AQueous one solution cell proliferation assay
|
[PMID: 30964987] |
| NCI-H727 | IC50 |
0.98 μM
Compound: MG-132
|
Cytotoxicity against human NCI-H727 cells after 72 hrs by CellTiter 96 AQueous one solution cell proliferation assay
Cytotoxicity against human NCI-H727 cells after 72 hrs by CellTiter 96 AQueous one solution cell proliferation assay
|
[PMID: 30964987] |
| NCI-H929 | IC50 |
0.17 μM
Compound: MG-132
|
Cytotoxicity against human NCI-H929 cells after 3 days by Alamar blue assay
Cytotoxicity against human NCI-H929 cells after 3 days by Alamar blue assay
|
[PMID: 24625088] |
| OCI-Ly3 | IC50 |
>10 μM
Compound: 1, MG-132
|
Cytotoxicity against NF-kappaB overexpressing human OCI-Ly3 cells after 4 hrs
Cytotoxicity against NF-kappaB overexpressing human OCI-Ly3 cells after 4 hrs
|
[PMID: 18024113] |
| PC-3 | IC50 |
600 nM
Compound: 5b
|
Antiproliferative activity against human PC3 cell line
Antiproliferative activity against human PC3 cell line
|
[PMID: 16686537] |
| RAW264.7 | IC50 |
0.08 μg/mL
Compound: MG132
|
Inhibition of LPS and IFN-gamma-stimulated nitric oxide production in mouse RAW264.7 cells after 18 hrs by Griess method
Inhibition of LPS and IFN-gamma-stimulated nitric oxide production in mouse RAW264.7 cells after 18 hrs by Griess method
|
[PMID: 26351042] |
| RAW264.7 | IC50 |
0.08 μM
Compound: MG-132
|
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated NO production after 18 hrs by Griess reagent method
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated NO production after 18 hrs by Griess reagent method
|
[PMID: 22620677] |
| RAW264.7 | IC50 |
0.1 μM
Compound: MG132
|
Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells by Griess method
Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells by Griess method
|
[PMID: 24597894] |
| RAW264.7 | IC50 |
0.1 μM
Compound: MG132
|
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production incubated for 18 hrs by Griess method
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production incubated for 18 hrs by Griess method
|
[PMID: 33422907] |
| RAW264.7 | IC50 |
0.1 μM
Compound: MG-132
|
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 18 hrs by Griess method
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 18 hrs by Griess method
|
[PMID: 23819871] |
| RAW264.7 | IC50 |
0.1 μM
Compound: MG-132
|
Inhibition of LPS-stimulated NO production in mouse RAW264.7 cells after 18 hrs by Griess assay
Inhibition of LPS-stimulated NO production in mouse RAW264.7 cells after 18 hrs by Griess assay
|
[PMID: 24219809] |
| RAW264.7 | IC50 |
0.1 μM
Compound: MG-132
|
Inhibition of nitric oxide production in LPS-stimulated mouse RAW264.7 cells after 18 hrs by griess reagent based plate reader analysis
Inhibition of nitric oxide production in LPS-stimulated mouse RAW264.7 cells after 18 hrs by griess reagent based plate reader analysis
|
[PMID: 24697496] |
| RAW264.7 | IC50 |
0.15 μM
Compound: MG-132
|
Inhibition of nitric oxide production in LPS-stimulated mouse RAW264.7 cells measured after 18 hrs by Griess reagent based multilabel plate reader analysis
Inhibition of nitric oxide production in LPS-stimulated mouse RAW264.7 cells measured after 18 hrs by Griess reagent based multilabel plate reader analysis
|
[PMID: 23327668] |
| RAW264.7 | IC50 |
0.15 μM
Compound: MG-132
|
Inhibition of LPS-induced NO production in mouse RAW264.7 cells at 25 uM preincubated with compound followed by LPS challenge measured after 18 hrs by Griess method
Inhibition of LPS-induced NO production in mouse RAW264.7 cells at 25 uM preincubated with compound followed by LPS challenge measured after 18 hrs by Griess method
|
[PMID: 26757019] |
| RAW264.7 | IC50 |
0.16 μM
Compound: MG-132
|
Anti-inflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-stimulated NO production after 18 hrs by Griess reagent based assay
Anti-inflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-stimulated NO production after 18 hrs by Griess reagent based assay
|
[PMID: 30629435] |
| RAW264.7 | IC50 |
0.17 μg/mL
Compound: MG-132
|
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of IFNgamma-induced NO production after 5 mins by Greiss method
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of IFNgamma-induced NO production after 5 mins by Greiss method
|
[PMID: 22277277] |
| RAW264.7 | IC50 |
0.17 μg/mL
Compound: MG-132
|
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production after 5 mins by Greiss method
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production after 5 mins by Greiss method
|
[PMID: 22277277] |
| RAW264.7 | IC50 |
0.18 μM
Compound: MG-132
|
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 18 hrs by Griess assay
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 18 hrs by Griess assay
|
[PMID: 27203291] |
| RAW264.7 | IC50 |
0.2 μM
Compound: MG132
|
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated iNOS activity preincubated with compound for 24 hrs followed by LPS stimulation for 2 hrs and measured 2 hrs after NADPH addition by fluorescence based assay
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated iNOS activity preincubated with compound for 24 hrs followed by LPS stimulation for 2 hrs and measured 2 hrs after NADPH addition by fluorescence based assay
|
[PMID: 33454546] |
| RAW264.7 | IC50 |
0.2 μM
Compound: MG132
|
Inhibition of NO production in LPS-stimulated mouse RAW264.7 cells preincubated with compound for 24 hrs followed by LPS stimulation and measured after 2 hrs by Griess reagent-based assay
Inhibition of NO production in LPS-stimulated mouse RAW264.7 cells preincubated with compound for 24 hrs followed by LPS stimulation and measured after 2 hrs by Griess reagent-based assay
|
[PMID: 33454546] |
| RAW264.7 | IC50 |
0.2 μM
Compound: MG-132
|
Antiinflammatory activity in mouse RAW264.7 cells assessed as reduction in LPS-induced NO production preincubated for 1 hr followed by LPS stimulation measured after 18 hrs by Griess assay
Antiinflammatory activity in mouse RAW264.7 cells assessed as reduction in LPS-induced NO production preincubated for 1 hr followed by LPS stimulation measured after 18 hrs by Griess assay
|
[PMID: 29338260] |
| RAW264.7 | IC50 |
0.35 μM
Compound: MG-132
|
Inhibition of LPS-induced NO production in mouse RAW264.7 cells after 18 hrs
Inhibition of LPS-induced NO production in mouse RAW264.7 cells after 18 hrs
|
[PMID: 21044847] |
| RAW264.7 | IC50 |
0.35 μM
Compound: MG-132
|
Inhibition of NO production in Interferon gamma-stimulated mouse RAW264.7 cells after 18 hrs
Inhibition of NO production in Interferon gamma-stimulated mouse RAW264.7 cells after 18 hrs
|
[PMID: 21044847] |
| RAW264.7 | IC50 |
0.439 μM
Compound: MG-132
|
Antiinflammatory against mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production
Antiinflammatory against mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production
|
[PMID: 21561060] |
| RAW264.7 | IC50 |
0.63 μM
Compound: MG132
|
Toxicity against mouse RAW264.7 cells by XTT assay
Toxicity against mouse RAW264.7 cells by XTT assay
|
[PMID: 22858297] |
| RAW264.7 | IC50 |
2.6 μM
Compound: MG132
|
Anti-inflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production pretreated with compound for 2 hrs followed by LPS stimulation for 12 hrs by Griess reagent based analysis
Anti-inflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production pretreated with compound for 2 hrs followed by LPS stimulation for 12 hrs by Griess reagent based analysis
|
[PMID: 36607819] |
| SW480 | IC50 |
29.5 μM
Compound: MG132
|
Inhibition of NFkappaB transcription in human SW480 cells at by luciferase reporter gene assay
Inhibition of NFkappaB transcription in human SW480 cells at by luciferase reporter gene assay
|
[PMID: 26841168] |
MG-132 (Z-Leu-Leu-Leu-al) initiates neurite outgrowth in PC12 cells at a low concentration (30 nM) and is a very strong inhibitor of 20S proteasome[3].
MG-132 (10 μM; 1 hour) reverses the effects of TNF- α on I κ B degradation and NF-κ B activation in A549 cells[4].
MG-132 (0.75-5 μM; 24 hours) potently induces p53-dependent apoptosis in KIM-2 cells by 26S proteasome inhibition[5].
MG-132 (10-40 μM; 24 hours) significantly reduces the viability of C6 glioma cells in both time- and concentration-dependent manners and shows the IC50 of 18.5 μM at 24 hours[6].
MG-132 (18.5 μM; 24 hours) induces down-regulation of anti-apoptotic proteins Bcl-2 and XIAP and up-regulates expression of pro-apoptotic protein Bax and caspase-3[6].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:C6 glioma cells
-
Concentration:10, 20, 30, 40 μM
-
Incubation Time:24 hours
-
Result:Significantly reduced the viability of C6 glioma cells beginning at 6 h in both time- and concentration-dependent manners and showed the IC50 of 18.5 μM at 24 hours.
-
Cell Line:A549 cells
-
Concentration:10 μM
-
Incubation Time:1 hour
-
Result:Reversed the effects of TNF-α on IκB degradation and resulted in a reversal of TNF-α-induced NF-κB activation.
MG-132 (1 mg/kg; i.v.; twice a week for 4 weeks) shows potent tumor inhibitory effect against mice bearing HeLa tumors[8].
MG-132 (1-10 μg/kg/24 hours; subcutaneously implanted osmotic pumps; for 8 days) greatly increases the expression levels of β-dystroglycan, α-dystroglycan, α-sarcoglycan, and dystrophin in skeletal muscle lysates in mice (six-month-old male C57BL/10ScSn DMD mdx mice)[9].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:5- to 6-weeks old female athymic nude mice (EC9706 xenograft)[7]
-
Dosage:10 mg/kg
-
Administration:I.p.; daily for 25 days starting 5 days after EC9706 cells injection
-
Result:Significantly inhibited tumor growth of the EC9706 xenograft without causing toxicity to the mice.
-
Animal Model:Five-week-old female C.B-17/lcr-scid/scidJcl mice (bearing HeLa cells)[8]
-
Dosage:1 mg/kg
-
Administration:Intravenous injection; twice a week for 4 weeks
-
Result:The growth inhibition rates in HeLa tumors was 49% compared to the control.
Note:
Please do not refer to only one article to determine the experimental conditions. It is recommended to determine the optimal experimental conditions (animal strain, age, dosage, frequency and cycle, detection time and indicators, etc.) through preliminary experiments before the formal experiment.
MG-132, characterized by a short plasma half-life and poor blood-brain barrier permeability, is administered via stereotactic intranigral injection (0.4 μg) to achieve sustained local proteasome inhibition, successfully inducing Parkinson's disease-like pathology in the substantia nigra[10].
Administration: MG-132 (0.4 μg in 4 μL) • stereotaxically injected into the substantia nigra at the target site (Bregma AP, 3.2 mm, ML, 2.0 mm, DV, 4.7 mm) in the right side
(2) Injection should be extremely slow (e.g., 0.5 μL/min), and the needle should be left in place for several minutes after injection to prevent fluid reflux and mechanical damage that could affect model specificity.
(3) The control side must use the same solvent as the drug solution (1% DMSO in PBS) to eliminate the influence of the solvent itself.
Histology analysis: Nigral tyrosine hydroxylase-positive (TH+) neurons loss
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS. Nr. 133407-82-6
-
Appearance Solid
-
Molecular Weight 475.62
-
Formel C26H41N3O5
-
Color White to yellow
-
SMILES
O=C(OCC1=CC=CC=C1)N[C@H](C(N[C@@H](CC(C)C)C(N[C@H](C([H])=O)CC(C)C)=O)=O)CC(C)C
-
Synonyms
Z-Leu-Leu-Leu-al; MG132
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Publications (2185)
-
Journal Impact Factor
-
Most Recent
-
Signal Transduct Target Ther
A nanobody-based proteolysis-targeting chimera offers broad-spectrum protection against diverse influenza virus infections. [Abstract]2026 May 15;11(1):182. PMID: 42140901 -
Signal Transduct Target Ther
BMX inhibition overcomes small cell lung cancer chemoresistance by stabilizing E2F1 via ERK1/2-Cyclin D1/CDK4/6 axis. [Abstract]2026 Apr 8;11(1):125. PMID: 41946708 -
Signal Transduct Target Ther
Ring finger protein 213 regulates B-cell receptor signaling, metabolism, and development in B lymphocytes. [Abstract]2026 Feb 18;11(1):59. PMID: 41702884 -
Signal Transduct Target Ther
Inhibin beta A drives colorectal cancer progression through macrophage M2 polarization and mitochondria-dependent ferroptosis suppression. [Abstract]2025 Dec 26;10(1):420. PMID: 41449244 -
Signal Transduct Target Ther
Selective depletion of tumor-associated SAMHD1 enhances chemotherapeutic efficacy and antitumor immune responses. [Abstract]2025 Dec 15;10(1):406. PMID: 41392286 -
Signal Transduct Target Ther
In vivo self-assembled nano-PROTAC for the dual degradation of AR and HSP90 to overcome castration-resistant prostate cancer resistance. [Abstract]2025 Oct 15;10(1):346. PMID: 41087345 -
Signal Transduct Target Ther
Glucosidase alpha neutral C promotes influenza virus replication by inhibiting proteosome-dependent degradation of hemagglutinin. [Abstract]2025 Apr 23;10(1):131. PMID: 40263249 -
Signal Transduct Target Ther
Palmitoylation regulates myelination by modulating the ZDHHC3-Cadm4 axis in the central nervous system. [Abstract]2024 Sep 26;9(1):254. PMID: 39327467 -
Signal Transduct Target Ther
Discovery of IHMT-337 as a potent irreversible EZH2 inhibitor targeting CDK4 transcription for malignancies. [Abstract]2023 Jan 16;8(1):18. PMID: 36642705 -
Signal Transduct Target Ther
MARCH3 negatively regulates IL-3-triggered inflammatory response by mediating K48-linked polyubiquitination and degradation of IL-3Rα. [Abstract]2022 Jan 24;7(1):21. PMID: 35075102 -
Signal Transduct Target Ther
CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1. [Abstract]2020 Dec 26;5(1):298. PMID: 33361760
MG-132 purchased from MedChemExpress. Usage Cited in: Signal Transduct Target Ther. 2020 Dec 26;5(1):298. [Abstract]
Western blot analysis of YBX1 and β-tubulin in HepG2-SR cells transfected with or without si-circRNA-SORE following proteasome inhibition with MG132 treatment (20 μM) for 3 h.
-
Nature
2026 Apr;652(8112):1339-1348. PMID: 41813904 -
Nature
2026 Jan;649(8099):1273-1281. PMID: 41183570 -
Nature
2025 Jul;643(8073):1107-1116. PMID: 40468084 -
Nature
2025 May;641(8061):202-210. PMID: 40140567 -
Nature
2021 Nov;599(7885):491-496. PMID: 34711951 -
Science
2020 Dec 4;370(6521):eaay2002. PMID: 33093214 -
Cancer Cell
Mapping cell type-resolved transcriptomic profiles to patient survival in pancreatic cancer. [Abstract]2026 Jun 11:S1535-6108(26)00257-6. PMID: 42276047 -
Cancer Cell
A pan-KRAS inhibitor and its derived degrader elicit multifaceted anti-tumor efficacy in KRAS-driven cancers. [Abstract]2025 Jul 25:S1535-6108(25)00310-1. PMID: 40780213 -
Cancer Cell
Context-dependent activation of STING-interferon signaling by CD11b agonists enhances anti-tumor immunity. [Abstract]2023 Jun 12;41(6):1073-1090.e12. PMID: 37236195
MG-132 purchased from MedChemExpress. Usage Cited in: Cancer Cell. 2023 Jun 12;41(6):1073-1090.e12. [Abstract]
Representative immunoblot for total p65 and β-ACTIN (loading control) in BMDMs treated with GB1275 for 7 hours after 1 hour-MG132 (10 μM) pretreatment.
-
Cancer Cell
Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responses. [Abstract]2022 Oct 10;40(10):1190-1206.e9. PMID: 36179686 -
Cell
2026 Jun 11;189(12):3553-3570.e30. PMID: 42049018 -
Cell
Comparative proteomic landscapes elucidate human preimplantation development and failure. [Abstract]2025 Feb 6;188(3):814-831.e21. PMID: 39855199
MG-132 purchased from MedChemExpress. Usage Cited in: Cell. 2025 Feb 6;188(3):814-831.e21. [Abstract]
MG132 (42 μM; 12 h) almost completely blocks mouse embryonic development.
-
Cell
2023 Feb 16;186(4):803-820.e25. PMID: 36738734 -
Nat Biotechnol
A rapid imaging-based screen for induced-proximity degraders identifies a potent degrader of oncoprotein SKP2. [Abstract]2025 Sep 10. PMID: 40931108 -
Nat Biotechnol
Intestinal mucosal barrier repair and immune regulation with an AI-developed gut-restricted PHD inhibitor. [Abstract]2024 Dec 11. PMID: 39663371 -
J Hematol Oncol
METTL16-SENP3-LTF axis confers ferroptosis resistance and facilitates tumorigenesis in hepatocellular carcinoma. [Abstract]2024 Sep 2;17(1):78. PMID: 39218945 -
J Hematol Oncol
Hepatic NOD2 promotes hepatocarcinogenesis via a RIP2-mediated proinflammatory response and a novel nuclear autophagy-mediated DNA damage mechanism. [Abstract]2021 Jan 7;14(1):9. PMID: 33413510 -
Circulation
2024 Apr 23;149(17):1354-1371. PMID: 38314588 -
Circulation
Ablation of Plasma Prekallikrein Decreases Low-Density Lipoprotein Cholesterol by Stabilizing Low-Density Lipoprotein Receptor and Protects Against Atherosclerosis. [Abstract]2022 Mar;145(9):675-687. PMID: 35189703 -
Nat Nanotechnol
2025 Feb;20(2):296-302. PMID: 39468359 -
Mol Cancer
ROCK1 inhibition primes anti-tumor immunity in EGFR-mutant NSCLC by triggering PD-L1 degradation mediated by SMURF2. [Abstract]2026 Apr 2;25(1):130. PMID: 41928228 -
Mol Cancer
o8G-modified circPLCE1 inhibits lung cancer progression via chaperone-mediated autophagy. [Abstract]2025 Mar 17;24(1):82. PMID: 40098195 -
Mol Cancer
ZDHHC20 mediated S-palmitoylation of fatty acid synthase (FASN) promotes hepatocarcinogenesis. [Abstract]2024 Dec 19;23(1):274. PMID: 39696259
MG-132 purchased from MedChemExpress. Usage Cited in: Mol Cancer. 2024 Dec 19;23(1):274. [Abstract]
MG132 (10 µM; 6 h) reversed the effect of Cycloheximide (CHX) (100 µg/mL) and enhanced the stability of FASN protein in HCCLM3 cells.
-
Mol Cancer
A positive feedback loop between PFKP and c-Myc drives head and neck squamous cell carcinoma progression. [Abstract]2024 Jul 9;23(1):141. PMID: 38982480 -
Mol Cancer
2024 Apr 29;23(1):86. PMID: 38685067
MG-132 purchased from MedChemExpress. Usage Cited in: Mol Cancer. 2024 Apr 29;23(1):86. [Abstract]
Western blot analysis of cell lysates from the indicated 293 cells treated with MG132 (20 µM) or DMSO for 6 h.
-
Mol Cancer
LINC01852 inhibits the tumorigenesis and chemoresistance in colorectal cancer by suppressing SRSF5-mediated alternative splicing of PKM. [Abstract]2024 Jan 24;23(1):23. PMID: 38263157
MG-132 purchased from MedChemExpress. Usage Cited in: Mol Cancer. 2024 Jan 24;23(1):23. [Abstract]
MG132 (20 µM; 6 h) reverses the reduced accumulation of endogenous SRSF5 in LINC01852-overexpressing HCT116 cells and inhibited the accumulation of SRSF5 in LINC01852-depleted HT29 cells
-
Mol Cancer
The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer. [Abstract]2023 May 20;22(1):86. PMID: 37210549 -
Cell Metab
Psoriasis modulates inflammatory bowel disease risk and intestinal epithelium lipid metabolism via IL-1β-producing macrophages. [Abstract]2026 May 5;38(5):963-980.e12. PMID: 41856104 -
Cell Metab
2026 Jan 23:S1550-4131(25)00584-4. PMID: 41579859 -
Cell Metab
2026 Jan 9:S1550-4131(25)00546-7. PMID: 41519131 -
Cell Metab
Induction of a metabolic switch from glucose to ketone metabolism programs ketogenic diet-induced therapeutic vulnerability in lung cancer. [Abstract]2025 Oct 24:S1550-4131(25)00435-8. PMID: 41138721 -
Cell Metab
Targeting gut microbial nitrogen recycling and cellular uptake of ammonium to improve bortezomib resistance in multiple myeloma. [Abstract]2024 Jan 2;36(1):159-175.e8. PMID: 38113887 -
Cell Metab
UBE2M-mediated neddylation of TRIM21 regulates obesity-induced inflammation and metabolic disorders. [Abstract]2023 Aug 8;35(8):1390-1405.e8. PMID: 37343564
MG-132 purchased from MedChemExpress. Usage Cited in: Cell Metab. 2023 Aug 8;35(8):1390-1405.e8. [Abstract]
Western blot analysis of HIF-1α and IL-1β in PMs isolated from Ube2mf/f 100 and Lysm+Ube2mf/f mice, stimulated with PA for 6 h, and treated with or without MG132 (10 μM).
-
Cell Metab
Serine metabolism antagonizes antiviral innate immunity by preventing ATP6V0d2-mediated YAP lysosomal degradation. [Abstract]2021 May 4;33(5):971-987.e6. PMID: 33798471 -
Nat Immunol
Exclusion of Notch from the contact site during efferocytosis restricts anticancer immunity. [Abstract]2026 Mar 3. PMID: 41776100 -
Nat Immunol
The RNA-binding E3 ligase MKRN2 selectively disrupts Il6 translation to restrain inflammation. [Abstract]2025 Jul;26(7):1036-1047. PMID: 40524017 -
Nat Immunol
Deactylation by SIRT1 enables liquid-liquid phase separation of IRF3/IRF7 in innate antiviral immunity. [Abstract]2022 Aug;23(8):1193-1207. PMID: 35879450 -
Adv Mater
An Iron Balance Dual-Drive Strategy (IBDS) Promotes Bone Regeneration in Smokers by Regulating Mitochondrial Iron Homeostasis. [Abstract]2025 May 16:e2501933. PMID: 40376835 -
Immunity
Alcaligenes faecalis induces intestinal T helper-17 cells by enhancing Rorc transcription through E3 ligase Trim21-mediated Fbxw7 degradation. [Abstract]2025 Apr 8:S1074-7613(25)00128-1. PMID: 40215968 -
Cell Res
Mannose antagonizes GSDME-mediated pyroptosis through AMPK activated by metabolite GlcNAc-6P. [Abstract]2023 Dec;33(12):904-922. PMID: 37460805 -
Cell Res
NudCL2 is an autophagy receptor that mediates selective autophagic degradation of CP110 at mother centrioles to promote ciliogenesis. [Abstract]2021 Nov;31(11):1199-1211. PMID: 34480124 -
Cell Res
2021 Mar;31(3):291-311. PMID: 33299139 -
Cancer Commun (Lond)
m6A-modified EHD1 controls PD-L1 endosomal trafficking to modulate immune evasion and immunotherapy responses in lung adenocarcinoma. [Abstract]2025 Jul 24. PMID: 40703029 -
Cancer Commun (Lond)
Cytoplasmic YAP1-mediated ESCRT-III assembly promotes autophagic cell death and is ubiquitinated by NEDD4L in breast cancer. [Abstract]2023 May;43(5):582-612. PMID: 37005481
MG-132 purchased from MedChemExpress. Usage Cited in: Cancer Commun (Lond). 2023 May;43(5):582-612. [Abstract]
YAP1 ubiquitination degradation assay. MCF7 and SKBR3 cells were transfected with NEDD4L overexpression plasmid or siNEDD4L and treated with MG132 (20 µmol/L, 6 h). YAP1 expression was detected with WB analysis.
-
Blood
2021 Mar 18;137(11):1478-1490. PMID: 32842143 -
Exploration
Caffeic Acid Acts as a Potent Senomorphic and Alleviates Inflammation and Lung Fibrosis by Covalently Targeting Annexin A5 Protein in Mice. [Abstract]2025 Dec 12;5(6):20240069. PMID: 41476649 -
Drug Resist Updat
RCN2 facilitates esophageal squamous cellular carcinoma metastasis and cisplatin resistance through UBR5-mediated PPP2CA ubiquitination and degradation. [Abstract]2025 Dec 4:85:101339. PMID: 41411970 -
Drug Resist Updat
DTX2 attenuates Lenvatinib-induced ferroptosis by suppressing docosahexaenoic acid biosynthesis through HSD17B4-dependent peroxisomal β-oxidation in hepatocellular carcinoma. [Abstract]2025 Jul:81:101224. PMID: 40058099 -
Drug Resist Updat
CPSF6-mediated XBP1 3'UTR shortening attenuates cisplatin-induced ER stress and elevates chemo-resistance in lung adenocarcinoma. [Abstract]2023 May:68:100933. PMID: 36821972 -
Sci Bull
A germline-specific vesicular structure licenses mRNA activation during spermiogenesis and is hijacked in gastric cancer. [Abstract]2026 Mar 2:S2095-9273(26)00213-6. PMID: 41925442 -
Nat Metab
2022 Sep;4(9):1202-1213. PMID: 36131205 -
Nat Neurosci
Emergence of consciousness from anesthesia through ubiquitin degradation of KCC2 in the ventral posteromedial nucleus of the thalamus. [Abstract]2023 May;26(5):751-764. PMID: 36973513
MG-132 purchased from MedChemExpress. Usage Cited in: Nat Neurosci. 2023 May;26(5):751-764. [Abstract]
MG-132 (10 μg in each side; loci VPM injection) not affecting the expression of KCC2 in VPM in awake mice and restoring the anesthetic-induced decreased KCC2.
-
Cell Mol Immunol
2026 Mar;23(3):284-300. PMID: 41530535 -
Cell Mol Immunol
The membrane-associated ubiquitin ligases MARCH2 and MARCH3 target TIM-1 to limit Zika virus infection. [Abstract]2025 Sep;22(9):1032-1044. PMID: 40817191 -
Cell Mol Immunol
The membrane-associated ubiquitin ligases MARCH2 and MARCH3 target IL-5 receptor alpha to negatively regulate eosinophilic airway inflammation. [Abstract]2022 Oct;19(10):1117-1129. PMID: 35982175 -
Cell Mol Immunol
SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy. [Abstract]2022 Jan;19(1):67-78. PMID: 34845370 -
Cell Mol Immunol
2020 May;17(5):496-506. PMID: 31160756 -
Nat Cell Biol
Targeting a key disulfide linkage to regulate RIG-I condensation and cytosolic RNA-sensing. [Abstract]2025 Apr 14. PMID: 40229436 -
Nat Cell Biol
TGF-β-induced DACT1 biomolecular condensates repress Wnt signalling to promote bone metastasis. [Abstract]2021 Mar;23(3):257-267. PMID: 33723425
MG-132 purchased from MedChemExpress. Usage Cited in: Nat Cell Biol. 2021 Mar;23(3):257-267. [Abstract]
Western blot analysis of DACT1 wild-type and DACT1-TdTomato fusion protein expression in both M1a and BM2 cells after treatment with either Bafilomycin A1 (10 nM) or MG-132 (20 μM) for 12 h.
-
Nat Cell Biol
TFAM is an autophagy receptor that limits inflammation by binding to cytoplasmic mitochondrial DNA. [Abstract]2024 May 23. PMID: 38783142 -
Nat Cell Biol
2022 Apr;24(4):497-512. PMID: 35332264 -
Mol Neurodegener
Death-associated protein kinase 1-dependent SENP1 degradation increases tau SUMOylation and leads to cognitive dysfunction in a mouse model for tauopathy. [Abstract]2025 Nov 21;20(1):121. PMID: 41272902 -
Natl Sci Rev
SNX14 deficiency-induced defective axonal mitochondrial transport in Purkinje cells underlies cerebellar ataxia and can be reversed by valproate. [Abstract]2021 Feb 10;8(7):nwab024. PMID: 34691693 -
Cancer Res
UFMylation Suppresses Hepatocellular Carcinoma Metastasis by Inhibiting β-Catenin-Driven Hybrid EMT and NK Cell Evasion. [Abstract]2026 Jul 2;86(13):3213-3232. PMID: 41996487 -
Cancer Res
TRAPPC4 Promotes GPX4 Stability to Drive Ferroptosis Resistance and Tumor Progression in Head and Neck Squamous Cell Carcinoma. [Abstract]2026 Jul 15;86(14):3436-3458. PMID: 41974002 -
Mol Cell
Intrinsic bias of the genetic code shapes the folding and stability landscapes of microproteins. [Abstract]2026 Jun 4;86(11):2173-2190.e11. PMID: 42161277 -
Cancer Res
Targeting Sialylation Enhances the Therapeutic Efficacy of the Nectin-4-Targeted Antibody-Drug Conjugate Enfortumab Vedotin in Bladder Cancer. [Abstract]2025 Oct 9. PMID: 41066596 -
Cancer Res
The Acetyltransferase ARD1 Induces Glutathione Synthesis to Facilitate Ferroptosis Evasion in Hepatocellular Carcinoma. [Abstract]2025 Aug 21. PMID: 40838989 -
Mol Cell
Phosphorylation-dependent charge blocks regulate the relaxation of nuclear speckle networks. [Abstract]2025 Apr 4:S1097-2765(25)00260-6. PMID: 40233760 -
Cancer Res
The Glycosyltransferase XYLT1 Activates NF-κB Signaling to Promote Metastasis of Early-Stage Lung Adenocarcinoma. [Abstract]2025 May 2;85(9):1628-1643. PMID: 39992715 -
Mol Cell
2024 Mar 21;84(6):1120-1138.e8. PMID: 38377992 -
Mol Cell
PTPS Facilitates Compartmentalized LTBP1 S-Nitrosylation and Promotes Tumor Growth under Hypoxia. [Abstract]2020 Jan 2;77(1):95-107.e5. PMID: 31628042 -
Mol Cell
CPT1A induction following epigenetic perturbation promotes MAVS palmitoylation and activation to potentiate antitumor immunity. [Abstract]2023 Dec 7;83(23):4370-4385.e9. PMID: 38016475 -
Mol Cell
TMUB1 is an endoplasmic reticulum-resident escortase that promotes the p97-mediated extraction of membrane proteins for degradation. [Abstract]2022 Sep 15;82(18):3453-3467.e14. PMID: 35961308 -
Mol Cell
Filamentous GLS1 promotes ROS-induced apoptosis upon glutamine deprivation via insufficient asparagine synthesis. [Abstract]2022 May 19;82(10):1821-1835.e6. PMID: 35381197 -
Mol Cell
SPT5 stabilizes RNA polymerase II, orchestrates transcription cycles, and maintains the enhancer landscape. [Abstract]2021 Nov 4;81(21):4425-4439.e6. PMID: 34534457 -
Mol Cell
Acetylation-Dependent Deubiquitinase OTUD3 Controls MAVS Activation in Innate Antiviral Immunity. [Abstract]2020 Jul 16;79(2):304-319.e7. PMID: 32679077 -
Mol Cell
RNF126-Mediated Reubiquitination Is Required for Proteasomal Degradation of p97-Extracted Membrane Proteins. [Abstract]2020 Jul 16;79(2):320-331.e9. PMID: 32645369 -
Cancer Res
EBF1-Mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the p53 Signaling Pathway. [Abstract]2019 May 1;79(9):2257-2270. PMID: 30862720 -
Cancer Res
A GYS2/p53 Negative Feedback Loop Restricts Tumor Growth in HBV-Related Hepatocellular Carcinoma. [Abstract]2019 Feb 1;79(3):534-545. PMID: 30584071
MG-132 purchased from MedChemExpress. Usage Cited in: Cancer Res. 2019 Feb 1;79(3):534-545. [Abstract]
Cells are transfected with GYS2 siRNA and pre-incubated with MG-132 (20 μM) for 12 h. Cell lysate are immunoprecipitated by anti-Ub and immunoblotted by anti-p53.
-
ACS Nano
Fluorinated Proteolysis Targeting Chimeras-Sorafenib Nanoassembly for Epigenetic Remodeling to Combat Multi-Pathway Drug Resistance in Hepatocellular Carcinoma. [Abstract]2025 Oct 7;19(39):34659-34676. PMID: 40977536 -
ACS Nano
Mechanism of S-Palmitoylation in Polystyrene Nanoplastics-Induced Macrophage Cuproptosis Contributing to Emphysema through Alveolar Epithelial Cell Pyroptosis. [Abstract]2025 May 20;19(19):18708-18728. PMID: 40335889 -
ACS Nano
Galloylated Toll-Like Receptor 7/8 Agonist Nanovaccine for Enhanced Tumor Antigen Delivery in Personalized Immunotherapy. [Abstract]2025 Mar 18. PMID: 40102033 -
ACS Nano
Polystyrene Nanoplastics Activate Autophagy and Suppress Trophoblast Cell Migration/Invasion and Migrasome Formation to Induce Miscarriage. [Abstract]2024 Jan 30;18(4):3733-3751. PMID: 38252510
MG-132 purchased from MedChemExpress. Usage Cited in: ACS Nano. 2024 Jan 30;18(4):3733-3751. [Abstract]
The protein levels of SOX2 in 100 μg/mL of PS-NP-exposed Swan 71 cells treated with CHX (10 μg/mL; 4 h) and MG132 (10 μM; 6 h) or chloroquine (CQ) (15 μM; 6 h).
-
ACS Nano
Long Noncoding RNA URB1-Antisense RNA 1 (AS1) Suppresses Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma by Driving Ferritin Phase Separation. [Abstract]2023 Nov 28;17(22):22240-22258. PMID: 37966480 -
Hepatology
Targeting VPS72 inhibits ACTL6A/MYC axis activity in hepatocellular carcinoma progression. [Abstract]2023 Nov 1;78(5):1384-1401. PMID: 36631007 -
Nat Commun
2026 Jun 19. PMID: 42321214 -
Nat Commun
All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immunotherapy in pancreatic cancer. [Abstract]2026 May 11. PMID: 42115161 -
Nat Commun
YY1/Asprosin/PFKP axis regulates glycolytic metabolic and exacerbates pathological cardiac hypertrophy. [Abstract]2026 Apr 1;17(1):4718. PMID: 41922343 -
Nat Commun
CD38 degrades MAVS through mitophagy to inhibit type I interferon secretion in nasopharyngeal carcinoma cells and impairs CD8+T cell-mediated anti-tumor immunity. [Abstract]2026 Feb 9;17(1):2544. PMID: 41663422 -
Nat Commun
Ubiquitination by HRD1 is essential for TLR3 trafficking and its innate immune signaling. [Abstract]2025 Dec 10. PMID: 41372171 -
Nat Commun
2025 Dec 12;16(1):11092. PMID: 41387436 -
Nat Commun
Highly efficient and long-acting split-and-mix proteolysis targeting chimera based on self-assembled polylactic acid. [Abstract]2025 Nov 26;16(1):10555. PMID: 41298394 -
Nat Commun
Inhibition of ICAM1 diminishes stemness and enhances antitumor immunity in glioblastoma via β-catenin/PD-L1 signaling. [Abstract]2025 Sep 30;16(1):8642. PMID: 41028719 -
Nat Commun
Transgenerational inheritance of diminished ovarian reserve triggered by prenatal propylparaben exposure in mice. [Abstract]2025 Sep 16;16(1):8289. PMID: 40957879 -
Nat Commun
Nucleus-translocated glucokinase functions as a protein kinase to phosphorylate TAZ and promote tumour growth. [Abstract]2025 Aug 4;16(1):7156. PMID: 40759645 -
Nat Commun
Harnessing artificial intelligence to identify Bufalin as a molecular glue degrader of estrogen receptor alpha. [Abstract]2025 Aug 22;16(1):7854. PMID: 40846852 -
Nat Commun
Stress granule assembly impairs macrophage efferocytosis to aggravate allergic rhinitis in mice. [Abstract]2025 Jul 1;16(1):5610. PMID: 40595582 -
Nat Commun
DSS1 inhibits autophagy to activate epithelial-mesenchymal transition in a pro-metastatic niche of renal cell carcinoma. [Abstract]2025 Jul 23;16(1):6769. PMID: 40695833 -
Nat Commun
PEAK1 maintains tight junctions in intestinal epithelial cells and resists colitis by inhibiting autophagy-mediated ZO-1 degradation. [Abstract]2025 Jul 24;16(1):6777. PMID: 40707483 -
Nat Commun
Myocardial mitochondrial antiviral signaling protein promotes heart Ischemia-reperfusion injury via RIG-I signaling in mice. [Abstract]2025 Jun 2;16(1):5101. PMID: 40456736 -
Nat Commun
Constitutive expression of the transcriptional co-activator IκBζ promotes melanoma growth and immunotherapy resistance. [Abstract]2025 Jun 25;16(1):5387. PMID: 40562773 -
Nat Commun
2025 May 23;16(1):4794. PMID: 40410168 -
Nat Commun
2025 May 30;16(1):5006. PMID: 40442064 -
Nat Commun
Endothelial major vault protein alleviates vascular remodeling via promoting Parkin-mediated mitophagy. [Abstract]2025 May 10;16(1):4365. PMID: 40348769 -
Nat Commun
Josephin Domain Containing 2 (JOSD2) inhibition as Pan-KRAS-mutation-targeting strategy for colorectal cancer. [Abstract]2025 Apr 16;16(1):3623. PMID: 40240366 -
Nat Commun
2025 Feb 21;16(1):1865. PMID: 39984467 -
Nat Commun
The TaCLE24b peptide signaling cascade modulates lateral root development and drought tolerance in wheat. [Abstract]2025 Feb 25;16(1):1952. PMID: 40000659 -
Nat Commun
AMFR-mediated Flavivirus NS2A ubiquitination subverts ER-phagy to augment viral pathogenicity. [Abstract]2024 Nov 6;15(1):9578. PMID: 39505910 -
Nat Commun
2025 Jan 20;16(1):867. PMID: 39833225 -
Nat Commun
CDK9 recruits HUWE1 to degrade RARα and offers therapeutic opportunities for cutaneous T-cell lymphoma. [Abstract]2024 Dec 5;15(1):10594. PMID: 39632829 -
Nat Commun
Deletion of ASPP1 in myofibroblasts alleviates myocardial fibrosis by reducing p53 degradation. [Abstract]2024 Sep 28;15(1):8425. PMID: 39341821 -
Nat Commun
2024 Sep 3;15(1):7654. PMID: 39227578 -
Nat Commun
2024 Jun 25;15(1):5392. PMID: 38918391 -
Nat Commun
FBXO7 ubiquitinates PRMT1 to suppress serine synthesis and tumor growth in hepatocellular carcinoma. [Abstract]2024 Jun 5;15(1):4790. PMID: 38839752 -
Nat Commun
2024 Mar 16;15(1):2377. PMID: 38493213 -
Nat Commun
Pharmaceutical targeting of OTUB2 sensitizes tumors to cytotoxic T cells via degradation of PD-L1. [Abstract]2024 Jan 2;15(1):9. PMID: 38167274 -
Nat Commun
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer. [Abstract]2023 Oct 10;14(1):6332. PMID: 37816716 -
Nat Commun
Endothelial Sp1/Sp3 are essential to the effect of captopril on blood pressure in male mice. [Abstract]2023 Sep 21;14(1):5891. PMID: 37735515 -
Nat Commun
2023 Jul 14;14(1):4217. PMID: 37452028 -
Nat Commun
ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy. [Abstract]2023 May 19;14(1):2859. PMID: 37208329 -
Nat Commun
KK-LC-1 as a therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancer. [Abstract]2023 May 5;14(1):2602. PMID: 37147285 -
Nat Commun
Acute liver steatosis translationally controls the epigenetic regulator MIER1 to promote liver regeneration in a study with male mice. [Abstract]2023 Mar 18;14(1):1521. PMID: 36934083 -
Nat Commun
2023 Jan 4;14(1):61. PMID: 36599845 -
Nat Commun
Isoform-specific and ubiquitination dependent recruitment of Tet1 to replicating heterochromatin modulates methylcytosine oxidation. [Abstract]2022 Sep 2;13(1):5173. PMID: 36056023 -
Nat Commun
2022 Sep 23;13(1):5594. PMID: 36151101 -
Nat Commun
Glutamine deficiency in solid tumor cells confers resistance to ribosomal RNA synthesis inhibitors. [Abstract]2022 Jun 28;13(1):3706. PMID: 35764642 -
Nat Commun
Neddylation inhibition induces glutamine uptake and metabolism by targeting CRL3SPOP E3 ligase in cancer cells. [Abstract]2022 May 31;13(1):3034. PMID: 35641493 -
Nat Commun
Ubiquitin ligase STUB1 destabilizes IFNγ-receptor complex to suppress tumor IFNγ signaling. [Abstract]2022 Apr 8;13(1):1923. PMID: 35395848 -
Nat Commun
PD-L1 degradation is regulated by electrostatic membrane association of its cytoplasmic domain. [Abstract]2021 Aug 24;12(1):5106. PMID: 34429434 -
Nat Commun
2021 Jul 20;12(1):4413. PMID: 34285210 -
Nat Commun
2021 Jun 3;12(1):3319. PMID: 34083547 -
Nat Commun
HPD degradation regulated by the TTC36-STK33-PELI1 signaling axis induces tyrosinemia and neurological damage. [Abstract]2019 Sep 19;10(1):4266. PMID: 31537781 -
Cell Death Differ
TRIM17 downregulation modulates CRPC progression and enzalutamide resistance by derepressing BCL2 expression via the p53-dependent and p53-independent pathways. [Abstract]2026 Jun 13. PMID: 42288623 -
Cell Death Differ
2026 Jun 24. PMID: 42337094 -
Cell Death Differ
USP21-mediated deubiquitylation stimulates NuMA recruitment to the cell cortex to promote mitotic spindle orientation. [Abstract]2026 Jun 23. PMID: 42337093 -
Cell Death Differ
The E3 ubiquitin ligase Itch plays an essential role in kidney fibrosis by inhibiting Dvl2/GSK3β/β-catenin signaling pathway. [Abstract]2026 May 22. PMID: 42168361 -
Cell Death Differ
Targeting ADAR1 lactylation activates innate immune and overcomes chemoresistance in ovarian cancer. [Abstract]2026 May 25. PMID: 42185630 -
Cell Death Differ
2026 Mar 23. PMID: 41872532 -
Cell Death Differ
TUFT1 stabilizes TGF-β receptor II protein and facilitates activation of hepatic stellate cells into metastasis-promoting myofibroblasts. [Abstract]2026 Jan 28. PMID: 41593321 -
Cell Death Differ
2025 Nov 17. PMID: 41249464 -
Cell Death Differ
2025 Jul 30. PMID: 40739328 -
Cell Death Differ
GLUL mediates FOXO3 O-GlcNAcylation to regulate the osteogenic differentiation of BMSCs and senile osteoporosis. [Abstract]2025 Jul 11. PMID: 40646162 -
Cell Death Differ
GPX4-AUTAC induces ferroptosis in breast cancer by promoting the selective autophagic degradation of GPX4 mediated by TRAF6-p62. [Abstract]2025 May 20. PMID: 40394165 -
Cell Death Differ
Sphingosine kinase 2 deficiency impairs VLDL secretion by inhibiting mTORC2 phosphorylation and activating chaperone-mediated autophagy. [Abstract]2025 Apr 8. PMID: 40200091 -
Cell Death Differ
FTDC1/2, oocyte-specific cofactors of DNMT1 required for epigenetic regulation and embryonic development. [Abstract]2025 Apr 28. PMID: 40295817 -
Cell Death Differ
2025 Apr 16. PMID: 40240520 -
Cell Death Differ
Glycogen stores mediated by the p53-GYS1 feedback circuit engenders platinum resistance in ovarian clear cell carcinoma. [Abstract]2025 Apr 11. PMID: 40210982 -
Cell Death Differ
AKAP1/PKA-mediated GRP75 phosphorylation at mitochondria-associated endoplasmic reticulum membranes protects cancer cells against ferroptosis. [Abstract]2025 Mar;32(3):488-505. PMID: 39537840 -
Cell Death Differ
Cullin 4B-RING E3 ligase negatively regulates the immunosuppressive capacity of mesenchymal stem cells by suppressing iNOS. [Abstract]2025 Jan;32(1):149-161. PMID: 39138375 -
Cell Death Differ
2024 May 18. PMID: 38762596 -
Cell Death Differ
ABLIM1, a novel ubiquitin E3 ligase, promotes growth and metastasis of colorectal cancer through targeting IĸBα ubiquitination and activating NF-ĸB signaling. [Abstract]2024 Feb;31(2):203-216. PMID: 38228802 -
Cell Death Differ
Loss of SMURF2 expression enhances RACK1 stability and promotes ovarian cancer progression. [Abstract]2023 Nov;30(11):2382-2392. PMID: 37828084 -
Cell Death Differ
2023 Jul;30(7):1811-1828. PMID: 37322264 -
Cell Death Differ
GAS5 protects against nonalcoholic fatty liver disease via miR-28a-5p/MARCH7/NLRP3 axis-mediated pyroptosis. [Abstract]2023 Jul;30(7):1829-1848. PMID: 37337032 -
Cell Death Differ
Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. [Abstract]2023 Feb;30(2):527-543. PMID: 36526897 -
Cell Death Differ
iASPP suppression mediates terminal UPR and improves BRAF-inhibitor sensitivity of colon cancers. [Abstract]2023 Feb;30(2):327-340. PMID: 36380064 -
Cell Death Differ
HSP90β promotes osteoclastogenesis by dual-activation of cholesterol synthesis and NF-κB signaling. [Abstract]2023 Mar;30(3):673-686. PMID: 36198833 -
Cell Death Differ
SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma. [Abstract]2023 Jan;30(1):137-151. PMID: 35995846 -
Cell Death Differ
CEND1 deficiency induces mitochondrial dysfunction and cognitive impairment in Alzheimer's disease. [Abstract]2022 Dec;29(12):2417-2428. PMID: 35732922 -
Cell Death Differ
Non-coding small nucleolar RNA SNORD17 promotes the progression of hepatocellular carcinoma through a positive feedback loop upon p53 inactivation. [Abstract]2022 May;29(5):988-1003. PMID: 35034103 -
Cell Death Differ
Glycoprotein PTGDS promotes tumorigenesis of diffuse large B-cell lymphoma by MYH9-mediated regulation of Wnt-β-catenin-STAT3 signaling. [Abstract]2022 Mar;29(3):642-656. PMID: 34743203 -
Cell Death Differ
Aagab acts as a novel regulator of NEDD4-1-mediated Pten nuclear translocation to promote neurological recovery following hypoxic-ischemic brain damage. [Abstract]2021 Aug;28(8):2367-2384. PMID: 33712741 -
Cell Death Differ
Constitutive GLI1 expression in chondrosarcoma is regulated by major vault protein via mTOR/S6K1 signaling cascade. [Abstract]2021 Jul;28(7):2221-2237. PMID: 33637972 -
Cell Death Differ
RPS23RG1 modulates tau phosphorylation and axon outgrowth through regulating p35 proteasomal degradation. [Abstract]2021 Jan;28(1):337-348. PMID: 32908202 -
Cell Death Differ
Ubiquitin ligase CHIP regulates OTUD3 stability and suppresses tumour metastasis in lung cancer. [Abstract]2020 Nov;27(11):3177-3195. PMID: 32483383 -
Cell Death Differ
Dual targeting of SREBP2 and ERRα by carnosic acid suppresses RANKL-mediated osteoclastogenesis and prevents ovariectomy-induced bone loss. [Abstract]2020 Jul;27(7):2048-2065. PMID: 31907393 -
Cell Death Differ
2020 Jun;27(6):1795-1806. PMID: 31767934 -
Cell Death Differ
MEK nuclear localization promotes YAP stability via sequestering β-TrCP in KRAS mutant cancer cells. [Abstract]2019 Nov;26(11):2400-2415. PMID: 30833665 -
Neuron
Targeting PGAM5-driven mitochondrial integrated stress response slows ALS progression across subtypes. [Abstract]2026 Mar 11:S0896-6273(26)00086-3. PMID: 41819100 -
Neuron
2025 Aug 22:S0896-6273(25)00556-2. PMID: 40865534 -
Bone Res
Chaperone-mediated autophagy directs a dual mechanism to balance premature senescence and senolysis to prevent intervertebral disc degeneration. [Abstract]2025 Jun 12;13(1):62. PMID: 40506462 -
Bone Res
Nuclear farnesoid X receptor protects against bone loss by driving osteoblast differentiation through stabilizing RUNX2. [Abstract]2025 Jan 30;13(1):20. PMID: 39885145 -
Acta Pharm Sin B
Insights into SARS-CoV-2 replication control via targeting the host hijacking function of NSP12. [Abstract]2026 Jul;16(7):4410-4425. PMID: 42453420 -
-
-
-
Acta Pharm Sin B
Sorafenib promotes the E3 ubiquitin ligase FBXW7 to increase tau degradation and ameliorate tauopathies. [Abstract]2025 Nov;15(11):5817-5831. PMID: 41311387 -
Acta Pharm Sin B
Cannabidiol alleviates methamphetamine addiction via targeting ATP5A1 and modulating the ATP-ADO-A1R signaling pathway. [Abstract]2025 Oct;15(10):5261-5276. PMID: 41132843 -
-
Acta Pharm Sin B
2025 Mar;15(3):1535-1551. PMID: 40370558 -
Acta Pharm Sin B
Demethylzeylasteral induces PD-L1 ubiquitin-proteasome degradation and promotes antitumor immunity via targeting USP22. [Abstract]2024 Oct;14(10):4312-4328. PMID: 39525573 -
Acta Pharm Sin B
GRK2 mediated degradation of SAV1 initiates hyperplasia of fibroblast-like synoviocytes in rheumatoid arthritis. [Abstract]2024 Mar;14(3):1222-1240. PMID: 38486990 -
Acta Pharm Sin B
SIRT1 activation synergizes with FXR agonism in hepatoprotection via governing nucleocytoplasmic shuttling and degradation of FXR. [Abstract]2023 Feb;13(2):559-576. PMID: 36873184 -
Acta Pharm Sin B
WSB1 regulates c-Myc expression through β-catenin signaling and forms a feedforward circuit. [Abstract]2022 Mar;12(3):1225-1239. PMID: 35530152 -
Acta Pharm Sin B
Chemical screen identifies shikonin as a broad DNA damage response inhibitor that enhances chemotherapy through inhibiting ATM and ATR. [Abstract]2022 Mar;12(3):1339-1350. PMID: 35530159 -
Acta Pharm Sin B
Discovery of a small molecule inhibitor of cullin neddylation that triggers ER stress to induce autophagy. [Abstract]2021 Nov;11(11):3567-3584. PMID: 34900537 -
Acta Pharm Sin B
Cholesterol-associated lysosomal disorder triggers cell death of hematological malignancy: Dynamic analysis on cytotoxic effects of LW-218. [Abstract]2021 Oct;11(10):3178-3192. PMID: 34729308 -
Acta Pharm Sin B
Activated PKB/GSK-3 β synergizes with PKC- δ signaling in attenuating myocardial ischemia/reperfusion injury via potentiation of NRF2 activity: Therapeutic efficacy of dihydrotanshinone-I. [Abstract]2021 Jan;11(1):71-88. PMID: 33532181 -
J Extracell Vesicles
Breast Cancer-Secreted DPP3 Promotes Lung Metastasis by Remodelling the Vascular Niche in Lung via the Rap1 Signalling Pathway. [Abstract]2025 Dec;14(12):e70182. PMID: 41311249 -
J Extracell Vesicles
Oxidative stress induces extracellular vesicle release by upregulation of HEXB to facilitate tumour growth in experimental hepatocellular carcinoma. [Abstract]2024 Jul;13(7):e12468. PMID: 38944674
MG-132 purchased from MedChemExpress. Usage Cited in: J Extracell Vesicles. 2024 Jul;13(7):e12468. [Abstract]
Western blotting showing the protein degradation of HEXB in HEXB-AS stable knockdown cells using MG132 (10 μM, 24 h).
-
Autophagy
EXOC5/SEC10 attenuates antiviral IFN-I signaling by targeting STING1 for autophagic degradation. [Abstract]2026 Jul;22(7):1639-1656. PMID: 41968661 -
Autophagy
Trophoblast aging driven by IL33 deficiency elevates recurrent pregnancy loss risk through SNAP29 lactylation-mediated autophagy impairment. [Abstract]2026 Jul;22(7):1679-1697. PMID: 41975562 -
Autophagy
PFN1 inhibits lytic replication of Kaposi sarcoma-associated herpesvirus through SQSTM1/p62-mediated selective autophagy targeting the KSHV helicase. [Abstract]2026 Jun 14:1-16. PMID: 42260986 -
Autophagy
2026 May 7:1-17. PMID: 42080372 -
Autophagy
Lipotoxic hepatocyte-derived UBQLN1-enriched small extracellular vesicles activate hepatic stellate cells to promote hepatic fibrosis. [Abstract]2026 Mar 13:1-23. PMID: 41795680 -
Autophagy
2026 Apr;22(4):763-778. PMID: 41697162 -
Autophagy
Kitasamycin overcomes ferroptosis and immunotherapy resistance by targeting the HUWE1-NCOA4-FTH1 axis. [Abstract]2026 Feb 15:1-19. PMID: 41612599 -
Autophagy
Activation of chaperone-mediated autophagy suppresses glioblastoma by promoting wild-type IDH1/isocitrate dehydrogenase 1 degradation. [Abstract]2025 Nov 30:1-21. PMID: 41231102 -
Autophagy
XIAP-ULK1-Mediated mitophagy modulates carnitine metabolism to mitigate diabetic kidney disease. [Abstract]2025 Oct 25. PMID: 41139215 -
Autophagy
Endothelial F3-mediated autolysosome and lipid metabolism promote resistance to anti-VEGFA therapy in metastatic colorectal cancer. [Abstract]2025 Sep 8:1-20. PMID: 40922383 -
Autophagy
Pseudorabies virus gM protein and herpesvirus homologs block selective autophagy to enhance viral replication. [Abstract]2025 Jun 3:1-17. PMID: 40462306 -
Autophagy
Unveiling EXOC4/SEC8: a key player in enhancing antiviral immunity by inhibiting the FBXL19-STING1-SQSTM1 signaling axis. [Abstract]2025 Jun 3:1-19. PMID: 40413753 -
Autophagy
SENP2-mediated deSUMOylation of NCOA4 protects against ferritinophagy-dependent ferroptosis in myocardial ischemia-reperfusion injury. [Abstract]2025 May 19:1-18. PMID: 40366738 -
Autophagy
Dual roles of CXCR4 (C-X-C motif chemokine receptor 4) in promoting entry of ebolavirus and targeting excessive glycoprotein for reticulophagic degradation to facilitate viral fitness. [Abstract]2025 Apr 13. PMID: 40223186 -
Autophagy
The alpha-coronavirus E protein inhibits the JAK-STAT pathway signaling by triggering STAT2 degradation through OPTN- and NBR1-mediated selective autophagy. [Abstract]2025 Aug;21(8):1644-1661. PMID: 40091174 -
Autophagy
Histone lactylation stimulated upregulation of PSMD14 alleviates neuron PANoptosis through deubiquitinating PKM2 to activate PINK1-mediated mitophagy after traumatic brain injury. [Abstract]2025 Jul;21(7):1473-1491. PMID: 40000916 -
Autophagy
Chaperone-mediated autophagy degrades SERPINA1E342K/α1-antitrypsin Z variant and alleviates cell stress. [Abstract]2025 Mar 20. PMID: 40114294 -
Autophagy
Salmonella Typhimurium persistently infects host via its effector SseJ-induced PHB2-mediated mitophagy. [Abstract]2025 Jun;21(6):1228-1244. PMID: 39902787 -
Autophagy
Upregulation of ISG15 induced by MAPT/tau accumulation represses autophagic flux by inhibiting HDAC6 activity: a vicious cycle in Alzheimer disease. [Abstract]2025 Apr;21(4):807-826. PMID: 39635882 -
Autophagy
SMURF1 mediates damaged lysosomal homeostasis by ubiquitinating PPP3CB to promote the activation of TFEB. [Abstract]2025 Mar;21(3):530-547. PMID: 39324484 -
Autophagy
Impaired degradation of PLCG1 by chaperone-mediated autophagy promotes cellular senescence and intervertebral disc degeneration. [Abstract]2025 Feb;21(2):352-373. PMID: 39212196 -
Autophagy
TRIM21-mediated ubiquitination of SQSTM1/p62 abolishes its Ser403 phosphorylation and enhances palmitic acid cytotoxicity. [Abstract]2025 Jan;21(1):178-190. PMID: 39172027 -
Autophagy
PLK2-mediated phosphorylation of SQSTM1 S349 promotes aggregation of polyubiquitinated proteins upon proteasomal dysfunction. [Abstract]2024 Oct;20(10):2221-2237. PMID: 39316746 -
Autophagy
Enteric coronavirus nsp2 is a virulence determinant that recruits NBR1 for autophagic targeting of TBK1 to diminish the innate immune response. [Abstract]2024 Aug;20(8):1762-1779. PMID: 38597182 -
Autophagy
SMURF1 controls the PPP3/calcineurin complex and TFEB at a regulatory node for lysosomal biogenesis. [Abstract]2024 Apr;20(4):735-751. PMID: 37909662 -
Autophagy
2023 Oct;19(10):2702-2718. PMID: 37312409 -
Autophagy
The Valsa mali effector Vm1G-1794 protects the aggregated MdEF-Tu from autophagic degradation to promote infection in apple. [Abstract]2023 Jun;19(6):1745-1763. PMID: 36449354 -
Autophagy
The ORF7a protein of SARS-CoV-2 initiates autophagy and limits autophagosome-lysosome fusion via degradation of SNAP29 to promote virus replication. [Abstract]2023 Feb;19(2):551-569. PMID: 35670302 -
Autophagy
LUBAC and OTULIN regulate autophagy initiation and maturation by mediating the linear ubiquitination and the stabilization of ATG13. [Abstract]2021 Jul;17(7):1684-1699. PMID: 32543267 -
Adv Sci (Weinh)
The E3 Ligase RNF115 Aggravates Pathological Cardiac Hypertrophy via Ubiquitin-Mediated Degradation of SPTBN1. [Abstract]2026 Jun 15:e76077. PMID: 42294585 -
Adv Sci (Weinh)
ZNF33B Promotes Japanese Encephalitis Virus Infection by Regulating the Stability of M6A-Modified Trim25 to Control the Autophagy Process. [Abstract]2026 Jun 18:e76122. PMID: 42314059 -
Adv Sci (Weinh)
Drug-Induced Cuproptosis Defines the Therapeutic Window of Celecoxib in Intervertebral Disc Degeneration via the HSP90-RBX1 Axis. [Abstract]2026 May 4:e75527. PMID: 42080393 -
Adv Sci (Weinh)
Caveolin-1 Stabilizes SERCA2 to Counteract Acute Kidney Injury via Suppression of Ca2+-Dependent Endoplasmic Reticulum Stress in Distal Tubules. [Abstract]2026 May 8:e75449. PMID: 42102380 -
Adv Sci (Weinh)
Dual Cytoplasmic and Chloroplastic Mechanisms Fine-Tune Chloroplast Division through ARC3 Protein Stability. [Abstract]2026 May 26:e23660. PMID: 42186756 -
Adv Sci (Weinh)
Promoter Hypermethylation-Induced Silencing of FXYD1 Drives Breast Cancer Metastasis via DDX5-Mediated Wnt/β-Catenin Pathway Activation. [Abstract]2026 Mar 4:e21921. PMID: 41782411 -
Adv Sci (Weinh)
2026 Mar 24:e15970. PMID: 41874446 -
Adv Sci (Weinh)
Targeting the GPX4-FUNDC1 Interaction with Magnesium Lithospermate B Attenuates Sepsis-Associated Lung Injury. [Abstract]2026 Apr;13(20):e16488. PMID: 41616122 -
Adv Sci (Weinh)
Artesunate Ameliorates APAP-induced Liver Injury by Promoting NEDD4L-Mediated Ubiquitination and Degradation of TXNIP. [Abstract]2026 Feb 28:e21818. PMID: 41762705 -
Adv Sci (Weinh)
ERAD Component MoHrd3 Facilitates Pathogenicity and Establishes a Direct Regulation on Autophagy in Magnaporthe Oryzae. [Abstract]2026 Apr;13(24):e20627. PMID: 41725610 -
Adv Sci (Weinh)
2026 Apr;13(20):e15159. PMID: 41637562 -
Adv Sci (Weinh)
Elevated TRIM25 Impairs Poly (ADP-ribose) Metabolism via PARG Degradation and Mediates Compression-Induced Intervertebral Disc Degeneration. [Abstract]2026 May;13(25):e19248. PMID: 41700742 -
Adv Sci (Weinh)
2026 Mar;13(16):e13310. PMID: 41589654 -
Adv Sci (Weinh)
HSP90AB1-Mediated Ubiquitin-Proteasome Degradation of ITGBL1 Promotes Osteosarcoma Progression by Inhibiting Endoplasmic Reticulum Stress-Induced Autophagy. [Abstract]2026 Apr;13(23):e15651. PMID: 41697125 -
Adv Sci (Weinh)
OTUD6A in Airway Epithelial Cells Exacerbates Allergic Asthma by Promoting Airway Inflammation and Airway Remodeling Through Deubiquitination of hResistin/mRELMα. [Abstract]2026 Jan 20:e16355. PMID: 41560298 -
Adv Sci (Weinh)
Microglial GPR35 Ameliorates Epileptogenesis and Neuroinflammation via PDGFA Domain 2 Signaling. [Abstract]2026 Jan 28:e19642. PMID: 41604576 -
Adv Sci (Weinh)
Microcystin-LR Triggers Renal Tubular Ferroptosis Through Epigenetic Repression of GPX4: Implications for Environmental Nephrotoxicity. [Abstract]2025 Nov 30:e14349. PMID: 41319283 -
Adv Sci (Weinh)
Fe-S Protein FDX1 Triggers Tumor-Intrinsic Innate Immunity via Mitochondrial Nucleic Acids Release to Orchestrate Ferroptosis in CCRCC. [Abstract]2025 Nov 7:e18323. PMID: 41199656 -
Adv Sci (Weinh)
CypA Mediates Non-Small Cell Lung Cancer Chemoresistance by Attenuating Ferroptosis via Stabilizing SLC7A11. [Abstract]2025 Nov 7:e11947. PMID: 41203575 -
Adv Sci (Weinh)
Reprogramming Tumor-Associated Macrophages via Targeted NAT10 Inhibition to Enhance Colorectal Cancer Immunotherapy. [Abstract]2025 Oct 27:e10854. PMID: 41144699 -
Adv Sci (Weinh)
Genetic and Functional Evidence Links Germline Biallelic Inactivating Variants in WWOX to Histological Mixed-Type Thyroid Cancer. [Abstract]2025 Oct 22:e07602. PMID: 41124647 -
Adv Sci (Weinh)
ACE-mediated Glycosylation Stabilizes PSAP To Promote GPR37-dependent Macrophage-Nucleus Pulposus Cells Crosstalk and TGFβ Signaling in Alleviating Intervertebral Disc Degeneration. [Abstract]2025 Oct 14:e10662. PMID: 41085015 -
Adv Sci (Weinh)
CircLRBA Promotes Epithelial-Mesenchymal Transition, Immune Evasion, Chemoimmunotherapy Resistance and Metastasis Through Stabilizing Twist1. [Abstract]2025 Oct 13:e08918. PMID: 41082269 -
Adv Sci (Weinh)
Serine/Threonine Kinase 33 as a Novel Target of Bufalin in Treatment of Triple-Negative Breast Cancer. [Abstract]2025 Sep 4:e06253. PMID: 40908551 -
Adv Sci (Weinh)
Structure-Tailoring Cerium Nanozymes with Self-Cascade ROS Scavenging Catalysis Modulate the Microbiota-Gut-Joint Axis for Rheumatoid Arthritis Therapy. [Abstract]2025 Sep 29:e12281. PMID: 41024355 -
Adv Sci (Weinh)
CircPVT1 Promotes Lung Metastasis and Tumor Progression in Renal Cell Carcinoma by Encoding the cP104aa Peptide and Targeting EIF4A3. [Abstract]2025 Sep 18:e01211. PMID: 40966379 -
Adv Sci (Weinh)
2025 Sep 15:e06294. PMID: 40953331 -
Adv Sci (Weinh)
Preservation of ALYREF Phase Separation Mitigates Doxorubicin-Induced Cardiomyocyte DNA Damage and Cardiotoxicity. [Abstract]2025 Sep 3:e05270. PMID: 40899520 -
Adv Sci (Weinh)
Branched-Chain α Keto-Acid Dehydrogenase Kinase-Mediated AKT Phosphorylation Promotes RCC Tumorigenesis and Drug Resistance. [Abstract]2025 Aug 11:e11081. PMID: 40789057 -
Adv Sci (Weinh)
2025 Aug 4:e03972. PMID: 40755418 -
Adv Sci (Weinh)
Fusidic Acid Reverses Chemoresistance in Breast Cancer via Targeting DDX6 to Downregulate GSK-3β/β-Catenin Signaling. [Abstract]2025 Aug 4:e04680. PMID: 40757496 -
Adv Sci (Weinh)
Neoeriocitrin Targeting Beclin1 Deubiquitination and Autophagy in Osteogenic Differentiation of Human Dental Pulp Stem Cells. [Abstract]2025 Aug 19:e04378. PMID: 40831238 -
Adv Sci (Weinh)
Targeting Intratumoral Copper Inhibits Tumor Progression via p62-Mediated EZH2 Degradation and Potentiates Anti-PD-1 Immunotherapy in Oral Squamous Cell Carcinoma. [Abstract]2025 Jul 28:e17795. PMID: 40719074 -
Adv Sci (Weinh)
Activation of Lysosomal Retrograde Transport Triggers TPC1-IP3R1 Ca2+ Crosstalk at Lysosome-ER MCSs Leading to Lethal Depleting of ER Calcium. [Abstract]2025 Jul 25:e15313. PMID: 40709664 -
Adv Sci (Weinh)
SNORA58 Facilitates Radioresistance via Suppressing JNK1-Mediated Ferroptosis in Esophageal Squamous Cell Carcinoma. [Abstract]2025 Jul 26:e08515. PMID: 40714828 -
Adv Sci (Weinh)
Dysfunctional Decidual CD4+T Cells Induce Recurrent Pregnancy Loss via Palmitoylation-Dependent Tim-3 Lysosomal Sorting and Degradation. [Abstract]2025 Jul 11:e00971. PMID: 40642872 -
Adv Sci (Weinh)
API5 Phosphorylation Promotes Antiviral Immunity by Inhibiting Degradation of Cytosolic RNA Sensor RLRs. [Abstract]2025 Jul 11:e05479. PMID: 40641422 -
Adv Sci (Weinh)
LncDARS-AS1 Regulates ATP1A1 Stability and Enhances Na+/K+ ATPase Activity to Promote Osteosarcoma Metastasis. [Abstract]2025 Jul 15:e03486. PMID: 40665639 -
Adv Sci (Weinh)
WTAP Mediated m6A Modification Stabilizes PDIA3P1 and Promotes Tumor Progression Driven by Histone Lactylation in Esophageal Squamous Cell Carcinoma. [Abstract]2025 Jun 5:e06529. PMID: 40470706 -
Adv Sci (Weinh)
Splicing Shift of RAC1 Accelerates Tumorigenesis and Defines a Potent Therapeutic Target in Lung Cancer. [Abstract]2025 Jun 23:e03322. PMID: 40548642 -
Adv Sci (Weinh)
Tryptophan Metabolite Indole-3-Aldehyde Induces AhR and c-MYC Degradation to Promote Tumor Immunogenicity. [Abstract]2025 Jun 29:e09533. PMID: 40583248 -
Adv Sci (Weinh)
PIP5K1A Suppresses Ferroptosis and Induces Sorafenib Resistance by Stabilizing NRF2 in Hepatocellular Carcinoma. [Abstract]2025 May 23:e04372. PMID: 40405713 -
Adv Sci (Weinh)
PSMD14 Stabilizes SLC7A11 to Ameliorate Glucocorticoid-Induced Osteoporosis by Suppressing Osteocyte Ferroptosis. [Abstract]2025 May 30:e14902. PMID: 40444470 -
Adv Sci (Weinh)
2025 May 31:e14956. PMID: 40448625 -
Adv Sci (Weinh)
MTFR2-Mediated Fission Drives Fatty Acid and Mitochondrial Co-Transfer from Hepatic Stellate Cells to Tumor Cells Fueling Oncogenesis. [Abstract]2025 May 14:e2416419. PMID: 40365837 -
Adv Sci (Weinh)
Pyruvate Carboxylase in Macrophages Aggravates Atherosclerosis by Regulating Metabolism Reprogramming to Promote Inflammatory Responses Through the Hypoxia-Inducible Factor-1 Signaling Pathway. [Abstract]2025 May 20:e17128. PMID: 40391718 -
Adv Sci (Weinh)
EccDNA-Driven VPS41 Amplification Alleviates Genotoxic Stress via Lysosomal KAI1 Degradation. [Abstract]2025 Apr 24:e2501934. PMID: 40271553 -
Adv Sci (Weinh)
FGF2 Mediated USP42-PPARγ Axis Activation Ameliorates Liver Oxidative Damage and Promotes Regeneration. [Abstract]2025 May;12(18):e2408724. PMID: 40091484 -
Adv Sci (Weinh)
Identification of a Novel Substrate for eEF2K and the AURKA-SOX8 as the Related Pathway in TNBC. [Abstract]2025 Apr;12(14):e2412985. PMID: 39950798 -
Adv Sci (Weinh)
The Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide Attenuates Colon Cancer Development by Regulating Glucose Metabolism. [Abstract]2025 Mar 24:e2411980. PMID: 40125821 -
Adv Sci (Weinh)
LncRNA TUG1 Repressed Angiogenesis by Promoting the Ubiquitination of HuR and Inhibiting Its Nuclear Translocation in Cerebral Ischemic Reperfusion Injury. [Abstract]2025 Jan 31:e2413333. PMID: 39887590 -
Adv Sci (Weinh)
A Novel tRF, HCETSR, Derived From tRNA-Glu/TTC, Inhibits HCC Malignancy by Regulating the SPBTN1-catenin Complex Axis. [Abstract]2025 Feb 8:e2415229. PMID: 39921434 -
Adv Sci (Weinh)
Itraconazole Reversing Acquired Resistance to Osimertinib in NSCLC by Inhibiting the SHH/DUSP13B/p-STAT3 Axis. [Abstract]2024 Dec 25:e2409416. PMID: 39721017 -
Adv Sci (Weinh)
Primary Cilia Formation Mediated by Hsa_Circ_0005185/OTUB1/RAB8A Complex Inhibits Prostate Cancer Progression by Suppressing Hedgehog Signaling Pathway. [Abstract]2025 Jan 9:e2411675. PMID: 39785769 -
Adv Sci (Weinh)
Targeting TTK Inhibits Tumorigenesis of T-Cell Lymphoma Through Dephosphorylating p38α and Activating AMPK/mTOR Pathway. [Abstract]2025 Jan 21:e2413990. PMID: 39836493 -
Adv Sci (Weinh)
HACD2 Promotes Pancreatic Cancer Progression by Enhancing PKM2 Dissociation From PRKN in a Dehydratase-Independent Manner. [Abstract]2025 Jan 21:e2407942. PMID: 39836601 -
Adv Sci (Weinh)
STAMBPL1/TRIM21 Balances AXL Stability Impacting Mesenchymal Phenotype and Immune Response in KIRC. [Abstract]2024 Nov 11:e2405083. PMID: 39527690 -
Adv Sci (Weinh)
Aldehyde Dehydrogenase 2 Lactylation Aggravates Mitochondrial Dysfunction by Disrupting PHB2 Mediated Mitophagy in Acute Kidney Injury. [Abstract]2024 Dec 31:e2411943. PMID: 39737891 -
Adv Sci (Weinh)
Network Medicine-Based Strategy Identifies Maprotiline as a Repurposable Drug by Inhibiting PD-L1 Expression via Targeting SPOP in Cancer. [Abstract]2024 Nov 5:e2410285. PMID: 39499771 -
Adv Sci (Weinh)
OTUD5 Protects Dopaminergic Neurons by Promoting the Degradation of α-Synuclein in Parkinson's Disease Model. [Abstract]2024 Dec 25:e2406700. PMID: 39721018 -
Adv Sci (Weinh)
Berberine Derivative B68 Promotes Tumor Immune Clearance by Dual-Targeting BMI1 for Senescence Induction and CSN5 for PD-L1 Degradation. [Abstract]2024 Dec 25:e2413122. PMID: 39721027 -
Adv Sci (Weinh)
Deletion of Pyruvate Carboxylase in Tubular Epithelial Cell Promotes Renal Fibrosis by Regulating SQOR/cGAS/STING-Mediated Glycolysis. [Abstract]2025 Jan 21:e2408753. PMID: 39836535 -
Adv Sci (Weinh)
Addressing Clinical Limitations of Glutaminase Inhibitors: Novel Strategies for Osimertinib-Resistant Lung Cancer by Exploiting Glutamine Metabolic Dependency. [Abstract]2024 Dec 16:e2411479. PMID: 39680480 -
Adv Sci (Weinh)
Targeting CDK2 Confers Vulnerability to Lenvatinib Via Driving Senescence in Anaplastic Thyroid Cancer. [Abstract]2024 Dec 24:e2413514. PMID: 39716890 -
Adv Sci (Weinh)
Targeting piRNA-137463 Inhibits Tumor Progression and Boosts Sensitivity to Immune Checkpoint Blockade via De Novo Cholesterol Biosynthesis in Lung Adenocarcinoma. [Abstract]2024 Dec 18:e2414100. PMID: 39692168 -
Adv Sci (Weinh)
RBBP6-Mediated ERRα Degradation Contributes to Mitochondrial Injury in Renal Tubular Cells in Diabetic Kidney Disease. [Abstract]2024 Oct 23:e2405153. PMID: 39441040 -
Adv Sci (Weinh)
siRNA/CS-PLGA Nanoparticle System Targeting Knockdown Intestinal SOAT2 Reduced Intestinal Lipid Uptake and Alleviated Obesity. [Abstract]2024 Sep 19:e2403442. PMID: 39297413 -
Adv Sci (Weinh)
TRIM56 Modulates YBX1 Degradation to Ameliorate ZBP1-Mediated Neuronal PANoptosis in Spinal Cord Injury. [Abstract]2024 Sep 18:e2407132. PMID: 39291396 -
Adv Sci (Weinh)
CircUGP2 Suppresses Intrahepatic Cholangiocarcinoma Progression via p53 Signaling Through Interacting With PURB to Regulate ADGRB1 Transcription and Sponging miR-3191-5p. [Abstract]2024 Aug 9:e2402329. PMID: 39120980 -
Adv Sci (Weinh)
2024 Aug 8:e2406633. PMID: 39116343 -
Adv Sci (Weinh)
Inhibition of CARM1-Mediated Methylation of ACSL4 Promotes Ferroptosis in Colorectal Cancer. [Abstract]2023 Dec;10(36):e2303484. PMID: 37946697 -
Adv Sci (Weinh)
TSPYL1 as a Critical Regulator of TGFβ Signaling through Repression of TGFBR1 and TSPYL2. [Abstract]2024 Jun;11(21):e2306486. PMID: 38588050 -
Adv Sci (Weinh)
SHMT2 Mediates Small-Molecule-Induced Alleviation of Alzheimer Pathology Via the 5'UTR-dependent ADAM10 Translation Initiation. [Abstract]2024 Mar;11(11):e2305260. PMID: 38183387 -
Adv Sci (Weinh)
Metabolic Enzyme SLC27A5 Regulates PIP4K2A pre-mRNA Splicing as a Noncanonical Mechanism to Suppress Hepatocellular Carcinoma Metastasis. [Abstract]2024 Feb;11(5):e2305374. PMID: 38059827 -
Adv Sci (Weinh)
Transgelin Promotes Glioblastoma Stem Cell Hypoxic Responses and Maintenance Through p53 Acetylation. [Abstract]2024 Feb;11(7):e2305620. PMID: 38087889 -
Adv Sci (Weinh)
HSPA8 Activates Wnt/β-Catenin Signaling to Facilitate BRAF V600E Colorectal Cancer Progression by CMA-Mediated CAV1 Degradation. [Abstract]2024 Jan;11(3):e2306535. PMID: 37973552 -
Adv Sci (Weinh)
Targeting USP8 Inhibits O-GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT. [Abstract]2023 Nov;10(33):e2302953. PMID: 37867237 -
Adv Sci (Weinh)
Protein-Nanocaged Selenium Induces t(8;21) Leukemia Cell Differentiation via Epigenetic Regulation. [Abstract]2023 Dec;10(35):e2300698. PMID: 37888866 -
Adv Sci (Weinh)
Palmitoyltransferase ZDHHC3 Aggravates Nonalcoholic Steatohepatitis by Targeting S-Palmitoylated IRHOM2. [Abstract]2023 Oct;10(28):e2302130. PMID: 37544908 -
Adv Sci (Weinh)
Yin Yang 1-Induced Long Noncoding RNA DUXAP9 Drives the Progression of Oral Squamous Cell Carcinoma by Blocking CDK1-Mediated EZH2 Degradation. [Abstract]2023 Sep;10(25):e2207549. PMID: 37401236 -
Adv Sci (Weinh)
EHBP1L1 Drives Immune Evasion in Renal Cell Carcinoma through Binding and Stabilizing JAK1. [Abstract]2023 Apr;10(11):e2206792. PMID: 36775874 -
Adv Sci (Weinh)
Loss-of-Function of p21-Activated Kinase 2 Links BMP Signaling to Neural Tube Patterning Defects. [Abstract]2023 Feb;10(4):e2204018. PMID: 36504449 -
Adv Sci (Weinh)
SETD8C302R Mutation Revealed from Myofibroblastoma-Discordant Monozygotic Twins Leads to p53/p21 Deficit and WEE1 Inhibitor Sensitivity. [Abstract]2020 Aug 5;7(19):2001041. PMID: 33042742 -
Adv Sci (Weinh)
Tumor Cell "Slimming" Regulates Tumor Progression through PLCL1/UCP1-Mediated Lipid Browning. [Abstract]2019 Mar 25;6(10):1801862. PMID: 31131187 -
Nat Chem Biol
2023 Dec;19(12):1513-1523. PMID: 37653169 -
Nat Chem Biol
2022 Nov;18(11):1214-1223. PMID: 35982226 -
J Clin Invest
2026 Jan 2;136(1):e192599. PMID: 41480765 -
Nat Plants
An apoplastic fungal effector disrupts N-glycosylation of ZmLecRK1, inducing its degradation to suppress disease resistance in maize. [Abstract]2025 Sep 12. PMID: 40940425 -
J Clin Invest
Asparagine drives immune evasion in bladder cancer via RIG-I stability and type I IFN signaling. [Abstract]2025 Feb 18;135(8):e186648. PMID: 39964752 -
J Clin Invest
An inherited predisposition allele promotes gastric cancer via enhancing deubiquitination-mediated activation of epithelial-to-mesenchymal transition signaling. [Abstract]2025 Feb 25;135(8):e179617. PMID: 39998882 -
J Clin Invest
TRIB3 mediates vascular calcification through facilitating self-ubiquitination and dissociation of Smurf1 in chronic renal disease. [Abstract]2025 Feb 11:e175972. PMID: 39932798 -
Nat Plants
A natural allele of proteasome maturation factor improves rice resistance to multiple pathogens. [Abstract]2023 Feb;9(2):228-237. PMID: 36646829 -
J Clin Invest
USP25 inhibition ameliorates Alzheimer's pathology through the regulation of APP processing and Aβ generation. [Abstract]2022 Mar 1;132(5):e152170. PMID: 35229730 -
Nat Plants
2021 Feb;7(2):209-218. PMID: 33574575
MG-132 purchased from MedChemExpress. Usage Cited in: Nat Plants. 2021 Feb;7(2):209-218. [Abstract]
In vitro degradation assays. The recombinant His-FBL17 proteins were incubated with WT extract in the presence of 1% DMSO (vehicle), 100 μM MG132 (proteasome inhibitor), or 100 μM PMSF (protease inhibitor) for 0, 1, and 2 h. The reactions were stopped by adding 5X SDS loading buffer and were subjected to western blotting using anti-His or anti-GS antibodies. The glutamine synthetase (GS) protein was used as a loading control.
-
Exp Hematol Oncol
Targeting ST8SIA6-AS1 counteracts KRASG12C inhibitor resistance through abolishing the reciprocal activation of PLK1/c-Myc signaling. [Abstract]2023 Dec 16;12(1):105. PMID: 38104151 -
Leukemia
Autophagosome-lysosome mediated secretion of the thrombopoietin receptor is modulated by distinct driver mutations of myeloproliferative neoplasm. [Abstract]2025 Sep;39(9):2181-2195. PMID: 40610764 -
Neuro Oncol
FAM129A promotes self-renewal and maintains invasive status via stabilizing the Notch intracellular domain in glioma stem cells. [Abstract]2023 Oct 3;25(10):1788-1801. PMID: 37083136
MG-132 purchased from MedChemExpress. Usage Cited in: Neuro Oncol. 2023 Oct 3;25(10):1788-1801. [Abstract]
Western blotting of FAM129A and NICD1 in indicated cells. GSC was treated with MG132 (5 μM; 6 h) for harvest.
-
Neuro Oncol
2023 Jan 5;25(1):82-96. PMID: 35727735 -
Theranostics
Endosome-microautophagy targeting chimera (eMIATAC) for targeted proteins degradation and enhance CAR-T cell anti-tumor therapy. [Abstract]2024 Jul 22;14(11):4481-4498. PMID: 39113807 -
Theranostics
2024 Jul 1;14(10):3984-3996. PMID: 38994020 -
Theranostics
E3 ubiquitin ligase TRIM21 targets TIF1γ to regulate β-catenin signaling in glioblastoma. [Abstract]2023 Sep 4;13(14):4919-4935. PMID: 37771771 -
Theranostics
The peroxisome proliferator-activated receptor agonist rosiglitazone specifically represses tumour metastatic potential in chromatin inaccessibility-mediated FABP4-deficient gastric cancer. [Abstract]2022 Jan 24;12(4):1904-1920. PMID: 35198079 -
Theranostics
Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells. [Abstract]2021 Jun 11;11(16):7640-7657. PMID: 34335955 -
Theranostics
A novel small-molecule PROTAC selectively promotes tau clearance to improve cognitive functions in Alzheimer-like models. [Abstract]2021 Mar 11;11(11):5279-5295. PMID: 33859747 -
Theranostics
Decreased neuronal synaptosome associated protein 29 contributes to poststroke cognitive impairment by disrupting presynaptic maintenance. [Abstract]2021 Mar 4;11(10):4616-4636. PMID: 33754017 -
Theranostics
ACSS3 represses prostate cancer progression through downregulating lipid droplet-associated protein PLIN3. [Abstract]2021 Jan 1;11(2):841-860. PMID: 33391508 -
Theranostics
H3K27 acetylation activated-COL6A1 promotes osteosarcoma lung metastasis by repressing STAT1 and activating pulmonary cancer-associated fibroblasts. [Abstract]2021 Jan 1;11(3):1473-1492. PMID: 33391546 -
Theranostics
Covalent modification of Keap1 at Cys77 and Cys434 by pubescenoside a suppresses oxidative stress-induced NLRP3 inflammasome activation in myocardial ischemia-reperfusion injury. [Abstract]2021 Jan 1;11(2):861-877. PMID: 33391509 -
Theranostics
2020 Aug 13;10(24):11110-11126. PMID: 33042273 -
Theranostics
STIM1 is a metabolic checkpoint regulating the invasion and metastasis of hepatocellular carcinoma. [Abstract]2020 May 16;10(14):6483-6499. PMID: 32483465 -
Theranostics
HSPA12A unstabilizes CD147 to inhibit lactate export and migration in human renal cell carcinoma. [Abstract]2020 Jul 9;10(19):8573-8590. PMID: 32754264 -
Theranostics
ATF4 destabilizes RET through nonclassical GRP78 inhibition to enhance chemosensitivity to bortezomib in human osteosarcoma. [Abstract]2019 Aug 14;9(21):6334-6353. PMID: 31534554 -
Theranostics
Inhibition of HSP90β Improves Lipid Disorders by Promoting Mature SREBPs Degradation via the Ubiquitin-proteasome System. [Abstract]2019 Aug 12;9(20):5769-5783. PMID: 31534518 -
Theranostics
EBV(LMP1)-induced metabolic reprogramming inhibits necroptosis through the hypermethylation of the RIP3 promoter. [Abstract]2019 Apr 13;9(9):2424-2438. PMID: 31131045 -
-
-
Nucleic Acids Res
Spatial regulation of DNA damage tolerance protein Rad5 interconnects genome stability maintenance and proteostasis networks. [Abstract]2024 Feb 9;52(3):1156-1172. PMID: 38055836 -
Nucleic Acids Res
ZYH005, a novel DNA intercalator, overcomes all-trans retinoic acid resistance in acute promyelocytic leukemia. [Abstract]2018 Apr 20;46(7):3284-3297. PMID: 29554366 -
J Adv Res
Melanoma cell-derived LAG-3 enhances CXCL1/8-driven MDSCs recruitment and immune escape via TRIM28-mediated IκBα degradation. [Abstract]2026 Jul 1:S2090-1232(26)00516-3. PMID: 42386072 -
J Adv Res
Renal tubular Nfe2l1 protect cisplatin-induced acute kidney injury via suppressing ACSL4-dependent ferroptosis. [Abstract]2026 May 3:S2090-1232(26)00381-4. PMID: 42086188 -
J Adv Res
LncRNA HCP5 remodels G6PD dual post-translational modification to mediate metabolic adaptations driving osimertinib resistance in lung adenocarcinoma. [Abstract]2026 Apr 6:S2090-1232(26)00296-1. PMID: 41951052 -
J Adv Res
OGT regulates histone demethylation and alleviates osteoarthritis progression by O-GlcNAcylation of KDM6B. [Abstract]2026 Jan 2:S2090-1232(26)00003-2. PMID: 41485575 -
J Adv Res
Selective degradation of DAPK1 via a novel hydrophobic tagging attenuates tau pathology in Alzheimer's disease. [Abstract]2025 Dec 27:S2090-1232(25)01027-6. PMID: 41461311 -
J Adv Res
Tetrahydrocurcumin targets TRIP13 inhibiting the interaction of TRIP13/USP7/c-FLIP to mediate c-FLIP ubiquitination in triple-negative breast cancer. [Abstract]2024 Nov 5:S2090-1232(24)00496-X. PMID: 39505147 -
J Adv Res
Parkin modulates the hepatocellular carcinoma microenvironment by regulating PD-1/PD-L1 signalling. [Abstract]2025 Jan 2:S2090-1232(24)00623-4. PMID: 39755271 -
J Adv Res
HSPA12A acts as a scaffolding protein to inhibit cardiac fibroblast activation and cardiac fibrosis. [Abstract]2025 Jan:67:217-229. PMID: 38219869 -
J Adv Res
IFP35 aggravates Staphylococcus aureus infection by promoting Nrf2-regulated ferroptosis. [Abstract]2024 Aug:62:143-154. PMID: 37777065 -
J Adv Res
FUNDC1 Interacts with GPx4 to Govern Hepatic Ferroptosis and Fibrotic Injury through a Mitophagy-Dependent Manner. [Abstract]2024 Jan:55:45-60. PMID: 36828120 -
Biomaterials
An ultrasound-activated PROTAC prodrug with self-reporting fluorescence for targeted protein degradation. [Abstract]2026 Jul:330:124045. PMID: 41643569 -
Biomaterials
Tumor microenvironment responsive nano-PROTAC for BRD4 degradation enhanced cancer photo-immunotherapy. [Abstract]2025 May 7:322:123387. PMID: 40344878 -
Exp Mol Med
USP15 promotes pulmonary vascular remodeling in pulmonary hypertension in a YAP1/TAZ-dependent manner. [Abstract]2023 Jan;55(1):183-195. PMID: 36635430 -
Exp Mol Med
Clusterin negatively modulates mechanical stress-mediated ligamentum flavum hypertrophy through TGF-β1 signaling. [Abstract]2022 Sep;54(9):1549-1562. PMID: 36131026 -
J Exp Clin Cancer Res
NOTCH3 regulates myofibroblastic CAF differentiation via the P62-ROS signaling axis to promote bladder cancer progression. [Abstract]2026 Jun 6. PMID: 42251414 -
J Exp Clin Cancer Res
TCF3 activates super-enhancer-driven TRIB2 overexpression to suppress ferroptosis and promote hepatoblastoma proliferation. [Abstract]2025 Dec 29;44(1):329. PMID: 41462308 -
J Exp Clin Cancer Res
SENP1 drives glycolysis and cisplatin resistance in gastric cancer via desumoylating ENO1. [Abstract]2025 Oct 8;44(1):285. PMID: 41063235 -
J Exp Clin Cancer Res
Targeting NOTCH1-KEAP1 axis retards chronic liver injury and liver cancer progression via regulating stabilization of NRF2. [Abstract]2025 Aug 9;44(1):232. PMID: 40781716 -
J Exp Clin Cancer Res
Pyrotinib targeted EGFR/GRP78 mediated cell apoptosis in high EGFR gene copy number gastric cancer. [Abstract]2025 Aug 19;44(1):245. PMID: 40830980 -
J Exp Clin Cancer Res
SLC14A1 and TGF-β signaling: a feedback loop driving EMT and colorectal cancer metachronous liver metastasis. [Abstract]2024 Jul 27;43(1):208. PMID: 39061061 -
J Exp Clin Cancer Res
The immunotoxin targeting PRLR increases tamoxifen sensitivity and enhances the efficacy of chemotherapy in breast cancer. [Abstract]2024 Jun 20;43(1):173. PMID: 38898487 -
Protein Cell
2024 May 9:pwae023. PMID: 38721690 -
J Exp Clin Cancer Res
PLAG1 interacts with GPX4 to conquer vulnerability to sorafenib induced ferroptosis through a PVT1/miR-195-5p axis-dependent manner in hepatocellular carcinoma. [Abstract]2024 May 14;43(1):143. PMID: 38745179 -
J Exp Clin Cancer Res
The feedback loop of EFTUD2/c-MYC impedes chemotherapeutic efficacy by enhancing EFTUD2 transcription and stabilizing c-MYC protein in colorectal cancer. [Abstract]2024 Jan 2;43(1):7. PMID: 38163859 -
J Exp Clin Cancer Res
TRIM25 promotes glioblastoma cell growth and invasion via regulation of the PRMT1/c-MYC pathway by targeting the splicing factor NONO. [Abstract]2024 Feb 2;43(1):39. PMID: 38303029 -
J Exp Clin Cancer Res
Anoikis resistance and immune escape mediated by Epstein-Barr virus-encoded latent membrane protein 1-induced stabilization of PGC-1α promotes invasion and metastasis of nasopharyngeal carcinoma. [Abstract]2023 Oct 7;42(1):261. PMID: 37803433 -
J Exp Clin Cancer Res
MKRN1 promotes colorectal cancer metastasis by activating the TGF-β signalling pathway through SNIP1 protein degradation. [Abstract]2023 Aug 24;42(1):219. PMID: 37620897 -
J Exp Clin Cancer Res
RNF31 represses cell progression and immune evasion via YAP/PD-L1 suppression in triple negative breast Cancer. [Abstract]2022 Dec 29;41(1):364. PMID: 36581998 -
Protein Cell
NDFIP1 limits cellular TAZ accumulation via exosomal sorting to inhibit NSCLC proliferation. [Abstract]2023 Mar 16;14(2):123-136. PMID: 36929005 -
J Exp Clin Cancer Res
PABPC1-induced stabilization of IFI27 mRNA promotes angiogenesis and malignant progression in esophageal squamous cell carcinoma through exosomal miRNA-21-5p. [Abstract]2022 Mar 28;41(1):111. PMID: 35346324 -
J Exp Clin Cancer Res
Loss of RPS27a expression regulates the cell cycle, apoptosis, and proliferation via the RPL11-MDM2-p53 pathway in lung adenocarcinoma cells. [Abstract]2022 Jan 24;41(1):33. PMID: 35073964 -
J Exp Clin Cancer Res
ROC1 promotes the malignant progression of bladder cancer by regulating p-IκBα/NF-κB signaling. [Abstract]2021 May 7;40(1):158. PMID: 33962660 -
J Exp Clin Cancer Res
Efficacy and mechanism of the combination of PARP and CDK4/6 inhibitors in the treatment of triple-negative breast cancer. [Abstract]2021 Apr 8;40(1):122. PMID: 33832512 -
J Exp Clin Cancer Res
IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way. [Abstract]2020 Sep 16;39(1):190. PMID: 32938489 -
Protein Cell
Loss of 4.1N in epithelial ovarian cancer results in EMT and matrix-detached cell death resistance. [Abstract]2021 Feb;12(2):107-127. PMID: 32448967 -
J Exp Clin Cancer Res
FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21. [Abstract]2019 Feb 26;38(1):101. PMID: 30808376
MG-132 purchased from MedChemExpress. Usage Cited in: J Exp Clin Cancer Res. 2019 Feb 26;38(1):101. [Abstract]
HLF and Hep3B cells are treated with Mg132 (10 μg/ml) for 4 h, total protein is extracted and subjected to western blotting using anti-Flag, anti-p21, or anti-GAPDH antibodies.
-
J Exp Clin Cancer Res
Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity. [Abstract]2018 Nov 27;37(1):287. PMID: 30482232 -
J Exp Clin Cancer Res
An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancer. [Abstract]2018 Oct 3;37(1):240. PMID: 30285798
MG-132 purchased from MedChemExpress. Usage Cited in: J Exp Clin Cancer Res. 2018 Oct 3;37(1):240. [Abstract]
Decrease of ERCC6 expression can be rescued with proteasome inhibitor MG132. Subconfluent SKOV3 cells are treated with FL118 and MG132 alone or in combination as shown for 8 h, followed by western blot analyses with ERCC6 antibody.
-
J Exp Clin Cancer Res
HJURP promotes hepatocellular carcinoma proliferation by destabilizing p21 via the MAPK/ERK1/2 and AKT/GSK3β signaling pathways. [Abstract]2018 Aug 15;37(1):193. PMID: 30111352
MG-132 purchased from MedChemExpress. Usage Cited in: J Exp Clin Cancer Res. 2018 Aug 15;37(1):193. [Abstract]
Western blot is performed in HCC-LM3 cells transfected with HJURP knockdown lentivirus and treated with DMSO or MG132.
-
Sci Adv
2026 Feb 20;12(8):eadz2439. PMID: 41706863 -
Cell Discov
ASCT2 palmitoylation regulated by JNK1-ZDHHC14 axis orchestrates glutamine metabolism and NSCLC progression. [Abstract]2026 Feb 24;12(1):13. PMID: 41730846 -
Sci Adv
Brain-derived extracellular vesicles circUsp32 polarized macrophages causing acute kidney injury after traumatic brain injury. [Abstract]2025 Nov 28;11(48):eadz1243. PMID: 41296848 -
Sci Adv
Targeting the ATM-TRMT10A-BRCA1 axis confers synthetic lethality to PARP inhibition in metastatic castration-resistant prostate cancer. [Abstract]2025 Oct 10;11(41):eadw7989. PMID: 41071892 -
Sci Adv
The citrullinating enzyme PADI4 governs progenitor cell proliferation and translation in developing hair follicles. [Abstract]2025 Sep 12;11(37):eadx4511. PMID: 40938992 -
Sci Adv
The TaCEP15 peptide signaling cascade modulates primary root length and drought tolerance in wheat. [Abstract]2025 Sep 5;11(36):eady1949. PMID: 40901958 -
Sci Adv
Abscisic acid enhances DNA damage response through the nuclear shuttling of clathrin light chain 2 in plant cells. [Abstract]2025 Jun 13;11(24):eadt2842. PMID: 40512838 -
Sci Adv
Acute BRCAness induction and AR pathway blockage through CDK12/7/9 degradation enhances PARP inhibitor sensitivity in prostate cancer. [Abstract]Sci Adv. 2025 Apr 25;11(17):eadu0847. PMID: 40267193 -
Sci Adv
USP8 and Hsp70 regulate endoreplication by synergistically promoting Fzr deubiquitination and stabilization. [Abstract]2025 Mar 21;11(12):eadq9111. PMID: 40106570 -
Cell Discov
Targeting SNRNP200-induced splicing dysregulation offers an immunotherapy opportunity for glycolytic triple-negative breast cancer. [Abstract]2024 Sep 17;10(1):96. PMID: 39285160 -
Cell Discov
The Fe-S cluster assembly protein IscU2 increases α-ketoglutarate catabolism and DNA 5mC to promote tumor growth. [Abstract]2023 Jul 25;9(1):76. PMID: 37488138 -
Cell Discov
Reprogramming of palmitic acid induced by dephosphorylation of ACOX1 promotes β-catenin palmitoylation to drive colorectal cancer progression. [Abstract]2023 Mar 7;9(1):26. PMID: 36878899 -
Sci Adv
2022 Aug 26;8(34):eabq4722. PMID: 36026448 -
Sci Adv
Trisomy 21-induced dysregulation of microglial homeostasis in Alzheimer's brains is mediated by USP25. [Abstract]2021 Jan 1;7(1):eabe1340. PMID: 33523861 -
Int J Oral Sci
Antisense oligonucleotide targeting TARDBP-EGFR splicing axis inhibits progression of oral squamous cell carcinoma through ABCA1-regulated cholesterol efflux. [Abstract]2026 Jan 16;18(1):10. PMID: 41540015 -
J Biomed Sci
2021 Jul 23;28(1):55. PMID: 34301262 -
Mol Ther
AAV-based gene therapy ameliorates neurological deficits in a mouse model of childhood-onset neurodegeneration with cerebellar atrophy. [Abstract]2025 Aug 5:S1525-0016(25)00628-8. PMID: 40754822 -
Mol Ther
Targeting the TRIM21-PD-1 axis potentiates immune checkpoint blockade and CAR-T cell therapy. [Abstract]2025 Mar 5;33(3):1073-1090. PMID: 39905727 -
Redox Biol
S100A9 modulates USP7-mediated stabilization of NCOA4 to promote ferroptosis in sepsis-associated acute lung injury. [Abstract]2026 Jun 21:95:104271. PMID: 42330601 -
Metabolism
2026 May 20:182:156651. PMID: 42162901 -
Redox Biol
PHB2 ameliorates ferroptosis and aortic aneurysm/dissection through NEDD4L-dependent ubiquitination of NCOA4. [Abstract]2026 May:92:104114. PMID: 41819783 -
Metabolism
PFKFB3 nuclear translocation improves diabetic retinopathy by attenuating endothelial cell senescence through inhibition of USP7-p53 axis. [Abstract]2026 May:178:156553. PMID: 41655956 -
Redox Biol
USP20 governs tyrosine kinase inhibitors resistance through ferroptosis evasion by targeting GPX4 in cancers. [Abstract]2026 May:92:104086. PMID: 41844497 -
Redox Biol
SMURF2 attenuates NRF2-driven tumor progression by acting as a nuclear brake on NRF2 during cellular stress. [Abstract]2026 May:92:104102. PMID: 41926909 -
Redox Biol
Small molecule HCY-NBD stabilizes GSTM2 via cys174 sulfenylation to attenuate high glucose induced endothelial cell senescence and calcification. [Abstract]2026 Mar:90:104058. PMID: 41637880 -
Redox Biol
A LNK-CBL-HNRPA2B1-GPX4 signaling axis mediates dopaminergic neuron vulnerability to ferroptosis in Parkinson's disease. [Abstract]2026 Mar:90:104039. PMID: 41616574 -
Redox Biol
p53 and fatty acids collaborate to trigger ferroptosis via the FBXO2-FABP5 axis in colorectal cancer. [Abstract]2026 Mar:90:104043. PMID: 41604941 -
Redox Biol
β-Hydroxybutyrate ameliorates lipopolysaccharide-induced liver injury through β-hydroxybutyrylation of the SOD2 protein in mice. [Abstract]2025 Dec:88:103949. PMID: 41319591 -
Redox Biol
2025 Sep:85:103751. PMID: 40628122 -
Redox Biol
Discovery of a novel chalcone-derived covalent Keap1 binder for mitigating cisplatin-induced mitochondrial dysfunction and nephrotoxicity. [Abstract]2025 Jun 21:85:103737. PMID: 40592144 -
Metabolism
WWP1-SHARP1-C/EBPβ positive feedback loop modulates development of metabolic dysfunction-associated steatotic liver disease. [Abstract]2025 Apr 23:169:156271. PMID: 40280477 -
Redox Biol
Quercetin alleviates LPS/iE-DAP-induced liver injury by suppressing ferroptosis via regulating ferritinophagy and intracellular iron efflux. [Abstract]2025 Apr:81:103557. PMID: 39986118 -
Redox Biol
Targeting p62 by sulforaphane promotes autolysosomal degradation of SLC7A11, inducing ferroptosis for osteosarcoma treatment. [Abstract]2024 Dec 5:79:103460. PMID: 39657365 -
Redox Biol
Activation of nuclear receptor pregnane-X-receptor protects against abdominal aortic aneurysm by inhibiting oxidative stress. [Abstract]2024 Nov:77:103397. PMID: 39427444 -
Redox Biol
Lipid peroxidation triggered by the degradation of xCT contributes to gasdermin D-mediated pyroptosis in COPD. [Abstract]2024 Nov:77:103388. PMID: 39374556 -
Redox Biol
Synergistic induction of ferroptosis by targeting HERC1-NCOA4 axis to enhance the photodynamic sensitivity of osteosarcoma. [Abstract]2024 Aug 26:76:103328. PMID: 39216271 -
Redox Biol
IL-13 facilitates ferroptotic death in asthmatic epithelial cells via SOCS1-mediated ubiquitinated degradation of SLC7A11. [Abstract]2024 May:71:103100. PMID: 38484644 -
Metabolism
Ubiquitination of cytoplasmic HMGB1 by RNF186 regulates hepatic lipophagy in non-alcoholic fatty liver disease. [Abstract]2024 Mar:152:155769. PMID: 38158076 -
Redox Biol
The SGK3-Catalase antioxidant signaling axis drives cervical cancer growth and therapy resistance. [Abstract]2023 Nov:67:102931. PMID: 37866161 -
Redox Biol
The novel β-TrCP protein isoform hidden in circular RNA confers trastuzumab resistance in HER2-positive breast cancer. [Abstract]2023 Nov:67:102896. PMID: 37783059 -
Redox Biol
2023 Jun:62:102705. PMID: 37087976 -
Redox Biol
Git1-PGK1 interaction achieves self-protection against spinal cord ischemia-reperfusion injury by modulating Keap1/Nrf2 signaling. [Abstract]2023 Jun:62:102682. PMID: 36963288 -
Redox Biol
Phospholipid peroxidation-driven modification of chondrogenic transcription factor mediates alkoxyl radicals-induced impairment of embryonic bone development. [Abstract]2022 Oct:56:102437. PMID: 36037588 -
Redox Biol
Ferroportin-dependent ferroptosis induced by ellagic acid retards liver fibrosis by impairing the SNARE complexes formation. [Abstract]2022 Oct;56:102435. PMID: 36029649 -
Redox Biol
2020 Nov 1;38:101771. PMID: 33189984 -
Redox Biol
Baicalin combats glutamate excitotoxicity via protecting glutamine synthetase from ROS-induced 20S proteasomal degradation. [Abstract]2020 Jul;34:101559. PMID: 32473460 -
Plant Cell
Fine-tuning of MYC2-mediated Botrytis defense response by the LBD40/42-CRL3BPM4 module in tomato. [Abstract]2025 Oct 24:koaf258. PMID: 41134692 -
Blood Cancer J
2024 Nov 26;14(1):207. PMID: 39592591 -
Plant Cell
2024 May 29;36(6):2103-2116. PMID: 38445983 -
J Control Release
Dual-action endoplasmic reticulum membrane-fusogenic immunogenic liposomes amplify cellular immunity in anti-tumor vaccine design. [Abstract]2026 Jul 10:395:114937. PMID: 41999902 -
J Control Release
The HSP90-dependent bioorthogonal PROTAC prodrug system enables tumor-selective and enhanced protein degradation. [Abstract]2026 May 10:393:114828. PMID: 41839264 -
J Control Release
2025 Dec 30:114591. PMID: 41478376 -
Biomark Res
A novel indirubin- 3-monoxime derivative I3MV- 8b exhibits remarkable cytotoxicity against multiple myeloma by targeting TRIM28. [Abstract]2025 Apr 7;13(1):57. PMID: 40197552 -
Biomark Res
2025 Jan 23;13(1):17. PMID: 39849645 -
J Hazard Mater
A new mechanism for ubiquitination in polystyrene nanoplastic-induced spatial cognitive dysfunction through microglial activation-induced apoptosis of neurons. [Abstract]2026 Mar 1:505:141552. PMID: 41734560 -
J Hazard Mater
Fine particulate matter exacerbates asthma by activating STC2-mediated mitophagy through METTL3/YTHDF2-dependent m6A methylation. [Abstract]2025 Jun 6:495:138854. PMID: 40499413 -
J Hazard Mater
Targeting m6A mRNA demethylase FTO alleviates manganese-induced cognitive memory deficits in mice. [Abstract]2024 Jun 18:476:134969. PMID: 38908185 -
J Hazard Mater
Benzo[a]pyrene evokes epithelial-mesenchymal transition and pulmonary fibrosis through AhR-mediated Nrf2-p62 signaling. [Abstract]2024 May 8:473:134560. PMID: 38759404 -
J Hazard Mater
Environmental cadmium inhibits testicular testosterone synthesis via Parkin-dependent MFN1 degradation. [Abstract]2024 May 15:470:134142. PMID: 38555669 -
J Hazard Mater
A regulatory module comprising G3BP1-FBXL5-IRP2 axis determines sodium arsenite-induced ferroptosis. [Abstract]2024 Mar 5:465:133038. PMID: 38118197 -
J Hazard Mater
MDM2 upregulation induces mitophagy deficiency via Mic60 ubiquitination in fetal microglial inflammation and consequently neuronal DNA damage caused by exposure to ZnO-NPs during pregnancy. [Abstract]2023 Sep 5:457:131750. PMID: 37315416 -
J Hazard Mater
Gestational exposure to environmental cadmium induces placental apoptosis and fetal growth restriction via Parkin-modulated MCL-1 degradation. [Abstract]2022 Feb 15;424(Pt A):127268. PMID: 34583167 -
Gut Microbes
Engineered probiotic-derived indole-3-propionic acid inhibits ubiquitination via AHR signaling to treat postmenopausal osteoporosis. [Abstract]2026 Dec 31;18(1):2612620. PMID: 41508814 -
Gut Microbes
Commensal microbiota-derived metabolite agmatine triggers inflammation to promote colorectal tumorigenesis. [Abstract]2024 Jan-Dec;16(1):2348441. PMID: 38706224 -
EBioMedicine
Differential regulation of FADS2 by EZH2 reveals a metabolic vulnerability in ovarian cancer treatment. [Abstract]2025 Aug 15:119:105879. PMID: 40818202 -
EBioMedicine
F. nucleatum facilitates oral squamous cell carcinoma progression via GLUT1-driven lactate production. [Abstract]2023 Feb:88:104444. PMID: 36709580 -
EBioMedicine
Intestinal epithelial β Klotho is a critical protective factor in alcohol-induced intestinal barrier dysfunction and liver injury. [Abstract]2022 Aug:82:104181. PMID: 35908416 -
EBioMedicine
Berberine Reduces Pyruvate-driven Hepatic Glucose Production by Limiting Mitochondrial Import of Pyruvate through Mitochondrial Pyruvate Carrier 1. [Abstract]2018 Aug:34:243-255. PMID: 30093307 -
MedComm (2020)
FBXW7 Targets the SPT6-ΔNp63 Axis for Degradation to Inhibit Esophageal Tumorigenesis Induced by 4-Nitroquinoline N-Oxide. [Abstract]2026 Mar 4;7(3):e70662. PMID: 41799933 -
MedComm (2020)
circRNA-SORE/UBQLN1/GPX4 Mediates the Acquisition of Sorafenib Resistance in Hepatocellular Carcinoma Through Inhibition of Ferroptosis. [Abstract]2025 Nov 23;6(12):e70488. PMID: 41287824 -
MedComm (2020)
Phytosphingosine Alleviates Cigarette Smoke-Induced Bronchial Epithelial Cell Senescence in Chronic Obstructive Pulmonary Disease by Targeting the Free Fatty Acid Receptor 4. [Abstract]2025 Aug 29;6(9):e70345. PMID: 40895192 -
Research (Wash D C)
Dual Regulation of Sprouty 4 Palmitoylation by ZDHHC7 and Palmitoyl-Protein Thioesterase 1: A Potential Therapeutic Strategy for Cisplatin-Resistant Osteosarcoma. [Abstract]2025 May 23:8:0708. PMID: 40416361 -
Research (Wash D C)
EGF-Upregulated lncRNA ESSENCE Promotes Colorectal Cancer Growth through Stabilizing CAD and Ferroptosis Defense. [Abstract]2025 Apr 3:8:0649. PMID: 40190348 -
MedComm (2020)
Noncanonical feedback loop between "RIP3-MLKL" and "4EBP1-eIF4E" promotes neuronal necroptosis. [Abstract]2025 Feb 18;6(3):e70107. PMID: 39974664 -
Research (Wash D C)
Diacylglycerol O-acyltransferase 2, a Novel Target of Flavivirus NS2B3 Protease, Promotes Zika Virus Replication by Regulating Lipid Droplet Formation. [Abstract]2024 Oct 24:7:0511. PMID: 39449854 -
MedComm (2020)
Ubiquitin-specific protease 22 controls melanoma metastasis and vulnerability to ferroptosis through targeting SIRT1/PTEN/PI3K signaling. [Abstract]2024 Aug 12;5(8):e684. PMID: 39135915 -
MedComm (2020)
5,7,4'-Trimethoxyflavone triggers cancer cell PD-L1 ubiquitin-proteasome degradation and facilitates antitumor immunity by targeting HRD1. [Abstract]2024 Jun 27;5(7):e611. PMID: 38938284 -
MedComm
2024 Apr 13;5(4):e537. PMID: 38617434 -
Cell Rep Med
Intracellular sclerostin promotes tumor progression and metastasis as a potential therapeutic target in triple-negative breast cancer. [Abstract]2026 May 19;7(5):102763. PMID: 42030934 -
Cell Rep Med
Engineered oncolytic virus armed with anti-PCSK9 scFv boosts long-term CD8+ T cell immunity via rewiring MHC-I antigen presentation. [Abstract]2026 Apr 21;7(4):102724. PMID: 41923622 -
J Immunother Cancer
HSP47 inhibition-induced CD155 expression through TRAF2 deubiquitination promotes tumor immune evasion. [Abstract]2025 Nov 28;13(11):e011976. PMID: 41314980 -
Cell Rep Med
2025 Oct 27:102424. PMID: 41151579 -
Cell Rep Med
CLDN4 palmitoylation promotes hepatic-to-biliary lineage transition and lenvatinib resistance in hepatocellular carcinoma. [Abstract]2025 Jul 15;6(7):102208. PMID: 40592346 -
Cell Rep Med
Targeting pancreatic cancer glutamine dependency confers vulnerability to GPX4-dependent ferroptosis. [Abstract]2025 Jan 27:101928. PMID: 39879992 -
Cell Rep Med
Benzosceptrin C induces lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting DHHC3. [Abstract]2024 Feb 20;5(2):101357. PMID: 38237597 -
J Immunother Cancer
Modification of PLAC8 by UFM1 affects tumorous proliferation and immune response by impacting PD-L1 levels in triple-negative breast cancer. [Abstract]2022 Dec;10(12):e005668. PMID: 36543379 -
Plant Biotechnol J
A Bacterial Effector Hijacks NBR1 to Modulate Both Autophagy and Ubiquitination-Mediated Degradation That Promotes Bacterial Infection. [Abstract]2025 Dec 17. PMID: 41405133 -
Pharmacol Res
Mitochondrial pyruvate dehydrogenase kinase 1 drives bevacizumab resistance and malignant phenotype of TNBC by enhancing mitophagy. [Abstract]2025 Dec 31:108081. PMID: 41482011 -
Pharmacol Res
CDC7 stabilized by KRAS signaling reactivation impairs chemosensitivity in KRAS-mutant colorectal cancer. [Abstract]2025 Dec:222:108027. PMID: 41207349 -
Plant Biotechnol J
ERF.D2 negatively controls drought tolerance through synergistic regulation of abscisic acid and jasmonic acid in tomato. [Abstract]2025 Aug;23(8):3363-3381. PMID: 40424069 -
Pharmacol Res
Sirtuin3 attenuates pressure overload-induced pathological myocardial remodeling by inhibiting cardiomyocyte cuproptosis. [Abstract]2025 Apr 16:107739. PMID: 40250507 -
Pharmacol Res
USP9X-enriched MSC-sEV inhibits LSEC angiogenesis in MASH mice by downregulating the IκBα/NF-κB/Ang-2 pathway. [Abstract]2024 Nov:209:107471. PMID: 39427871 -
Pharmacol Res
RHBDF1 deficiency suppresses melanoma glycolysis and enhances efficacy of immunotherapy by facilitating glucose-6-phosphate isomerase degradation via TRIM32. [Abstract]2023 Dec:198:106995. PMID: 37979663 -
Pharmacol Res
Hypoxia-induced circSTT3A enhances serine synthesis and promotes H3K4me3 modification to facilitate breast cancer stem cell formation. [Abstract]2023 Nov:197:106964. PMID: 37865128 -
Pharmacol Res
m6A methylation-induced NR1D1 ablation disrupts the HSC circadian clock and promotes hepatic fibrosis. [Abstract]2023 Mar:189:106704. PMID: 36813093
MG-132 purchased from MedChemExpress. Usage Cited in: Pharmacol Res. 2023 Mar:189:106704. [Abstract]
MG132 (10 µM) significantly reduces the degradation of YTHDC1 protein mediated by Dihydroartemisinin (DHA) in HSCs.
-
Pharmacol Res
3'-epi-12β-hydroxyfroside-mediated autophagy degradation of RIPK1/RIPK3 necrosomes leads to anergy of immunogenic cell death in triple-negative breast cancer cells. [Abstract]2023 Jan:187:106613. PMID: 36535569 -
Pharmacol Res
Epigenetic regulation of the DNMT1/MT1G/KLF4/CA9 axis synergises the anticancer effects of sorafenib in hepatocellular carcinoma. [Abstract]2022 Jun;180:106244. PMID: 35550167 -
Pharmacol Res
Anti-tumor effects of Skp2 inhibitor AAA-237 on NSCLC by arresting cell cycle at G0/G1 phase and inducing senescence. [Abstract]2022 May 13;181:106259. PMID: 35577307 -
Pharmacol Res
Brusatol has therapeutic efficacy in non-small cell lung cancer by targeting Skp1 to inhibit cancer growth and metastasis. [Abstract]2022 Feb:176:106059. PMID: 34998973 -
Pharmacol Res
Mangiferin activates Nrf2 to attenuate cardiac fibrosis via redistributing glutaminolysis-derived glutamate. [Abstract]2020 Jul;157:104845. PMID: 32353588 -
ACS Cent Sci
O-GlcNAcylation Facilitates the Interaction between Keratin 18 and Isocitrate Dehydrogenases and Potentially Influencing Cholangiocarcinoma Progression. [Abstract]2024 Apr 23;10(5):1065-1083. PMID: 38799671 -
ACS Cent Sci
2022 Feb 23;8(2):192-204. PMID: 35229034 -
Cell Mol Biol Lett
2025 Oct 2;30(1):109. PMID: 41039223 -
Clin Cancer Res
UBE2T-mediated HP1α ubiquitination enhances nucleolar function and promotes the progression of IDH1/TP53-mutant glioma. [Abstract]2025 Jul 8. PMID: 40627452 -
Cell Mol Biol Lett
FNDC3B promotes gastric cancer metastasis via interacting with FAM83H and preventing its proteasomal degradation. [Abstract]2025 May 31;30(1):65. PMID: 40450207 -
Cell Mol Biol Lett
Narciclasine enhances cisplatin-induced apoptotic cell death by inducing unfolded protein response-mediated regulation of NOXA and MCL1. [Abstract]2025 May 14;30(1):59. PMID: 40369444 -
Mater Today Bio
An "EVs-in-ECM" mimicking system orchestrates transcription and translation of RUNX1 for in-situ cartilage regeneration. [Abstract]2025 Feb 14:31:101569. PMID: 40040797 -
Mater Today Bio
Self-assembled genistein nanoparticles suppress the epithelial-mesenchymal transition in glioblastoma by targeting MMP9. [Abstract]2025 Feb 27:31:101606. PMID: 40104644 -
Cell Mol Biol Lett
The low-complexity domains of the KMT2D protein regulate histone monomethylation transcription to facilitate pancreatic cancer progression. [Abstract]2021 Nov 10;26(1):45. PMID: 34758724 -
Diabetologia
Obesity-induced reduced expression of the lncRNA ROIT impairs insulin transcription by downregulation of Nkx6.1 methylation. [Abstract]2020 Apr;63(4):811-824. PMID: 32008054 -
Cancer Lett
The BTN3A3-TOMM22 axis preserves mitochondrial homeostasis to facilitate HCC stemness and drug resistance. [Abstract]2026 Sep 1:655:218557. PMID: 42069175 -
Mol Biomed
Targeting the RNA-binding motif protein 15 suppresses prostate cancer progression and hormone therapy resistance by promoting androgen receptor degradation. [Abstract]2026 Apr 8;7(1):47. PMID: 41949706 -
Cancer Lett
DysUFMylation reprograms immunosuppressive neutrophils to potentiate anti-PD-1 therapy in hepatocellular carcinoma. [Abstract]2026 May 1:645:218395. PMID: 41780840 -
Cancer Lett
Nutrient deprivation promotes bladder cancer metastasis through Beclin-1 deacetylation-mediated autophagy activation. [Abstract]2026 May 1:645:218337. PMID: 41707981 -
Cancer Lett
Succinate dehydrogenase B palmitoylation promotes T cell exhaustion through the H3K27ac-PD1 axis in pancreatic cancer. [Abstract]2026 Apr 1:642:218277. PMID: 41577075 -
Mol Biomed
Histone methyltransferase KMT2D targets the SPOP-G3BP1 axis to enhance AR stability and drive castration-resistant prostate cancer progression. [Abstract]2025 Nov 17;6(1):112. PMID: 41247636 -
Mol Biomed
Ubiquitin-specific protease 13 promotes colorectal cancer progression by stabilizing mitogen-activated protein kinase kinase 3. [Abstract]2025 Nov 27;6(1):122. PMID: 41307804 -
Cancer Lett
2026 Jan 28:638:218156. PMID: 41265630 -
J Neuroinflammation
Microglial NLRC5 drives lysosomal dysfunction to disrupt autophagic flux and promote post-stroke neuroinflammation. [Abstract]2025 Oct 31;22(1):253. PMID: 41174779 -
Mol Biomed
Epithelial membrane protein 1 drives hepatic stellate cell activation via the TLN1/FAK cascade in MASLD donor liver transplantation. [Abstract]2025 Nov 24;6(1):116. PMID: 41284206 -
Cancer Lett
2025 Oct 2:218073. PMID: 41045985 -
Cancer Lett
2025 Apr 16:217726. PMID: 40250791 -
Nat Struct Mol Biol
ERK-USP9X-coupled regulation of thymidine kinase 1 promotes both its enzyme activity-dependent and its enzyme activity-independent functions for tumor growth. [Abstract]2025 May;32(5):853-863. PMID: 39824978 -
Int J Surg
Loss of RPN1 Promotes Antitumor Immunity via PD-L1 Checkpoint Blockade in Triple-negative Breast Cancer--Experimental Studies. [Abstract]2025 Feb 1;111(2):1801-1813. PMID: 39705151 -
Cancer Lett
A novel protein encoded by circFOXP1 enhances ferroptosis and inhibits tumor recurrence in intrahepatic cholangiocarcinoma. [Abstract]2024 Jun 28:217092. PMID: 38945202 -
Cancer Lett
m6A modification of lncRNA ABHD11-AS1 promotes colorectal cancer progression and inhibits ferroptosis through TRIM21/IGF2BP2/ FOXM1 positive feedback loop. [Abstract]2024 Aug 1:596:217004. PMID: 38838765 -
Cancer Lett
Acetylation-dependent deubiquitinase USP26 stabilizes BAG3 to promote breast cancer progression. [Abstract]2024 Jun 14:597:217005. PMID: 38880224 -
Cancer Lett
USP40 promotes hepatocellular carcinoma progression through a YAP/USP40 positive feedback loop. [Abstract]2024 May 1:589:216832. PMID: 38537774 -
Nat Struct Mol Biol
RNAi screens identify HES4 as a regulator of redox balance supporting pyrimidine synthesis and tumor growth. [Abstract]2024 May 20. PMID: 38769389 -
Cancer Lett
Targeting the molecular chaperone CCT2 inhibits GBM progression by influencing KRAS stability. [Abstract]2024 May 28:590:216844. PMID: 38582394 -
Cancer Lett
Super-enhancer mediated upregulation of MYEOV suppresses ferroptosis in lung adenocarcinoma. [Abstract]2024 May 1:589:216811. PMID: 38490328 -
Cancer Lett
Acidosis activates breast cancer ferroptosis through ZFAND5/SLC3A2 signaling axis and elicits M1 macrophage polarization. [Abstract]2024 Apr 10:587:216732. PMID: 38360142 -
Cancer Lett
NONO promotes gallbladder cancer cell proliferation by enhancing oncogenic RNA splicing of DLG1 through interaction with IGF2BP3/RBM14. [Abstract]2024 Apr 10:587:216703. PMID: 38341127 -
Cancer Lett
SKP2 promotes the metastasis of pancreatic ductal adenocarcinoma by suppressing TRIM21-mediated PSPC1 degradation. [Abstract]2024 Apr 10:587:216733. PMID: 38360141 -
Cancer Lett
The deubiquitinating enzyme USP19 facilitates hepatocellular carcinoma progression through stabilizing YAP. [Abstract]2023 Nov 28:577:216439. PMID: 37832781 -
Cancer Lett
DUSP2 recruits CSNK2A1 to suppress AKT1-mediated apoptosis resistance under hypoxic microenvironment in pancreatic cancer. [Abstract]2023 Aug 1:568:216288. PMID: 37390887 -
Nat Struct Mol Biol
2023 Jun;30(6):785-799. PMID: 37188808 -
Cancer Lett
HDAC4 mediated LHPP deacetylation enhances its destabilization and promotes the proliferation and metastasis of nasopharyngeal carcinoma. [Abstract]2023 May 28:562:216158. PMID: 37023940 -
Cancer Lett
HDAC6-dependent deacetylation of AKAP12 dictates its ubiquitination and promotes colon cancer metastasis. [Abstract]2022 Nov 28:549:215911. PMID: 36122629 -
Cancer Lett
LncRNA MNX1-AS1 sustains inactivation of Hippo pathway through a positive feedback loop with USP16/IGF2BP3 axis in gallbladder cancer. [Abstract]2022 Oct 28:547:215862. PMID: 35953000 -
Cancer Lett
De novo pyrimidine synthesis fuels glycolysis and confers chemoresistance in gastric cancer. [Abstract]2022 Nov 28:549:215837. PMID: 35921972 -
Cancer Lett
CYLD deficiency enhances metabolic reprogramming and tumor progression in nasopharyngeal carcinoma via PFKFB3. [Abstract]2022 Apr 28:532:215586. PMID: 35131382 -
Cancer Lett
DAB2IP suppresses tumor malignancy by inhibiting GRP75-driven p53 ubiquitination in colon cancer. [Abstract]2022 Apr 28:532:215588. PMID: 35150809 -
Cancer Lett
Deubiquitination of the repressor E2F6 by USP22 facilitates AKT activation and tumor growth in hepatocellular carcinoma. [Abstract]2021 Oct 10:518:266-277. PMID: 34339800 -
Cancer Lett
ANXA10 promotes melanoma metastasis by suppressing E3 ligase TRIM41-directed PKD1 degradation. [Abstract]2021 Oct 28:519:237-249. PMID: 34324862 -
Cancer Lett
Long noncoding RNA TP53TG1 suppresses the growth and metastasis of hepatocellular carcinoma by regulating the PRDX4/β-catenin pathway. [Abstract]2021 Aug 10:513:75-89. PMID: 33957185 -
Cancer Lett
All-trans retinoic acid exerts selective anti-FLT3-ITD acute myeloid leukemia efficacy through downregulating Chk1 kinase. [Abstract]2020 Mar 31;473:130-138. PMID: 31904486 -
Cancer Lett
GRP78 inhibition enhances ATF4-induced cell death by the deubiquitination and stabilization of CHOP in human osteosarcoma. [Abstract]2017 Dec 1:410:112-123. PMID: 28947141
MG-132 purchased from MedChemExpress. Usage Cited in: Cancer Lett. 2017 Dec 1:410:112-123. [Abstract]
Immunoprecipitation of ubiquitin from lysates of U-2 OS cells expressing CHOP after treatment with different concentrations of MG7 for 48 h. Cells are incubated with MG132 (20 mM) for 4 h before harvest. Cell lysates are immunoblotted with the indicated antibodies.
-
Int J Biol Sci
E3 ligase UHRF2 hijacks nuclear TBK1 to epigenetically repress type I interferons expression. [Abstract]2026 May 18;22(10):5385-5398. PMID: 42212328 -
Int J Biol Sci
A Novel PROTAC Confers a Dual Benefit Against Amyloid and Tau Pathology in Alzheimer's Disease via DAPK1 Degradation. [Abstract]2026 Apr 23;22(9):4724-4746. PMID: 42157943 -
Int J Biol Sci
APT1-derived depalmitoylation of CD36 alleviates diabetes-induced lipotoxicity in podocytes. [Abstract]2025 Jun 9;21(9):3852-3866. PMID: 40607256 -
Int J Biol Sci
XPOT Disruption Suppresses TNBC Growth through Inhibition of Specific tRNA Nuclear Exportation and TTC19 Expression to Induce Cytokinesis Failure. [Abstract]2023 Oct 24;19(16):5319-5336. PMID: 37928256 -
Int J Biol Sci
Ubiquitin-specific Protease 35 Promotes Gastric Cancer Metastasis by Increasing the Stability of Snail1. [Abstract]2024 Jan 12;20(3):953-967. PMID: 38250150 -
Int J Biol Sci
SMURF2 facilitates ubiquitin-mediated degradation of ID2 to attenuate lung cancer cell proliferation. [Abstract]2023 Jun 26;19(11):3324-3340. PMID: 37497010 -
Int J Biol Sci
Anomanolide C suppresses tumor progression and metastasis by ubiquitinating GPX4-driven autophagy-dependent ferroptosis in triple negative breast cancer. [Abstract]2023 May 8;19(8):2531-2550. PMID: 37215985 -
Int J Biol Sci
Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradation. [Abstract]2023 Feb 27;19(5):1471-1489. PMID: 37056925 -
Int J Biol Sci
PHGDH Inhibits Ferroptosis and Promotes Malignant Progression by Upregulating SLC7A11 in Bladder Cancer. [Abstract]2022 Aug 29;18(14):5459-5474. PMID: 36147463 -
Int J Biol Sci
The m6A-induced lncRNA CASC8 promotes proliferation and chemoresistance via upregulation of hnRNPL in esophageal squamous cell carcinoma. [Abstract]2022 Jul 18;18(13):4824-4836. PMID: 35982900 -
Int J Biol Sci
RASAL2 mediated the enhancement of YAP1/TIAM1 signaling promotes malignant phenotypes of pancreatic ductal adenocarcinoma. [Abstract]2022 Jun 27;18(10):4245-4259. PMID: 35844783 -
Int J Biol Sci
2022 Jun 21;18(10):4135-4150. PMID: 35844792 -
Int J Biol Sci
Hypoxia-inducible CircPFKFB4 Promotes Breast Cancer Progression by Facilitating the CRL4DDB2 E3 Ubiquitin Ligase-mediated p27 Degradation. [Abstract]2022 Jun 6;18(9):3888-3907. PMID: 35813480 -
Int J Biol Sci
2022 May 1;18(8):3122-3136. PMID: 35637948 -
Int J Biol Sci
Cold atmospheric plasmas target breast cancer stemness via modulating AQP3-19Y mediated AQP3-5K and FOXO1 K48-ubiquitination. [Abstract]2022 May 16;18(8):3544-3561. PMID: 35637961 -
Int J Biol Sci
Long noncoding RNA Linc01612 represses hepatocellular carcinoma progression by regulating miR-494/ATF3/p53 axis and promoting ubiquitination of YBX1. [Abstract]2022 Apr 11;18(7):2932-2948. PMID: 35541917 -
Int J Biol Sci
CD147 confers temozolomide resistance of glioma cells via the regulation of β-TrCP/Nrf2 pathway. [Abstract]2021 Jul 13;17(12):3013-3023. PMID: 34421346 -
Environ Int
From phthalate exposure to venous thrombotic risk: Decoding the DEHP-ROS mediated OTUD1- p53 stabilization loop in endothelium. [Abstract]2026 Apr:210:110254. PMID: 41967174 -
Cell Death Dis
Targeting mitochondrial α-ketoglutarate sequestration disables dual oncogenic drivers and metabolic adaptability in pancreatic ductal adenocarcinoma. [Abstract]2026 Jun 25. PMID: 42350388 -
Cell Death Dis
MTHFR functions as a metabolic checkpoint in NSCLC through SLC25A26-mediated SHMT2 inhibition. [Abstract]2026 Jun 1. PMID: 42225644 -
Cell Death Dis
PEBP4 alleviates muscle wasting in lung cancer cachexia via KEAP1-NRF2-mediated redox homeostasis. [Abstract]2026 Jun 3. PMID: 42236665 -
Cell Death Dis
The E3 ligase TRIM29 drives renal ischemia-reperfusion injury by targeting DUSP10 for proteasomal degradation. [Abstract]2026 Jun 13. PMID: 42288472 -
Cell Death Dis
USP16 regulates mitochondrial function by deubiquitinating TOM40, a core component of the translocase in the mitochondrial outer membrane. [Abstract]2026 Jun 3. PMID: 42236685 -
Cell Death Dis
E2F-mediated activation of mTORC1 through the ubiquitin-proteasome system promotes lung adenocarcinoma progression. [Abstract]2026 May 19;17(1):635. PMID: 42156726 -
Cell Death Dis
TRIM26-mediated NKRF degradation drives Osimertinib resistance through SNRPD2-dependent stress granule formation in lung adenocarcinoma. [Abstract]2026 Apr 24;17(1):541. PMID: 42026030 -
-
Cell Death Dis
2026 Apr 10;17(1):465. PMID: 41963301 -
Cell Death Dis
A Lamp2a-linked RNA secreted by ADSCs prevents ENO1-lactylation-glycolysis feedback and cell malignant behavior in triple-negative breast cancer. [Abstract]2026 Mar 2;17(1):288. PMID: 41771848 -
Cell Death Dis
USP30-mediated Deubiquitination of Hexokinase 2 controls the metabolic fate of glucose and tumor progression. [Abstract]2026 Feb 14;17(1):225. PMID: 41688443 -
Cell Death Dis
PRDM1 restricts bladder cancer progression and enhances chemosensitivity by suppressing OTUD6A-mediated deubiquitination of CDC6. [Abstract]2026 Feb 23;17(1):247. PMID: 41724787 -
Cell Death Dis
TIGAR maintains intestinal epithelial regeneration by stabilizing HMGCL and promoting β-catenin β-hydroxybutyrylation in burn-induced sepsis. [Abstract]2026 Feb 19;17(1):233. PMID: 41708588 -
Cell Death Dis
ZC3H15 regulates the ubiquitination of PTEN via recruitment of TRIM56 and promotes malignant progression of non-small cell lung cancer. [Abstract]2026 Jan 9;17(1):17. PMID: 41513632 -
Cell Death Dis
2026 Jan 24;17(1):165. PMID: 41580425 -
Cell Death Dis
IRX3-CDK14 axis promotes glioblastoma progression by regulating LRP6-mediated canonical Wnt/β-catenin pathway. [Abstract]2025 Dec 23. PMID: 41436436 -
-
Cell Death Dis
De-ubiquitinase USP35 promotes peritoneal dissemination of gastric cancer by regulating metabolic reprogramming. [Abstract]2025 Dec 10;16(1):889. PMID: 41372134 -
Cell Death Dis
BRD4 inhibition suppresses histone H4 UFMylation to increase ferroptosis sensitivity through TXNIP. [Abstract]2025 Nov 17;16(1):843. PMID: 41249136 -
Cell Death Dis
2025 Nov 24;16(1):856. PMID: 41285805 -
Cell Death Dis
Fatty acid synthase-mediated lipid droplet formation enhances macrophage killing of Staphylococcus aureus. [Abstract]2025 Oct 7;16(1):715. PMID: 41057302 -
Cell Death Dis
Hypoxia-induced exosomal LUCAT1 promotes osimertinib resistance in lung adenocarcinoma by stabilizing c-MET. [Abstract]2025 Oct 27;16(1):763. PMID: 41145422 -
Cell Death Dis
Deacetylation of TALDO1 by HDAC6 promotes glycolysis and nasopharyngeal carcinoma progression through a moonlighting function. [Abstract]2025 Oct 21;16(1):743. PMID: 41120289 -
Cell Death Dis
YY1-induced USP43 drives ferroptosis suppression by FASN stabilization and subsequent activation of SLC7A11 in ovarian cancer. [Abstract]2025 Sep 1;16(1):589. PMID: 40890129 -
Cell Death Dis
2025 Aug 28;16(1):655. PMID: 40877231 -
Cell Death Dis
DCAF7 recruits USP2 to facilitate hepatocellular carcinoma progression by suppressing clockophagy-induced ferroptosis. [Abstract]2025 Aug 28;16(1):654. PMID: 40877242 -
Cell Death Dis
DJ-1 counteracts Caveolin-1-mediated necroptosis to inhibit epithelial barrier dysfunction in colitis. [Abstract]2025 Aug 29;16(1):657. PMID: 40877233 -
Cell Death Dis
UBE4B promotes gastric cancer proliferation and metastasis by mediating FAT4 ubiquitination and degradation. [Abstract]2025 Jul 23;16(1):551. PMID: 40701960 -
Cell Death Dis
FGFR inhibitors promote the autophagic degradation of IFN-γ-induced PD-L1 and alleviate the PD-L1-mediated transcriptional suppression of FGFR3-TACC3 in non-muscle-invasive bladder cancer. [Abstract]2025 Jul 2;16(1):485. PMID: 40603902 -
Cell Death Dis
Anlotinib enhances the efficacy of KRAS-G12C inhibitors through c-Myc/ORC2 axis inhibition in non-small cell lung cancer. [Abstract]2025 May 2;16(1):356. PMID: 40316534 -
Adv Healthc Mater
Ultrasmall Nanoparticles Mitigate Tau Hyperphosphorylation to Restore Synaptic Integrity and Boost Cognitive Function in Alzheimer's Disease. [Abstract]2025 May 16:e2500941. PMID: 40376857 -
Cell Death Dis
2025 May 28;16(1):422. PMID: 40436845 -
Cell Death Dis
2025 May 22;16(1):409. PMID: 40399264 -
Cell Death Dis
NUB1 reduction promotes PCNA-mediated tumor growth by disturbing the PCNA polyubiquitination/NEDDylation in hepatocellular carcinoma cells. [Abstract]2025 Mar 31;16(1):228. PMID: 40164590 -
Cell Death Dis
FTO controls CD8+ T cell survival and effector response by modulating m6A methylation of Fas. [Abstract]2025 Apr 15;16(1):301. PMID: 40234389 -
Cell Death Dis
TMEM160 inhibits KEAP1 to suppress ferroptosis and induce chemoresistance in gastric cancer. [Abstract]2025 Apr 13;16(1):287. PMID: 40223081 -
Cell Death Dis
ELANE enhances KEAP1 protein stability and reduces NRF2-mediated ferroptosis inhibition in metabolic dysfunction-associated fatty liver disease. [Abstract]2025 Apr 9;16(1):266. PMID: 40204709 -
Cell Death Dis
Pharmacological targeting of the mitochondrial phosphatase PTPMT1 sensitizes hepatocellular carcinoma to ferroptosis. [Abstract]2025 Apr 6;16(1):257. PMID: 40189563 -
Cell Death Dis
HAT1/HDAC2 mediated ACSL4 acetylation confers radiosensitivity by inducing ferroptosis in nasopharyngeal carcinoma. [Abstract]2025 Mar 6;16(1):160. PMID: 40050614 -
Cell Death Dis
Both direct and indirect suppression of MCL1 synergizes with BCLXL inhibition in preclinical models of gastric cancer. [Abstract]2025 Mar 12;16(1):170. PMID: 40075071 -
Cell Death Dis
Lactylation-driven transcriptional activation of FBXO33 promotes gallbladder cancer metastasis by regulating p53 polyubiquitination. [Abstract]2025 Feb 28;16(1):144. PMID: 40021626 -
Cell Death Dis
Dimethyl fumarate promotes the degradation of HNF1B and suppresses the progression of clear cell renal cell carcinoma. [Abstract]2025 Feb 6;16(1):71. PMID: 39915461 -
Cell Death Dis
Enhanced ferroptosis sensitivity promotes the formation of highly myopic cataract via the DDR2-Hippo pathway. [Abstract]2025 Feb 3;16(1):64. PMID: 39900894 -
Cell Death Dis
2025 Jan 14;16(1):17. PMID: 39809787 -
Cell Death Dis
2024 Nov 1;15(11):786. PMID: 39487118 -
Cell Death Dis
MDM4 inhibits ferroptosis in p53 mutant colon cancer via regulating TRIM21/GPX4 expression. [Abstract]2024 Nov 14;15(11):825. PMID: 39543140 -
Cell Death Dis
The USP11/Nrf2 positive feedback loop promotes colorectal cancer progression by inhibiting mitochondrial apoptosis. [Abstract]2024 Dec 1;15(12):873. PMID: 39617751 -
Cell Death Dis
The interaction between UBR7 and PRMT5 drives PDAC resistance to gemcitabine by regulating glycolysis and immune microenvironment. [Abstract]2024 Oct 18;15(10):758. PMID: 39424627 -
Cell Death Dis
Protein phosphatase 4 maintains the survival of primordial follicles by regulating autophagy in oocytes. [Abstract]2024 Sep 8;15(9):658. PMID: 39245708 -
Cell Death Dis
Phosphatase LHPP confers prostate cancer ferroptosis activation by modulating the AKT-SKP2-ACSL4 pathway. [Abstract]2024 Sep 11;15(9):665. PMID: 39261475 -
Cell Death Dis
Chemotherapy-induced acetylation of ACLY by NAT10 promotes its nuclear accumulation and acetyl-CoA production to drive chemoresistance in hepatocellular carcinoma. [Abstract]2024 Jul 31;15(7):545. PMID: 39085201 -
Cell Death Dis
ATM inhibition enhance immunotherapy by activating STING signaling and augmenting MHC Class I. [Abstract]2024 Jul 20;15(7):519. PMID: 39033176 -
Cell Death Dis
TGF-β1 facilitates gallbladder carcinoma metastasis by regulating FOXA1 translation efficiency through m6A modification. [Abstract]2024 Jun 17;15(6):422. PMID: 38886389 -
Cell Death Dis
ACAT2 suppresses the ubiquitination of YAP1 to enhance the proliferation and metastasis ability of gastric cancer via the upregulation of SETD7. [Abstract]2024 Apr 26;15(4):297. PMID: 38670954 -
Cell Death Dis
2024 May 20;15(5):347. PMID: 38769122 -
Cell Death Dis
Phosphorylation of USP27X by GSK3β maintains the stability and oncogenic functions of CBX2. [Abstract]2023 Nov 29;14(11):782. PMID: 38030604 -
Cell Death Dis
METTL3 promotes colorectal cancer progression through activating JAK1/STAT3 signaling pathway. [Abstract]2023 Nov 25;14(11):765. PMID: 38001065 -
Cell Death Dis
Major vault protein (MVP) suppresses aging- and estrogen deficiency-related bone loss through Fas-mediated apoptosis in osteoclasts. [Abstract]2023 Sep 13;14(9):604. PMID: 37704623 -
Cell Death Dis
2023 Sep 19;14(9):614. PMID: 37726265 -
Cell Death Dis
Smurf1 and Smurf2 mediated polyubiquitination and degradation of RNF220 suppresses Shh-group medulloblastoma. [Abstract]2023 Aug 3;14(8):494. PMID: 37537194 -
Cell Death Dis
PHF23 promotes NSCLC proliferation, metastasis, and chemoresistance via stabilization of ACTN4 and activation of the ERK pathway. [Abstract]2023 Aug 25;14(8):558. PMID: 37626047 -
Cell Death Dis
SMURF1 attenuates endoplasmic reticulum stress by promoting the degradation of KEAP1 to activate NRF2 antioxidant pathway. [Abstract]2023 Jun 14;14(6):361. PMID: 37316499 -
Cell Death Dis
USP8 positively regulates hepatocellular carcinoma tumorigenesis and confers ferroptosis resistance through β-catenin stabilization. [Abstract]2023 Jun 13;14(6):360. PMID: 37311739 -
Cell Death Dis
TRIM56 acts through the IQGAP1-CDC42 signaling axis to promote glioma cell migration and invasion. [Abstract]2023 Mar 4;14(3):178. PMID: 36870986 -
Cell Death Dis
PDIA4 confers resistance to ferroptosis via induction of ATF4/SLC7A11 in renal cell carcinoma. [Abstract]2023 Mar 11;14(3):193. PMID: 36906674 -
Cell Death Dis
Fatostatin induces ferroptosis through inhibition of the AKT/mTORC1/GPX4 signaling pathway in glioblastoma. [Abstract]2023 Mar 25;14(3):211. PMID: 36966152 -
Cell Death Dis
UBE2E2 enhances Snail-mediated epithelial-mesenchymal transition and Nrf2-mediated antioxidant activity in ovarian cancer. [Abstract]2023 Feb 10;14(2):100. PMID: 36765041 -
Cell Death Dis
TRAF6 regulates the abundance of RIPK1 and inhibits the RIPK1/RIPK3/MLKL necroptosis signaling pathway and affects the progression of colorectal cancer. [Abstract]2023 Jan 5;14(1):6. PMID: 36604411 -
Cell Death Dis
MFG-E8 stabilized by deubiquitinase USP14 suppresses cigarette smoke-induced ferroptosis in bronchial epithelial cells. [Abstract]2023 Jan 3;14(1):2. PMID: 36596780 -
Cell Death Dis
Idarubicin combats abiraterone and enzalutamide resistance in prostate cells via targeting XPA protein. [Abstract]2022 Dec 12;13(12):1034. PMID: 36509750 -
Cell Death Dis
2022 Dec 5;13(12):1021. PMID: 36470870 -
Cell Death Dis
Ciclopirox drives growth arrest and autophagic cell death through STAT3 in gastric cancer cells. [Abstract]2022 Nov 28;13(11):1007. PMID: 36443287 -
Cell Death Dis
4EBP1 senses extracellular glucose deprivation and initiates cell death signaling in lung cancer. [Abstract]2022 Dec 27;13(12):1075. PMID: 36575176 -
Cell Death Dis
A dual Keap1 and p47phox inhibitor Ginsenoside Rb1 ameliorates high glucose/ox-LDL-induced endothelial cell injury and atherosclerosis. [Abstract]2022 Sep 26;13(9):824. PMID: 36163178 -
Cell Death Dis
Fbxo22 promotes cervical cancer progression via targeting p57Kip2 for ubiquitination and degradation. [Abstract]2022 Sep 20;13(9):805. PMID: 36127346 -
Cell Death Dis
Long noncoding RNA LINC00239 inhibits ferroptosis in colorectal cancer by binding to Keap1 to stabilize Nrf2. [Abstract]2022 Aug 29;13(8):742. PMID: 36038548 -
Cell Death Dis
LncRNA HEPFAL accelerates ferroptosis in hepatocellular carcinoma by regulating SLC7A11 ubiquitination. [Abstract]2022 Aug 25;13(8):734. PMID: 36008384 -
Cell Death Dis
Aurora-A/FOXO3A/SKP2 axis promotes tumor progression in clear cell renal cell carcinoma and dual-targeting Aurora-A/SKP2 shows synthetic lethality. [Abstract]2022 Jul 13;13(7):606. PMID: 35831273 -
Cell Death Dis
SHANK1 facilitates non-small cell lung cancer processes through modulating the ubiquitination of Klotho by interacting with MDM2. [Abstract]2022 Apr 25;13(4):403. PMID: 35468874 -
Cell Death Dis
2022 Apr 9;13(4):326. PMID: 35397626 -
Cell Death Dis
2022 May 12;13(5):451. PMID: 35551175 -
Cell Death Dis
piR-823 inhibits cell apoptosis via modulating mitophagy by binding to PINK1 in colorectal cancer. [Abstract]2022 May 17;13(5):465. PMID: 35581181 -
Cell Death Dis
POU6F1 cooperates with RORA to suppress the proliferation of lung adenocarcinoma by downregulation HIF1A signaling pathway. [Abstract]2022 May 3;13(5):427. PMID: 35504868 -
Cell Death Dis
HJURP regulates cell proliferation and chemo-resistance via YAP1/NDRG1 transcriptional axis in triple-negative breast cancer. [Abstract]2022 Apr 22;13(4):396. PMID: 35459269 -
Cell Death Dis
A novel mechanism for A-to-I RNA-edited AZIN1 in promoting tumor angiogenesis in colorectal cancer. [Abstract]2022 Apr 2;13(4):294. PMID: 35365616 -
Cell Death Dis
2022 Jan 13;13(1):55. PMID: 35027542 -
Cell Death Dis
RNA-binding protein p54nrb/NONO potentiates nuclear EGFR-mediated tumorigenesis of triple-negative breast cancer. [Abstract]2022 Jan 10;13(1):42. PMID: 35013116 -
Cell Death Dis
FKBP51 promotes invasion and migration by increasing the autophagic degradation of TIMP3 in clear cell renal cell carcinoma. [Abstract]2021 Oct 1;12(10):899. PMID: 34599146 -
Cell Death Dis
2021 Sep 25;12(10):876. PMID: 34564711 -
Cell Death Dis
Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1/EZH2 complex in pancreatic cancer. [Abstract]2021 Sep 25;12(10):878. PMID: 34564701 -
Cell Death Dis
2021 Oct 20;12(11):968. PMID: 34671022 -
Cell Death Dis
TXNIP, a novel key factor to cause Schwann cell dysfunction in diabetic peripheral neuropathy, under the regulation of PI3K/Akt pathway inhibition-induced DNMT1 and DNMT3a overexpression. [Abstract]2021 Jun 23;12(7):642. PMID: 34162834 -
Cell Death Dis
2021 May 25;12(6):534. PMID: 34035221 -
Cell Death Dis
2021 Apr 12;12(4):388. PMID: 33846307 -
Cell Death Dis
SIRT6 promotes angiogenesis and hemorrhage of carotid plaque via regulating HIF-1α and reactive oxygen species. [Abstract]2021 Jan 12;12(1):77. PMID: 33436551 -
Cell Death Dis
TRIB2 modulates proteasome function to reduce ubiquitin stability and protect liver cancer cells against oxidative stress. [Abstract]2021 Jan 7;12(1):42. PMID: 33414446 -
Cell Death Dis
Legumain is a predictor of all-cause mortality and potential therapeutic target in acute myocardial infarction. [Abstract]2020 Nov 26;11(11):1014. PMID: 33243972 -
Cell Death Dis
Inactivation of ribosomal protein S27-like impairs DNA interstrand cross-link repair by destabilization of FANCD2 and FANCI. [Abstract]2020 Oct 13;11(10):852. PMID: 33051438 -
Cell Death Dis
The transcriptional landscape of lncRNAs reveals the oncogenic function of LINC00511 in ER-negative breast cancer. [Abstract]2019 Aug 8;10(8):599. PMID: 31395854 -
Cell Death Dis
The proton pump inhibitor pantoprazole disrupts protein degradation systems and sensitizes cancer cells to death under various stresses. [Abstract]2018 May 22;9(6):604. PMID: 29789637
MG-132 purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2018 May 22;9(6):604. [Abstract]
AGS cells were either untreated or treated with Bortezomib (25 nM) or MG132 (0.1 μM) for 24 h in the absence or presence of baf A1 (100 nM).
-
Sci China Life Sci
2025 Aug;68(8):2348-2362. PMID: 40410652 -
Sci China Life Sci
RpL38 modulates germ cell differentiation by controlling Bam expression in Drosophila testis. [Abstract]2024 Nov;67(11):2411-2425. PMID: 39187660 -
-
Genes Dis
Isoleucyl-tRNA synthetase 2 promotes pancreatic ductal adenocarcinoma proliferation and metastasis by stabilizing β-catenin. [Abstract]2024 Jul 24;12(3):101382. PMID: 40092487 -
Gene Dis
2019 May 25;7(3):401-407. PMID: 32884994 -
J Integr Plant Biol
MdGRF10 phosphorylation stabilizes MdASMT1 for melatonin-mediated salt tolerance in apple. [Abstract]2025 Aug 19. PMID: 40827728 -
Proc Natl Acad Sci U S A
Light-controlled disruption of cancer cell dormancy via photoswitchable stress hormone receptor degraders. [Abstract]2026 May 26;123(21):e2528760123. PMID: 42166243 -
J Cachexia Sarcopenia Muscle
2025 Aug;16(4):e70044. PMID: 40810552 -
Proc Natl Acad Sci U S A
2025 May 20;122(20):e2425812122. PMID: 40366693 -
Proc Natl Acad Sci U S A
Light signal regulates endoreduplication and tomato fruit expansion through the SlPIF1a-SlTLFP8-SlCDKB2 module. [Abstract]2025 Jan 28;122(4):e2404445122. PMID: 39847324 -
Proc Natl Acad Sci U S A
Low-sugar universal mRNA vaccine against coronavirus variants with deletion of glycosites in the S2 or stem of SARS-CoV-2 spike messenger RNA (mRNA). [Abstract]2023 Dec 5;120(49):e2314392120. PMID: 38011546 -
Proc Natl Acad Sci U S A
The moonlighting function of glycolytic enzyme enolase-1 promotes choline phospholipid metabolism and tumor cell proliferation. [Abstract]2023 Apr 11;120(15):e2209435120. PMID: 37011206 -
Proc Natl Acad Sci U S A
Activation of the NLRP1 inflammasome in human keratinocytes by the dsDNA mimetic poly(dA:dT). [Abstract]2023 Jan 31;120(5):e2213777120. PMID: 36693106 -
Proc Natl Acad Sci U S A
2022 Apr 19;119(16):e2202970119. PMID: 35412914 -
Proc Natl Acad Sci U S A
2022 Mar 1;119(9):e2119995119. PMID: 35149556 -
Bioresour Technol
Multifactorial interaction and influence of culture conditions on yellow fluorescent protein production in Phaeodactylum tricornutum. [Abstract]2025 Jun:425:132336. PMID: 40044057 -
-
Cell Commun Signal
EBV (LMP1) enhances cisplatin resistance by enhancing degradation of interferon regulatory factor 3. [Abstract]2026 May 15;24(1):395. PMID: 42141449 -
Cell Commun Signal
NSP1 of Alongshan virus antagonizes type I interferon responses by promoting STUB1-mediated degradation of RIG-I. [Abstract]2026 Mar 24;24(1):262. PMID: 41877189 -
-
Cell Commun Signal
p53 regulates early mucosal immunity via antigen presentation in zebrafish intestine post-SVCV vaccination. [Abstract]2026 Feb 17;24(1):191. PMID: 41703546 -
Cell Commun Signal
Grass carp reovirus VP35 hijacks DHX15 into phase-separated inclusion bodies to evade host antiviral immunity. [Abstract]2026 Feb 9;24(1):168. PMID: 41664180 -
-
Cell Commun Signal
2025 Nov 21;23(1):502. PMID: 41272808 -
Cell Commun Signal
Decursin induces FLT3-ITD acute myeloid leukemia cell apoptosis by increasing the expression of the ubiquitin-conjugase UBE2L6. [Abstract]2025 Apr 2;23(1):162. PMID: 40176110 -
J Pharm Anal
1,8-Cineole ameliorates vascular endothelial senescence in diabetes mellitus by directly targeting and deubiquitinating PPAR-γ in vivo and in vitro. [Abstract]2025 Dec;15(12):101307. PMID: 41492461 -
J Pharm Anal
E3 ubiquitin ligase FBXW11-mediated downregulation of S100A11 promotes sensitivity to PARP inhibitor in ovarian cancer. [Abstract]2025 Jul;15(7):101246. PMID: 40747341 -
J Pharm Anal
Caffeic acid alleviates myocardial ischemia-reperfusion injury by directly targeting Keap1N532/M550 and promoting its degradation. [Abstract]2025 Nov;15(11):101219. PMID: 41333838 -
Cell Commun Signal
Novel Ser74 of NF-κB/IκBα phosphorylated by MAPK/ERK regulates temperature adaptation in oysters. [Abstract]2024 Nov 11;22(1):539. PMID: 39529137 -
Cell Commun Signal
Nesfatin-1 enhances vascular smooth muscle calcification through facilitating BMP-2 osteogenic signaling. [Abstract]2024 Oct 11;22(1):488. PMID: 39394127 -
Cell Commun Signal
USP9X-mediated deubiquitination of Raptor contributes to autophagy impairment and memory deficits in P301S mice. [Abstract]2024 Oct 24;22(1):516. PMID: 39449082 -
Cell Commun Signal
E3 ubiquitin ligase RNF128 negatively regulates the IL-3/STAT5 signaling pathway by facilitating K27-linked polyubiquitination of IL-3Rα. [Abstract]2024 May 3;22(1):254. PMID: 38702781 -
Cell Commun Signal
TMEM160 promotes tumor immune evasion and radiotherapy resistance via PD-L1 binding in colorectal cancer. [Abstract]2024 Mar 7;22(1):168. PMID: 38454413 -
Cell Commun Signal
Neuronal-specific TNFAIP1 ablation attenuates postoperative cognitive dysfunction via targeting SNAP25 for K48-linked ubiquitination. [Abstract]2023 Dec 15;21(1):356. PMID: 38102610 -
Cell Commun Signal
Exo-miR-1290-induced by COX-2 overexpression promotes cancer-associated fibroblasts activation and tumor progression by CUL3-Nrf2 pathway in lung adenocarcinoma. [Abstract]2023 Sep 18;21(1):242. PMID: 37723559 -
Cell Commun Signal
The deubiquitinase EIF3H promotes hepatocellular carcinoma progression by stabilizing OGT and inhibiting ferroptosis. [Abstract]2023 Aug 9;21(1):198. PMID: 37559097 -
Cell Commun Signal
2023 Jun 22;21(1):152. PMID: 37349820 -
Cell Commun Signal
Alpha5 nicotinic acetylcholine receptor mediated immune escape of lung adenocarcinoma via STAT3/Jab1-PD-L1 signalling. [Abstract]2022 Aug 15;20(1):121. PMID: 35971127 -
Cell Commun Signal
NEK2 promotes the migration and proliferation of ESCC via stabilization of YAP1 by phosphorylation at Thr-143. [Abstract]2022 Jun 15;20(1):87. PMID: 35705994 -
Cell Commun Signal
Hepatitis B virus X protein promotes vimentin expression via LIM and SH3 domain protein 1 to facilitate epithelial-mesenchymal transition and hepatocarcinogenesis. [Abstract]2021 Mar 15;19(1):33. PMID: 33722250 -
Dev Cell
2026 Apr 29:S1534-5807(26)00150-4. PMID: 42061405 -
Dev Cell
A pathological role of O-GlcNAcylation-driven TR11B production and function in lung adenocarcinoma. [Abstract]2025 Sep 3:S1534-5807(25)00530-1. PMID: 40930100 -
Dev Cell
PIF4 controls autophagy during hypocotyl response to elevated ambient temperatures via ArpC5 in Arabidopsis. [Abstract]2025 Jul 9:S1534-5807(25)00402-2. PMID: 40669463 -
Dev Cell
Calcium-responsive phosphorylation of SlLHP1b epigenetically suppresses auxin synthesis to control drought-induced flower drop in tomato. [Abstract]2025 May 27:S1534-5807(25)00296-5. PMID: 40460834 -
Dev Cell
PCP-B peptides and CrRLK1L receptor kinases control pollination via pH gating of aquaporins in Arabidopsis. [Abstract]2025 May 5;60(9):1336-1347.e5. PMID: 39793583 -
Dev Cell
Hepatocytic lipocalin-2 controls HDL metabolism and atherosclerosis via Nedd4-1-SR-BI axis in mice. [Abstract]2023 Nov 6;58(21):2326-2337.e5. PMID: 37863040 -
Dev Cell
A HD-ZIP transcription factor specifies fates of multicellular trichomes via dosage-dependent mechanisms in tomato. [Abstract]2023 Feb 27;58(4):278-288.e5. PMID: 36801006 -
Int J Biol Macromol
Identifying the regulatory network of the key lipid metabolism transcription factor peroxisome proliferator-activated receptor in oysters. [Abstract]2026 Jun 22:153160. PMID: 42331158 -
Int J Biol Macromol
Acetylation of GPRC5A at Lys348 facilitates cisplatin resistance and promotes the recurrence and poor prognosis in ovarian cancer. [Abstract]2026 May:362:152113. PMID: 42009151 -
-
-
Int J Biol Macromol
E3 ubiquitin ligase DTX3L promotes breast cancer progression by enhancing PKCα ubiquitination and inhibiting the p38 MAPK signaling pathway. [Abstract]2026 Mar:349:150861. PMID: 41679478 -
Int J Biol Macromol
Lentinan inhibits breast cancer cell growth through the dual downregulation of tumor-promoting effectors CD133 and SCGB2A2. [Abstract]2026 Apr:354:151391. PMID: 41819333 -
-
Int J Biol Macromol
2025 Dec 15:149611. PMID: 41407221 -
Int J Biol Macromol
SEMA5B depletion suppresses cell proliferation and glycolysis by downregulating VDAC2 expression in esophageal squamous cell carcinoma. [Abstract]2025 Dec 15:149690. PMID: 41407227 -
Int J Biol Macromol
Deubiquitinase USP45 stabilizes RTCB and DDX1, promoting tumorigenesis and chemoresistance. [Abstract]2025 Dec 28;339(Pt 2):149970. PMID: 41468936 -
Int J Biol Macromol
2025 Dec;334(Pt 2):149085. PMID: 41260444 -
Int J Biol Macromol
Laminin β1 stimulates the Hippo-YAP1 pathway to advance the progression and lenvatinib resistance in hepatocellular carcinoma. [Abstract]2026 Jan:336:149150. PMID: 41274476 -
Int J Biol Macromol
CLIC1 regulates cellular oxidative stress and gastric cancer progress by enhancing ACOX1 ubiquitination. [Abstract]2025 Oct 13;330(Pt 4):148292. PMID: 41093222 -
Int J Biol Macromol
GPX2 induces macrophage M2 polarization through the MIF signaling pathway to promote colorectal cancer progression. [Abstract]2025 Oct 15;331(Pt 1):148341. PMID: 41106750 -
Int J Biol Macromol
PSAT1 knockdown mediated VDAC1 oligomerization promotes ferroptosis and suppresses cell proliferation in esophageal squamous cell carcinoma. [Abstract]2025 Oct 7;330(Pt 4):148112. PMID: 41061782 -
Int J Biol Macromol
PSMD14 promotes breast cancer progression by reducing K63-linked ubiquitination on FOXM1 and activating the PI3K/AKT/mTOR pathway. [Abstract]2025 Sep 1;327(Pt 1):147275. PMID: 40902741 -
Int J Biol Macromol
The E3 ubiquitin ligase STUB1 inhibits glioblastoma progression though promoting IKKα ubiquitination and blocking NF-κB signaling pathway. [Abstract]2025 Sep;321(Pt 2):146064. PMID: 40675300 -
Int J Biol Macromol
Crucian carp HERC7 is an RNA binding protein that selectively targets IRF7 mRNA to downregulate IFN response. [Abstract]2025 Jul 3;320(Pt 1):145732. PMID: 40614997 -
Int J Biol Macromol
CD38 inhibits ferroptosis to promote radiotherapy resistance in nasopharyngeal carcinoma by competitively binding to TRIM21 to stabilize SLC7A11 protein. [Abstract]2025 May 29:144742. PMID: 40449774 -
Int J Biol Macromol
2025 May 1:143885. PMID: 40318732 -
Int J Biol Macromol
Cold atmospheric plasma targets triple negative breast cancer cells via SCAF11-mediated competitive protein degradation and synergizes with miRNA-146b-5p. [Abstract]2025 May 11:312:144142. PMID: 40360112 -
Int J Biol Macromol
THY1 inhibits the replication of ALV - J by diverting chNHE1 for proteasomal degradation. [Abstract]2025 May 30:144816. PMID: 40451353 -
Int J Biol Macromol
Dynamic bidirectional regulation between Stk38 and rabies virus M protein coordinates apoptosis progression during neurotropic infection. [Abstract]2025 May 19:144398. PMID: 40398756 -
Int J Biol Macromol
Dihydroartemisinin requires NR1D1 mediated Rab7 ubiquitination to regulate hepatic stellate cells lipophagy in liver fibrosis. [Abstract]2025 Feb 15;305(Pt 1):141055. PMID: 39956231 -
Int J Biol Macromol
lncRNA ENST000000454471 promotes lung adenocarcinoma progression and tumor immune escape: Protein structure and biological functions of histone deacetylase 8. [Abstract]2025 Feb 3:303:140664. PMID: 39909272 -
Int J Biol Macromol
Polysaccharides from Scrophularia ningpoensis Hemsl. improve reserpine-induced depression-like behavior by inhibiting HTR2A/HTR2C mediated AKT/GSK3β/β-catenin/CBP/BDNF signalling. [Abstract]2025 Jan 28:301:140445. PMID: 39884598 -
Int J Biol Macromol
2024 Sep 17:135764. PMID: 39299429 -
Int J Biol Macromol
O-GlcNAcylation regulates long-chain fatty acid metabolism by inhibiting ACOX1 ubiquitination-dependent degradation. [Abstract]2024 May;266(Pt 2):131151. PMID: 38547945 -
Int J Biol Macromol
YAP induces FAK phosphorylation to inhibit gastric cancer cell proliferation via upregulation of HMGB1. [Abstract]2024 Feb 6;262(Pt 1):130037. PMID: 38331059 -
Int J Biol Macromol
Zebrafish spop promotes ubiquitination and degradation of mavs to suppress antiviral response via the lysosomal pathway. [Abstract]2024 Jan;256(Pt 2):128451. PMID: 38029910 -
Int J Biol Macromol
ADRM1/RPN13 attenuates cartilage extracellular matrix degradation via enhancing UCH37-mediated ALK5 deubiquitination. [Abstract]2023 Aug 30:247:125670. PMID: 37406898 -
Int J Biol Macromol
Proteomic screening identifies RPLp2 as a specific regulator for the translation of coronavirus. [Abstract]2023 Mar 1:230:123191. PMID: 36632964 -
Int J Biol Macromol
Hepatitis B virus X protein increases LASP1 SUMOylation to stabilize HER2 and facilitate hepatocarcinogenesis. [Abstract]2023 Jan 31:226:996-1009. PMID: 36473530 -
Int J Biol Macromol
Self-stabilizing regulation of deubiquitinating enzymes in an enzymatic activity-dependent manner. [Abstract]2021 Jun 30:181:1081-1091. PMID: 33864866 -
Acta Pharmacol Sin
PGK1 epigenetically silences STING via DNMT1 and its knockdown synergizes with STING agonists in pancreatic cancer. [Abstract]2026 May 18. PMID: 42144444 -
Acta Pharmacol Sin
Deficient chaperone-mediated autophagy drives multiorgan fibrogenesis via SMAD2/4 stabilization to sustain TGFβ-SMAD signaling. [Abstract]2026 Apr 30. PMID: 42062474 -
Acta Pharmacol Sin
Intracellular LRG1 recruits MARCH2 to ubiquitinate and degrade endothelial VE-cadherin in septic lung injury. [Abstract]2026 Apr 27. PMID: 42045382 -
Acta Pharmacol Sin
Epigenetic regulation of NDGA and its synergistic inhibition with EZH2 inhibitors in prostate cancer via NRP1. [Abstract]2026 Feb 19. PMID: 41714725 -
Acta Pharmacol Sin
LAMTOR5 promotes hepatoma growth in mice by disrupting LC3-p62-mediated autophagy and preventing p62 proteasome degradation. [Abstract]2026 Jan 1. PMID: 41478881 -
Acta Pharmacol Sin
SMURF2 inhibition attenuates cardiac hypertrophy through blocking ubiquitination degradation of AXIN1. [Abstract]2025 Jun 20. PMID: 40542282 -
Acta Pharmacol Sin
STING inhibits the progression of esophageal squamous cell carcinoma by suppressing CPT1A-mediated fatty acid β-oxidation. [Abstract]2025 May 20. PMID: 40394235 -
Acta Pharmacol Sin
p-Coumaric acid alleviates neuronal damage in ischemic stroke mice by promoting BACH1 nuclear export and degradation. [Abstract]2025 Aug;46(8):2136-2150. PMID: 40087473 -
Acta Pharmacol Sin
Inhibiting the Otub1/phosphorylated STAT3 axis for the treatment of non-small cell lung cancer. [Abstract]2025 Jan;46(1):184-195. PMID: 39198663 -
Acta Pharmacol Sin
A novel FAK-degrading PROTAC molecule exhibited both anti-tumor activities and efficient MDR reversal effects. [Abstract]2024 Oct;45(10):2174-2185. PMID: 38844788 -
Acta Pharmacol Sin
2023 Sep;44(9):1920-1931. PMID: 37055530 -
Acta Pharmacol Sin
SL010110, a lead compound, inhibits gluconeogenesis via SIRT2-p300-mediated PEPCK1 degradation and improves glucose homeostasis in diabetic mice. [Abstract]2021 Nov;42(11):1834-1846. PMID: 33574568 -
Acta Pharmacol Sin
Carnosine suppresses human glioma cells under normoxic and hypoxic conditions partly via inhibiting glutamine metabolism. [Abstract]2021 May;42(5):767-779. PMID: 32782394 -
Phytomedicine
Astragaloside IV directly targets PPP1R14B to sensitize prostate cancer to anti-PD-1 immunotherapy by remodeling the CX3CL1/CD8+ T cell axis. [Abstract]2026 Jun:155:158158. PMID: 41950731 -
Phytomedicine
Polyphyllin VI induces Forkhead box O3 nuclear liquid-liquid phase separation to promote mitophagy in breast cancer. [Abstract]2026 Jun:155:158166. PMID: 41985230 -
Phytomedicine
Therapeutic effects of jaceosidin on atopic dermatitis via ubiquitin-mediated JAK1 degradation. [Abstract]2026 Jun 17:159:158446. PMID: 42341525 -
Phytomedicine
Kaempferitrin attenuates DSS-induced colitis by promoting ubiquitination-mediated degradation of the nuclear factor kappa B p65. [Abstract]2026 Jun 11:159:158429. PMID: 42398207 -
Phytomedicine
Erzhi pill enhances methotrexate efficacy in rheumatoid arthritis bone homeostasis via activation of the IDO1-KYN-AhR pathway. [Abstract]2026 May 14:157:158290. PMID: 42208105 -
Phytomedicine
Liquiritigenin targets transferrin receptor to potentiate ferroptosis sensitivity in colorectal cancer cells. [Abstract]2026 May:154:158057. PMID: 41833103 -
Phytomedicine
Flavonoids of Ziziphora clinopodioides improve Alzheimer's cognitive impairment and inhibit NLRP3 inflammasome activation via autophagy-lysosome pathway. [Abstract]2026 May:154:158028. PMID: 41818943 -
Phytomedicine
Ethyl ferulate suppresses choroidal neovascularization by accelerating Keap1 degradation through the inhibition of PSMD14-mediated deubiquitination. [Abstract]2026 Apr:153:157913. PMID: 41650523 -
Phytomedicine
Ginkgetin alleviates sepsis-induced acute lung injury by promoting autophagy via inhibiting ubiquitination of Laptm5 in macrophages. [Abstract]2026 Jan 28:153:157894. PMID: 41666511 -
Phytomedicine
Elucidating the molecular mechanisms of the mongolian medicine Ana Gaqi Nari in gastric cancer treatment through a multi-omics-guided experimental validation. [Abstract]2025 Nov 26:150:157623. PMID: 41330183 -
EMBO J
Polyubiquitin architecture editing on collided ribosomes maintains persistent RQC activity. [Abstract]2025 Sep 16. PMID: 40957981 -
Phytomedicine
5,2',4'-trihydroxy-6,7,5'-trimethoxyflavone-nanoparticle regulation mechanism of basic transcription factor 3 through hypoxia inducible factor-1α ubiquitination mediation to inhibit human hepatoma cell proliferation. [Abstract]2025 Nov:147:157236. PMID: 40939546 -
Phytomedicine
Cinobufagin overcomes bortezomib resistance in multiple myeloma strains by targeting SEC62/TRPM4-mediated NECSO. [Abstract]2025 Aug 16:147:157171. PMID: 40839992 -
Phytomedicine
Dendrobine attenuates lipopolysaccharide-induced acute lung injury by modulating FAM134B-mediated endoplasmic reticulum autophagy and mitochondrial function. [Abstract]2025 Aug:144:156952. PMID: 40532488 -
Phytomedicine
Dihydromyricetin alleviates lipid peroxidation-induced Pyroptosis by inhibiting xCT ubiquitination and degradation in experimental COPD model. [Abstract]2025 May 29:144:156929. PMID: 40483790 -
Phytomedicine
Picropodophyllin induces ferroptosis via blockage of AKT/NRF2/SLC7A11 and AKT/NRF2/SLC40A1 axes in hepatocellular carcinoma as a natural IGF1R inhibitor. [Abstract]2025 May 10:143:156840. PMID: 40412057 -
Phytomedicine
Indole-3-carbinol inhibits PD-L1-mediated immune evasion in hepatocellular carcinoma via suppressing NF-κB p105 Ubiquitination. [Abstract]2025 Apr 1:141:156692. PMID: 40215823 -
EMBO Mol Med
Deubiquitination of RIPK3 by OTUB2 potentiates neuronal necroptosis after ischemic stroke. [Abstract]2025 Apr;17(4):679-695. PMID: 40021931 -
EMBO J
SLC25A1 and ACLY maintain cytosolic acetyl-CoA and regulate ferroptosis susceptibility via FSP1 acetylation. [Abstract]2025 Mar;44(6):1641-1662. PMID: 39881208 -
EMBO J
Micropeptide hSPAR regulates glutamine levels and suppresses mammary tumor growth via a TRIM21-P27KIP1-mTOR axis. [Abstract]2025 Mar;44(5):1414-1441. PMID: 39875724 -
Phytomedicine
Proteomic screening identifies brusatol targets TGFβRII to suppresses non-small cell lung cancer metastasis. [Abstract]2025 Apr:139:156468. PMID: 39978271 -
Phytomedicine
Ginkgo biloba extract alleviates deltamethrin-induced testicular injury by upregulating SKP2 and inhibiting Beclin1-independent autophagy. [Abstract]2024 Nov 9:135:156245. PMID: 39550920 -
EMBO Mol Med
Targeting USP11 regulation by a novel lithium-organic coordination compound improves neuropathologies and cognitive functions in Alzheimer transgenic mice. [Abstract]2024 Nov;16(11):2856-2881. PMID: 39394468 -
Phytomedicine
Alizarin attenuates oxidative stress-induced mitochondrial damage in vascular dementia rats by promoting TRPM2 ubiquitination and proteasomal degradation via Smurf2. [Abstract]2024 Oct 5:135:156119. PMID: 39418971 -
Phytomedicine
Polyphyllin I ameliorates gefitinib resistance and inhibits the VEGF/VEGFR2/p38 pathway by targeting HIF-1a in lung adenocarcinoma. [Abstract]2024 May 8:129:155690. PMID: 38761523 -
Phytomedicine
Ganoderic acid D attenuates gemcitabine resistance of triple-negative breast cancer cells by inhibiting glycolysis via HIF-1α destabilization. [Abstract]2024 Jul:129:155675. PMID: 38678954 -
Phytomedicine
Baicalin attenuates neuronal damage associated with SDH activation and PDK2-PDH axis dysfunction in early reperfusion. [Abstract]2024 Jul:129:155570. PMID: 38579645 -
Phytomedicine
Ursolic acid alleviates lupus nephritis by suppressing SUMO1-mediated stabilization of NLRP3. [Abstract]2024 Jul 25:130:155556. PMID: 38810552 -
Phytomedicine
Moracin D suppresses cell growth and induces apoptosis via targeting the XIAP/PARP1 axis in pancreatic cancer. [Abstract]2024 Jun:128:155527. PMID: 38489888 -
Phytomedicine
Magnolol attenuates depressive-like behaviors by polarizing microglia towards the M2 phenotype through the regulation of Nrf2/HO-1/NLRP3 signaling pathway. [Abstract]2021 Oct:91:153692. PMID: 34411834 -
EMBO J
MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression. [Abstract]2023 Dec 1;42(23):e114558. PMID: 37905571 -
Phytomedicine
2024 Jan:122:155156. PMID: 37897861 -
BMC Med
ACVRL1 drives resistance to multitarget tyrosine kinase inhibitors in colorectal cancer by promoting USP15-mediated GPX2 stabilization. [Abstract]2023 Sep 25;21(1):366. PMID: 37743483 -
Phytomedicine
Sculponeatin A promotes the ETS1-SYVN1 interaction to induce SLC7A11/xCT-dependent ferroptosis in breast cancer. [Abstract]2023 Aug:117:154921. PMID: 37327642 -
Phytomedicine
Kaempferol inhibits non-homologous end joining repair via regulating Ku80 stability in glioma cancer. [Abstract]2023 Jul 25:116:154876. PMID: 37210962 -
EMBO J
KNO1-mediated autophagic degradation of the Bloom syndrome complex component RMI1 promotes homologous recombination. [Abstract]2023 May 15;42(10):e111980. PMID: 36970874 -
EMBO Mol Med
Sigma-1 receptor attenuates osteoclastogenesis by promoting ER-associated degradation of SERCA2. [Abstract]2022 Jul 7;14(7):e15373. PMID: 35611810 -
Phytomedicine
Rosmarinic Acid Decreases the Malignancy of Pancreatic Cancer Through Inhibiting Gli1 Signaling. [Abstract]2022 Jan:95:153861. PMID: 34864627 -
Phytomedicine
Lycorine, a natural alkaloid, promotes the degradation of alpha-synuclein via PKA-mediated UPS activation in transgenic Parkinson's disease models. [Abstract]2021 Jul:87:153578. PMID: 34038839 -
Phytomedicine
Sanguinarine combats hypoxia-induced activation of EphB4 and HIF-1α pathways in breast cancer. [Abstract]2021 Apr:84:153503. PMID: 33636580 -
Phytomedicine
Antileukemic effect of caffeic acid 3,4-dihydroxyphenetyl ester. Evidences for its mechanisms of action. [Abstract]2021 Jan;80:153383. PMID: 33091855 -
EMBO J
ABRO1 promotes NLRP3 inflammasome activation through regulation of NLRP3 deubiquitination. [Abstract]2019 Mar 15;38(6):e100376. PMID: 30787184
MG-132 purchased from MedChemExpress. Usage Cited in: EMBO J. 2019 Mar 15;38(6):e100376. [Abstract]
Brcc3+/+ and Brcc3-/- (Abro1+/+ and Abro1-/-)BMDMs are treated with or without LPS for 1 h. Before LPS treatment, Brcc3-/- (Abro1-/-) BMDMs are pretreated with MG132 (10 μM) for 6 h to rescue the expression of ABRO1. Immunoblot analysis of NLRP3 and ABRO1 proteins in cell lysates immunoprecipitated with anti-ABRO1 antibody.
-
Free Radic Biol Med
Histone lactylation exacerbates neuronal ferroptosis after traumatic brain injury: The effect of the upregulation of TNFAIP3 by mediating mitochondrial damage through the deubiquitination of ENO1. [Abstract]2026 Sep:253:561-577. PMID: 42178000 -
NPJ Parkinsons Dis
Metabotropic signaling downstream of GABAA receptors suppresses neuroinflammation in Parkinson's disease. [Abstract]2026 Jun 6. PMID: 42251036 -
Free Radic Biol Med
Troxerutin mitigates ferroptosis-related neuroinflammation by regulating the microglial NOX4/Nrf2 axis in Parkinson's disease. [Abstract]2026 Jun 6:254:46-61. PMID: 42252064 -
Free Radic Biol Med
Ginsenoside Rk1 suppresses osteosarcoma progression by coordinately activating ferritinophagy and disrupting antioxidant defense to induce ferroptosis. [Abstract]2026 Jun 27:S0891-5849(26)00907-X. PMID: 42364854 -
ACS Appl Mater Interfaces
Development of AuxCuyPdz Nanocomposites as Therapeutic Agents: Enhancing Cancer Treatment through Autophagy Modulation and Immune-Associated Effects. [Abstract]2026 Mar 18;18(10):14540-14557. PMID: 41778422 -
Free Radic Biol Med
The autophagy receptor NDP52 recruits the E3 ligase ASB2 to mediate NOX4 degradation, suppressing cardiomyocyte ferroptosis and ameliorating heart failure. [Abstract]2026 Apr:247:378-392. PMID: 41662915 -
Free Radic Biol Med
LINC01116 promotes glycolysis by up-regulating HIF-1α via YBX1-mediated dual mechanism in lung cancer. [Abstract]2026 May:248:320-332. PMID: 41740687 -
Free Radic Biol Med
Dihydroartemisinin targets GPX4 to induce autophagy-dependent ferroptosis and reduce radioresistance in triple-negative breast cancer. [Abstract]2026 Mar 16:246:35-50. PMID: 41520847 -
Free Radic Biol Med
Fyn deficiency drives pro-inflammatory macrophage activation to exacerbate septic acute lung injury. [Abstract]2026 Mar 16:246:80-92. PMID: 41490764 -
Free Radic Biol Med
HIF-1α translation mediated by PKCδ facilitates RSV-induced production of innate inflammatory cytokines in vitro and in vivo. [Abstract]2026 Mar 16:246:614-626. PMID: 41611036 -
Free Radic Biol Med
TRIB2 promotes pulmonary artery smooth muscle cell proliferation through SERCA2 ubiquitination in pulmonary hypertension. [Abstract]2025 Nov 8:243:414-433. PMID: 41213438 -
Cancer Immunol Res
FAM135B Deficiency Inhibits Cytotoxic T-Cell Activity in Triple-negative Breast Cancer by Blocking the IFI16-dependent STING Pathway. [Abstract]2025 Nov 11. PMID: 41218197 -
ACS Appl Mater Interfaces
A Simple Proton-Driven Allosteric Aptamer Nanorobot for Receptor Tyrosine Kinase Degradation and Behavior Modulation in Cancer Cells. [Abstract]2025 Jul 23;17(29):41781-41791. PMID: 40632939 -
Free Radic Biol Med
Alexidine dihydrochloride enhances the sensitivity of human hepatocellular carcinoma to disulfidptosis via ATF4-DDIT3 activation. [Abstract]2025 Jun 14:237:585-599. PMID: 40518125 -
Free Radic Biol Med
p67phox/NOX2 inhibits psoriasis by regulating the HIF-1α-glycolysis axis via p53-AMPK in keratinocytes. [Abstract]2025 Sep:237:503-514. PMID: 40516795 -
Free Radic Biol Med
Ubiquitination of ALOX15 regulates endoplasmic reticulum stress in Schwann cells and experimental autoimmune neuritis (EAN) models. [Abstract]2025 Apr 11:S0891-5849(25)00228-X. PMID: 40222426 -
Free Radic Biol Med
Resveratrol induces ferroptosis in triple-negative breast cancer through NEDD4L-mediated GPX4 ubiquitination and degradation. [Abstract]2025 Aug 1:235:231-247. PMID: 40316059 -
Free Radic Biol Med
Glabridin protects against paraquat-induced acute lung injury by targeting ME1 to mitigate oxidative stress, mitochondrial dysfunction, and cGAS-STING activation. [Abstract]2025 Aug 1:235:317-334. PMID: 40316060 -
Free Radic Biol Med
LRRC45 accelerates bladder cancer development and ferroptosis inhibition via stabilizing NRF2 by competitively KEAP1 interaction. [Abstract]2024 Nov 8:226:29-42. PMID: 39522565 -
Free Radic Biol Med
Targeting non-classical autophagy-dependent ferroptosis and the subsequent HMGB1/TfR1 feedback loop accounts for alleviating solar dermatitis by senkyunolide I. [Abstract]2024 Aug 6:S0891-5849(24)00591-4. PMID: 39117049 -
Free Radic Biol Med
The new pattern for dual NOTCH pathway involving nuclear transcription and mitochondrial regulation supports therapeutic mechanism of 4-butyl benzophenone derivatives against SIRS. [Abstract]2024 Aug 10:S0891-5849(24)00582-3. PMID: 39134162 -
Free Radic Biol Med
PIAS3 acts as a zinc sensor under zinc deficiency and plays an important role in myocardial ischemia/reperfusion injury. [Abstract]2024 May 13:S0891-5849(24)00460-X. PMID: 38750767 -
Free Radic Biol Med
UCHL3 inhibits ferroptosis by stabilizing β-catenin and maintains stem-like properties of hepatocellular carcinoma cells. [Abstract]2024 Feb 20:212:162-173. PMID: 38092274 -
Free Radic Biol Med
PM2.5 contributed to pulmonary epithelial senescence and ferroptosis by regulating USP3-SIRT3-P53 axis. [Abstract]2023 Aug 20:205:291-304. PMID: 37348684 -
Free Radic Biol Med
PET117 assembly factor stabilizes translation activator TACO1 thereby upregulates mitochondria-encoded cytochrome C oxidase 1 synthesis. [Abstract]2023 Aug 20:205:13-24. PMID: 37247699 -
Free Radic Biol Med
Targeting ABCB6 with nitidine chloride inhibits PI3K/AKT signaling pathway to promote ferroptosis in multiple myeloma. [Abstract]2023 Jul:203:86-101. PMID: 37044150 -
Free Radic Biol Med
WDR45 mutation dysregulates iron homeostasis by promoting the chaperone-mediated autophagic degradation of ferritin heavy chain in an ER stress/p38 dependent mechanism. [Abstract]2023 May 20:201:89-97. PMID: 36940732 -
Free Radic Biol Med
IRF1/ZNF350/GPX4-mediated ferroptosis of renal tubular epithelial cells promote chronic renal allograft interstitial fibrosis. [Abstract]2022 Nov 20;193(Pt 2):579-594. PMID: 36356714 -
Free Radic Biol Med
Sequestered SQSTM1/p62 crosstalk with Keap1/NRF2 axis in hPDLCs promotes oxidative stress injury induced by periodontitis. [Abstract]2022 Sep:190:62-74. PMID: 35940517 -
Free Radic Biol Med
m6A methylation is required for dihydroartemisinin to alleviate liver fibrosis by inducing ferroptosis in hepatic stellate cells. [Abstract]2022 Mar:182:246-259. PMID: 35248719 -
Free Radic Biol Med
Bufotalin induces ferroptosis in non-small cell lung cancer cells by facilitating the ubiquitination and degradation of GPX4. [Abstract]2022 Feb 20:180:75-84. PMID: 35038550 -
Free Radic Biol Med
2022 Feb 20:180:95-107. PMID: 35045311 -
Free Radic Biol Med
2021 Jun:169:271-282. PMID: 33895289 -
Free Radic Biol Med
Suppressing long noncoding RNA OGRU ameliorates diabetic retinopathy by inhibition of oxidative stress and inflammation via miR-320/USP14 axis. [Abstract]2021 Jun:169:361-381. PMID: 33762162 -
Free Radical Bio Med
Hypoxic preconditioning combined with curcumin promotes cell survival and mitochondrial quality of bone marrow mesenchymal stem cells, and accelerates cutaneous wound healing via PGC-1α/SIRT3/HIF-1α signaling. [Abstract]2020 Nov 1;159:164-176. PMID: 32745765 -
Free Radic Biol Med
2020 Nov 20;160:303-318. PMID: 32846217 -
Free Radic Biol Med
Trans-4,4'-dihydroxystilbene ameliorates cigarette smoke-induced progression of chronic obstructive pulmonary disease via inhibiting oxidative stress and inflammatory response. [Abstract]2020 May 20;152:525-539. PMID: 31760092 -
Apoptosis
CSN5 overexpression promotes the integral progression of cervical cancer by enhancing ENO3-mediated glycolysis. [Abstract]2026 Jan 12;31(1):41. PMID: 41524948 -
Apoptosis
HSPA8 lactylation attenuates neuronal pyroptosis via E3 ligase-mediated NLRP3 degradation after ischemic stroke. [Abstract]2026 Jan 10;31(1):37. PMID: 41518395 -
Apoptosis
Cathayanon E induces apoptosis and enhances oxaliplatin sensitivity in colorectal cancer through suppression of MCL1. [Abstract]2025 Sep 9. PMID: 40924299 -
New Phytol
Receptor-like cytoplasmic kinase MdPBL34 phosphorylates melatonin biosynthetic enzyme MdSNAT5 to trigger disease resistance to apple Alternaria blotch. [Abstract]2025 Oct;248(1):193-210. PMID: 40761001 -
Apoptosis
PRELP inhibits colorectal cancer progression by suppressing epithelial-mesenchymal transition and angiogenesis via the inactivation of the FGF1/PI3K/AKT pathway. [Abstract]2025 Feb;30(1-2):16-34. PMID: 39242474 -
Apoptosis
EVA1A reverses lenvatinib resistance in hepatocellular carcinoma through regulating PI3K/AKT/p53 signaling axis. [Abstract]2024 May 14. PMID: 38743191 -
Apoptosis
Role of Escin in breast cancer therapy: potential mechanism for inducing ferroptosis and synergistic antitumor activity with cisplatin. [Abstract]2023 Aug;28(7-8):1154-1167. PMID: 37149513 -
Apoptosis
Contribution of microRNA-30d to the prevention of the thyroid cancer occurrence and progression: mechanism and implications. [Abstract]2023 Apr;28(3-4):576-593. PMID: 36695983 -
Apoptosis
Tumor-suppressive E3 ubiquitin ligase CHIP inhibits the PBK/ERK axis to repress stem cell properties and radioresistance in non-small cell lung cancer. [Abstract]2023 Apr;28(3-4):397-413. PMID: 36436119 -
New Phytol
An HD-ZIP-MYB complex regulates glandular secretory trichome initiation in Artemisia annua. [Abstract]2021 Sep;231(5):2050-2064. PMID: 34043829 -
Chemosphere
2021 Feb;264(Pt 1):128440. PMID: 33002802 -
NPJ Precis Oncol
2025 Nov 4;9(1):338. PMID: 41188443 -
NPJ Precis Oncol
METTL21A promotes hepatocellular carcinoma progression via methylating and stabilizing BAG3. [Abstract]2025 Jul 10;9(1):234. PMID: 40640484 -
NPJ Precis Oncol
TRIM65 regulates glucose metabolic reprogramming to promote glioma cell proliferation via ubiquitination and degradation of AMPK. [Abstract]2025 Jun 5;9(1):163. PMID: 40473847 -
NPJ Precis Oncol
Hepatocellular carcinoma cells downregulate PGAM2 via SIRT2-mediated deacetylation modification to enhance aerobic glycolysis. [Abstract]2025 May 16;9(1):143. PMID: 40379975 -
Food Res Int
Polystyrene microplastics exposure reduces meat quality and disturbs skeletal muscle angiogenesis via thrombospondin 1. [Abstract]2024 Aug:190:114581. PMID: 38945601 -
NPJ Precis Oncol
Stabilization of p18 by deubiquitylase CYLD is pivotal for cell cycle progression and viral replication. [Abstract]2021 Mar 2;5(1):14. PMID: 33654169 -
Br J Pharmacol
KCTD10 weakens m6A modification of IL-11 in a ubiquitin-dependent manner to repress tumour immune escape in lung adenocarcinoma. [Abstract]2026 May 10. PMID: 42107984 -
Br J Pharmacol
Noncanonical function of sphingosine kinase 2 (SPHK2) sustains hepatic triglyceride homeostasis. [Abstract]2026 Mar 10. PMID: 41804573 -
Br J Pharmacol
Fenofibrate potentiates the therapeutic efficacy of EZH2 inhibitors on melanoma via TRIM21- and OTUD4-mediated EZH2 ubiquitination. [Abstract]2026 Jun;183(11):2675-2694. PMID: 41652905 -
Neoplasia
2026 Mar:73:101285. PMID: 41687501 -
Neoplasia
MYLK4 promotes colorectal cancer progression by regulating lipid metabolism reprogramming via targeting ferroptosis. [Abstract]2026 Mar:73:101270. PMID: 41616458 -
Br J Pharmacol
CircPTK2 enhances non-small cell lung cancer proliferation by inhibiting cellular senescence through stabilizing NFYA and elevating FOXM1. [Abstract]2025 Nov 7. PMID: 41204684 -
Br J Pharmacol
Quercetin alleviates postmenopausal atherosclerosis by suppressing endothelial cell ferroptosis via regulating the KEAP1/NRF2/GPX4 signalling pathway. [Abstract]2025 Oct 8. PMID: 41063334 -
Br J Pharmacol
Semax peptide targets the μ opioid receptor gene Oprm1 to promote deubiquitination and functional recovery after spinal cord injury in female mice. [Abstract]2025 Jul 21. PMID: 40692165 -
Br J Pharmacol
Sculponeatin A induces mitochondrial dysfunction in non-small cell lung cancer through WWP2-mediated degradation of mitochondrial STAT3. [Abstract]2025 Jun;182(12):2662-2681. PMID: 39993792 -
Neoplasia
ZC3H15 suppression ameliorates bone cancer pain through inhibiting neuronal oxidative stress and microglial inflammation. [Abstract]2025 Feb 4:61:101123. PMID: 39908779 -
Br J Pharmacol
SGK3 promotes estrogen receptor-positive breast cancer proliferation by activating STAT3/ZMIZ2 pathway to stabilise β-catenin. [Abstract]2025 Apr;182(8):1856-1875. PMID: 39876548 -
Br J Pharmacol
Chicoric acid exerts therapeutic effects in DSS-induced ulcerative colitis by targeting the USP9X/IGF2BP2 axis. [Abstract]2024 Oct 22. PMID: 39435543 -
Br J Pharmacol
The plant extract PNS mitigates atherosclerosis via promoting Nrf2-mediated inhibition of ferroptosis through reducing USP2-mediated Keap1 deubiquitination. [Abstract]2024 Dec;181(23):4822-4844. PMID: 39228119 -
Br J Pharmacol
HSP90β shapes the fate of Th17 cells with the help of glycolysis-controlled methylation modification. [Abstract]2024 Oct;181(20):3886-3907. PMID: 38881036 -
Environ Res
2024 Jun 4:257:119325. PMID: 38844032 -
Neoplasia
Inducing ubiquitination and degradation of TrxR1 protein by LW-216 promotes apoptosis in non-small cell lung cancer via triggering ROS production. [Abstract]2024 May 10:53:101004. PMID: 38733769 -
Br J Pharmacol
A novel sorbicillinoid compound as a potent anti-inflammation agent through inducing NLRP3 protein degradation. [Abstract]2023 Aug;180(15):1930-1948. PMID: 36788033 -
Neoplasia
2022 Dec:34:100839. PMID: 36240645 -
Neoplasia
PAD4-dependent citrullination of nuclear translocation of GSK3β promotes colorectal cancer progression via the degradation of nuclear CDKN1A. [Abstract]2022 Nov;33:100835. PMID: 36113195 -
Br J Pharmacol
Limonin stabilises sirtuin 6 (SIRT6) by activating ubiquitin specific peptidase 10 (USP10) in cardiac hypertrophy. [Abstract]2022 Sep;179(18):4516-4533. PMID: 35727596 -
Neoplasia
ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma. [Abstract]2021 Dec;23(12):1227-1239. PMID: 34768109 -
Br J Pharmacol
A new therapeutic effect of fenofibrate in Duchenne muscular dystrophy: The promotion of myostatin degradation. [Abstract]2022 Mar;179(6):1237-1250. PMID: 34553378 -
Mov Disord
Reversing Autophagy Inhibition Ameliorates Neurodegeneration in Hereditary Spastic Paraplegia Caused by a Degradation-Resistant SPAST Mutation. [Abstract]2025 Dec 17. PMID: 41403389 -
Brain Behav Immun
Kynurenic acid/GPR35 axis restricts NLRP3 inflammasome activation and exacerbates colitis in mice with social stress. [Abstract]2019 Jul:79:244-255. PMID: 30790702
MG-132 purchased from MedChemExpress. Usage Cited in: Brain Behav Immun. 2019 Jul:79:244-255. [Abstract]
Effect of autolysosome inhibitor (Chloroquine, CQ, 50 μM) or proteasome inhibitor (MG132, 5 μM) on KA-induced NLRP3 degradation. Cells are treated with the inhibitors for 0.5 h before KA (10 μM, 2 h) treatment.
-
Emerg Microbes Infect
Streptococcus suis Stk1 sensitizes epithelial cells to ferroptosis and exacerbates disruption of the respiratory epithelial barrier. [Abstract]2026 Dec;15(1):2627066. PMID: 41630441 -
Arch Pharm Res
JAK2/STAT3-dependent regulation of MDM4/MDM2-p53 signaling in methotrexate-induced ferroptosis and nephrotoxicity. [Abstract]2026 Feb;49(2):223-241. PMID: 41723769 -
J Transl Med
Truncated APC impairs innate immune response by targeting MAVS on mitochondria in colorectal cancer. [Abstract]2025 Nov 10;23(1):1252. PMID: 41214683 -
J Transl Med
CX26 promotes pancreatic cancer progression by competitively inhibiting interaction of c-Myc with PSMD2 and enhancing c-Myc stability. [Abstract]2025 Aug 19;23(1):939. PMID: 40830962 -
J Transl Med
2025 Jul 2;23(1):729. PMID: 40605005 -
J Transl Med
Polystyrene nanoplastics trigger pyroptosis in dopaminergic neurons through TSC2/TFEB-mediated disruption of autophagosome-lysosome fusion in Parkinson's disease. [Abstract]2025 Jun 5;23(1):631. PMID: 40474178 -
J Transl Med
RBX1 mitigates ferroptosis by inhibiting NCOA4-mediated ferritinophagy and contributes to the attenuation of intervertebral disc degeneration. [Abstract]2025 May 7;23(1):514. PMID: 40335979 -
J Transl Med
Endogenous protein S100A14 stabilizes glutaminase to render hepatocellular carcinoma resistant to sorafenib. [Abstract]2025 Apr 11;23(1):435. PMID: 40217256 -
J Transl Med
2025 Apr 10;23(1):415. PMID: 40211376 -
J Transl Med
SPICE1 promotes osteosarcoma growth by enhancing the deubiquitination of FASN mediated by USP10. [Abstract]2025 Feb 21;23(1):220. PMID: 39985078 -
J Transl Med
2025 Jan 16;23(1):74. PMID: 39819457 -
J Transl Med
YY1 drives PARP1 expression essential for PARylation of NONO in mRNA maturation during neuroblastoma progression. [Abstract]2024 Dec 27;22(1):1153. PMID: 39731187 -
J Transl Med
Ubiquitin-specific protease 7 maintains c-Myc stability to support pancreatic cancer glycolysis and tumor growth. [Abstract]2024 Dec 20;22(1):1135. PMID: 39707401 -
J Transl Med
NL101 synergizes with the BCL-2 inhibitor venetoclax through PI3K-dependent suppression of c-Myc in acute myeloid leukaemia. [Abstract]2024 Sep 27;22(1):867. PMID: 39334157 -
J Transl Med
ML335 inhibits TWIK2 channel-mediated potassium efflux and attenuates mitochondrial damage in MSU crystal-induced inflammation. [Abstract]2024 Aug 22;22(1):785. PMID: 39175013 -
Biomed Pharmacother
Berbamine promotes ferroptosis of esophageal squamous cell carcinoma by facilitating USP51-mediated GPX4 ubiquitination and degradation. [Abstract]2024 Aug 15:179:117309. PMID: 39151312 -
J Transl Med
A novel protein FNDC3B-267aa encoded by circ0003692 inhibits gastric cancer metastasis via promoting proteasomal degradation of c-Myc. [Abstract]2024 May 27;22(1):507. PMID: 38802851 -
Biomed Pharmacother
12-O-deacetyl-phomoxanthone A inhibits ovarian tumor growth and metastasis by downregulating PDK4. [Abstract]2024 May 12:175:116736. PMID: 38739992 -
Biomed Pharmacother
Inhibition the ubiquitination of ENaC and Na,K-ATPase with erythropoietin promotes alveolar fluid clearance in sepsis-induced acute respiratory distress syndrome. [Abstract]2024 May:174:116447. PMID: 38518606 -
J Transl Med
LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability. [Abstract]2023 Nov 21;21(1):838. PMID: 37990271 -
J Transl Med
CircNFATC3 promotes the proliferation of gastric cancer through binding to IGF2BP3 and restricting its ubiquitination to enhance CCND1 mRNA stability. [Abstract]2023 Jun 20;21(1):402. PMID: 37340423 -
J Transl Med
The oncogenic role of NF1 in gallbladder cancer through regulation of YAP1 stability by direct interaction with YAP1. [Abstract]2023 May 5;21(1):306. PMID: 37147639 -
Biomed Pharmacother
Inhibition of autophagy in macrophage promotes IL-1β-mediated hepatocellular carcinoma progression via inflammasome accumulation and self-recruitment. [Abstract]2023 May:161:114560. PMID: 36940618 -
Emerg Microbes Infect
Compartmentalisation of Hepatitis B virus X gene evolution in hepatocellular carcinoma microenvironment and the genotype-phenotype correlation of tumorigenicity in HBV-related patients with hepatocellular carcinoma. [Abstract]2022 Dec;11(1):2486-2501. PMID: 36102940 -
J Transl Med
TPI1 activates the PI3K/AKT/mTOR signaling pathway to induce breast cancer progression by stabilizing CDCA5. [Abstract]2022 May 4;20(1):191. PMID: 35509067 -
Diabetes
Hepatic P38 Activation Modulates Systemic Metabolism Through Fgf21-Mediated Interorgan Communication. [Abstract]2021 Oct 21:db210240. PMID: 34675006 -
Diabetes
Dedicator of Cytokinesis 5 Regulates Keratinocyte Function and Promotes Diabetic Wound Healing. [Abstract]2021 May;70(5):1170-1184. PMID: 33627322 -
Biomed Pharmacother
C-CBL is required for inhibition of angiogenesis through modulating JAK2/STAT3 activity in ROP development. [Abstract]2020 Dec;132:110856. PMID: 33125970 -
Biomed Pharmacother
Engeletin suppresses lung cancer progression by inducing apoptotic cell death through modulating the XIAP signaling pathway: A molecular mechanism involving ER stress. [Abstract]2020 Aug;128:110221. PMID: 32447208 -
Redox Rep
The novel thioredoxin reductase inhibitor butaselen suppresses lung cancer by inducing oxidative stress. [Abstract]2025 Dec;30(1):2588086. PMID: 41292488 -
J Transl Int Med
N-acetylglucosaminyltransferase V attenuates myocardial infarction by mediating the insulin-like growth factor 1 receptor signaling pathway. [Abstract]2025 Jun 20;13(3):281-294. PMID: 40896287 -
Cell Mol Gastroenterol Hepatol
Apolipoprotein A-1 accelerated liver regeneration through regulating autophagy via AMPK-ULK1 pathway. [Abstract]2024;17(4):539-551. PMID: 38122985 -
Oncogene
CPSF2-mediated 3' UTR truncation of MTERF3 drives mitochondrial dysfunction and osteosarcoma progression. [Abstract]2026 Jul;45(28):2851-2864. PMID: 42286305 -
Oncogene
GOT1 inhibits hepatocellular carcinoma progression by regulating SLC25A5-dependent mitochondrial apoptosis. [Abstract]2026 Jun;45(20):1930-1940. PMID: 41981252 -
Oncogene
2026 Jun;45(22):2098-2110. PMID: 42000926 -
Oncogene
The NPC1/USP7/p53 axis regulates cholesterol and promotes the proliferation of hepatocellular carcinoma. [Abstract]2026 Apr;45(15):1386-1397. PMID: 41882104 -
Oncogene
TBKBP1 induces capecitabine resistance through negative regulation of type I interferon pathway in triple-negative breast cancer. [Abstract]2026 Feb;45(6):703-714. PMID: 41606294 -
Oncogene
Targeting FZD6 creates therapeutically actionable vulnerabilities for advanced prostate cancer. [Abstract]2025 Dec;44(50):4868-4877. PMID: 41286306 -
Oncogene
SLC7A5-ERBB2 axis drives olaparib resistance via de novo lipid synthesis in ovarian cancer. [Abstract]2025 Nov 28. PMID: 41315667 -
Oncogene
Aging-associated ZNF573 methylation regulates RNF19B-PIK3CA ubiquitination to promote prostate cancer. [Abstract]2025 Sep 19. PMID: 40973794 -
Oncogene
USP10-mediated Ku70/80 stabilization inhibits PANoptosis and promotes chemoresistance in colorectal cancer. [Abstract]2025 Sep 18. PMID: 40968255 -
Environ Pollut
UCHL3-mediated proteasomal degradation of GOPC drives microcystin-LR-induced acrosomal dysgenesis. [Abstract]2025 Aug 8:384:126969. PMID: 40784473 -
Oncogene
HDAC1/2-mediated deacetylation of KLF9 promotes the malignant progression of nasopharyngeal carcinoma via CDH17. [Abstract]2025 Sep;44(35):3183-3198. PMID: 40615689 -
Stem Cell Res Ther
Targeting prominin-2/BACH1/GLS pathway to inhibit oxidative stress-induced ferroptosis of bone mesenchymal stem cells. [Abstract]2025 Apr 29;16(1):213. PMID: 40301995 -
Oncogene
CBX3 promotes multidrug resistance by suppressing ferroptosis in colorectal carcinoma via the CUL3/NRF2/GPX2 axis. [Abstract]2025 Jun;44(22):1678-1693. PMID: 40089640 -
Oncogene
The protection of UCK2 protein stability by GART maintains pyrimidine salvage synthesis for HCC growth under glucose limitation. [Abstract]2025 May;44(16):1078-1092. PMID: 39865175 -
Oncogene
2024 Nov;43(49):3570-3585. PMID: 39402372 -
Oncogene
The tumor suppressor Parkin exerts anticancer effects through regulating mitochondrial GAPDH activity. [Abstract]2024 Oct;43(44):3215-3226. PMID: 39285229 -
Oncogene
USP33 facilitates the ovarian cancer progression via deubiquitinating and stabilizing CBX2. [Abstract]2024 Oct;43(43):3170-3183. PMID: 39256572 -
Oncogene
GSK3β and UCHL3 govern RIPK4 homeostasis via deubiquitination to enhance tumor metastasis in ovarian cancer. [Abstract]2024 Jun;43(25):1885-1899. PMID: 38664501 -
Oncogene
D-mannose induces TFE3-dependent lysosomal degradation of EGFR and inhibits the progression of NSCLC. [Abstract]2023 Nov;42(47):3503-3513. PMID: 37845392 -
Oncogene
USP13 deubiquitinates and stabilizes cyclin D1 to promote gastric cancer cell cycle progression and cell proliferation. [Abstract]2023 Jul;42(29):2249-2262. PMID: 37311811 -
Oncogene
E3 ligase MAEA-mediated ubiquitination and degradation of PHD3 promotes glioblastoma progression. [Abstract]2023 Apr;42(16):1308-1320. PMID: 36882523 -
Oncogene
2023 Mar;42(10):725-736. PMID: 36604567 -
Oncogene
EXOSC8 promotes colorectal cancer tumorigenesis via regulating ribosome biogenesis-related processes. [Abstract]2022 Dec;41(50):5397-5410. PMID: 36348012 -
Oncogene
2022 Sep;41(40):4524-4536. PMID: 36042349 -
Oncogene
AKR1C3 regulated by NRF2/MAFG complex promotes proliferation via stabilizing PARP1 in hepatocellular carcinoma. [Abstract]2022 Jul;41(31):3846-3858. PMID: 35773412 -
Environ Pollut
1-Nitropyrene disrupts testosterone biogenesis via AKAP1 degradation promoted mitochondrial fission in mouse Leydig cell. [Abstract]2022 Aug 15:307:119484. PMID: 35613681 -
Oncogene
PBLD inhibits angiogenesis via impeding VEGF/VEGFR2-mediated microenvironmental cross-talk between HCC cells and endothelial cells. [Abstract]2022 Mar;41(13):1851-1865. PMID: 35140333 -
Oncogene
Melatonin potentiates the cytotoxic effect of Neratinib in HER2+ breast cancer through promoting endocytosis and lysosomal degradation of HER2. [Abstract]2021 Nov;40(44):6273-6283. PMID: 34556812 -
Oncogene
EAG1 enhances hepatocellular carcinoma proliferation by modulating SKP2 and metastasis through pseudopod formation. [Abstract]2021 Jan;40(1):163-176. PMID: 33097858 -
Cell Chem Biol
Chemical modulation of Miro1 alleviates cell-type-specific vulnerabilities in Friedreich's ataxia. [Abstract]2026 Jun 8:S2451-9456(26)00156-X. PMID: 42259290 -
Cell Chem Biol
A nature-inspired nanoplatform for multi-protein targeted degradation via the autophagy-lysosome pathway. [Abstract]2026 Apr 16;33(4):523-537.e7. PMID: 41932333 -
Cell Chem Biol
2024 Feb 15;31(2):326-337.e11. PMID: 38016478 -
PLoS Biol
Optineurin promotes myogenesis during muscle regeneration in mice by autophagic degradation of GSK3β. [Abstract]2022 Apr 27;20(4):e3001619 PMID: 35476671 -
Cell Chem Biol
Pharmacological Targeting of Vacuolar H+-ATPase via Subunit V1G Combats Multidrug-Resistant Cancer. [Abstract]2020 Nov 19;27(11):1359-1370.e8. PMID: 32649904 -
Aging Cell
A Primate-Specific lncRNA LINC01021 Contributes to Cellular and Organismal Aging via DAZAP1-Dependent Destabilization of RBMX. [Abstract]2026 Jul;25(7):e70603. PMID: 42348295 -
Aging Cell
MSC-Derived Exosomal lnc-AGT-3: A Novel Anti-Angiogenic Target in Age-Related Macular Degeneration Through p53 Signaling Pathway. [Abstract]2026 Feb;25(2):e70377. PMID: 41524223 -
J Genet Genomics
circRNAs derived from a nuclear hormone receptor act differentially on insect metamorphosis and reproduction. [Abstract]2025 Oct 7:S1673-8527(25)00277-2. PMID: 41067527 -
J Genet Genomics
USP21 deubiquitinates DPYSL2 and enhances its centrosomal abundance to promote cilium formation. [Abstract]2025 Jul 5:S1673-8527(25)00193-6. PMID: 40619097 -
Eur J Cancer
BAP1-mediated MAFF deubiquitylation regulates tumor growth and is associated with adverse outcomes in colorectal cancer. [Abstract]2024 Aug 10:210:114278. PMID: 39151323 -
J Genet Genomics
2024 Oct;51(10):1020-1029. PMID: 38663479 -
Eur J Cancer
CDCA2 promotes melanoma progression by inhibiting ubiquitin-mediated degradation of Aurora kinase A. [Abstract]2023 Jul:188:49-63. PMID: 37196484 -
Aging Cell
Gamma frequency light flicker regulates amyloid precursor protein trafficking for reducing β-amyloid load in Alzheimer's disease model. [Abstract]2022 Mar;21(3):e13573. PMID: 35199454 -
Aging Cell
2020 Jul;19(7):e13171. PMID: 32662244 -
Blood Adv
Mature murine megakaryocytes present antigen-MHC class I molecules to T cells and transfer them to platelets. [Abstract]2017 Sep 8;1(20):1773-1785. PMID: 29296823 -
Cell Death Discov
PER2 reprograms intracellular cholesterol synthesis to inhibit oral squamous cell carcinoma and the chronotherapeutic efficacy of simvastatin. [Abstract]2026 Jun 20. PMID: 42323285 -
Cell Death Discov
FBXW7α regulates amyloid pathology by mediating ubiquitination and degradation of BACE1 in Alzheimer's disease. [Abstract]2026 May 20;12(1):300. PMID: 42161904 -
Cell Death Discov
ARHGAP21 enhances metastasis in hepatocellular carcinoma by inhibiting ubiquitination of filamin A. [Abstract]2026 Apr 9;12(1):240. PMID: 41957357 -
Cell Death Discov
Non-enzymatic function of QSOX2 directly regulates the JUNB-ITGB4 axis and enhanced resistance to osimertinib in EGFR-mutation lung adenocarcinoma. [Abstract]2026 Apr 1;12(1):215. PMID: 41922310 -
Cell Death Discov
Low-dose TNF-α drives malignant progression and lipid metabolism in glioblastoma through the TRAF2-FASN axis. [Abstract]2026 Apr 9;12(1):242. PMID: 41956989 -
Cell Death Discov
2026 Mar 19;12(1):156. PMID: 41856994 -
Cell Death Discov
Deciphering the STAT3-PXN positive feedback loop in GBM, IDH-wildtype: transcriptional regulation and inhibition of YB-1 ubiquitination. [Abstract]2026 Mar 23;12(1):168. PMID: 41872167 -
Cell Death Discov
Amlodipine exerts inhibitory effects against glioma stem cells through degrading EGFR and down-regulating its downstream pro-survival pathways. [Abstract]2025 Oct 27;11(1):492. PMID: 41145413 -
Cell Death Discov
The RNF8/OPTN/KDM6A axis controls macrophage polarization to maintain testicular microenvironment homeostasis. [Abstract]2025 Jul 24;11(1):339. PMID: 40707433 -
Cell Death Discov
Single-cell multi-omics elucidates the role of RPS27-RPS24 fusion gene in osteosarcoma chemoresistance and metabolic regulation. [Abstract]2025 Apr 25;11(1):197. PMID: 40280903 -
Cell Death Discov
Integrative insights into the role of CAV1 in ketogenic diet and ferroptosis in pancreatic cancer. [Abstract]2025 Apr 4;11(1):139. PMID: 40180904 -
Cell Death Discov
Deficiency of UBE3D in mice leads to severe embryonic abnormalities and disrupts the mRNA of Homeobox genes via CPSF3. [Abstract]2025 Mar 12;11(1):99. PMID: 40075082 -
Cell Death Discov
CDK4/6 inhibition initiates cell cycle arrest by nuclear translocation of RB and induces a multistep molecular response. [Abstract]2024 Oct 26;10(1):453. PMID: 39461947 -
Cell Death Discov
2024 Jun 22;10(1):298. PMID: 38909032 -
Cell Death Discov
2023 Nov 28;9(1):427. PMID: 38016969 -
Cell Death Discov
USP35 promotes HCC development by stabilizing ABHD17C and activating the PI3K/AKT signaling pathway. [Abstract]2023 Nov 22;9(1):421. PMID: 37993419 -
Cell Death Discov
Targeting the up-regulated CNOT3 reverses therapeutic resistance and metastatic progression of EGFR-mutant non-small cell lung cancer. [Abstract]2023 Nov 2;9(1):406. PMID: 37919290 -
Cell Death Discov
SOSSB1 and SOSSB2 mutually regulate protein stability through competitive binding of SOSSA. [Abstract]2023 Aug 28;9(1):319. PMID: 37640700 -
Cell Death Discov
MicroRNA-375 restrains the progression of lung squamous cell carcinoma by modulating the ERK pathway via UBE3A-mediated DUSP1 degradation. [Abstract]2023 Jun 29;9(1):199. PMID: 37385985 -
Cell Death Discov
CAV2 promotes the invasion and metastasis of head and neck squamous cell carcinomas by regulating S100 proteins. [Abstract]2022 Sep 16;8(1):386. PMID: 36114176 -
Cell Death Discov
Acetylation stabilizes stathmin1 and promotes its activity contributing to gallbladder cancer metastasis. [Abstract]2022 May 17;8(1):265. PMID: 35581193 -
Cell Death Discov
WWP1 upregulation predicts poor prognosis and promotes tumor progression by regulating ubiquitination of NDFIP1 in intrahepatic cholangiocarcinoma. [Abstract]2022 Mar 9;8(1):107. PMID: 35264565 -
Cell Death Discov
YAP ISGylation increases its stability and promotes its positive regulation on PPP by stimulating 6PGL transcription. [Abstract]2022 Feb 11;8(1):59. PMID: 35149670 -
Cell Death Discov
TRAP1 inhibits MIC60 ubiquitination to mitigate the injury of cardiomyocytes and protect mitochondria in extracellular acidosis. [Abstract]2021 Dec 14;7(1):389. PMID: 34907169 -
Cell Death Discov
Oncogenic microRNA-181d binding to OGT contributes to resistance of ovarian cancer cells to cisplatin. [Abstract]2021 Dec 8;7(1):379. PMID: 34876558 -
Cell Rep
The TNRC6B/circTNRC6B axis drives lymphovascular invasion and metastasis through an intragenic self-degradation loop. [Abstract]2026 Jun 25;45(7):117606. PMID: 42360875 -
Cell Rep
nsP3-FXR co-condensation enables alphavirus replication and reveals a targetable alphavirus vulnerability. [Abstract]2026 Jun 3;45(6):117495. PMID: 42241276 -
Cell Rep
Type I unconventional protein secretion of the SARS-CoV-2 nucleocapsid protein promotes inflammatory cytokine release. [Abstract]2026 Jun 25;45(7):117613. PMID: 42360880 -
Cell Rep
Accumulated sotorasib-bound KRASG12C reactivates the MAPK pathway and drives sotorasib resistance via the DHX9-RAC1-PAK1 axis. [Abstract]2026 May 4;45(5):117338. PMID: 42090290 -
Cell Rep
SEPHS2 loss reprograms cancer metabolism from oxidative phosphorylation to gluconeogenesis via PCK1 stabilization. [Abstract]2026 Apr 25;45(5):117297. PMID: 42035418 -
Cell Rep
USP15 stabilizes c-Myc to drive sunitinib resistance by suppressing cuproptosis in clear cell renal cell carcinoma. [Abstract]2026 Apr 28;45(5):117328. PMID: 42054210 -
Cell Rep
Scap stabilizes PKM2 to promote glycolysis and enhance anti-fungal immunity in macrophages. [Abstract]2026 Mar 13;45(3):117106. PMID: 41831231 -
Cell Rep
2026 Mar 24;45(3):117086. PMID: 41831232 -
Cell Rep
HRD1 negatively regulates autolysosome formation by inhibiting liquid-liquid phase separation of SNAP29. [Abstract]2026 Feb 24;45(2):116914. PMID: 41615796 -
Cell Rep
Viral action on the auxin signaling repressor IAA16 reveals a conserved negative regulator of plant growth and immunity. [Abstract]2026 Feb 23;45(3):117034. PMID: 41734062 -
Cell Rep
Polystyrene nanoplastics readily penetrate intestine and cause sex-specific effects mediated by bile acids and microbiome. [Abstract]2026 Jan 22;45(2):116859. PMID: 41575856 -
Cell Rep
Lactylation-stabilized NOL6 promotes colorectal cancer progression via STAMBP-mediated YY1 deubiquitination and c-Myc transcription upregulation. [Abstract]2025 Dec 26;45(1):116774. PMID: 41456274 -
Cell Rep
Liprin-α1 enhances PHLDB3 oncogenic function in colorectal cancer via activation of mTORC2-AKT1 pathway. [Abstract]2025 Dec 16;45(1):116722. PMID: 41405991 -
-
Cell Rep
IGF2BP2 stabilized by USP7 promotes cancer-associated fibroblast activation and attenuates gemcitabine sensitivity in PDAC. [Abstract]2025 Nov 25;44(11):116476. PMID: 41201091 -
Cell Rep
Herpes simplex virus type 1 disseminates from the cornea to the CNS in mice by thwarting type III interferon immune defenses. [Abstract]2025 Nov 18;44(12):116581. PMID: 41259200 -
Cell Rep
Harnessing the E3 ligase SPOP for targeted degradation of the NUP98::KDM5A fusion oncoprotein. [Abstract]2025 Nov 25;44(12):116602. PMID: 41307993 -
Cell Rep
2025 Oct 15;44(10):116433. PMID: 41105513 -
Cell Rep
SLC6A8-mediated creatine uptake suppresses ERK2-FSP1 signaling and induces ferroptosis in colorectal cancer. [Abstract]2025 Sep 1;44(9):116139. PMID: 40892544 -
Aging Dis
SCAP Interacts with Trim27 to Promote Vascular Neointimal Hyperplasia by Regulating the Stability and Ubiquitination of IκBα. [Abstract]2025 Aug 6. PMID: 40901979 -
Cell Rep
Cancer-associated fibroblast-derived fibulin-5 promotes radioresistance in non-small-cell lung cancer. [Abstract]2025 Jul 23;44(8):116018. PMID: 40711881 -
Cell Rep
TRIM65 as a key regulator of ferroptosis and glycolysis in lactate-driven renal tubular injury and diabetic kidney disease. [Abstract]2025 Jul 30;44(8):116091. PMID: 40748757 -
Cell Rep
VCPIP1 potentiates innate immune responses by non-catalytically reducing the ubiquitination of IRAK1/2. [Abstract]2025 Jun 27;44(7):115931. PMID: 40581931 -
Cell Rep
Inhibiting UPF1 methylation enhances tumor immunotherapy sensitivity by reducing nonsense-mediated mRNA decay. [Abstract]2025 Jun 25;44(7):115919. PMID: 40570371 -
Cell Rep
The N-degron pathway mediates the autophagic degradation of cytosolic mitochondrial DNA during sterile innate immune responses. [Abstract]2024 Dec 21;44(1):115094. PMID: 39709605 -
Cell Rep
ZDHHC3-mediated SCAP S-acylation promotes cholesterol biosynthesis and tumor immune escape in hepatocellular carcinoma. [Abstract]2024 Nov 9;43(11):114962. PMID: 39522165 -
Cell Rep
A MYC-STAMBPL1-TOE1 positive feedback loop mediates EGFR stability in hepatocellular carcinoma. [Abstract]2024 Oct 8;43(10):114812. PMID: 39388352 -
Cell Rep
ICP22-defined condensates mediate RNAPII deubiquitylation by UL36 and promote HSV-1 transcription. [Abstract]2024 Oct 8;43(10):114792. PMID: 39383039 -
Cell Rep
HSV-1-induced N6-methyladenosine reprogramming via ICP0-mediated suppression of METTL14 potentiates oncolytic activity in glioma. [Abstract]2024 Sep 25;43(10):114756. PMID: 39325621 -
Cell Rep
STUB1-mediated ubiquitination and degradation of NSUN2 promotes hepatocyte ferroptosis by decreasing m5C methylation of Gpx4 mRNA. [Abstract]2024 Oct 24;43(11):114885. PMID: 39453812 -
Cell Rep
Transient splicing inhibition causes persistent DNA damage and chemotherapy vulnerability in triple-negative breast cancer. [Abstract]2024 Sep 13;43(9):114751. PMID: 39276346 -
Cell Rep
A nature-inspired HIF stabilizer derived from a highland-adaptation insertion of plateau pika Epas1 protein. [Abstract]2024 Sep 12;43(9):114727. PMID: 39269902 -
Cell Rep
2024 Sep 3;43(9):114691. PMID: 39235944 -
Cell Rep
Tumor suppressor KEAP1 promotes HSPA9 degradation, controlling mitochondrial biogenesis in breast cancer. [Abstract]2024 Jul 13;43(7):114507. PMID: 39003742 -
Cell Rep
Translocational attenuation mediated by the PERK-SRP14 axis is a protective mechanism of unfolded protein response. [Abstract]2024 Jun 27;43(7):114402. PMID: 38943644 -
Cell Rep
Deubiquitylase OTUD3 regulates integrated stress response to suppress progression and sorafenib resistance of liver cancer. [Abstract]2024 Jul 11;43(7):114487. PMID: 38996071 -
Cell Rep
Targeting high circDNA2v levels in colorectal cancer induces cellular senescence and elicits an anti-tumor secretome. [Abstract]2024 Apr 23;43(4):114111. PMID: 38615319 -
Cell Rep
Non-canonical isoforms of the mRNA polyadenylation factor WDR33 regulate STING-mediated immune responses. [Abstract]2024 Mar 1;43(3):113886. PMID: 38430516 -
Cell Rep
2023 Aug 29;42(8):112851. PMID: 37481723 -
Cell Rep
Histone deacetylase OsHDA706 orchestrates rice broad-spectrum antiviral immunity and is impeded by a viral effector. [Abstract]2024 Feb 21;43(3):113838. PMID: 38386554 -
Cell Rep
LINC00921 reduces lung cancer radiosensitivity by destabilizing NUDT21 and driving aberrant MED23 alternative polyadenylation. [Abstract]2023 Nov 23;42(12):113479. PMID: 37999979 -
Cell Rep
p53-responsive CMBL reprograms glucose metabolism and suppresses cancer development by destabilizing phosphofructokinase PFKP. [Abstract]2023 Nov 14;42(11):113426. PMID: 37967006 -
Cell Rep
Aspartyl-tRNA synthetase 2 orchestrates iron-sulfur metabolism in hematopoietic stem cells via fine-tuning alternative RNA splicing. [Abstract]2023 Oct 13;42(10):113264. PMID: 37838946 -
Cell Rep
AMER1 deficiency promotes the distant metastasis of colorectal cancer by inhibiting SLC7A11- and FTL-mediated ferroptosis. [Abstract]2023 Sep 7;42(9):113110. PMID: 37682704 -
Cell Rep
The miR-17∼92 miRNAs promote plasma cell differentiation by suppressing SOCS3-mediated NIK degradation. [Abstract]2023 Aug 13;42(8):112968. PMID: 37578862 -
Cell Rep
LHPP-mediated inorganic pyrophosphate hydrolysis-driven lysosomal acidification in astrocytes regulates adult neurogenesis. [Abstract]2023 Aug 11;42(8):112975. PMID: 37573508 -
Plant Physiol
2023 Jul 3;192(3):2507-2522. PMID: 36946197 -
Cell Rep
2023 Mar 25;42(4):112309. PMID: 36966392 -
Cell Rep
Numb/Parkin-directed mitochondrial fitness governs cancer cell fate via metabolic regulation of histone lactylation. [Abstract]2023 Jan 30;42(2):112033. PMID: 36724072 -
Cell Rep
Type I interferon/STAT1 signaling regulates UBE2M-mediated antiviral innate immunity in a negative feedback manner. [Abstract]2023 Jan 31;42(1):112002. PMID: 36662617 -
Cell Rep
METTL3 regulates m6A methylation of PTCH1 and GLI2 in Sonic hedgehog signaling to promote tumor progression in SHH-medulloblastoma. [Abstract]2022 Oct 25;41(4):111530. PMID: 36288719 -
Cell Rep
S-palmitoylation of PCSK9 induces sorafenib resistance in liver cancer by activating the PI3K/AKT pathway. [Abstract]2022 Aug 16;40(7):111194. PMID: 35977495 -
Cell Rep
An oxygen-adaptive interaction between SNHG12 and occludin maintains blood-brain barrier integrity. [Abstract]2022 Apr 12;39(2):110656. PMID: 35417709 -
Cell Rep
CLOCK regulates Drp1 mRNA stability and mitochondrial homeostasis by interacting with PUF60. [Abstract]2022 Apr 12;39(2):110635. PMID: 35417690 -
Cell Rep
MK2 promotes Tfcp2l1 degradation via β-TrCP ubiquitin ligase to regulate mouse embryonic stem cell self-renewal. [Abstract]2021 Nov 2;37(5):109949. PMID: 34731635 -
Cell Rep
DOT1L O-GlcNAcylation promotes its protein stability and MLL-fusion leukemia cell proliferation. [Abstract]2021 Sep 21;36(12):109739. PMID: 34551297 -
Cell Rep
EGY3 mediates chloroplastic ROS homeostasis and promotes retrograde signaling in response to salt stress in Arabidopsis. [Abstract]2021 Jul 13;36(2):109384. PMID: 34260941 -
Cell Rep
Macrophage K63-Linked Ubiquitination of YAP Promotes Its Nuclear Localization and Exacerbates Atherosclerosis. [Abstract]2020 Aug 4;32(5):107990. PMID: 32755583
MG-132 purchased from MedChemExpress. Usage Cited in: Cell Rep. 2020 Aug 4;32(5):107990. [Abstract]
PMs are treated with MG132 (10 μM). Endogenous YAP protein accumulated in the presence of MG132 starts from 2 h and further increases at 4 and 6 h after treatment in WT macrophages.
-
Cell Rep
The Interaction between Lymphoid Tissue Inducer-Like Cells and T Cells in the Mesenteric Lymph Node Restrains Intestinal Humoral Immunity. [Abstract]2020 Jul 21;32(3):107936. PMID: 32698011 -
Cell Rep
The Zscan4-Tet2 Transcription Nexus Regulates Metabolic Rewiring and Enhances Proteostasis to Promote Reprogramming. [Abstract]2020 Jul 14;32(2):107877. PMID: 32668244 -
Plant Physiol
N-Terminal Acetylation Stabilizes SIGMA FACTOR BINDING PROTEIN1 Involved in Salicylic Acid-Primed Cell Death. [Abstract]2020 May;183(1):358-370. PMID: 32139475 -
-
Cell Rep
BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance. [Abstract]2018 Sep 25;24(13):3513-3527.e7. PMID: 30257212 -
Clin Transl Med
USP43-mediated deubiquitination of SLC7A11 protects against LPS-induced acute lung injury by inhibiting ferroptosis. [Abstract]2026 Jul;16(7):e70718. PMID: 42381269 -
J Med Chem
Discovery of a Biased Kelch-like ECH-Associated Protein 1-p62 (Keap1-p62) Protein-Protein Interaction (PPI) Inhibitor for the Management of p62 Aberrant Hepatocellular Carcinoma. [Abstract]2026 Jun 11;69(11):13141-13164. PMID: 42216892 -
Clin Transl Med
TMEM92 shields DDX3X from TTC3-mediated degradation to confer chemoresistance in triple-negative breast cancer. [Abstract]2026 May;16(5):e70681. PMID: 42138474 -
J Med Chem
Hsp70-Targeting Chimeras Enable Dual Proteasomal and Lysosomal Degradation of Intracellular and Extracellular Proteins. [Abstract]2026 Apr 9;69(7):8417-8432. PMID: 41874277 -
J Med Chem
Chemical Space Navigation of Nitidine Leads to the Discovery of a Novel PD-L1 Degradation Agent by Targeting CSN5 for Enhanced Antitumor Immunity. [Abstract]2026 Apr 9;69(7):8237-8254. PMID: 41824767 -
Clin Transl Med
Oncofetal dual‑specificity phosphatase 9 drives stem-like properties through ERK1/2-PPARG-SCD axis-mediated lipid metabolism in hepatocellular carcinoma. [Abstract]2025 Dec;15(12):e70550. PMID: 41383134 -
J Med Chem
Discovery of DN1679 as a Potent, Orally Bioavailable, and Highly Selective CDK12/13 Dual Degrader for the Treatment of Triple-Negative Breast Cancer. [Abstract]2025 Dec 31. PMID: 41474050 -
Br J Cancer
The Rac1-USP11 feedback amplification loop: a radiation-activated engine driving radioresistance in hepatocellular carcinoma. [Abstract]2025 Nov 26. PMID: 41298816 -
J Med Chem
Discovery of Oral Natural Benzofuranoid p-Terphenyl Derivative CHNQD-03301 as a Potent Hypoxia-Inducible Factor-1α Signaling Inhibitor for Cancer Therapy. [Abstract]2025 Oct 29. PMID: 41159374 -
J Med Chem
Discovery of TNI-97 as a Highly Selective, Orally Bioavailable HDAC6 Inhibitor for the Treatment of Triple-Negative Breast Cancer. [Abstract]2025 Jul 24;68(14):14333-14356. PMID: 40607730 -
Br J Cancer
2025 Jul 15. PMID: 40665012 -
Clin Transl Med
2025 Mar;15(3):e70257. PMID: 40000422 -
J Med Chem
Dual-Targeting TrxR-EGFR Alkynyl-Au(I) Gefitinib Complex Induces Ferroptosis in Gefitinib-Resistant Lung Cancer via Degradation of GPX4. [Abstract]2025 Mar 13;68(5):5275-5291. PMID: 39968846 -
Clin Transl Med
Vitamin K-dependent gamma-carboxyglutamic acid protein 1 promotes pancreatic ductal adenocarcinoma progression through stabilizing oncoprotein KRAS and tyrosine kinase receptor EGFR. [Abstract]2025 Jan;15(1):e70191. PMID: 39843398 -
Clin Transl Med
Deubiquitination of RIPK2 by OTUB2 augments NOD2 signalling and protective effects in intestinal inflammation. [Abstract]2024 Oct;14(10):e70038. PMID: 39358938 -
Clin Transl Med
N6-methyladenosine-mediated upregulation of LNCAROD confers radioresistance in esophageal squamous cell carcinoma through stabilizing PARP1. [Abstract]2024 Oct;14(10):e70039. PMID: 39367700 -
J Med Chem
Discovery of ZLC491 as a Potent, Selective, and Orally Bioavailable CDK12/13 PROTAC Degrader. [Abstract]2024 Oct 24;67(20):18247-18264. PMID: 39388374 -
J Med Chem
Target Ligand Separation and Identification of Isoforsythiaside as a Histone Lysine-Specific Demethylase 1 Covalent Inhibitor Against Breast Cancer Metastasis. [Abstract]2024 Nov 14;67(21):19874-19888. PMID: 39499621 -
J Med Chem
2024 Aug 8;67(15):12521-12533. PMID: 39047113 -
J Med Chem
Distinct Amino Acid-Based PROTACs Target Oncogenic Kinases for Degradation in Non-Small Cell Lung Cancer (NSCLC). [Abstract]2024 Aug 22;67(16):13666-13680. PMID: 39114932 -
Clin Transl Med
Deletion of endothelial IGFBP5 protects against ischaemic hindlimb injury by promoting angiogenesis. [Abstract]2024 Jun;14(6):e1725. PMID: 38886900 -
J Med Chem
Peptide Inhibitor Targeting the Extraterminal Domain in BRD4 Potently Suppresses Breast Cancer Both In Vitro and In Vivo. [Abstract]2024 Apr 25;67(8):6658-6672. PMID: 38569135 -
Br J Cancer
GSTM3 enhances radiosensitivity of nasopharyngeal carcinoma by promoting radiation-induced ferroptosis through USP14/FASN axis and GPX4. [Abstract]2024 Mar;130(5):755-768. PMID: 38228715 -
J Med Chem
2023 Sep 14;66(17):12614-12628. PMID: 37652467 -
J Med Chem
2023 Jul 13;66(13):9184-9200. PMID: 37386884 -
Clin Transl Med
Loss of LncRNA DUXAP8 synergistically enhanced sorafenib induced ferroptosis in hepatocellular carcinoma via SLC7A11 de-palmitoylation. [Abstract]2023 Jun;13(6):e1300. PMID: 37337470 -
J Med Chem
2023 May 11;66(9):6070-6081. PMID: 36892138 -
Clin Transl Med
Alternative splicing of HSPA12A pre-RNA by SRSF11 contributes to metastasis potential of colorectal cancer. [Abstract]2022 Nov;12(11):e1113. PMID: 36394206 -
Clin Transl Med
P301S-hTau acetylates KEAP1 to trigger synaptic toxicity via inhibiting NRF2/ARE pathway: A novel mechanism underlying hTau-induced synaptic toxicities. [Abstract]2022 Aug;12(8):e1003. PMID: 35917404 -
Clin Transl Med
Both SUMOylation and ubiquitination of TFE3 fusion protein regulated by androgen receptor are the potential target in the therapy of Xp11.2 translocation renal cell carcinoma. [Abstract]2022 Apr;12(4):e797. PMID: 35452181 -
Clin Transl Med
c-Myb facilitates immune escape of esophageal adenocarcinoma cells through the miR-145-5p/SPOP/PD-L1 axis. [Abstract]2021 Sep;11(9):e464. PMID: 34586738 -
Clin Transl Med
FABP4 deactivates NF-κB-IL1α pathway by ubiquitinating ATPB in tumor-associated macrophages and promotes neuroblastoma progression. [Abstract]2021 Apr;11(4):e395. PMID: 33931964 -
Clin Transl Med
A selected small molecule prevents inflammatory osteolysis through restraining osteoclastogenesis by modulating PTEN activity. [Abstract]2020 Dec;10(8):e240. PMID: 33377656 -
Neural Regen Res
TP53 drives neuronal ferroptosis by promoting KLHL4-mediated SLC7A11 ubiquitination after spinal cord injury. [Abstract]2025 Sep 3. PMID: 40903977 -
Anal Chem
Combining the NanaPPI Toolbox and AI-Driven Virtual Inhibitor Screening for the p53-MDM2 Interaction. [Abstract]2025 Jul 29;97(29):15687-15697. PMID: 40624834 -
Neural Regen Res
The Cullin3-Ring E3 ubiquitin ligase complex and USP14 regulate spastin-mediated microtubule severing and promotion of neurite outgrowth. [Abstract]2026 Apr 1;21(4):1641-1651. PMID: 40587243 -
Antioxidants (Basel)
Alpha-Lipoic Acid Inhibits IFN-γ-Induced PD-L1 Expression in Prostate Cancer Cells and Enhances T-Cell-Mediated Anti-Tumor Cytotoxicity. [Abstract]2026 Mar 25;15(4):413. PMID: 42072056 -
Sci Signal
USP5 deubiquitylates and stabilizes FcεRIγ to enhance IgE-induced mast cell activation and allergic inflammation. [Abstract]2025 Jul 29;18(897):eadr3411. PMID: 40729432 -
Sci Signal
The kinase PLK1 promotes Hedgehog signaling-dependent resistance to the antiandrogen enzalutamide in metastatic prostate cancer. [Abstract]2025 Mar 18;18(878):eadi5174. PMID: 40100956 -
Sci Signal
Cooperative transcriptional regulation by ATAF1 and HY5 promotes light-induced cotyledon opening in Arabidopsis thaliana. [Abstract]2024 Jan 2;17(817):eadf7318. PMID: 38166030 -
Antioxidants (Basel)
Genipin Attenuates Diabetic Cognitive Impairment by Reducing Lipid Accumulation and Promoting Mitochondrial Fusion via FABP4/Mfn1 Signaling in Microglia. [Abstract]2022 Dec 29;12(1):74. PMID: 36670935 -
Sci Signal
Degradation of HDAC10 by autophagy promotes IRF3-mediated antiviral innate immune responses. [Abstract]2022 Dec 20;15(765):eabo4356. PMID: 36538592 -
Int J Nanomedicine
IR-820@NBs Combined with MG-132 Enhances the Anti-Hepatocellular Carcinoma Effect of Sonodynamic Therapy. [Abstract]2023 Nov 1:18:6199-6212. PMID: 37933299 -
Oncogenesis
The central precocious puberty-associated gene MKRN3 is a tumor suppressor regulating CSDE1 ubiquitination in ovarian cancer. [Abstract]2026 May 27. PMID: 42204155 -
Oncogenesis
Stabilization of FASN by USP5-mediated deubiquitination promotes hepatocellular carcinoma progression. [Abstract]2025 Nov 28;14(1):46. PMID: 41315248 -
J Cell Biol
2025 Oct 6;224(10):e202412224. PMID: 40728580 -
J Cell Biol
Rhythmic TDP-43 affects RNA splicing of USP13, resulting in alteration of BMAL1 ubiquitination. [Abstract]2025 May 5;224(5):e202405142. PMID: 40202498 -
Mol Med
AdipoR1 enhances the radiation resistance via ESR1/CCNB1IP1/cyclin B1 pathway in hepatocellular carcinoma cells. [Abstract]2025 Jan 23;31(1):21. PMID: 39849382 -
Mol Med
New perspectives on YTHDF2 O-GlcNAc modification in the pathogenesis of intervertebral disc degeneration. [Abstract]2024 Oct 18;30(1):180. PMID: 39425013 -
Oncogenesis
USP21-mediated G3BP1 stabilization accelerates proliferation and metastasis of esophageal squamous cell carcinoma via activating Wnt/β-Catenin signaling. [Abstract]2024 Jun 21;13(1):23. PMID: 38906857 -
Mol Med
ECHDC2 inhibits the proliferation of gastric cancer cells by binding with NEDD4 to degrade MCCC2 and reduce aerobic glycolysis. [Abstract]2024 May 23;30(1):69. PMID: 38783226 -
Mol Med
2024 Apr 15;30(1):50. PMID: 38622518 -
Mol Med
Mechanism of RhoA regulating benign prostatic hyperplasia: RhoA-ROCK-β-catenin signaling axis and static & dynamic dual roles. [Abstract]2023 Oct 20;29(1):139. PMID: 37864185 -
Mol Med
Histone acetyltransferase P300 deficiency promotes ferroptosis of vascular smooth muscle cells by activating the HIF-1α/HMOX1 axis. [Abstract]2023 Jul 6;29(1):91. PMID: 37415103 -
J Cell Biol
Endothelial depletion of Atg7 triggers astrocyte-microvascular disassociation at blood-brain barrier. [Abstract]2023 May 1;222(5):e202103098. PMID: 36995368 -
Oncogenesis
Spindle function and Wnt pathway inhibition by PBX1 to suppress tumor progression via downregulating DCDC2 in colorectal cancer. [Abstract]2023 Feb 4;12(1):3. PMID: 36739270 -
Elife
Zbtb14 regulates monocyte and macrophage development through inhibiting pu.1 expression in zebrafish. [Abstract]2022 Oct 7;11:e80760. PMID: 36205309 -
Elife
MARCH5 mediates NOXA-dependent MCL1 degradation driven by kinase inhibitors and integrated stress response activation. [Abstract]2020 Jun 2;9:e54954. PMID: 32484436 -
Oncogenesis
ACSL4 promotes hepatocellular carcinoma progression via c-Myc stability mediated by ERK/FBW7/c-Myc axis. [Abstract]2020 Apr 29;9(4):42. PMID: 32350243 -
Oncogenesis
The long non-coding RNA PIK3CD-AS2 promotes lung adenocarcinoma progression via YBX1-mediated suppression of p53 pathway. [Abstract]2020 Mar 12;9(3):34. PMID: 32165621 -
Phytother Res
20(R)-Ginsenoside Rg3 Suppresses P-Glycoprotein-Mediated Multidrug Resistance in A549/Taxol Cells by Targeting MDM2-IκB-α Signaling Axis. [Abstract]2026 Apr;40(4):1935-1950. PMID: 41630373 -
Phytother Res
Harringtonine Elicits Ferroptosis by Regulating SYVN1-Mediated FASN Ubiquitination for Evoking Anti-Lung Cancer Efficacy. [Abstract]2025 Dec 12. PMID: 41388624 -
Phytother Res
Fresh Ginseng Reduces Sphingosine Secretion Through Ubiquitin Degradation of SPTLC2 to Antagonize the Progression of Non-Small Cell Lung Cancer. [Abstract]2025 Nov 20. PMID: 41265852 -
Phytother Res
Oridonin Ameliorates Metabolic-Dysfunction-Associated Fatty Liver Disease by Inhibiting PANoptosis via Modulating SIRT2/NLRP3 Pathway. [Abstract]2025 Aug 6. PMID: 40765411 -
Commun Med (Lond)
Targeted protein degraders of SARS-CoV-2 Mpro are more active than enzymatic inhibition alone with activity against nirmatrelvir resistant virus. [Abstract]2025 Apr 26;5(1):140. PMID: 40287552 -
Plant Cell Environ
Non-Specific Lipid Transfer Protein StLTP6 Promotes Virus Infection by Inhibiting Jasmonic Acid Signalling Pathway in Response to PVS TGB1. [Abstract]2025 Mar;48(3):2343-2356. PMID: 39601376 -
Phytother Res
Capsaicin inhibits the stemness of anaplastic thyroid carcinoma cells by triggering autophagy-lysosome mediated OCT4A degradation. [Abstract]2022 Feb;36(2):938-950. PMID: 35076979 -
Phytother Res
The alleviative effect of flavonol-type Nrf2 activator rhamnazin from Physalis alkekengi L. var. franchetii (Mast.) Makino on pulmonary disorders. [Abstract]2022 Apr;36(4):1692-1707. PMID: 35129872 -
Cell Mol Life Sci
TRIM47 drives metabolic reprogramming and tumor progression in Nasopharyngeal Carcinoma via K48-linked ubiquitination and degradation of SDHB. [Abstract]2026 Jun 6. PMID: 42250096 -
Cell Mol Life Sci
Obesity-induced oleic acid metabolic dysregulation may exacerbate osteoarthritis through the degradation of SOX9. [Abstract]2026 May 22. PMID: 42171703 -
J Agric Food Chem
Citrulline Modulates Milk Fat Metabolism via the RTN3-FABP5 Axis in Bovine Mammary Epithelial Cells. [Abstract]2026 Apr 8;74(13):11079-11091. PMID: 41889269 -
-
Cell Mol Life Sci
2025 Nov 19;82(1):408. PMID: 41258568 -
J Agric Food Chem
2025 Oct 15;73(41):26060-26072. PMID: 41043107 -
J Agric Food Chem
Capsaicin Inhibits Ferroptosis through Facilitating SYVN1-Mediated Ubiquitination and Degradation of ACSL4. [Abstract]2025 Jul 23;73(29):18437-18447. PMID: 40658633 -
EMBO Rep
PCAF-mediated acetylation regulates RAD51 dynamic localization on chromatin during HR repair. [Abstract]2025 Aug;26(16):4100-4123. PMID: 40664718 -
Cell Biosci
2025 Feb 5;15(1):14. PMID: 39910656 -
Cell Mol Life Sci
Dnajc5b contributes to male fertility by maintaining the mitochondrial functions and autophagic homeostasis during spermiogenesis. [Abstract]2025 Feb 3;82(1):69. PMID: 39899042 -
Cell Mol Life Sci
rTM reprograms macrophages via the HIF-1α/METTL3/PFKM axis to protect mice against sepsis. [Abstract]2024 Nov 16;81(1):456. PMID: 39549085 -
EMBO Rep
RNF144B negatively regulates antiviral immunity by targeting MDA5 for autophagic degradation. [Abstract]2024 Oct;25(10):4594-4624. PMID: 39285245 -
EMBO Rep
2024 Oct;25(10):4337-4357. PMID: 39242776 -
J Agric Food Chem
2024 Mar 27;72(12):6178-6188. PMID: 38483540 -
Cell Mol Life Sci
Silencing circSERPINE2 restrains mesenchymal stem cell senescence via the YBX3/PCNA/p21 axis. [Abstract]2023 Oct 13;80(11):325. PMID: 37831180 -
EMBO Rep
ATAD1 inhibits hepatitis C virus infection by removing the viral TA-protein NS5B from mitochondria. [Abstract]2023 Nov 6;24(11):e56614. PMID: 37789674 -
EMBO Rep
GAPDH facilitates homologous recombination repair by stabilizing RAD51 in an HDAC1-dependent manner. [Abstract]2023 Aug 3;24(8):e56437. PMID: 37306047 -
Cell Biosci
Enhanced liquidity of p62 droplets mediated by Smurf1 links Nrf2 activation and autophagy. [Abstract]2023 Feb 21;13(1):37. PMID: 36810259 -
Cell Biosci
VHL-recruiting PROTAC attenuates renal fibrosis and preserves renal function via simultaneous degradation of Smad3 and stabilization of HIF-2α. [Abstract]2022 Dec 19;12(1):203. PMID: 36536448 -
Cell Biosci
Inhibition of sphingolipid metabolism in osteosarcoma protects against CD151-mediated tumorigenicity. [Abstract]2022 Oct 8;12(1):169. PMID: 36209197 -
Cell Biosci
Arsenic nano complex induced degradation of YAP sensitized ESCC cancer cells to radiation and chemotherapy. [Abstract]2020 Dec 22;10(1):146. PMID: 33353561 -
Cell Biosci
KLHL18 inhibits the proliferation, migration, and invasion of non-small cell lung cancer by inhibiting PI3K/PD-L1 axis activity. [Abstract]2020 Nov 27;10(1):139. PMID: 33292627 -
JCI Insight
Therapeutic targeting of YOD1 disrupts the PAX-FOXO1-N-Myc feedback loop in rhabdomyosarcoma. [Abstract]2025 Dec 16:e193221. PMID: 41401084 -
Ecotoxicol Environ Saf
Bisphenol A exacerbates osteoblast ferroptosis via the p53/SLC7A11 axis: A novel mechanistic insight into environmental osteoporosis pathogenesis. [Abstract]2025 Dec 13:309:119560. PMID: 41391364 -
Antioxid Redox Signal
Kindlin-2/Otub1/Slc7a11 Axis Improved Cardiac Ischemia Reperfusion Injury by Inhibiting Cardiomyocyte Ferroptosis. [Abstract]2025 Oct 13. PMID: 41081614 -
JCI Insight
Deletion of SH2D5 alleviates epileptic seizures and NMDAR expression via autophagic degradation of STAT1. [Abstract]2025 Aug 22;10(16):e191347. PMID: 40857409 -
Ecotoxicol Environ Saf
Phthalates promote lenvatinib resistance in hepatocellular carcinoma through the HPX-MAPK pathway. [Abstract]2025 Aug 25:303:118932. PMID: 40858030 -
Antioxid Redox Signal
α-Tocopherol Ameliorates Liver Fibrosis by Inhibiting Hepatic Stellate Cell Activation by Promoting Nrf2 Nuclear Translocation. [Abstract]2025 Aug 1. PMID: 40762285 -
Hepatol Int
USP13 promotes hepatic stellate cells activation and aggravates liver fibrosis through deubiquitinating SMAD3. [Abstract]2025 Jul 28. PMID: 40719972 -
JCI Insight
2025 Apr 29:e190838. PMID: 40299657 -
Antioxid Redox Signal
Exosomal miR-196a-5p Secreted by Bone Marrow Mesenchymal Stem Cells Inhibits Ferroptosis and Promotes Drug Resistance of Acute Myeloid Leukemia. [Abstract]2025 Jun;42(16-18):933-953. PMID: 40388337 -
Hepatol Int
TRIM28 functions as SUMO ligase to SUMOylate TRAF6 and regulate NF-κB activation in HBV-replicating cells. [Abstract]2025 Jun;19(3):529-546. PMID: 39920527 -
Antioxid Redox Signal
Sestrin 2 deficiency exacerbates noise-induced cochlear injury through inhibiting ULK1/Parkin-mediated mitophagy. [Abstract]2023 Jan;38(1-3):115-136. PMID: 35708118 -
-
Mol Ther Nucleic Acids
HFD-induced TRAF6 upregulation promotes liver cholesterol accumulation and fatty liver development via EZH2-mediated miR-429/PPARα axis. [Abstract]2021 Jan 26:24:711-727. PMID: 33996254 -
Ecotoxicol Environ Saf
Heavy ion radiation-induced DNA damage mediates apoptosis via the Rpl27a-Rpl5-MDM2-p53/E2F1 signaling pathway in mouse spermatogonia. [Abstract]2020 Sep 15;201:110831. PMID: 32535367 -
Mol Ther Nucleic Acids
lncRNA SLC7A11-AS1 Promotes Chemoresistance by Blocking SCFβ-TRCP-Mediated Degradation of NRF2 in Pancreatic Cancer. [Abstract]2020 Mar 6;19:974-985. PMID: 32036249 -
Antioxid Redox Signal
Tanshinone IIA Activates Nuclear Factor-Erythroid 2-Related Factor 2 to Restrain Pulmonary Fibrosis via Regulation of Redox Homeostasis and Glutaminolysis. [Abstract]2019 May 20;30(15):1831-1848. PMID: 30105924
MG-132 purchased from MedChemExpress. Usage Cited in: Antioxid Redox Signal. 2019 May 20;30(15):1831-1848. [Abstract]
Tan-IIA increases the endogenous induction of Nrf2 induction and this effect is further enhanced by cotreatment with the proteasome inhibitor MG-132.
-
JCI Insight
Inhibiting neddylation modification alters mitochondrial morphology and reprograms energy metabolism in cancer cells. [Abstract]2019 Feb 21;4(4). pii: 121582. PMID: 30668548 -
Cancer Cell Int
INHBA promotes chemoresistance in pancreatic cancer by enhancing CTPS1 stability and mediating pyrimidine metabolism. [Abstract]2025 Nov 14;25(1):403. PMID: 41239468 -
Cancer Cell Int
FBXL18 promotes endometrial carcinoma progression via destabilizing DUSP16 and thus activating JNK signaling pathway. [Abstract]2025 May 17;25(1):180. PMID: 40382593 -
Cancer Cell Int
2024 Jul 7;24(1):238. PMID: 38973004 -
Cancer Cell Int
miR-181c-5p/DERL1 pathway controls breast cancer progression mediated by TRAF6-linked K63 ubiquitination of AKT. [Abstract]2024 Jun 10;24(1):204. PMID: 38858669 -
Cancer Cell Int
NEK2 contributes to radioresistance in esophageal squamous cell carcinoma by inducing protective autophagy via regulating TRIM21. [Abstract]2024 May 23;24(1):179. PMID: 38783335 -
Cancer Cell Int
CDK5 promotes apoptosis and attenuates chemoresistance in gastric cancer via E2F1 signaling. [Abstract]2023 Nov 21;23(1):286. PMID: 37990321 -
Cancer Cell Int
Annexin A1 promotes the progression of bladder cancer via regulating EGFR signaling pathway. [Abstract]2022 Jan 6;22(1):7. PMID: 34991599 -
Cancer Cell Int
NEDD4L-induced ubiquitination mediating UBE2T degradation inhibits progression of lung adenocarcinoma via PI3K-AKT signaling. [Abstract]2021 Nov 27;21(1):631. PMID: 34838005 -
Cancer Cell Int
2020 Dec 7;20(1):587. PMID: 33372599 -
J Mol Cell Biol
Emerging role of FUS in TGFB1 and COL1A1 transcription dependent on GADD45B to induce NASH-fibrosis. [Abstract]2025 Dec 18:mjaf049. PMID: 41410503 -
J Mol Cell Biol
The inwardly rectifying potassium channel KCNJ12 regulates the stemness of hepatocellular carcinoma cells through the Wnt/β-catenin pathway. [Abstract]2025 Dec 2:mjaf048. PMID: 41328864 -
Cell Biol Toxicol
ZMIZ1 lactylation induces tamoxifen resistance in breast cancer through increasing transcriptional activity of Nanog to impact cell stemness and cholesterol uptake. [Abstract]2025 Jul 16;41(1):117. PMID: 40670831 -
Eur J Med Chem
Targeting both wild-type EGFR and its drug-resistant mutants with erlotinib-aptamer conjugates. [Abstract]2025 Jun 14:296:117871. PMID: 40554308 -
Cell Biol Toxicol
The key regulator circPDE3B promotes arsenic-induced bladder carcinogenesis by affecting STAT3 and NF-κB stability. [Abstract]2025 May 28;41(1):91. PMID: 40437145 -
Cell Biol Toxicol
Neutrophil-derived heparin-binding protein increases endothelial permeability in acute lung injury by promoting TRIM21 and the ubiquitination of P65. [Abstract]2025 Mar 5;41(1):55. PMID: 40045003 -
Cell Biol Toxicol
2024 Nov 6;40(1):94. PMID: 39503881 -
Cell Biol Toxicol
Nrf2/NRF1 signaling activation and crosstalk amplify mitochondrial biogenesis in the treatment of triptolide-induced cardiotoxicity using calycosin. [Abstract]2024 Dec 20;41(1):2. PMID: 39707073 -
Cell Biol Toxicol
RNF38 promotes gilteritinib resistance in acute myeloid leukemia via inducing autophagy by regulating ubiquitination of LMX1A. [Abstract]2024 Nov 28;40(1):105. PMID: 39604755 -
Cell Biol Toxicol
NPR1 promotes cisplatin resistance by inhibiting PARL-mediated mitophagy-dependent ferroptosis in gastric cancer. [Abstract]2024 Oct 30;40(1):93. PMID: 39476297 -
Eur J Med Chem
Targeting oncogenic transcriptional factor c-myc by oligonucleotide PROTAC for the treatment of hepatocellular carcinoma. [Abstract]2024 Dec 15:280:116978. PMID: 39447458 -
-
Cell Biol Toxicol
Proteasome activity inhibition mediates endoplasmic reticulum stress-apoptosis in triptolide/lipopolysaccharide-induced hepatotoxicity. [Abstract]2024 Jul 29;40(1):60. PMID: 39073694 -
Cell Biol Toxicol
Deoxynivalenol induces m6A-mediated upregulation of p21 and growth arrest of mouse hippocampal neuron cells in vitro. [Abstract]2024 Jun 4;40(1):41. PMID: 38833095 -
Transl Res
Genetic and pharmacological targeting of XBP1 alleviates hepatic ischemia reperfusion injury by enhancing FoxO1-dependent mitophagy. [Abstract]2024 Oct:272:162-176. PMID: 38494125 -
J Mol Cell Biol
2023 Aug 3;15(3):mjad019. PMID: 36948605 -
Eur J Med Chem
2020 Nov 15;206:112708. PMID: 32810752 -
Eur J Med Chem
Discovery of a Keap1-dependent peptide PROTAC to knockdown Tau by ubiquitination-proteasome degradation pathway. [Abstract]2018 Feb 25:146:251-259. PMID: 29407955 -
Stress Biol
Reversible S-palmitoylation of C4 protein encoded by TYLCCxV orchestrates geminiviral pathogenesis. [Abstract]2026 May 6;6(1):35. PMID: 42086987 -
Int J Mol Med
2026 Jun;57(6):141. PMID: 41891968 -
Stress Biol
Areca palm velarivirus 1 encoded CP suppresses antiviral RNA silencing by mediating the autophagic degradation of SGS3 and disrupting the SGS3-RDR6 interaction. [Abstract]2026 Jan 4;6(1):1. PMID: 41485154 -
Int J Mol Med
FBXO22 promotes hepatocellular carcinoma progression via paracrine myo‑inositol‑induced M2‑type polarization of macrophages. [Abstract]2026 Feb;57(2):36. PMID: 41347800 -
Neurosci Bull
Complement C3a Suppresses Spinal Cord Neural Stem Cell Activation by Inhibiting UCHL1 via the NF-κB p65/Nrf2 Pathway. [Abstract]2025 Oct 3. PMID: 41044292 -
Int J Mol Med
SDF2 promotes glioma progression via GRP78‑mediated ERAD and copper homeostasis disruption. [Abstract]2025 Oct;56(4):154. PMID: 40709395 -
Int J Mol Med
Proteasome inhibitors decrease paclitaxel‑induced cell death in nasopharyngeal carcinoma with the accumulation of CDK1/cyclin B1. [Abstract]2021 Oct;48(4):193. PMID: 34435645 -
Chin Med
Evodiamine induces ferroptosis in prostate cancer cells by inhibiting TRIM26-mediated stabilization of GPX4. [Abstract]2025 May 26;20(1):71. PMID: 40420092 -
Plant J
The SmMYC2-SmMYB36 complex is involved in methyl jasmonate-mediated tanshinones biosynthesis in Salvia miltiorrhiza. [Abstract]2024 Jul;119(2):746-761. PMID: 38733631 -
J Invest Dermatol
Involvement of p53 Acetylation in Growth Suppression of Cutaneous T-Cell Lymphomas Induced by HDAC Inhibition. [Abstract]2020 Oct;140(10):2009-2022.e4. PMID: 32119867 -
J Exp Bot
Chalcone synthase is ubiquitinated and degraded via interactions with a RING-H2 protein in petals of Paeonia 'He Xie'. [Abstract]2019 Sep 24;70(18):4749-4762. PMID: 31106836
MG-132 purchased from MedChemExpress. Usage Cited in: J Exp Bot. 2019 Sep 24;70(18):4749-4762. [Abstract]
Cell-free degradation assay of recombinant His-PhCHS protein. Recombinant His- PhCHS is purified from Escherichia coli incubated with petal crude proteins at stages and treated with specific 26S proteasome inhibitor MG132 at various time intervals. Western blot analysis was conducted using an anti-His antibody and anti-β-actin protein concentration was used as a loading control.
-
Acta Neuropathol Commun
Age-dependent changes in synaptic plasticity enhance tau oligomerization in the mouse hippocampus. [Abstract]2017 Sep 6;5(1):67. PMID: 28874186 -
Biochem Pharmacol
Targeting neuropilin-1 attenuates 4-hydroxytamoxifen-induced stemness and sensitizes ERα-re-expressing TNBC to tamoxifen. [Abstract]2026 Jun 12;251(Pt 2):118163. PMID: 42285368 -
Acta Physiol
GRP94 Promotes the Fusion of Mouse C2C12 Myoblasts and the Regeneration of Skeletal Muscle Injuries Through Myomaker. [Abstract]2026 Jun;242(6):e70236. PMID: 42057593 -
Biochem Pharmacol
Duvelisib upregulates p27 expression and leads to intestinal damage via the NEDD4L/CK1ε axis. [Abstract]2026 Mar 28;250(Pt 1):117939. PMID: 41905427 -
Biochem Pharmacol
RNF144B deficiency aggravated neuroinflammatory response induced by cerebral ischemic stroke via regulating TRAF3 ubiquitination. [Abstract]2026 Mar 27;250(Pt 1):117936. PMID: 41903812 -
Biochem Pharmacol
Oroxylin A attenuates sepsis-associated coagulopathy by targeting the ALOX12-lipid peroxidation. [Abstract]2026 Jun:248:117862. PMID: 41794265 -
Biochem Pharmacol
Momordin Ic suppresses breast cancer growth by targeting ACTL8‑dependent glutamine metabolism and PI3K/AKT/mTOR-MYC. [Abstract]2026 May:247:117761. PMID: 41621692 -
Acta Physiol
Activation of TGR5 Alleviates Renal Fibrosis by Promoting NEDD4L-Mediated p-Smad2/3 Ubiquitination. [Abstract]2026 Feb;242(2):e70163. PMID: 41536162 -
Biochem Pharmacol
Targeted degradation of CD24 by a transferrin receptor-engaging bispecific degrader enhances antitumor immunity. [Abstract]2026 Apr:246:117721. PMID: 41558617 -
Biochem Pharmacol
Deubiquitinase USP5 promotes acute myeloid leukemia through C2CD5 stabilization and PI3K/AKT/mTOR/HIF-1α-driven glycolysis. [Abstract]2026 Feb:244:117591. PMID: 41344512 -
Biochem Pharmacol
Circ_0057582 inhibits breast cancer progression via hnRNPF/YAP/SOX9 axis and M2 polarization in TAMs by autophagic degradation of ISG15. [Abstract]2026 Jan;243(Pt 2):117543. PMID: 41241017 -
Biochem Pharmacol
PCDH7 promotes EMT and chemoresistance by stabilizing ZEB1 via inhibition of TRIM26-mediated ubiquitination in lung adenocarcinoma. [Abstract]2026 Jan;243(Pt 2):117554. PMID: 41271034 -
Biochem Pharmacol
Tauroursodeoxycholic acid ameliorates palmitic acid induced endoplasmic reticulum stress and impaired autophagy via IRE1- XBP1-FoxO1 pathway in KGN cells. [Abstract]2025 Dec;242(Pt 4):117377. PMID: 41043520 -
Biochem Pharmacol
FSTL1 promotes osteoclast differentiation and Accelerates periprosthetic osteolysis via PP2A Cα-Mediated activation of the JNK signaling pathway. [Abstract]2025 Oct 21;242(Pt 4):117450. PMID: 41130306 -
Neurobiol Dis
2025 Oct 15:215:107090. PMID: 40930427 -
Biochem Pharmacol
Lasiokaurin suppresses breast cancer growth by blocking autophagic flux and regulating cellular energy homeostasis. [Abstract]2025 Aug 7;242(Pt 3):117212. PMID: 40782951 -
Breast Cancer Res
Erdafitinib inhibits the tumorigenicity of MDA-MB-231 triple-negative breast cancer cells by inducing TRIM25/ubiquitin-dependent degradation of FGFR4. [Abstract]2025 Jul 9;27(1):128. PMID: 40635078 -
Biochem Pharmacol
Nodosin alleviates cholestatic liver injury by activation of SIRT1/FXR signaling pathway and inhibition of hepatic inflammation. [Abstract]2025 Jul 30;242(Pt 2):117200. PMID: 40749957 -
Biochem Pharmacol
Discovery of a potent BRD4 PROTAC and evaluation of its bioactivity in breast cancer cell lines. [Abstract]2025 Jul 12:241:117159. PMID: 40659131 -
Biochem Pharmacol
2025 Jul 26:241:117191. PMID: 40721007 -
Biochem Pharmacol
Dexmedetomidine alleviates renal ischemia reperfusion injury via suppressing SLC2A1-mediated glycolysis. [Abstract]2025 Jul 12:241:117166. PMID: 40659130 -
Biochem Pharmacol
CREM-activated LTBP1 transcription promotes radioresistance and immune escape in triple-negative breast cancer. [Abstract]2025 Jul 16:241:117172. PMID: 40675224 -
Biochem Pharmacol
Promoting ubiquitin-dependent Drp1 degradation contributes to the protective effect of Astragalin against diabetic renal fibrosis. [Abstract]2025 Jul 12:241:117158. PMID: 40659133 -
Biochem Pharmacol
2025 Jun 23:117078. PMID: 40562127 -
Biochem Pharmacol
FATS alleviates ulcerative colitis by inhibiting M1 macrophage polarization and aerobic glycolysis through promoting the ubiquitination-mediated degradation of HIF-1α. [Abstract]2025 Jun 19:117053. PMID: 40543763 -
Biochem Pharmacol
Triflupromazine and tranylcypromine alleviate primary cisplatin resistance in lung adenocarcinoma by promoting LDHA-mediated AMBRA1 ubiquitination. [Abstract]2025 Jun 23:117073. PMID: 40562117 -
Biochem Pharmacol
ALKBH5 reverses romidepsin-mediated anti-multiple myeloma activity via regulation of m6A modification of FOXM1. [Abstract]2025 May 24:239:116998. PMID: 40419197 -
Biochem Pharmacol
Discovery of targeting USP10-mediated proline metabolism arrangement to inhibit hepatocellular carcinoma progression. [Abstract]2025 Mar 28:116904. PMID: 40158816 -
Biochem Pharmacol
2025 Apr 6:116925. PMID: 40199403 -
Biochem Pharmacol
Discovery of Bi-magnolignan as a novel BRD4 inhibitor inducing apoptosis and DNA damage for cancer therapy. [Abstract]2025 May:235:116843. PMID: 40024351 -
Biochem Pharmacol
Inhibition of ferroptosis protects intrahepatic bile duct cells against ischemia-reperfusion and bile salt toxicity. [Abstract]2025 Jan 29:116788. PMID: 39890033 -
Biochem Pharmacol
WWOX-mediated p53/SAT1 and NRF2/FPN1 axis contribute to toosendanin-induced ferroptosis in hepatocellular carcinoma. [Abstract]2025 Jan 31:116790. PMID: 39894307 -
Cell Prolif
Crotonylation of MCM6 enhances chemotherapeutics sensitivity of breast cancer via inducing DNA replication stress. [Abstract]2024 Oct 30:e13759. PMID: 39477811 -
Biochem Pharmacol
E3 ubiquitin ligase ITCH-mediated proteasomal degradation of WBP2 sensitizes breast cancer cells to chemotherapy through restraining AMOTL2/c-JUN axis. [Abstract]2024 Dec 19:116720. PMID: 39709035 -
Biochem Pharmacol
USP10-mediated deubiquitination of NR3C1 regulates bone homeostasis by controlling CST3 expression. [Abstract]2024 Sep 3:116519. PMID: 39236936 -
Biochem Pharmacol
A novel L-shaped ortho-quinone analog suppresses glioblastoma progression by targeting acceleration of AR degradation and regulating PI3K/AKT pathway. [Abstract]2024 Jun 27:116398. PMID: 38944395 -
Cell Prolif
MCL restrained ROS/AKT/ASAH1 pathway to therapy tamoxifen resistance breast cancer by stabilizing NRF2. [Abstract]2024 Jun 26:e13700. PMID: 38924190 -
Biochem Pharmacol
The deubiquitinase OTUD1 deubiquitinates TIPE2 and plays a protective role in sepsis-induced lung injury by targeting TAK1-mediated MAPK and NF-κB signaling. [Abstract]2024 Jul 10:116418. PMID: 38996928 -
Biochem Pharmacol
Ubiquitin-specific peptidase 15 regulates the TFAP4/PCGF1 axis facilitating liver metastasis of colorectal cancer and cell stemness. [Abstract]2024 May 25:116319. PMID: 38801926 -
Breast Cancer Res
TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mTOR signaling axis by binding to MYH9. [Abstract]2024 Mar 19;26(1):48. PMID: 38504374 -
Breast Cancer Res
UCHL1 contributes to insensitivity to endocrine therapy in triple-negative breast cancer by deubiquitinating and stabilizing KLF5. [Abstract]2024 Mar 11;26(1):44. PMID: 38468288 -
Biochem Pharmacol
WP1066, a small molecule inhibitor of STAT3, chemosensitizes paclitaxel-resistant ovarian cancer cells to paclitaxel by simultaneously inhibiting the activity of STAT3 and the interaction of STAT3 with Stathmin. [Abstract]2024 Mar:221:116040. PMID: 38311257 -
Breast Cancer Res
Protein disulfide isomerase family member 4 promotes triple-negative breast cancer tumorigenesis and radiotherapy resistance through JNK pathway. [Abstract]2024 Jan 2;26(1):1. PMID: 38167446 -
Immun Ageing
Circular RNA ZBTB46 depletion alleviates the progression of Atherosclerosis by regulating the ubiquitination and degradation of hnRNPA2B1 via the AKT/mTOR pathway. [Abstract]2023 Nov 21;20(1):66. PMID: 37990246 -
Biochem Pharmacol
Galectin-7 promotes cisplatin efficacy by facilitating apoptosis and G3BP1 degradation in cervical cancer. [Abstract]2023 Nov:217:115834. PMID: 37778447 -
Biochem Pharmacol
Curcumin reduces paclitaxel resistance in ovarian carcinoma cells by upregulating SNIP1 and inhibiting NFκB activity. [Abstract]2023 Jun:212:115581. PMID: 37146834 -
Breast Cancer Res
S100A6 inhibits MDM2 to suppress breast cancer growth and enhance sensitivity to chemotherapy. [Abstract]2023 May 22;25(1):55. PMID: 37217945 -
Biochem Pharmacol
Lenvatinib inhibited HCC cell migration and invasion through regulating the transcription and ubiquitination of UHRF1 and DNMT1. [Abstract]2023 Apr:210:115489. PMID: 36893815 -
Biochem Pharmacol
Inhibition of deubiquitinase USP28 attenuates cyst growth in autosomal dominant polycystic kidney disease. [Abstract]2023 Jan:207:115355. PMID: 36442624 -
Cell Prolif
Novel lncRNA-prader willi/angelman region RNA, SNRPN neighbour (PWARSN) aggravates tubular epithelial cell pyroptosis by regulating TXNIP via dual way in diabetic kidney disease. [Abstract]2023 Feb;56(2):e13349. PMID: 36316968 -
Biochem Pharmacol
Bortezomib inhibits NLRP3 inflammasome activation and NF-κB pathway to reduce psoriatic inflammation. [Abstract]2022 Dec:206:115326. PMID: 36326534 -
Biochem Pharmacol
Acid-sensitive ion channel 1a mediates osteoarthritis chondrocyte senescence by promoting Lamin B1 degradation. [Abstract]2022 Aug:202:115107. PMID: 35643339 -
Biochem Pharmacol
Gelsevirine improves age-related and surgically induced osteoarthritis in mice by reducing STING availability and local inflammation. [Abstract]2022 Apr:198:114975. PMID: 35202579 -
Breast Cancer Res
Triptonide effectively inhibits triple-negative breast cancer metastasis through concurrent degradation of Twist1 and Notch1 oncoproteins. [Abstract]2021 Dec 18;23(1):116. PMID: 34922602 -
Biochem Pharmacol
Canagliflozin inhibits p-gp function and early autophagy and improves the sensitivity to the antitumor effect of doxorubicin. [Abstract]2020 May;175:113856. PMID: 32061772 -
Biochem Pharmacol
Catalpol suppresses osteoclastogenesis and attenuates osteoclast-derived bone resorption by modulating PTEN activity. [Abstract]2020 Jan;171:113715. PMID: 31751538 -
Cell Prolif
GIT1 regulates angiogenic factor secretion in bone marrow mesenchymal stem cells via NF-κB/Notch signalling to promote angiogenesis. [Abstract]2019 Nov;52(6):e12689. PMID: 31502302 -
Cell Prolif
Reduced USP33 expression in gastric cancer decreases inhibitory effects of Slit2-Robo1 signalling on cell migration and EMT. [Abstract]2019 May;52(3):e12606. PMID: 30896071 -
Biochem Pharmacol
PR-957, a selective immunoproteasome inhibitor, reactivates latent HIV-1 through p-TEFb activation mediated by HSF-1. [Abstract]2018 Oct:156:511-523. PMID: 30170098
MG-132 purchased from MedChemExpress. Usage Cited in: Biochem Pharmacol. 2018 Oct:156:511-523. [Abstract]
The accumulated poly-ubiquitinated protein is detected by Western blotting after J-Lat 10.6 cells are treated with DMSO, PR-957 (100 nM), PR-957 (150 nM) or MG132 (500 nM) for 48 h.
-
Cell Prolif
2018 Aug;51(4):e12451. PMID: 29484762
MG-132 purchased from MedChemExpress. Usage Cited in: Cell Prolif. 2018 Aug;51(4):e12451. [Abstract]
Immunoblot analysis of CDK4 in cells treated with 4 μM of CGN for 24 hours in the presence and absence of MG132.
-
Biochem Pharmacol
Lanatoside C inhibits cell proliferation and induces apoptosis through attenuating Wnt/β-catenin/c-Myc signaling pathway in human gastric cancer cell. [Abstract]2018 Apr:150:280-292. PMID: 29475060 -
J Gastroenterol
RNF207 promotes colorectal cancer growth by regulating the Hippo-YAP pathway via enhanced MST1 ubiquitination and degradation. [Abstract]2026 May 27. PMID: 42203851 -
Am J Chin Med
Cepharanthine Triggers Ferroptosis in Gastric Cancer by PINK1/FUNDC1-Mediated Mitophagy-Dependent GPX4 Degradation. [Abstract]2026;54(1):329-348. PMID: 41684093 -
Pharmaceutics
CC-90009, a Cereblon E3 Ligase Modulator, Exhibits Antiviral Efficacy Against JEV In Vitro and In Vivo via Targeted Degradation of GSPT1 and Viral NS5 Protein. [Abstract]2025 Nov 27;17(12):1524. PMID: 41471039 -
Pharmaceutics
C118P Suppresses Gastric Cancer Growth via Promoting Autophagy-Lysosomal Degradation of RAB1A. [Abstract]2024 Dec 21;16(12):1620. PMID: 39771598 -
Mol Cell Proteomics
Prenylated PALM2 Promotes the Migration of Esophageal Squamous Cell Carcinoma Cells through Activating Ezrin. [Abstract]2023 Aug;22(8):100593. PMID: 37328063 -
Mol Cancer Ther
2020 Jan;19(1):221-230. PMID: 31548295 -
Chem Biol Interact
F-53B exacerbates doxorubicin-induced cardiotoxicity by impairing NRF2-dependent ferroptosis defense. [Abstract]2026 Aug 1:436:112210. PMID: 42297177 -
Chem Biol Interact
The novel piperlongumine-ligustrazine derivative PL-Lig-11 inhibits VSMC phenotypic switching and intimal hyperplasia via the PDGFRα/β-RhoGDI3-NLRP3 inflammasome axis. [Abstract]2026 Jun 25:433:112083. PMID: 41967560 -
J Ethnopharmacol
Physcion alleviates ulcerative colitis by upregulating SIRT3 to suppress PANoptosis via inhibition of the cGAS-STING pathway. [Abstract]2026 May 27:121893. PMID: 42202913 -
Virulence
HIV-1 Vpr activates microglia by upregulating m6A modification through ubiquitin-proteasome pathway-mediated degradation of the demethylase ALKBH5. [Abstract]2026 Dec;17(1):2645908. PMID: 41824629 -
Chem Biol Interact
Oridonin exposure induces testicular impairment through regulating ferroptosis via HIF-1α/HO-1 activation and STUB1-driven GPX4 ubiquitination-dependent degradation. [Abstract]2026 Jan 5:423:111838. PMID: 41265811 -
J Ethnopharmacol
Chinese herbal prescription JZ-1 enhances host resistance to herpes simplex virus type 2 through regulating the MRN-ATM-CHK2 DNA damage response. [Abstract]2025 Oct 23:356:120777. PMID: 41135621 -
Chem Biol Interact
Erianin reverses 5-FU resistance by targeting CALM1/CAMKK2 and activating autophagy in colorectal cancer. [Abstract]2025 Sep 19:111750. PMID: 40976489 -
Chem Biol Interact
Cigarette smoke-induced glycerophospholipid DLPC promotes macrophage ferroptosis through the USP7/GPX4 regulatory axis in chronic obstructive pulmonary disease. [Abstract]2025 Oct 22:420:111697. PMID: 40769290 -
Food Funct
Hyperoside promotes autophagy of colonic epithelial cells to protect intestinal barrier function in ulcerative colitis. [Abstract]2025 Jul 1;16(13):5543-5555. PMID: 40525776 -
Chem Biol Interact
Acetyl alkannin, a Shikonin monomer, inhibits the ATM/DDR pathway by targeting ATM and sensitizes cisplatin in solid tumors. [Abstract]2025 May 17:111559. PMID: 40389196 -
Virulence
2025 Dec;16(1):2458681. PMID: 39927690 -
J Ethnopharmacol
Centipeda minima extracts and the active sesquiterpene lactones have therapeutic efficacy in non-small cell lung cancer by suppressing Skp2/p27 signaling pathway. [Abstract]2024 Dec 23:340:119277. PMID: 39722328 -
J Ethnopharmacol
Eurycomanone inhibits osteosarcoma growth and metastasis by suppressing GRP78 expression. [Abstract]2024 Aug 18:118709. PMID: 39163893 -
Chem Biol Interact
2024 May 25:395:110999. PMID: 38608999 -
Virulence
The host protein CALCOCO2 interacts with bovine viral diarrhoea virus Npro, inhibiting type I interferon production and thereby promoting viral replication. [Abstract]2024 Dec;15(1):2289764. PMID: 38047736 -
J Ethnopharmacol
Yishen Tongluo formula alleviates diabetic kidney disease through regulating Sirt6/TGF-β1/Smad2/3 pathway and promoting degradation of TGF-β1. [Abstract]2023 May 10:307:116243. PMID: 36791927
MG-132 purchased from MedChemExpress. Usage Cited in: J Ethnopharmacol. 2023 May 10:307:116243. [Abstract]
Both MG-132 (10 μM) and Baf A1 (10 μM) markedly increased TGF-β1 protein expression in HG-stimulated SV40-MES-13 cells.
-
Chem Biol Interact
Berberine promotes IGF2BP3 ubiquitination by TRIM21 to induce G1/S phase arrest in colorectal cancer cells. [Abstract]2023 Apr 1:374:110408. PMID: 36822301 -
Chem Biol Interact
TH5487, a small molecule inhibitor of OGG1, attenuates pulmonary fibrosis by NEDD4L-mediated OGG1 degradation. [Abstract]2022 Aug 1:362:109999. PMID: 35654123 -
Virulence
DDIT3 antagonizes innate immune response to promote bovine alphaherpesvirus 1 replication via the DDIT3-SQSTM1-STING pathway. [Abstract]2022 Dec;13(1):514-529. PMID: 35259065 -
Chem Biol Interact
E3 ubiquitin ligase RNF180 reduces sensitivity of triple-negative breast cancer cells to Gefitinib by downregulating RAD51. [Abstract]2022 Feb 25:354:109798. PMID: 34998818 -
Chem Biol Interact
Digitoxin promotes apoptosis and inhibits proliferation and migration by reducing HIF-1α and STAT3 in KRAS mutant human colon cancer cells. [Abstract]2022 Jan 5:351:109729. PMID: 34717917 -
J Ethnopharmacol
The ethanol extract of flower buds of Tussilago farfara L. attenuates cigarette smoke-induced lung inflammation through regulating NLRP3 inflammasome, Nrf2, and NF-κB. [Abstract]2022 Jan 30:283:114694. PMID: 34601084 -
Mar Drugs
Antiproliferative Activity and Potential Mechanism of Marine-Sourced Streptoglutarimide H against Lung Cancer Cells. [Abstract]2021 Jan 31;19(2):79. PMID: 33572615 -
Mol Ther Oncolytics
TRIM22 orchestrates the proliferation of GBMs and the benefits of TMZ by coordinating the modification and degradation of RIG-I. [Abstract]2022 Aug 25:26:413-428. PMID: 36159777 -
Mol Ther Oncolytics
Oleanolic acid blocks the purine salvage pathway for cancer therapy by inactivating SOD1 and stimulating lysosomal proteolysis. [Abstract]2021 Aug 28:23:107-123. PMID: 34703880 -
Cells
Detection of Calpain-Mediated Beclin-1 Cleavage for Drug Discovery in Inflammatory Bowel Diseases. [Abstract]2026 May 18;15(10):917. PMID: 42193926 -
J Pathol
BIRC3 deficiency blocks the ubiquitination and degradation of GOT2 to impede antitumor immune responses in lung squamous cell carcinoma. [Abstract]2025 Jul 21. PMID: 40690196 -
Liver Int
The DEAD-box helicase DDX3x ameliorates non-alcoholic fatty liver disease via mTORC1 signalling pathway. [Abstract]2022 Aug;42(8):1793-1802. PMID: 35460172 -
J Pathol
2021 Jun;254(2):185-198. PMID: 33638154 -
Commun Biol
SREBF2 enhances lipid metabolism and represses anti-tumor immune responses in cervical cancer by increasing ACAT2. [Abstract]2026 Feb 7;9(1):373. PMID: 41654690 -
Commun Biol
Targeting PAK4 promotes Gemcitabine-induced pyroptosis in pancreatic cancer via NLRP1/caspase-3/GSDME axis. [Abstract]2026 Jan 16;9(1):260. PMID: 41540224 -
Commun Biol
Inhibition of STING-mediated antiviral innate immunity activation by CD97 via modulation of ER-phagy. [Abstract]2025 Dec 18. PMID: 41413198 -
Commun Biol
Dcaf15-mediated EphA2 degradation triggers disruption of the blood-brain barrier during Streptococcus suis meningitis. [Abstract]2025 Nov 23. PMID: 41276610 -
Commun Biol
LAPTM5 exacerbates STING-mediated inflammation induced by LL-37 through stabilizing STING in rosacea. [Abstract]2025 Oct 14;8(1):1470. PMID: 41087666 -
Cancer Immunol Immunother
Circ_0074158 and QKI6: A regulatory axis for PD-L1 ubiquitination and immune evasion in NSCLC. [Abstract]2025 Sep 11;74(10):300. PMID: 40931215 -
Cancer Immunol Immunother
Spautin-1 inhibits the growth of diffuse large B-cell lymphoma by inducing mitochondrial damage-mediated PANoptosis and anti-tumor immunity. [Abstract]2025 Aug 25;74(9):293. PMID: 40853486 -
Commun Biol
Macrophage-derived IL-1β directs fibroblast progenitor cell fate via metabolic reprogramming in wound healing. [Abstract]2025 Aug 27;8(1):1291. PMID: 40866544 -
Glia
WWP2 Overexpression Represses NLRP3 Inflammasome Activation in Cerebral Ischemia/Reperfusion Injury Through the Degradation of MAVS. [Abstract]2025 Aug 8. PMID: 40781638 -
Commun Biol
TRIM2 inhibits apoptosis by ubiquitinating BNIP3 to protect the intestine against ischemia-reperfusion injury in mice. [Abstract]2025 Aug 29;8(1):1308. PMID: 40883557 -
Commun Biol
Pantothenic acid ameliorates hepatic fibrosis by targeting IGFBP6 to regulate the TGF-β/SMADs pathway. [Abstract]2025 Jul 29;8(1):1127. PMID: 40730679 -
Life Sci
METTL3-mediated m6A modification of FUNDC1/IP3R2 pathway facilitates cardiac hypertrophy in obesity hypertension. [Abstract]2025 May 30:123780. PMID: 40451326 -
Commun Biol
The gut microbiota metabolite trimethylamine N-oxide promotes cardiac hypertrophy by activating the autophagic degradation of SERCA2a. [Abstract]2025 Apr 10;8(1):596. PMID: 40210720 -
Life Sci
2024 Nov 13:359:123240. PMID: 39542206 -
Commun Biol
Retinol binding protein 4 restricts PCV2 replication via selective autophagy degradation of viral ORF1 protein. [Abstract]2024 Nov 5;7(1):1438. PMID: 39500783 -
Commun Biol
USP24 promotes autophagy-dependent ferroptosis in hepatocellular carcinoma by reducing the K48-linked ubiquitination of Beclin1. [Abstract]2024 Oct 8;7(1):1279. PMID: 39379617 -
Commun Biol
2024 Jul 17;7(1):872. PMID: 39020075 -
Life Sci
Hypoxia-induced degradation of PICK1 by RBCK1 promotes the proliferation of nasopharyngeal carcinoma cells. [Abstract]2023 May 15:321:121594. PMID: 36934971 -
Life Sci
TRIM21 ubiquitylates GPX4 and promotes ferroptosis to aggravate ischemia/reperfusion-induced acute kidney injury. [Abstract]2023 May 15:321:121608. PMID: 36958437 -
Mech Ageing Dev
Artesunate delays the dysfunction of age-related intestinal epithelial barrier by mitigating endoplasmic reticulum stress/unfolded protein response. [Abstract]2023 Mar:210:111760. PMID: 36476344 -
Commun Biol
2022 Mar 1;5(1):182. PMID: 35233061 -
Commun Biol
A small-molecule compound D6 overcomes EGFR-T790M-mediated resistance in non-small cell lung cancer. [Abstract]2021 Dec 13;4(1):1391. PMID: 34903832 -
Life Sci
Skp2 promotes APL progression through the stabilization of oncoprotein PML-RARα and the inhibition of JunB expression. [Abstract]2021 Dec 16;289:120231. PMID: 34921867 -
Life Sci
Histone deacetylase 3 suppresses the expression of SHP-1 via deacetylation of DNMT1 to promote heart failure. [Abstract]2022 Mar 1:292:119552. PMID: 33932446 -
Life Sci
TRIB3 destabilizes tumor suppressor PPARα expression through ubiquitin-mediated proteasome degradation in acute myeloid leukemia. [Abstract]2020 Sep 15;257:118021. PMID: 32621919 -
Life Sci
Arctigenin inhibits proliferation of ER-positive breast cancer cells through cell cycle arrest mediated by GSK3-dependent cyclin D1 degradation. [Abstract]2020 Sep 1;256:117983. PMID: 32565252 -
Life Sci
Inhibition of RELM-β prevents hypoxia-induced overproliferation of human pulmonary artery smooth muscle cells by reversing PLC-mediated KCNK3 decline. [Abstract]2020 Apr 1;246:117419. PMID: 32045592 -
Respir Res
TGM2-TUFM promotes acquired resistance to EGFR-TKIs in EGFR-mutated NSCLC through p62-mediated lipophagy. [Abstract]2026 May 9. PMID: 42106683 -
Inflammation
2026 May 16. PMID: 42141182 -
Respir Res
Endothelial NEDD4L exacerbates acute lung injury by targeting A20 for ubiquitination degradation. [Abstract]2026 Apr 6;27(1):222. PMID: 41943017 -
Cancer Gene Ther
GPR107: A key driver of breast cancer invasion and metastasis through collagen IV modulation. [Abstract]2025 Dec;32(12):1414-1427. PMID: 41073571 -
Cancer Gene Ther
2025 Oct 2. PMID: 41039015 -
Respir Res
MTMR14 depletion aggravates intrapulmonary inflammation and emphysema in experimental COPD through activating macrophage M1 polarization. [Abstract]2025 Jul 10;26(1):238. PMID: 40640787 -
Respir Res
High matrix stiffness promotes senescence of type II alveolar epithelial cells by lysosomal degradation of lamin A/C in pulmonary fibrosis. [Abstract]2025 Apr 9;26(1):128. PMID: 40205454 -
Biofactors
FAM49B drives colorectal cancer progression by stabilizing c-Myc through NEK9 phosphorylation. [Abstract]2025 Jan-Feb;51(1):e2158. PMID: 39780509 -
Inflammation
FBXW7-Mediated Downregulation of GPX4 Aggravates Acute Kidney Injury Following Ischemia‒Reperfusion. [Abstract]2025 Jun;48(3):1484-1498. PMID: 39207602 -
CNS Neurosci Ther
Activation of transient receptor potential vanilloid 1 ameliorates tau accumulation-induced synaptic damage and cognitive dysfunction via autophagy enhancement. [Abstract]2024 Mar;30(3):e14432. PMID: 37641913 -
Cancer Gene Ther
MORC4 plays a tumor-promoting role in colorectal cancer via regulating PCGF1/CDKN1A axis in vitro and in vivo. [Abstract]2023 Jul;30(7):985-996. PMID: 36932196 -
Nutrients
Anti-Melanogenesis Effect of Polysaccharide from Saussurea involucrata on Forskolin-Induced Melanogenesis in B16F10 Melanoma Cells. [Abstract]2022 Nov 27;14(23):5044. PMID: 36501075 -
Cancer Gene Ther
Tumor-promoting properties of karyopherin β1 in melanoma by stabilizing Ras-GTPase-activating protein SH3 domain-binding protein 1. [Abstract]2022 Dec;29(12):1939-1950. PMID: 35902727 -
Inflammation
ALDH2 Hampers Immune Escape in Liver Hepatocellular Carcinoma through ROS/Nrf2-mediated Autophagy. [Abstract]2022 Dec;45(6):2309-2324. PMID: 35715591 -
Inflammation
JNK/Itch Axis Mediates the Lipopolysaccharide-Induced Ubiquitin-Proteasome-Dependent Degradation of Ferritin Light Chain in Murine Macrophage Cells. [Abstract]2022 Jun;45(3):1089-1100. PMID: 34837126 -
Cancer Gene Ther
Human umbilical vein endothelial cells-derived microRNA-203-containing extracellular vesicles alleviate non-small-cell lung cancer progression through modulating the DTL/p21 axis. [Abstract]2022 Jan;29(1):87-100. PMID: 33558703 -
Int J Mol Sci
African Swine Fever Virus pD345L Suppresses JAK-STAT Signaling by Selectively Triggering STAT1 Degradation. [Abstract]2026 Jun 5;27(11):5116. PMID: 42278638 -
PLoS Pathog
SUMOylation and ubiquitination reciprocally regulate SMCHD1 antiviral activity against herpes simplex virus 1. [Abstract]2026 Jun 24;22(6):e1014371. PMID: 42341060 -
PLoS Pathog
Duck plague virus LORF2 utilizes RNF34 to inhibit antiviral innate immunity by ubiquitination and degradation of IRF7. [Abstract]2026 Apr 24;22(4):e1014174. PMID: 42030364 -
PLoS Pathog
MCL1 promotes porcine epidemic diarrhea virus replication by modulating arachidonic acid metabolic pathway. [Abstract]2026 Apr 24;22(4):e1014170. PMID: 42030333 -
PLoS Pathog
Microsporidian Encephalitozoon hellem inhibits host mitophagy by inducing ERAD to degrade BNIP3L. [Abstract]2026 Mar 23;22(3):e1014078. PMID: 41871091 -
PLoS Pathog
A novel SO2 probe inhibits lysophagy induced by Senecavirus A infection by promoting LAMP1 Cys375 sulfenylation. [Abstract]2026 Feb 5;22(2):e1013932. PMID: 41642933 -
Int J Mol Sci
2026 Jan 22;27(2):1119. PMID: 41596759 -
-
PLoS Pathog
2025 Dec 3;21(12):e1013731. PMID: 41337097 -
PLoS Pathog
UBXN7 facilitates SARS-CoV-2 replication via inhibiting the K48-linked ubiquitination of viral N protein. [Abstract]2025 Oct 14;21(10):e1013593. PMID: 41086194 -
Biol Direct
MINPP1 promotes ferroptosis in HBV-related hepatocellular carcinoma by regulating CTSB K33-linked deubiquitination via ZRANB1. [Abstract]2025 Oct 1;20(1):100. PMID: 41035046 -
PLoS Pathog
HBV p22-interacting protein C1QBP inhibits viral replication through impeding nucleocapsid formation and nuclear import. [Abstract]2025 Oct 17;21(10):e1013581. PMID: 41105696 -
PLoS Pathog
Sec10 suppresses antiviral innate immune response by facilitating STUB1-mediated STAT1 degradation. [Abstract]2025 Sep 8;21(9):e1013472. PMID: 40920886 -
Mol Plant Pathol
Proteome and Ubiquitinome Analyses Reveal the Involvement of Ubiquitination in Resistance to Maize Lethal Necrosis. [Abstract]2025 Sep;26(9):e70147. PMID: 40913280 -
Int J Mol Sci
2025 Aug 23;26(17):8201. PMID: 40943126 -
Int J Mol Sci
CRY1 Lysine 151 Regulates Circadian Rhythms Through Ubiquitination-Independent Protein Interactions. [Abstract]2025 Aug 18;26(16):7962. PMID: 40869282 -
Int J Mol Sci
Low BOK Expression Promotes Epithelial-Mesenchymal Transition and Migration via the Wnt Signaling Pathway in Breast Cancer Cells. [Abstract]2025 Jul 27;26(15):7252. PMID: 40806384 -
PLoS Pathog
2025 Jul 16;21(7):e1013344. PMID: 40668819 -
Int J Mol Sci
Decursin Suppresses Esophageal Squamous Cell Carcinoma Progression via Orchestrated Cell Cycle Deceleration, Apoptotic Activation, and Oncoprotein Degradation. [Abstract]2025 Jun 4;26(11):5391. PMID: 40508204 -
PLoS Pathog
Chlamydial protease-like activity factor targets SLC7A11 for degradation to induce ferroptosis and facilitate progeny releases. [Abstract]2025 Apr 8;21(4):e1013060. PMID: 40198689 -
Biol Direct
Deubiquitination of DNM1L by USP3 triggers the development and metastasis of gallbladder carcinoma. [Abstract]2025 Apr 7;20(1):47. PMID: 40197257 -
Biol Direct
MLL1 promotes placental trophoblast ferroptosis and aggravates preeclampsia symptoms through epigenetic regulation of RBM15/TRIM72/ADAM9 axis. [Abstract]2024 Dec 22;19(1):133. PMID: 39709463 -
PLoS Pathog
Porcine reproductive and respiratory syndrome virus nonstructural protein 2 promotes the autophagic degradation of adaptor protein SH3KBP1 to antagonize host innate immune responses by enhancing K63-linked polyubiquitination of RIG-I. [Abstract]2024 Oct 28;20(10):e1012670. PMID: 39466846 -
PLoS Pathog
Methylation of KSHV vCyclin by PRMT5 contributes to cell cycle progression and cell proliferation. [Abstract]2024 Sep 10;20(9):e1012535. PMID: 39255317 -
PLoS Pathog
Human coronavirus NL63 nsp1 induces degradation of RNA polymerase II to inhibit host protein synthesis. [Abstract]2024 Jun 20;20(6):e1012329. PMID: 38900816 -
Biol Direct
OTUD5 promotes the growth of hepatocellular carcinoma by deubiquitinating and stabilizing SLC38A1. [Abstract]2024 Apr 24;19(1):31. PMID: 38658981 -
Biol Direct
Circ_0002669 promotes osteosarcoma tumorigenesis through directly binding to MYCBP and sponging miR-889-3p. [Abstract]2024 Apr 3;19(1):25. PMID: 38570856 -
Int J Mol Sci
Mitophagy Regulates the Circadian Rhythms by Degrading NR1D1 in Simulated Microgravity and Isolation Environments. [Abstract]2024 Apr 29;25(9):4853. PMID: 38732079 -
PLoS Pathog
Palmitoylation of KSHV pORF55 is required for Golgi localization and efficient progeny virion production. [Abstract]2024 Apr 16;20(4):e1012141. PMID: 38626263 -
PLoS Pathog
Polyubiquitylated rice stripe virus NS3 translocates to the nucleus to promote cytosolic virus replication via miRNA-induced fibrillin 2 upregulation. [Abstract]2024 Mar 20;20(3):e1012112. PMID: 38507423 -
PLoS Pathog
Glycolytic interference blocks influenza A virus propagation by impairing viral polymerase-driven synthesis of genomic vRNA. [Abstract]2023 Jul 13;19(7):e1010986. PMID: 37440521 -
PLoS Pathog
The HN protein of Newcastle disease virus induces cell apoptosis through the induction of lysosomal membrane permeabilization. [Abstract]2024 Feb 14;20(2):e1011981. PMID: 38354122 -
PLoS Pathog
Non-canonical regulation of the reactivation of an oncogenic herpesvirus by the OTUD4-USP7 deubiquitinases. [Abstract]2024 Jan 12;20(1):e1011943. PMID: 38215174 -
Int J Mol Sci
Krüppel-like Factor 15 Suppresses Ferroptosis by Activating an NRF2/GPX4 Signal to Protect against Folic Acid-Induced Acute Kidney Injury. [Abstract]2023 Sep 26;24(19):14530. PMID: 37833977 -
PLoS Pathog
Influenza A virus inhibits TET2 expression by endoribonuclease PA-X to attenuate type I interferon signaling and promote viral replication. [Abstract]2023 Jul 27;19(7):e1011550. PMID: 37498975 -
Int J Mol Sci
Inhibition of Cxcr4 Disrupts Mouse Embryonic Palatal Mesenchymal Cell Migration and Induces Cleft Palate Occurrence. [Abstract]2023 Aug 13;24(16):12740. PMID: 37628919 -
Int J Oncol
circRPS19 affects HK2‑mediated aerobic glycolysis and cell viability via the miR‑125a‑5p/USP7 pathway in gastric cancer. [Abstract]2023 Aug;63(2):98. PMID: 37449524 -
Int J Mol Sci
Stearoyl-CoA Desaturases1 Accelerates Non-Small Cell Lung Cancer Metastasis by Promoting Aromatase Expression to Improve Estrogen Synthesis. [Abstract]2023 Apr 6;24(7):6826. PMID: 37047797 -
J Nutr Biochem
Glycophagy mediated glucose-induced changes of hepatic glycogen metabolism via OGT1-AKT1-FOXO1Ser238 pathway. [Abstract]2023 Jul:117:109337. PMID: 36990368 -
Int J Mol Sci
2023 Feb 3;24(3):2960. PMID: 36769281 -
Int J Oncol
FBXO30 functions as a tumor suppressor and an E3 ubiquitin ligase for hZIP1‑mediated HIF‑1α degradation in renal cell carcinoma. [Abstract]2023 Mar;62(3):40. PMID: 36799168 -
Int J Mol Sci
TRIOBP-1 Protein Aggregation Exists in Both Major Depressive Disorder and Schizophrenia, and Can Occur through Two Distinct Regions of the Protein. [Abstract]2022 Sep 21;23(19):11048. PMID: 36232351 -
Int J Mol Sci
TRAF4 Promotes the Proliferation of Glioblastoma by Stabilizing SETDB1 to Activate the AKT Pathway. [Abstract]2022 Sep 5;23(17):10161. PMID: 36077559 -
PLoS Pathog
TRIM25 inhibits infectious bursal disease virus replication by targeting VP3 for ubiquitination and degradation. [Abstract]2021 Sep 13;17(9):e1009900. PMID: 34516573 -
PLoS Pathog
NDRG1 facilitates lytic replication of Kaposi's sarcoma-associated herpesvirus by maintaining the stability of the KSHV helicase. [Abstract]2021 Jun 2;17(6):e1009645. PMID: 34077484 -
PLoS Pathog
The unfolded protein response plays dual roles in rice stripe virus infection through fine-tuning the movement protein accumulation. [Abstract]2021 Mar 4;17(3):e1009370. PMID: 33662041 -
J Zhejiang Univ Sci B
Porcine circovirus 3 capsid protein induces autophagy in HEK293T cells by inhibiting phosphorylation of the mammalian target of rapamycin. [Abstract]2020 Jul;21(7):560-570. PMID: 32633110 -
Int J Oncol
2020 Jan;56(1):232-242. PMID: 31789387 -
Mol Plant Pathol
Phytoplasma effector SWP1 induces witches' broom symptom by destabilizing the TCP transcription factor BRANCHED1. [Abstract]2018 Dec;19(12):2623-2634. PMID: 30047227
MG-132 purchased from MedChemExpress. Usage Cited in: Mol Plant Pathol. 2018 Dec;19(12):2623-2634. [Abstract]
Destabilization of BRC1 mediated by SWP1 is inhibited by proteasome inhibitors Epoxomicin and MG132.
-
Pharm Biol
Sauchinone attenuates UVB-induced photoaging by suppressing oxidative stress and ferroptosis through activation of the Keap1-Nrf2 pathway in dermal fibroblasts. [Abstract]2026 Dec;64(1):764-782. PMID: 42165632 -
Cell Oncol (Dordr)
Pharmacological inhibition of PGK1 suppresses EGFR-positive esophageal squamous cell carcinoma by dual targeting of glycolysis and autophagy-dependent EGFR degradation. [Abstract]2026 Apr 29;49(3):82. PMID: 42053736 -
Biomolecules
RSL3 Promotes STAT3 Ubiquitination to Induce Autophagy and Apoptosis in PARPi-Resistant Breast Cancer Cells. [Abstract]2025 Dec 18;15(12):1749. PMID: 41463402 -
Cell Oncol (Dordr)
SERPINA1 drives TACE resistance in hepatocellular carcinoma by competitively binding ITGB3 to block ITCH-mediated ubiquitination and degradation. [Abstract]2025 Dec 30;49(1):11. PMID: 41467954 -
Pharmaceuticals (Basel)
TAIII Suppresses the Growth of T790M-Mutant Non-Small-Cell Lung Cancer by Targeting the EGFR/ERK Signaling Pathway. [Abstract]2025 Sep 24;18(10):1431. PMID: 41155547 -
Pharmaceuticals (Basel)
The hMetrnl-PLGA-PEG-PLGA Hydrogel Facilitates Skin Wound Healing Through Dual Regulation on eNOS Activity and Stability. [Abstract]2025 Aug 10;18(8):1180. PMID: 40872571 -
Cell Oncol (Dordr)
Enhanced ZBTB10 expression induced by betulinic acid inhibits gastric cancer progression by inactivating the ARRDC3/ITGB4/PI3K/AKT pathway. [Abstract]2025 Jun;48(3):675-692. PMID: 39873948 -
Cell Oncol (Dordr)
2024 Dec;47(6):2427-2438. PMID: 39695045 -
Front Cell Infect Microbiol
ZIKV prM hijacks PIM1 kinase for phosphorylation to prevent ubiquitin-mediated degradation and facilitate viral replication. [Abstract]2024 Nov 29:14:1502770. PMID: 39679197 -
Biomolecules
CircInpp5b Ameliorates Renal Interstitial Fibrosis by Promoting the Lysosomal Degradation of DDX1. [Abstract]2024 May 23;14(6):613. PMID: 38927017 -
Front Pharmacol
Berberine stimulates lysosomal AMPK independent of PEN2 and maintains cellular AMPK activity through inhibiting the dephosphorylation regulator UHRF1. [Abstract]2023 Apr 18:14:1148611. PMID: 37144221 -
Cell Oncol (Dordr)
2022 Dec;45(6):1421-1434. PMID: 36331797 -
Front Pharmacol
Pharmacological suppression of Nedd4-2 rescues the reduction of Kv11.1 channels in pathological cardiac hypertrophy. [Abstract]2022 Aug 17:13:942769. PMID: 36059970 -
Front Pharmacol
TRAF6 Suppresses the Development of Pulmonary Fibrosis by Attenuating the Activation of Fibroblasts. [Abstract]2022 May 20;13:911945. PMID: 35668944 -
Front Pharmacol
Myricetin Induces Autophagy and Cell Cycle Arrest of HCC by Inhibiting MARCH1-Regulated Stat3 and p38 MAPK Signaling Pathways. [Abstract]2021 Oct 18;12:709526. PMID: 34733155 -
Front Pharmacol
Osthole Attenuates Macrophage Activation in Experimental Asthma by Inhibitingthe NF-ĸB/MIF Signaling Pathway. [Abstract]2021 Mar 22;12:572463. PMID: 33828480 -
Front Cell Infect Microbiol
2021 Aug 12;11:662404. PMID: 34485169 -
Cell Oncol (Dordr)
Ubiquitin-specific protease 2a promotes hepatocellular carcinoma progression via deubiquitination and stabilization of RAB1A. [Abstract]2021 Apr;44(2):329-343. PMID: 33074477 -
Front Pharmacol
USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/β-Catenin Pathway. [Abstract]2020 May 8:11:668. PMID: 32477134 -
Front Pharmacol
Salidroside Promotes the Pathological α-Synuclein Clearance Through Ubiquitin-Proteasome System in SH-SY5Y Cells. [Abstract]2018 Apr 19:9:377. PMID: 29725300
MG-132 purchased from MedChemExpress. Usage Cited in: Front Pharmacol. 2018 Apr 19:9:377. [Abstract]
Immunoblot levels of highly molecular weight (HMW)-ubiquitinated proteins and pSer129-α-syn after inhibiting the ubiquitin-proteasome system (UPS) by various concentrations of MG132 (0.25, 0.5, and 1 μM; 24 h) in SH-SY5Y cells.
-
Bioorg Chem
A novel ERα-targeted hydrophobic tag degrader, overcomes tamoxifen resistance via unfolded protein response-induced apoptosis and homologous recombination repair inhibition in breast cancer. [Abstract]2026 Jun 18:180:110129. PMID: 42348942 -
Int Immunopharmacol
SIRT5 desuccinylates PRDX3 to promote its chaperone-mediated autophagy and mitigate mitochondrial dysfunction in MSU crystal-induced inflammation. [Abstract]2026 Jun 26:186:117064. PMID: 42361528 -
Int Immunopharmacol
Baicalein limits subchondral bone lesions via AMPKα/BECN1 activation in osteoarthritis osteoblast. [Abstract]2026 Apr 15:175:116446. PMID: 41791307 -
Bioorg Chem
UM-6 remodels the tumor immune microenvironment by blocking PD-L1 N-glycosylation and promoting ERAD-mediated degradation in cervical cancer. [Abstract]2026 Jul 5:175:109788. PMID: 41916036 -
Int Immunopharmacol
A multi-omics R-loop-linked risk program highlights CKS2-positive proliferative tumor cells as drivers of glioma growth. [Abstract]2026 Apr 15:175:116421. PMID: 41763168 -
Int Immunopharmacol
Oridonin downregulates PD-L1 expression and promotes anti-tumor immunity via inhibiting NLRP3 and STAT3. [Abstract]2026 Apr 15:175:116423. PMID: 41740339 -
Int Immunopharmacol
Trimethyltin chloride (TMT) - induced vascular injury through ubiquitination proteasome pathway - regulated GPX4 degradation. [Abstract]2026 Mar 15:173:116250. PMID: 41605050 -
Bioorg Chem
Lometrexol targets MRPL2 to suppress NSCLC via dual regulation of mitochondrial ribosomal activity and nuclear PDCD11/ Ca2+ signaling. [Abstract]2026 Mar:170:109509. PMID: 41558196 -
Eur J Pharmacol
Z11, a small-molecule inhibitor of NAP1L1, alleviates cardiac fibrosis by regulating AKT/mTOR pathway. [Abstract]2026 Jan 12:1011:178440. PMID: 41354299 -
Int Immunopharmacol
UBE2C-PI3K/AKT-mediated upregulation of MTHFD2 promotes tumor progression in hepatocellular carcinoma. [Abstract]2025 Dec 27:170:116081. PMID: 41456492 -
Int Immunopharmacol
Cyclosporin A indirectly suppresses NK cells activity in renal microvascular inflammation by inducing ubiquitination-dependent degradation of ULBP1. [Abstract]2026 Jan 1;168(Pt 2):115929. PMID: 41297348 -
Int Immunopharmacol
2025 Nov 20;168(Pt 2):115904. PMID: 41270644 -
Int Immunopharmacol
Microbial metabolite tigloside alleviates osteoarthritis by repolarizing macrophages from M1 to M2 phenotype through Trafd1 destabilization and Trafd1-mediated NF-κB/STAT6 signaling pathways. [Abstract]2026 Jan 1;168(Pt 1):115747. PMID: 41192114 -
Eur J Pharmacol
Neoprzewaquinone A suppresses hepatocellular carcinoma through promoting the ubiquitin-related degradation of EGFR and inhibiting PI3K-AKT pathway. [Abstract]2025 Oct 21:1007:178274. PMID: 41130376 -
Int Immunopharmacol
RNF180 suppressed aggressiveness by degrading NOTCH1, TRIM24 and FOXC1, and chemoresistance by degrading ACC1 and ACLY in colorectal cancer. [Abstract]2025 Sep 6:165:115445. PMID: 40915184 -
Int Immunopharmacol
Inhibition of Skp2 enhances anti-tumor immunity of macrophages by regulating CD47 in gastric cancer. [Abstract]2025 Jul 23:163:115262. PMID: 40706211 -
Eur J Pharmacol
VOPP1, a determinant of the sensitivity of non-small cell lung cancer cells to NAE inhibitors. [Abstract]2025 Sep 15:1003:177942. PMID: 40651787 -
Int Immunopharmacol
Gastrodin regulates H3K14la through the CDT2-KAT2A axis to treat Sepsis-induced myocardial dysfunction. [Abstract]2025 Jun 17:161:115065. PMID: 40532326 -
Int Immunopharmacol
Targeting notch1 with berbamine alleviates the inflammatory responses of macrophages in sepsis. [Abstract]2025 Jun 8:161:115033. PMID: 40489907 -
Int Immunopharmacol
2025 Mar 29:154:114490. PMID: 40158433 -
Bioorg Chem
2β-methoxy-2-deethoxyphantomolin synergistically enhances epirubicin effect against triple-negative breast cancer via targeted inhibition of AKT and HR pathways. [Abstract]2025 Apr 8:160:108453. PMID: 40253761 -
Int Immunopharmacol
Cornuside as a promising therapeutic agent for diabetic kidney disease: Targeting regulation of Ca2+ disorder-mediated renal tubular epithelial cells apoptosis. [Abstract]2025 Feb 3:149:114190. PMID: 39904045 -
Int Immunopharmacol
Genome-wide screen based on 2DG activated NLRP3 inflammasome reveals the priming signal of TLR2/4 to IKKβ but not IKKα. [Abstract]2024 Dec 9:145:113781. PMID: 39657538 -
Mol Cancer Res
Gut microbiota-mediated hsa_circ_0126925 targets BCAA metabolic enzyme BCAT2 to exacerbate colorectal cancer progression. [Abstract]2025 Mar 3;23(3):202-218. PMID: 39642324 -
Int Immunopharmacol
USP38 exacerbates myocardial injury and malignant ventricular arrhythmias after ischemia/reperfusion by promoting ferroptosis through the P53/SLC7A11 pathway. [Abstract]2024 Dec 4:145:113727. PMID: 39642563 -
Int Immunopharmacol
VCPIP1 negatively regulates NF-κB signaling pathways by deubiquitinating and stabilizing Erbin in MDP-stimulated macrophages. [Abstract]2024 Nov 16;143(Pt 3):113622. PMID: 39550842 -
Int Immunopharmacol
The role of the PI3K/AKT/mTOR pathway in mediating PD-L1 upregulation during fibroblast transdifferentiation. [Abstract]2024 Sep 18;142(Pt B):113186. PMID: 39298817 -
Noncoding RNA Res
Upregulation of circGDI2 inhibits tumorigenesis by stabilizing the expression of RNA m6A demethylase FTO in oral squamous cell carcinoma. [Abstract]2024 Aug 9:10:140-152. PMID: 39399378 -
Eur J Pharmacol
MFN2-dependent mitochondrial dysfunction contributes to Relm-β-induced pulmonary arterial hypertension via USP18/Twist1/miR-214 pathway. [Abstract]2024 Jul 31:980:176828. PMID: 39094924 -
mBio
Infectious bursal disease virus VP5 triggers host shutoff in a transcription-dependent manner. [Abstract]2024 Mar 13;15(3):e0343323. PMID: 38289089 -
mBio
Regulation of the WNT-CTNNB1 signaling pathway by severe fever with thrombocytopenia syndrome virus in a cap-snatching manner. [Abstract]2023 Dec 19;14(6):e0168823. PMID: 37882780 -
mBio
Respiratory syncytial virus co-opts hypoxia-inducible factor-1α-mediated glycolysis to favor the production of infectious virus. [Abstract]2023 Oct 31;14(5):e0211023. PMID: 37796013 -
Eur J Pharmacol
Guggulsterone inhibits migration and invasion through proteasomal and lysosomal degradation in human glioblastoma cells. [Abstract]2023 Jan 5:938:175411. PMID: 36436590 -
mBio
Heat Shock Protein 60 Is Involved in Viral Replication Complex Formation and Facilitates Foot and Mouth Virus Replication by Stabilizing Viral Nonstructural Proteins 3A and 2C. [Abstract]2022 Oct 26;13(5):e0143422. PMID: 36106732 -
Eur J Pharmacol
2022 Apr 5:920:174822. PMID: 35151642 -
mBio
MGF360-9L Is a Major Virulence Factor Associated with the African Swine Fever Virus by Antagonizing the JAK/STAT Signaling Pathway. [Abstract]2022 Feb 22;13(1):e0233021. PMID: 35076286 -
Int Immunopharmacol
Costunolide ameliorates colitis via specific inhibition of HIF1α/glycolysis-mediated Th17 differentiation. [Abstract]2021 Aug:97:107688. PMID: 33932695 -
Mol Cancer Res
UBE2C Is Upregulated by Estrogen and Promotes Epithelial-Mesenchymal Transition via p53 in Endometrial Cancer. [Abstract]2020 Feb;18(2):204-215. PMID: 31662448 -
Int J Cancer
The NEDD4-1 E3 ubiquitin ligase: A potential molecular target for bortezomib sensitivity in multiple myeloma. [Abstract]2020 Apr 1;146(7):1963-1978. PMID: 31390487 -
Molecules
Curcumol Induces G1 Phase Arrest in SK-Hep-1 Cells by Targeting SKP2-Mediated p27 Degradation. [Abstract]2026 Mar 16;31(6):997. PMID: 41900096 -
Toxicology
Polystyrene nanoplastics disrupt iron homeostasis by promoting FPN1 ubiquitination in GC-2spd(ts) cells. [Abstract]2026 Jun:523:154429. PMID: 41722726 -
Neuropharmacology
TIM3 attenuates morphine antinociceptive tolerance and microglial neuroinflammation by suppressing the TRAF6/NF-κB pathway in male mice. [Abstract]2025 Nov 15:279:110638. PMID: 40840715 -
Cancer Biol Ther
PCK2 promotes invasion and epithelial-to-mesenchymal transition in triple-negative breast cancer by promoting TGF-β/SMAD3 signaling through inhibiting TRIM67-mediated SMAD3 ubiquitination. [Abstract]2025 Dec;26(1):2478670. PMID: 40081967 -
Toxicology
Prenatal exposure to di-n-butyl phthalate promotes RIPK1-regulated necroptosis of uroepithelial cells and induces hypospadias through the epithelial-mesenchymal transition process in newborn male rats. [Abstract]2024 Dec:509:153982. PMID: 39461407 -
J Med Virol
2024 Oct;96(10):e29945. PMID: 39370874 -
J Med Virol
EIF4A3 is stabilized by the long noncoding RNA BC200 to regulate gene expression during Epstein-Barr virus infection. [Abstract]2024 Oct;96(10):e29955. PMID: 39370864 -
J Med Virol
E3 ubiquitin ligase FBXO22 inhibits SARS-CoV-2 replication via promoting proteasome-dependent degradation of NSP5. [Abstract]2024 Sep;96(9):e29891. PMID: 39223933 -
Toxicology
miR-15b-5p promotes HgCl2-induced chicken embryo kidney cells ferroptosis by targeting β-TrCP-mediated ATF4 ubiquitin degradation. [Abstract]2024 Mar:503:153742. PMID: 38325558 -
Cancer Biol Ther
2023 Dec 31;24(1):2230641. PMID: 37405957 -
J Med Virol
FBXO6 regulates the anti-viral immune-responses via mediating alveolar macrophages survival. [Abstract]2023 Jan;95(1):e28203. PMID: 36217277 -
Arthritis Res Ther
MicroRNA-15b shuttled by bone marrow mesenchymal stem cell-derived extracellular vesicles binds to WWP1 and promotes osteogenic differentiation. [Abstract]2020 Nov 16;22(1):269. PMID: 33198785 -
J Med Virol
2020 Dec;92(12):3057-3066. PMID: 32776519 -
Molecules
Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway. [Abstract]2019 Jan 22;24(3):393. PMID: 30678274
MG-132 purchased from MedChemExpress. Usage Cited in: Molecules. 2019 Jan 22;24(3):393. [Abstract]
The HepG2 cells are pretreated for 5 h MG 132 which is a proteasome inhibitor. Then, the MARCH1 protein expressions in HepG2 cells treated with 0 μM, 5,0 μM SAF, and 2.5 μM MG 132 are measured by immunoblotting.
-
BMC Biol
Juvenile hormone and BMP signaling modulate fat body cell fate during the transition of previtellogenic development to vitellogenesis. [Abstract]2025 May 28;23(1):143. PMID: 40437481 -
Front Aging Neurosci
Parishin A ameliorates cognitive decline by promoting PS1 autophagy in Alzheimer's disease. [Abstract]2025 Mar 20:17:1516190. PMID: 40182757 -
BMC Biol
2024 Mar 25;22(1):71. PMID: 38523261 -
Mol Oncol
USP22-mediated deubiquitination of PTEN inhibits pancreatic cancer progression by inducing p21 expression. [Abstract]2022 Mar;16(5):1200-1217. PMID: 34743406 -
Mol Oncol
ALKBH1-mediated m1 A demethylation of METTL3 mRNA promotes the metastasis of colorectal cancer by downregulating SMAD7 expression. [Abstract]2023 Feb;17(2):344-364. PMID: 36550779 -
Gene Ther
CCR1 enhances SUMOylation of DGCR8 by up-regulating ERK phosphorylation to promote spinal nerve ligation-induced neuropathic pain. [Abstract]2022 Jun;29(6):379-389. PMID: 34413501 -
Front Microbiol
Cyclooxygenase-2 Facilitates Newcastle Disease Virus Proliferation and Is as a Target for Canthin-6-One Antiviral Activity. [Abstract]2020 May 20;11:987. PMID: 32508794 -
Front Microbiol
BICP0 Negatively Regulates TRAF6-Mediated NF-κB and Interferon Activation by Promoting K48-Linked Polyubiquitination of TRAF6. [Abstract]2020 Jan 8;10:3040. PMID: 31969874 -
Artif Cells Nanomed Biotechnol
Ras-AKT signaling represses the phosphorylation of histone H1.5 at threonine 10 via GSK3 to promote the progression of glioma. [Abstract]2019 Dec;47(1):2882-2890. PMID: 31307224 -
Artif Cells Nanomed Biotechnol
Ras-ERK signalling represses H1.4 phosphorylation at serine 36 to promote non-small-cell lung carcinoma cells growth and migration. [Abstract]2019 Dec;47(1):2343-2351. PMID: 31184227 -
-
Cancers (Basel)
KIF21B, Ubiquitinated by TRIM3, Exerts Oncogenic Role in T-Cell Acute Lymphoblastic Leukemia by Activating Wnt/β-Catenin Pathway. [Abstract]2026 Apr 22;18(9):1327. PMID: 42122124 -
J Dairy Sci
Mechanism of mitofusin 2, mitochondria-associated membrane, and the mitochondrial pathway in alleviating oxidative stress and cell senescence in bovine mammary epithelial cells. [Abstract]2025 Sep;108(9):10151-10172. PMID: 40645484 -
J Physiol
Jun-activated SOCS1 enhances ubiquitination and degradation of CCAAT/enhancer-binding protein β to ameliorate cerebral ischaemia/reperfusion injury. [Abstract]2024 Oct;602(19):4959-4985. PMID: 39197117 -
Cancers (Basel)
USP53 Exerts Tumor-Promoting Effects in Triple-Negative Breast Cancer by Deubiquitinating CRKL. [Abstract]2023 Oct 18;15(20):5033. PMID: 37894400 -
Cancers (Basel)
USP14 Positively Modulates Head and Neck Squamous Carcinoma Tumorigenesis and Potentiates Heat Shock Pathway through HSF1 Stabilization. [Abstract]2023 Sep 1;15(17):4385. PMID: 37686660 -
Clin Epigenetics
E3 ubiquitin ligase RNF180 prevents excessive PCDH10 methylation to suppress the proliferation and metastasis of gastric cancer cells by promoting ubiquitination of DNMT1. [Abstract]2023 May 5;15(1):77. PMID: 37147733 -
Cancers (Basel)
Circ_RNF13 Regulates the Stemness and Chemosensitivity of Colorectal Cancer by Transcriptional Regulation of DDX27 Mediated by TRIM24 Stabilization. [Abstract]2022 Dec 16;14(24):6218. PMID: 36551703 -
Cancers (Basel)
Deregulation of Exo70 Facilitates Innate and Acquired Cisplatin Resistance in Epithelial Ovarian Cancer by Promoting Cisplatin Efflux. [Abstract]2021 Jul 11;13(14):3467. PMID: 34298686 -
ACS Omega
RS-1: A Novel Hydrophobic Tagging GPX4 Degrader Inducing Ferroptosis and Suppressing Tumor Growth. [Abstract]2026 Feb 2;11(6):9098-9106. PMID: 41726627 -
ACS Omega
Dynamic Detection of the E3-PROTAC-Target Protein Ternary Complex In Vitro and In Vivo via Bimolecular Fluorescence Complementation. [Abstract]2024 Dec 3;9(50):49739-49748. PMID: 39713624 -
J Physiol Biochem
TNFAIP1 promotes macrophage lipid accumulation and accelerates the development of atherosclerosis through the LEENE/FoxO1/ABCA1 pathway. [Abstract]2024 Aug;80(3):523-539. PMID: 38878215 -
Front Cell Dev Biol
Nuclear Receptor Interacting Protein-2 Mediates the Stabilization and Activation of β-Catenin During Podocyte Injury. [Abstract]2021 Dec 24;9:781792. PMID: 35004680 -
Front Cell Dev Biol
Metformin-Enhanced Cardiac AMP-Activated Protein Kinase/Atrogin-1 Pathways Inhibit Charged Multivesicular Body Protein 2B Accumulation in Ischemia-Reperfusion Injury. [Abstract]2021 Feb 5:8:621509. PMID: 33614629 -
Front Cell Dev Biol
2021 Mar 30:9:633259. PMID: 33859984 -
Mol Neurobiol
Neuroprotective Effects Against Cerebral Ischemic Injury Exerted by Dexmedetomidine via the HDAC5/NPAS4/MDM2/PSD-95 Axis. [Abstract]2021 May;58(5):1990-2004. PMID: 33411316 -
Front Cell Dev Biol
2020 May 7:8:287. PMID: 32457900 -
Biochim Biophys Acta Mol Basis Dis
2026 Aug;1872(6):168257. PMID: 41966283 -
Biochim Biophys Acta Mol Basis Dis
Hepatic GAL1 deficiency alleviates steatosis via WWP2-mediated PARP1 degradation and activation of the SIRT1-CPT1A pathway. [Abstract]2026 Aug;1872(6):168237. PMID: 41951010 -
FASEB J
Integrated Machine Learning and SHAP Analysis Identifies TRIM21 Ubiquitination of HSPA8 Driving Progression of Metabolic Dysfunction-Associated Fatty Liver Disease. [Abstract]2026 Jun 30;40(12):e72071. PMID: 42329327 -
FASEB J
TurboID-Based Proximity Labeling Map Reveals the Protein Interaction Network and Anti-Viral Mechanism Against Influenza A H1N1. [Abstract]2026 Jun 15;40(11):e72019. PMID: 42247242 -
FASEB J
2026 May 31;40(10):e71905. PMID: 42149696 -
FASEB J
Glypican-3 Upregulated by YTHDF1 in an m6A-Dependent Manner Interacts With MUL1 to Repress HSF1 Ubiquitination Degradation, Boost CD276 Transcription, and Mediate Immune Escape in Gastric Cancer. [Abstract]2026 Apr 15;40(7):e71743. PMID: 41944736 -
FASEB J
2026 Apr 15;40(7):e71755. PMID: 41934343 -
Biochim Biophys Acta Mol Basis Dis
USP47 alleviates metabolic-associated fatty liver disease by activating the PPARα signaling pathway through the stabilization of SIRT1. [Abstract]2026 Apr 1;1872(5):168232. PMID: 41930505 -
FASEB J
Regulator of Calcineurin 1 Aggravates Tubular Epithelial Cell Injury in Diabetic Mice Through Promoting Liver Kinase B1 Ubiquitination. [Abstract]2026 Mar 31;40(6):e71712. PMID: 41854627 -
FEBS J
The sulfonamide anticancer agent indisulam enhances the chemosensitivity of gastric cancer cells by targeting FKBP8. [Abstract]2026 Mar 20. PMID: 41860182 -
Poult Sci
ERAD inhibitor Eeyarestatin I (EerI) suppresses duck plague virus by restoring STING-mediated antiviral immunity. [Abstract]2026 Mar 17;105(6):106808. PMID: 41865653 -
J Cell Mol Med
Betulinic Acid Suppresses UBE2T Expression via MAPK/ERK Inhibition to Block FANCI and FANCD2 Monoubiquitination in Glioblastoma. [Abstract]2026 Jan;30(1):e71000. PMID: 41486508 -
FASEB J
ADSCs-EVs Carrying circITCH Inhibit Pyroptosis of Renal Tubular Epithelial Cells and Alleviate LPS-Induced Acute Kidney Injury. [Abstract]2026 Jan 15;40(1):e71285. PMID: 41445440 -
FASEB J
Propofol Inhibits the Stem Characteristics and Tumor Growth of NSCLC by Altering the Expression and Localization of HDAC1. [Abstract]2025 Dec 31;39(24):e71337. PMID: 41427950 -
Mediators Inflamm
LncRNA NEAT1 Knockdown Alleviates Macrophage Ferroptosis and Atherosclerosis by Suppressing STAT3 Activation. [Abstract]2025 Nov 12:2025:8862449. PMID: 41268533 -
J Cell Mol Med
Inhibition of Histone Deacetylases Induces Cancer Cell Apoptosis Through the PERK Pathway of ER Stress Response. [Abstract]2025 Nov;29(21):e70928. PMID: 41160734 -
FASEB J
2025 Oct 31;39(20):e71096. PMID: 41082179 -
FASEB J
USP44 Regulates Chemoresistance Induced by ROS and the MAPK/NF-κB Pathway Through the Stabilization of ITGB4 in Gastric Cancer. [Abstract]2025 Aug 31;39(16):e70945. PMID: 40824171 -
Biochim Biophys Acta Mol Basis Dis
PRAG1 promotes cholangiocyte epithelial-mesenchymal transition and liver fibrosis in biliary atresia. [Abstract]2025 Jul 29;1871(8):167994. PMID: 40743806 -
Biochim Biophys Acta Mol Basis Dis
Small extracellular vesicles from HO-1 modified BMMSCs alleviate steatotic liver grafts ischemia-reperfusion injury by delivering PDIA4 to promote reparative macrophage polarization. [Abstract]2025 Jun 9;1871(7):167947. PMID: 40494182 -
FASEB J
2025 May 31;39(10):e70670. PMID: 40406987 -
Exp Neurol
SDF2L1 downregulation mediates high glucose-caused Schwann cell dysfunction by inhibiting nuclear import of TFEB and CREB via KPNA3. [Abstract]2025 Apr 26:115273. PMID: 40294738 -
J Cell Mol Med
Nitric oxide facilitates the S-nitrosylation and deubiquitination of Notch1 protein to maintain cancer stem cells in human NSCLC. [Abstract]2024 Nov;28(21):e70203. PMID: 39523215 -
J Cell Mol Med
NEDD4L affects KLF5 stability through ubiquitination to control ferroptosis and radiotherapy resistance in oesophageal squamous cell carcinoma. [Abstract]2024 Sep;28(18):e70062. PMID: 39317954 -
Drug Dev Res
Epigenetic mechanism of EZH2-mediated histone methylation modification in regulating ferroptosis of alveolar epithelial cells in sepsis-induced acute lung injury. [Abstract]2024 Nov;85(7):e22263. PMID: 39344139 -
FEBS J
A high cholesterol diet aggravates experimental colitis through SREBP2-modulated endocytosis and degradation of occludin and Zo-1 proteins. [Abstract]2025 Mar;292(5):1052-1069. PMID: 39279038 -
Poult Sci
Up-regulated Lnc BTU promotes the production of duck plague virus DNA polymerase and inhibits the activation of JAK-STAT pathway to facilitate duck plague virus replication. [Abstract]2024 Dec;103(12):104238. PMID: 39383668 -
Biochim Biophys Acta Mol Basis Dis
PGRMC1 promotes NSCLC stemness phenotypes by disrupting TRIM56-mediated ubiquitination of AHR. [Abstract]2024 Jul 24:167440. PMID: 39059592 -
Biochim Biophys Acta Mol Basis Dis
USP46 enhances tamoxifen resistance in breast cancer cells by stabilizing PTBP1 to facilitate glycolysis. [Abstract]2024 Mar;1870(3):167011. PMID: 38176460 -
Chem Commun
2024 Jan 16;60(6):686-689. PMID: 38054347 -
J Ovarian Res
IFN-γ in ovarian tumor microenvironment upregulates HLA-E expression and predicts a poor prognosis. [Abstract]2023 Nov 25;16(1):229. PMID: 38007483 -
Mol Nutr Food Res
2023 Dec;67(24):e2300444. PMID: 37897323 -
Poult Sci
Guanxin V alleviates ventricular remodeling by promoting transforming growth factor-beta 1-mediated proteasomal degradation of Vimentin. [Abstract]2023 Nov;102(11):103026. PMID: 37633081 -
FASEB J
Nur77 is involved in the regulation of obesity-related lower muscle mass by promoting Pten degradation. [Abstract]2023 Aug;37(8):e23083. PMID: 37402127 -
J Cell Mol Med
2024 Mar;28(5):e17856. PMID: 37461162 -
FASEB J
CEBPB upregulates P4HA2 to promote the malignant biological behavior in IDH1 wildtype glioma. [Abstract]2023 Apr;37(4):e22848. PMID: 36906285 -
FASEB J
The downregulation of HSP90-controlled CRALBP expression is associated with age-related vision attenuation. [Abstract]2023 Mar;37(3):e22832. PMID: 36826429 -
J Cell Mol Med
ISGylation of EMD promotes its interaction with PDHA to inhibit aerobic oxidation in lung adenocarcinoma. [Abstract]2022 Oct;26(19):5078-5094. PMID: 36071546 -
J Cell Mol Med
Reactive oxygen species-induced SIAH1 promotes granulosa cells' senescence in premature ovarian failure. [Abstract]2022 Apr;26(8):2417-2427. PMID: 35261172 -
Lab Invest
Induction of cancer cell stemness in glioma through glycolysis and the long noncoding RNA HULC-activated FOXM1/AGR2/HIF-1α axis. [Abstract]2022 Jul;102(7):691-701. PMID: 35013529 -
Lab Invest
The E3 ubiquitin ligase SOCS-7 reverses immunosuppression via Shc1 signaling in hepatocellular carcinoma. [Abstract]2022 Jun;102(6):613-620. PMID: 35042950 -
J Cell Mol Med
Interfering with mitochondrial dynamics sensitizes glioblastoma multiforme to temozolomide chemotherapy. [Abstract]2022 Feb;26(3):893-912. PMID: 34964241 -
Lab Invest
microRNA-155-5p initiates childhood acute lymphoblastic leukemia by regulating the IRF4/CDK6/CBL axis. [Abstract]2022 Apr;102(4):411-421. PMID: 34775495 -
Bioengineered
Increased FUN14 domain containing 1 (FUNDC1) ubiquitination level inhibits mitophagy and alleviates the injury in hypoxia-induced trophoblast cells. [Abstract]2022 Feb;13(2):3620-3633. PMID: 34699308 -
Mol Nutr Food Res
Morin Acts as a USP7 Inhibitor to Hold Back the Migration of Rheumatoid Arthritis Fibroblast-Like Synoviocytes in a "Prickle1-mTORC2" Dependent Manner. [Abstract]2021 Oct;65(19):e2100367. PMID: 34331380 -
Biochim Biophys Acta Mol Basis Dis
TRIM15 promotes the invasion and metastasis of pancreatic cancer cells by mediating APOA1 ubiquitination and degradation. [Abstract]2021 Nov 1;1867(11):166213. PMID: 34311082 -
J Cell Mol Med
Ring finger protein 19A is overexpressed in non-small cell lung cancer and mediates p53 ubiquitin-degradation to promote cancer growth. [Abstract]2021 Aug;25(16):7796-7808. PMID: 34184814 -
J Cell Mol Med
HIF-1α is necessary for activation and tumour-promotion effect of cancer-associated fibroblasts in lung cancer. [Abstract]2021 Jun;25(12):5457-5469. PMID: 33943003 -
FEBS J
ID1 inhibits foot-and-mouth disease virus replication via targeting of interferon pathways. [Abstract]2021 Jul;288(14):4364-4381. PMID: 33492759 -
J Cell Mol Med
Sirtuin 5 regulates the proliferation, invasion and migration of prostate cancer cells through acetyl-CoA acetyltransferase 1. [Abstract]2020 Dec;24(23):14039-14049. PMID: 33103371 -
Drug Dev Res
Proteolysis targeting chimera (PROTAC) for epidermal growth factor receptor enhances anti-tumor immunity in non-small cell lung cancer. [Abstract]2021 May;82(3):422-429. PMID: 33231319 -
J Cell Mol Med
NR4A1 counteracts JNK activation incurred by ER stress or ROS in pancreatic β-cells for protection. [Abstract]2020 Dec;24(24):14171-14183. PMID: 33124187 -
J Cell Mol Med
microRNA-148a-3p in extracellular vesicles derived from bone marrow mesenchymal stem cells suppresses SMURF1 to prevent osteonecrosis of femoral head. [Abstract]2020 Oct;24(19):11512-11523. PMID: 32871042 -
J Cell Mol Med
LncRNA ARAP1-AS2 promotes high glucose-induced human proximal tubular cell injury via persistent transactivation of the EGFR by interacting with ARAP1. [Abstract]2020 Nov;24(22):12994-13009. PMID: 32969198 -
FASEB J
2020 Aug;34(8):10966-10983. PMID: 32592217 -
FASEB J
Smurf1 aggravates non-alcoholic fatty liver disease by stabilizing SREBP-1c in an E3 activity-independent manner. [Abstract]2020 Jun;34(6):7631-7643. PMID: 32301540 -
Biochim Biophys Acta Mol Basis Dis
LAZ3 protects cardiac remodeling in diabetic cardiomyopathy via regulating miR-21/PPARa signaling. [Abstract]2018 Oct;1864(10):3322-3338. PMID: 30031228
MG-132 purchased from MedChemExpress. Usage Cited in: Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3322-3338. [Abstract]
The neonatal rat cardiomyocytes (NRCMs) are treated with MG132 (10 μM). The protein expression level of PPARα in the indicated group.
-
iScience
2026 Jun 11;29(6):116226. PMID: 42325274 -
Plants
Nitric Oxide Enhances Drought Tolerance in Gossypium hirsutum L. via S-Nitrosylation of the Plasma Membrane H+-ATPase Isoform GhHA2 and Antioxidant Defense Activation. [Abstract]2026 May 11;15(10):1463. PMID: 42197598 -
iScience
GUTK induces apoptosis in reactivating quiescent prostate cancer cells via Aurora A-mediated stabilization of SOD2. [Abstract]2026 Apr 15;29(5):115739. PMID: 42095070 -
iScience
USP18 promotes clear cell renal cell carcinoma progression by regulating the ubiquitination and stability of YBX3. [Abstract]2026 Apr 17;29(5):115808. PMID: 42111157 -
iScience
2026 Mar 4;29(4):115223. PMID: 41890968 -
iScience
USP5-mediated CD73 deubiquitination drives osimertinib resistance via PI3K/AKT and glycolysis activation in LUAD. [Abstract]2026 Feb 5;29(3):114916. PMID: 41767275 -
iScience
CCT3-mediated regulation of XPO1/RB1 axis stability promotes cellular senescence and tumor progression in clear cell renal carcinoma. [Abstract]2026 Jan 29;29(3):114840. PMID: 41732260 -
J Inflamm (Lond)
USP8 inhibits cigarette smoke extract combined with LPS-induced inflammatory response and ER stress by regulating the ABCB1-mediated MAPK signaling pathway in human bronchial epithelial cells. [Abstract]2025 Dec 29;22(1):53. PMID: 41462251 -
Oncol Res
MINDY1 Induces PD-L1 Deubiquitination to Promote Immune Escape in Hepatocellular Carcinoma by the Wnt/β-Catenin Pathway. [Abstract]2025 Oct 22;33(11):3583-3603. PMID: 41179305 -
iScience
ATP6V0D2 drives triple-negative breast cancer progression and inhibits cisplatin sensitivity by promoting PHLPP2 lysosomal degradation. [Abstract]2025 Oct 27;28(11):113853. PMID: 41312388 -
iScience
TRIM36 inhibits lung fibroblast activation and pulmonary fibrosis through the degradation of phospho-AKT1. [Abstract]2025 Oct 15;28(11):113775. PMID: 41323265 -
Transl Oncol
2025 Sep 29:62:102549. PMID: 41027284 -
Transl Oncol
USP11 is involved in the sensitivity of liver cancer cells to ferroptosis and taxanes through the regulation of NRF2 ubiquitin-mediated degradation. [Abstract]2025 Sep 30:62:102553. PMID: 41033073 -
iScience
SENP3 protects hepatocyte from pyroptosis during acute liver injury through deSUMOylation of HNRNPL. [Abstract]2025 Jul 7;28(8):113067. PMID: 40792025 -
J Neuroendocrinol
The role of NMDA receptors in fish stress response: Assessments based on physiology of the caudal neurosecretory system and defensive behavior. [Abstract]2024 Dec;36(12):e13448. PMID: 39351903 -
J Lipid Res
siRNA nanoparticle targeting Usp20 lowers lipid levels and ameliorates metabolic syndrome in mice. [Abstract]2024 Aug 20:100626. PMID: 39173829 -
iScience
2024 Aug 20;27(9):110757. PMID: 39280623 -
iScience
2024 Jun 4;27(7):110144. PMID: 38989466 -
iScience
Deficiency in Prader-Willi syndrome gene necdin leads to attenuated cardiac contractility. [Abstract]2024 May 14;27(6):109974. PMID: 38832028 -
iScience
Organic phosphate but not inorganic phosphate regulates Fgf23 expression through MAPK and TGF-ꞵ signaling. [Abstract]2024 Mar 29;27(6):109625. PMID: 38883842 -
iScience
Genome editing of FTR42 improves zebrafish survival against virus infection by enhancing IFN immunity. [Abstract]2024 Mar 12;27(4):109497. PMID: 38550983 -
iScience
TET2 stabilized by deubiquitinase USP21 ameliorates cigarette smoke-induced apoptosis in airway epithelial cells. [Abstract]2024 Feb 16;27(3):109252. PMID: 38439981 -
iScience
Circ-CIMIRC inhibition alleviates CIH-induced myocardial damage via FbxL4-mediated ubiquitination of PINK1. [Abstract]2024 Jan 20;27(2):108982. PMID: 38333696 -
iScience
Autophagy is involved in degradation of AQP1 in response to an acute decrement in tonicity. [Abstract]2023 Nov 20;26(12):108485. PMID: 38094243 -
iScience
IDH1 K224 acetylation promotes colorectal cancer via miR-9-5p/NHE1 axis-mediated regulation of acidic microenvironment. [Abstract]2023 Jun 25;26(7):107206. PMID: 37456829 -
iScience
Cathepsin K promotes the proliferation of hepatocellular carcinoma cells through induction of SIAH1 ubiquitination and degradation. [Abstract]2023 May 9;26(6):106852. PMID: 37250786 -
Tissue Eng Regen Med
Wnt/β-Catenin Promotes the Osteoblastic Potential of BMP9 Through Down-Regulating Cyp26b1 in Mesenchymal Stem Cells. [Abstract]2023 Aug;20(5):705-723. PMID: 37010733 -
iScience
Non-canonical function of DPP4 promotes cognitive impairment through ERp29-associated mitochondrial calcium overload in diabetes. [Abstract]2023 Feb 27;26(3):106271. PMID: 36936785 -
J Lipid Res
Loss of Splicing Factor SRSF3 Impairs Lipophagy through Ubiquitination and Degradation of Syntaxin17 in Hepatocytes. [Abstract]2023 Mar;64(3):100342. PMID: 36764525 -
Toxicol Sci
2,3,7,8-Tetrachlorodibenzo-dioxin induces liver lipid metabolism disorder via the ROS/AMPK/CD36 signaling pathway. [Abstract]2023 Feb 17;191(2):276-284. PMID: 36534932 -
iScience
Chemoproteomics reveals berberine directly binds to PKM2 to inhibit the progression of colorectal cancer. [Abstract]2022 Jul 20;25(8):104773. PMID: 35992091 -
iScience
Murine double minute 2 aggravates adipose tissue dysfunction through ubiquitin-mediated six-transmembrane epithelial antigen of prostate 4 degradation. [Abstract]2022 Jun 7;25(7):104544. PMID: 35747386 -
iScience
Identification of STAU1 as a regulator of HBV replication by TurboID-based proximity labeling. [Abstract]2022 May 18;25(6):104416. PMID: 35663023 -
Transl Oncol
poly(I:C) synergizes with proteasome inhibitors to induce apoptosis in cervical cancer cells. [Abstract]2022 Apr;18:101362. PMID: 35151092 -
Transl Oncol
Knockdown of CDK5 down-regulates PD-L1 via the ubiquitination-proteasome pathway and improves antitumor immunity in lung adenocarcinoma. [Abstract]2021 Sep;14(9):101148. PMID: 34130052 -
Drug Metab Dispos
Neddylation inhibition sensitizes gastric cancer to 5-fluorouracil by targeting the post-translational stability of the metabolic enzyme dihydropyrimidine dehydrogenase. [Abstract]2026 Apr;54(4):100274. PMID: 41962314 -
Virol Sin
2025 Aug;40(4):658-668. PMID: 40701343 -
J Integr Med
Morin inhibits ubiquitination degradation of BCL-2 associated agonist of cell death and synergizes with BCL-2 inhibitor in gastric cancer cells. [Abstract]2025 Apr 22:S2095-4964(25)00050-0. PMID: 40319008 -
-
J Cell Physiol
SIRT2 regulates high mobility group protein B1 nucleoplasmic shuttle and degradation via deacetylation in microglia. [Abstract]2024 Aug 11:e31364. PMID: 39129208 -
J Cell Physiol
Neuromedin S regulates goat ovarian granulosa cell proliferation and steroidogenesis via endoplasmic reticulum Ca2+-YAP1-ATF4-c-Jun pathway. [Abstract]2024 Jul 9:e31368. PMID: 38982727 -
Virol Sin
AIMP2 restricts EV71 replication by recruiting SMURF2 to promote the degradation of 3D polymerase. [Abstract]2024 Jun 28:S1995-820X(24)00108-1. PMID: 38945214 -
J Cell Physiol
ZNF263 cooperates with ZNF31 to promote the drug resistance and EMT of pancreatic cancer through transactivating RNF126. [Abstract]2024 Jun;239(6):e31259. PMID: 38515383 -
Virol Sin
PRRSV degrades MDA5 via dual autophagy receptors P62 and CCT2 to evade antiviral innate immunity. [Abstract]2024 Apr;39(2):264-276. PMID: 38272236 -
Virol Sin
Classical swine fever virus NS5A protein antagonizes innate immune response by inhibiting the NF-κB signaling. [Abstract]2023 Dec;38(6):900-910. PMID: 37714433 -
J Cell Physiol
Autophagy mediates cementoblast mineralization under compression through periostin/β-catenin axis. [Abstract]2023 Sep;238(9):2147-2160. PMID: 37475648 -
Antiviral Res
Anisomycin inhibits Coxsackievirus B replication by promoting the lysosomal degradation of eEF1A1. [Abstract]2023 Jul:215:105621. PMID: 37156267 -
Antiviral Res
Mutations at site 207 of influenza a virus NS1 protein switch its function in regulating RIG-I-like receptors mediated antiviral responses. [Abstract]2023 Jul:215:105641. PMID: 37230297 -
J Neurosci
USP1/UAF1-stabilized METTL3 promotes reactive astrogliosis and improves functional recovery after spinal cord injury through m6A modification of YAP1 mRNA. [Abstract]2023 Mar 1;43(9):1456-1474. PMID: 36653190 -
J Neurosci
Microglial Tmem59 Deficiency Impairs Phagocytosis of Synapse and Leads to Autism-Like Behaviors in Mice. [Abstract]2022 Jun 22;42(25):4958-4979. PMID: 35606143 -
Front Mol Biosci
NPC1 Deficiency Contributes to Autophagy-Dependent Ferritinophagy in HEI-OC1 Auditory Cells. [Abstract]2022 Jul 22:9:952608. PMID: 35936782 -
Front Cell Neurosci
TMAO Aggregates Neurological Damage Following Ischemic Stroke by Promoting Reactive Astrocytosis and Glial Scar Formation via the Smurf2/ALK5 Axis. [Abstract]2021 Mar 18;15:569424. PMID: 33815059 -
J Cell Physiol
IGFBP6 regulates vascular smooth muscle cell proliferation and morphology via cyclin E-CDK2. [Abstract]2020 Dec;235(12):9538-9556. PMID: 32529639 -
J Cell Physiol
PLCε regulates metabolism and metastasis signaling via HIF-1α/MEK/ERK pathway in prostate cancer. [Abstract]2020 Nov;235(11):8546-8557. PMID: 32383180 -
J Cell Commun Signal
Gemcitabine activates the Hippo signaling pathway and suppresses tumor growth by stabilizing large tumor suppressor kinase 2 through the hypoxia-inducible factor 1-alpha/ubiquitin protein ligase E3 component N-recognin 5 axis. [Abstract]2026 Jun 17;20(2):e70085. PMID: 42318009 -
Neuromolecular Med
Single-cell Transcriptomics Reveals that the SORBS1/FBXO22/BAG3 Axis Drives Astrocyte Senescence via Calcium Signaling and Affects Alzheimer's Disease-Related Neuronal Damage. [Abstract]2026 Jun 17;28(1):37. PMID: 42307825 -
Sci Rep
Pomolic acid alleviates CCl4‑induced liver fibrosis in mice by suppressing β-arrestin 2-mediated pro-fibrotic macrophage polarization. [Abstract]2026 Mar 31. PMID: 41917130 -
Sci Rep
2026 Feb 26;16(1):11190. PMID: 41748789 -
J Biol Chem
Andrographolide targets syndecan4 to impair its interaction with syntenin and inhibits the biogenesis of small extracellular vesicles. [Abstract]2026 Jan 20:111182. PMID: 41570990 -
Fish Shellfish Immunol
IGF2BP stabilizes RNF34 mRNA to orchestrate apoptosis and host susceptibility to Vibrio splendidus in Apostichopus japonicus. [Abstract]2026 Mar:170:111129. PMID: 41544989 -
Sci Rep
USP8 modulates primary ovarian insufficiency through regulation of Beclin1-dependent autophagy-induced ferroptosis. [Abstract]2025 Oct 14;15(1):35910. PMID: 41087554 -
Sci Rep
EIF4A3 enhances the viability, invasion and osteogenic differentiation of BMSCs via the USP53/SMAD5 pathway. [Abstract]2025 Jun 6;15(1):19979. PMID: 40481141 -
Sci Rep
The hydroxamate based HDAC inhibitor WMJ-J-09 induces colorectal cancer cell death by targeting tubulin and downregulating survivin. [Abstract]2025 Jun 4;15(1):19590. PMID: 40467895 -
Sci Rep
Mechanistic insights into proteasome inhibitor MG132 induced apoptosis in melanoma A375 cells. [Abstract]2025 Apr 27;15(1):14731. PMID: 40289224 -
Neurotoxicology
Inhibition of P2X7R by hypericin improves diabetic cardiac autonomic neuropathy through the proteasome- Nrf2 - GPX4 signaling axis. [Abstract]2025 Jul:109:1-10. PMID: 40412558 -
Sci Rep
PPM1B degradation mediated by TRIM25 ubiquitination modulates cell cycle and promotes gastric cancer growth. [Abstract]2025 Feb 20;15(1):6160. PMID: 39979355 -
Sci Rep
2025 Mar 4;15(1):7553. PMID: 40038378 -
J Biol Chem
Cabozantinib selectively induces proteasomal degradation of p53 somatic mutant Y220C and impedes tumor growth. [Abstract]2025 Jan 8:108167. PMID: 39793887 -
J Biol Chem
The ubiquitin ligase UBR4 and the deubiquitylase USP5 modulate the stability of DNA mismatch repair protein MLH1. [Abstract]2024 Jul 18:107592. PMID: 39032648 -
Sci Rep
COPII cage assembly factor Sec13 integrates information flow regulating endomembrane function in response to human variation. [Abstract]2024 May 3;14(1):10160. PMID: 38698045 -
J Biol Chem
2024 May;300(5):107270. PMID: 38599381 -
J Biol Chem
YTHDF2 protein stabilization by the deubiquitinase OTUB1 promotes prostate cancer cell proliferation via PRSS8 mRNA degradation. [Abstract]2024 Apr;300(4):107152. PMID: 38462165 -
J Biol Chem
CHIP suppresses the proliferation and migration of A549 cells by mediating the ubiquitination of eIF2α and upregulation of tumor suppressor RBM5. [Abstract]2024 Mar;300(3):105673. PMID: 38272235 -
Fish Shellfish Immunol
Vitamin D ameliorates Aeromonas hydrophila-induced iron-dependent oxidative damage of grass carp splenic macrophages by manipulating Nrf2-mediated antioxidant pathway. [Abstract]2023 Nov:142:109145. PMID: 37805110 -
J Biol Chem
SUMOylation of the ubiquitin ligase component KEAP1 at K39 upregulates NRF2 and its target function in lung cancer cells proliferation. [Abstract]2023 Oct;299(10):105215. PMID: 37660919 -
J Biol Chem
Single amino acid-based PROTACs trigger degradation of the oncogenic kinase BCR-ABL in chronic myeloid leukemia (CML). [Abstract]2023 Aug;299(8):104994. PMID: 37392851 -
Fish Shellfish Immunol
march2 negatively regulates antiviral immune response by targeting tbk1 in grass carp (Ctenopharyngodon idella). [Abstract]2023 Sep:140:108965. PMID: 37490971 -
J Biol Chem
VBP1 negatively regulates CHIP and selectively inhibits the activity of hypoxia-inducible factor (HIF)-1α but not HIF-2α. [Abstract]2023 Jun;299(6):104829. PMID: 37201586 -
J Biol Chem
Diarylheptanoid 35d overcomes EGFR TKI resistance by inducing hsp70-mediated lysosomal degradation of EGFR in EGFR-mutant lung adenocarcinoma. [Abstract]2023 Jun;299(6):104814. PMID: 37178919 -
J Biol Chem
HRD1 Promotes Non-small Cell Lung Carcinoma Metastasis by Blocking Autophagy-mediated MIEN1 Degradation. [Abstract]2023 Jun;299(6):104723. PMID: 37075843 -
J Biol Chem
TRIM28 represses renal cell carcinoma cell proliferation by inhibiting TFE3/KDM6A-regulated autophagy. [Abstract]2023 May;299(5):104621. PMID: 36935008 -
J Biol Chem
The main protease of SARS-CoV-2 cleaves histone deacetylases and DCP1A, attenuating the immune defense of the interferon-stimulated genes. [Abstract]2023 Mar;299(3):102990. PMID: 36758802 -
Neurotoxicology
Ursolic acid ameliorates amyloid β-induced pathological symptoms in Caenorhabditis elegans by activating the proteasome. [Abstract]2022 Jan:88:231-240. PMID: 34902447 -
Oncol Rep
Berberine exerts its antineoplastic effects by reversing the Warburg effect via downregulation of the Akt/mTOR/GLUT1 signaling pathway. [Abstract]2021 Dec;46(6):253. PMID: 34643248 -
J Biol Chem
Neddylation modification of the U3 snoRNA-binding protein RRP9 by Smurf1 promotes tumorigenesis. [Abstract]2021 Nov;297(5):101307. PMID: 34662580 -
Aging (Albany NY)
2021 Sep 8;13(17):21547-21570. PMID: 34495872 -
J Biol Chem
The adaptor protein GIPC1 stabilizes the scavenger receptor SR-B1 and increases its cholesterol uptake. [Abstract]2021 Jan-Jun:296:100616. PMID: 33811857 -
ACS Chem Neurosci
2021 Apr 21;12(8):1343-1350. PMID: 33818056 -
Oncol Rep
MMP11 promotes the proliferation and progression of breast cancer through stabilizing Smad2 protein. [Abstract]2021 Apr;45(4):16. PMID: 33649832 -
Aging
CUEDC1 inhibits epithelial-mesenchymal transition via the TβRI/Smad signaling pathway and suppresses tumor progression in non-small cell lung cancer. [Abstract]2020 Oct 25;12(20):20047-20068. PMID: 33099540 -
J Biol Chem
VBP1 modulates Wnt/β-catenin signaling by mediating the stability of the transcription factors TCF/LEFs. [Abstract]2020 Dec 4;295(49):16826-16839. PMID: 32989053 -
J Biol Chem
PDLIM5 inhibits STUB1-mediated degradation of SMAD3 and promotes the migration and invasion of lung cancer cells. [Abstract]2020 Oct 2;295(40):13798-13811. PMID: 32737199 -
J Biol Chem
Aryl hydrocarbon receptor (AhR) regulates adipocyte differentiation by assembling CRL4B ubiquitin ligase to target PPARγ for proteasomal degradation. [Abstract]2019 Nov 29;294(48):18504-18515. PMID: 31653699 -
J Biol Chem
2019 Jul 19;294(29):11119-11130. PMID: 31167779 -
Aging (Albany NY)
Ubiquitin-specific protease 4 promotes metastasis of hepatocellular carcinoma by increasing TGF-β signaling-induced epithelial-mesenchymal transition. [Abstract]2018 Oct 18;10(10):2783-2799. PMID: 30335615 -
Sci Rep
Attenuation of Innate Immunity by Andrographolide Derivatives Through NF-κB Signaling Pathway. [Abstract]2017 Jul 5;7(1):4738. PMID: 28680097 -
Sci Rep
ω-3 free fatty acids and all-trans retinoic acid synergistically induce growth inhibition of three subtypes of breast cancer cell lines. [Abstract]2017 Jun 7;7(1):2929. PMID: 28592877
MG-132 purchased from MedChemExpress. Usage Cited in: Sci Rep. 2017 Jun 7;7(1):2929. [Abstract]
p53 and Cell apoptosis. MCF7 and MDA-MB-231 cells are treated with 80 μM ω-3 FFAs, 20 μM ATRA alone or in combination for 48 h. The expression of PARP and p53 protein. β-Actin is used as an internal control.
-
J Virol
Adaptive mutations at lysine residues of PRRSV-2 nsp12 enable evasion of host proteasomal degradation to promote subgenomic RNA synthesis. [Abstract]2026 Jun 10:e0047926. PMID: 42267824 -
J Virol
Equine arteritis virus Nsp10 promotes MAVS proteasomal degradation via E3 ligases Smurf1/MARCH5. [Abstract]2026 Jun 23;100(6):e0206125. PMID: 42153738 -
J Virol
2026 Jun 15:e0048126. PMID: 42294954 -
Microbiol Spectr
2026 Jun 2;14(6):e0160825. PMID: 41995456 -
J Virol
E3 ubiquitin ligase NEDD4 inhibits PEDV infection through ubiquitination and degradation of the viral primase NSP8. [Abstract]2026 Apr 21;100(4):e0215625. PMID: 41910270 -
J Virol
PTBP1 is upregulated in response to Zika virus infection and restrains viral replication by hijacking viral NS1 protein to induce NS1 degradation. [Abstract]2026 Apr 27:e0149525. PMID: 42037413 -
J Virol
2026 Apr 21;100(4):e0179325. PMID: 41805193 -
Neurochem Res
YY1 Transcriptionally Activates USP19 to Mediate TRAF6 Deubiquitination to Promote Microglial Inflammation and M1 Polarization in Depression Development. [Abstract]2026 Mar 25;51(2):124. PMID: 41882442 -
J Virol
Chicken infectious anemia virus exploits host CK2α as an essential factor for its replication via VP2 Ser182/Asp183-mediated interaction. [Abstract]2026 Apr 21;100(4):e0173925. PMID: 41914604 -
J Virol
Small-molecule PS10 inhibits PRRSV replication by targeting HSP90 and multiple viral non-structural proteins. [Abstract]2026 Mar 24;100(3):e0212125. PMID: 41705837 -
J Virol
The ASFV CD2v protein inhibits apoptosis by inducing proteasomal degradation of BimEL via activation of the TPL2-MEK-ERK signaling pathway. [Abstract]2026 Mar 24;100(3):e0195225. PMID: 41631827 -
J Virol
MARCH2 inhibits avian leukosis virus replication by targeting gp85 for ubiquitination and degradation. [Abstract]2025 Dec 23;99(12):e0161625. PMID: 41334913 -
Mol Divers
A potent and selective PROTAC degrader of CDK9 as effective inhibitor of HIV-1 RNA synthesis. [Abstract]2025 Nov 12. PMID: 41225073 -
J Virol
SUMOylation-dependent degradation of nucleocapsid is responsible for Pestivirus uncoating. [Abstract]2025 Nov 25:e0164825. PMID: 41288382 -
J Virol
Galectin 3-binding protein suppresses PRRSV replication via Cullin3-mediated ubiquitination degradation of non-structural protein 12. [Abstract]2025 Oct 15:e0108325. PMID: 41090922 -
Microbiol Spectr
2025 Oct 7;13(10):e0136225. PMID: 40910953 -
J Virol
ZNF33B facilitates Japanese encephalitis virus replication by controlling HSPB1/8-mediated SUMOylation of nonstructural protein 5. [Abstract]2025 Sep 8:e0086825. PMID: 40919930 -
J Virol
2025 Aug 11:e0077125. PMID: 40788012 -
Food Sci Nutr
Proteostasis Disruption by Proteasome Inhibitor MG132 and Propolin G Induces ER Stress- and Autophagy-Mediated Apoptosis in Breast Cancer. [Abstract]2025 Jul 13;13(7):e70632. PMID: 40661805 -
J Virol
PEDV Nsp14 induces mitophagy-mediated degradation of MAVS to antagonize host innate immunity and facilitate viral proliferation. [Abstract]2025 Aug 19;99(8):e0049825. PMID: 40631894 -
Microbiol Spectr
2025 Aug 5;13(8):e0018825. PMID: 40662581 -
ACS Chem Biol
Targeted O-GlcNAcylation of CK2α Triggers Its Ubiquitin-Proteasome Degradation and Alters Downstream Phosphorylation. [Abstract]2025 Jul 18;20(7):1646-1659. PMID: 40521680 -
J Virol
METTL3 regulates PRRSV replication by suppressing interferon beta through autophagy-mediated IKKε degradation. [Abstract]2025 Jun 23:e0009825. PMID: 40548751 -
J Virol
CypA inhibits respiratory syncytial virus (RSV) replication by suppressing glycolysis through the downregulation of PKM2 expression. [Abstract]2025 Jun 24:e0007425. PMID: 40552816 -
J Virol
Cullin 3-mediated ubiquitination restricts enterovirus D68 replication and is counteracted by viral protease 3C. [Abstract]2025 May 21:e0035425. PMID: 40396757 -
Neurochem Res
The Ubiquitination and Degradation of SH2B3 Mediated by MEF2A/WWP2 Axis Restores Microglial Homeostasis to Alleviate Cerebral Microvascular Endothelial Cell Injury in Ischemic Stroke. [Abstract]2025 May 23;50(3):170. PMID: 40407948 -
J Virol
Ubiquitin-dependent proteasomal degradation of small hepatitis B virus surface antigen mediated by TRIM21 and antagonized by OTUD4. [Abstract]2025 Apr 25:e0230924. PMID: 40277358 -
J Virol
Heat shock protein A1 inhibits the replication of foot-and-mouth disease virus by degrading viral RNA polymerase 3D through chaperone-mediated autophagy. [Abstract]2025 Mar 31:e0016825. PMID: 40162788 -
J Virol
2025 Mar 27:e0013325. PMID: 40145735 -
J Virol
2025 Mar 18;99(3):e0198024. PMID: 39976465 -
J Virol
Potassium molybdate blocks APN-dependent coronavirus entry by degrading receptor via PIK3C3-mediated autophagy. [Abstract]2024 Dec 6:e0144924. PMID: 39641621 -
J Virol
Swine RNF5 positively regulates the antiviral activity of IFITM1 by mediating the degradation of ABHD16A. [Abstract]2024 Nov 27:e0127724. PMID: 39601593 -
ACS Chem Biol
2022 Dec 16;17(12):3389-3406. PMID: 36446024 -
J Virol
2024 Aug 30:e0133524. PMID: 39212385 -
J Virol
2024 Aug 28:e0078424. PMID: 39194214 -
J Virol
2024 Feb 20;98(2):e0190923. PMID: 38289118 -
Microbiol Spectr
miR-26a exerts broad-spectrum antiviral effects via the enhancement of RIG-I-mediated type I interferon response by targeting USP15. [Abstract]2024 Jan 11;12(1):e0312423. PMID: 38019020 -
J Virol
Foot-and-mouth disease virus downregulates vacuolar protein sorting 28 to promote viral replication. [Abstract]2023 Aug 31;97(8):e0018123. PMID: 37565750 -
J Virol
Palmitoylation at Residue C221 of Japanese Encephalitis Virus NS2A Protein Contributes to Viral Replication Efficiency and Virulence. [Abstract]2023 Jun 29;97(6):e0038223. PMID: 37289075 -
J Virol
PSMB4 Degrades the Porcine Reproductive and Respiratory Syndrome Virus Nsp1α Protein via the Autolysosome Pathway and Induces the Production of Type I Interferon. [Abstract]2023 Apr 27;97(4):e0026423. PMID: 36943051 -
J Virol
9-Butyl-Harmol Exerts Antiviral Activity against Newcastle Disease Virus through Targeting GSK-3β and HSP90β. [Abstract]2023 Mar 30;97(3):e0198422. PMID: 36877059
MG-132 purchased from MedChemExpress. Usage Cited in: J Virol. 2023 Mar 30;97(3):e0198422. [Abstract]
MG-132 (200 nM; 24 h) significantly inhibits Newcastle disease virus (NDV) infection-caused degradation of β-catenin in DF-1 cells.
-
J Virol
Zebrafish maoc1 Attenuates Spring Viremia of Carp Virus Propagation by Promoting Autophagy-Lysosome-Dependent Degradation of Viral Phosphoprotein. [Abstract]2023 Feb 28;97(2):e0133822. PMID: 36744960 -
Clin Immunol
CD47-targeted immunotherapy unleashes antitumour immunity in Epstein-Barr virus-associated gastric cancer. [Abstract]2023 Feb:247:109238. PMID: 36690192 -
ACS Chem Biol
Celastrol Targets Cullin-Associated and Neddylation-Dissociated 1 to Prevent Fibroblast-Myofibroblast Transformation against Pulmonary Fibrosis. [Abstract]2022 Oct 21;17(10):2734-2743. PMID: 36076154 -
J Virol
African Swine Fever Virus pI215L Inhibits Type I Interferon Signaling by Targeting Interferon Regulatory Factor 9 for Autophagic Degradation. [Abstract]2022 Sep 14;96(17):e0094422. PMID: 35972295 -
J Virol
Hsp70 Inhibits the Replication of Fowl Adenovirus Serotype 4 by Suppressing Viral Hexon with the Assistance of DnaJC7. [Abstract]2022 Aug 10;96(15):e0080722. PMID: 35852354 -
Cell Signal
Betaine induces ferroptotic stress by enhancing KEAP1-mediated NRF2 degradation in breast cancer cells. [Abstract]2026 Oct:146:112664. PMID: 42263898 -
Cell Signal
circFAM53B-1 and circFAM53B-2 drive VSMC phenotypic modulation via ISG15-mediated suppression of SRF. [Abstract]2026 Jul:143:112498. PMID: 41861925 -
Biochim Biophys Acta Mol Cell Res
FBXO32 activates the PI3K/AKT pathway by inhibiting PTEN through ubiquitination of TAL1 in hepatocellular carcinoma. [Abstract]2026 Apr;1873(4):120125. PMID: 41713558 -
Cell Signal
2026 Jun:142:112402. PMID: 41621465 -
Cell Signal
Hsp70/CHIP E3 ligase complex triggers K149-linked ubiquitination and degradation of BEST1 mutants p.P233L and p.P346H, impairing chloride channel function and retinal integrity. [Abstract]2025 Dec 26:139:112343. PMID: 41456629 -
Mol Cell Biochem
Deubiquitinase OTUD5 facilitates stiffness-induced hepatic stellate cell activation by stabilizing YAP. [Abstract]2025 Dec 1. PMID: 41324862 -
Cell Signal
PERK-eIF2alpha-mediated translational inhibition of MCL-1 contributes to potential 2-deoxy-D-glucose and BAD mimetic combinatorial cancer therapy. [Abstract]2025 Dec 19:139:112333. PMID: 41423011 -
Cytokine
Macrophage USP14 suppresses Wnt/β-catenin signaling via NLK deubiquitination to enhance immune response. [Abstract]2025 Dec 6:198:157079. PMID: 41353967 -
Cell Signal
2025 Dec 26:139:112344. PMID: 41456627 -
J Photochem Photobiol B
Selaginella Tamariscina extract reduces UVA-induced skin photodamage via regulating apoptosis and autophagy by AKT phosphorylation. [Abstract]2025 Dec 16:274:113343. PMID: 41421059 -
Cell Signal
Renal tubular-derived retinoic acid drives renal fibrosis via a RAI14-TRIOBP-YAP mechanotransduction axis. [Abstract]2026 Feb:138:112246. PMID: 41242366 -
Brain Res Bull
HDAC2 exacerbates carbon monoxide poisoning-induced brain injury by promoting neuronal ferroptosis through the NEDD4L/ACSL4 axis. [Abstract]2025 Nov:232:111619. PMID: 41192741 -
Biochim Biophys Acta Mol Cell Res
O-GlcNAcylation of DDX46 promotes hepatocellular carcinoma progression by activating the PI3K/Akt signaling pathway. [Abstract]2025 Oct 30:120080. PMID: 41176131 -
Biochim Biophys Acta Mol Cell Res
Glaucoma-associated polymorphism M98K-OPTN sensitizes retinal cells to protein homeostasis stress through p62-mediated caspase activation. [Abstract]2025 Sep 24;1873(1):120064. PMID: 41005546 -
Cell Signal
Gambogic acid induces ferroptosis and suppresses colorectal cancer progression by modulating the m6A modification of p62. [Abstract]2025 Nov:135:112024. PMID: 40721064 -
PLoS Genet
2025 Jul 10;21(7):e1011794. PMID: 40638681 -
Cell Signal
TFAP2A-mediated downregulation of UBE2C is crucial for endometrial decidualization and embryo implantation. [Abstract]2025 Nov:135:112016. PMID: 40701315 -
Cell Signal
Ubiquitin-editing enzyme A20 protects the inflammatory injury of human corneal epithelial cells against lipoteichoic acid. [Abstract]2025 Jun 25:111962. PMID: 40578588 -
Biochim Biophys Acta Mol Cell Res
GPX4 degradation contributes to heat stress-induced liver injury via chaperone-mediated autophagy. [Abstract]2025 May 12;1872(6):119988. PMID: 40368268 -
Cell Signal
LAPTM5 confers cisplatin resistance in NSCLC by suppressing LAMP1 ubiquitination to stabilize lysosomal membranes and sustain autophagic flux. [Abstract]2025 Apr 23:132:111834. PMID: 40280227 -
Cell Signal
OTUB1 promotes the progression of acute myeloid leukemia by regulating glycolysis via deubiquitinating c-Myc. [Abstract]2025 Jul:131:111735. PMID: 40081551 -
Cell Signal
Two novel SH3TC2 mutations predispose to Charcot-Marie-Tooth disease type 4C by mistargeting away from TFRC. [Abstract]2025 Jun:130:111669. PMID: 39961410 -
Biochim Biophys Acta Mol Cell Res
MARCH5 ameliorates aortic valve calcification via RACGAP1-DRP1 associated mitochondrial quality control. [Abstract]2025 Jan 27:119911. PMID: 39880131 -
Cell Signal
KGF impedes TRIM21-enhanced stabilization of keratin 10 mediating differentiation in hypopharyngeal cancer. [Abstract]2025 Jan 21:127:111614. PMID: 39848455 -
Cell Signal
SLC35C2 promotes stemness and progression in hepatocellular carcinoma by activating lipogenesis. [Abstract]2025 Jan 5:111589. PMID: 39765278 -
Cell Signal
Inhibition of ERO1L induces autophagy and apoptosis via endoplasmic reticulum stress in colorectal cancer. [Abstract]2024 Dec 8:127:111560. PMID: 39657838 -
Cell Signal
2024 Sep 7:111387. PMID: 39251053 -
Mol Cell Biochem
Death associated protein like 1 acts as a novel tumor suppressor in melanoma by increasing the stability of P21 protein. [Abstract]2025 Mar;480(3):1595-1610. PMID: 38980592 -
Cell Signal
BMSC derived EVs inhibit colorectal Cancer progression by transporting MAGI2-AS3 or something similar. [Abstract]2024 Sep:121:111235. PMID: 38806109 -
Cell Signal
MicroRNA-1205 promotes breast cancer cell metastasis by regulating epithelial-to-mesenchymal transition via targeting of CDK3. [Abstract]2024 Jun 17:121:111264. PMID: 38897528 -
Circ J
Long Non-Coding RNA Nuclear-Enriched Abundant Transcript 1 (NEAT1) Facilitates Foam Cell Formation and Atherosclerosis Progression Through the miR-17-5p/Itchy E3 Ubiquitin Protein Ligase (ITCH)/Liver Kinase B1 (LKB1) Axis. [Abstract]2024 Sep 25;88(10):1697-1708. PMID: 38631864 -
AAPS J
Ginsenoside Rg1 Alleviates Sepsis-Induced Acute Lung Injury by Reducing FBXO3 Stability in an m6A-Dependent Manner to Activate PGC-1α/Nrf2 Signaling Pathway. [Abstract]2024 Apr 15;26(3):47. PMID: 38622374 -
Cell Signal
2024 May:117:111070. PMID: 38307305 -
ACS Pharmacol Transl Sci
Importance of N-Glycosylation for the Expression and Function of Human Organic Anion Transporting Polypeptide 2B1. [Abstract]2023 Sep 1;6(10):1347-1356. PMID: 37854627 -
Biochim Biophys Acta Mol Cell Res
2023 Dec;1870(8):119556. PMID: 37544381 -
Biochim Biophys Acta Mol Cell Res
Long noncoding RNA MIAT regulates TP53 ubiquitination and expedites prostate adenocarcinoma progression by recruiting TBL1X. [Abstract]2023 Oct;1870(7):119527. PMID: 37356458 -
Cell Signal
2023 Sep:109:110739. PMID: 37269961 -
Cell Signal
2023 Sep:109:110744. PMID: 37271349 -
Biochim Biophys Acta Mol Cell Res
2023 Jan 24;1870(3):119433. PMID: 36706922 -
Cytokine
2022 Mar:151:155789. PMID: 34998158 -
Cell Signal
2021 Jul:83:110002. PMID: 33823241 -
Cell Signal
2020 Aug;72:109654. PMID: 32334028 -
Cell Signal
The status of MAPK cascades contributes to the induction and activation of Gata4 and Nkx2.5 during the stepwise process of cardiac differentiation. [Abstract]2019 Feb:54:17-26. PMID: 30471465 -
Bone
METTL3-mediated m6A modification of circWDR85 drives breast cancer bone metastasis via the CKB/c-Jun axis. [Abstract]2026 Mar 28:208:117869. PMID: 41912059 -
Digestion
E3 Ubiquitin Ligase NEDD4L Regulates TGF-β1/Smad Signaling Pathway to Mediate High-glucose and High-fat-induced Ferroptosis of Hepatocytes. [Abstract]2025 Jul 31:1-20. PMID: 40743910 -
J Cell Sci
2024 May 1;137(9):jcs261744. PMID: 38661008 -
Heliyon
NEK2 promotes the migration, invasion, proliferation of ESCC and mediates ESCC immunotherapy. [Abstract]2024 Apr 23;10(9):e29682. PMID: 38707418 -
J Cell Sci
Tbl1 promotes Wnt/β-catenin signaling-induced degradation of the Tcf7l1 protein in mouse ESCs. [Abstract]2024 May 1;137(9):jcs261241. PMID: 38639717 -
Heliyon
Gkongensin A, an HSP90β inhibitor, improves hyperlipidemia, hepatic steatosis, and insulin resistance. [Abstract]2024 Apr 9;10(8):e29367. PMID: 38655315 -
Heliyon
2023 Jun 8;9(6):e17103. PMID: 37484432 -
J Proteome Res
Proximity Proteomics and Biochemical Analysis Reveal a Noncanonical Function for UFM1-Specific Protease 1 in the p62 Body Formation. [Abstract]2023 Jul 7;22(7):2352-2363. PMID: 37285312 -
Am J Pathol
2023 Sep;193(9):1248-1266. PMID: 37301536 -
J Cell Sci
AMBRA1 promotes dsRNA- and virus-induced apoptosis through interacting with and stabilizing MAVS. [Abstract]2022 Jan 1;135(1):jcs258910. PMID: 34859815 -
Am J Pathol
Heat Shock Protein 27 Enhances SUMOylation of Heat Shock Protein B8 to Accelerate the Progression of Breast Cancer. [Abstract]2020 Dec;190(12):2464-2477. PMID: 33222991 -
Bone
hPTH(3-34)(29-34) selectively activated PKC and mimicked osteoanabolic effects of hPTH(1-34). [Abstract]2020 Jun;135:115326. PMID: 32200023 -
J Nat Prod
4β-Hydroxywithanolide E from Goldenberry (Whole Fruits of Physalis peruviana L.) as a Promising Agent against Chronic Obstructive Pulmonary Disease. [Abstract]2020 Apr 24;83(4):1217-1228. PMID: 32159343 -
J Cell Sci
ARF6 protects sister chromatid cohesion to ensure the formation of stable kinetochore-microtubule attachments. [Abstract]2018 Jun 11;131(11). pii: jcs216598. PMID: 29724911 -
Exp Cell Res
GFPT1 facilitates immune escape in lung adenocarcinoma by promoting the O-GlcNAcylation of MYC and regulating PD-L1. [Abstract]2026 Jun 15;459(2):115024. PMID: 41999836 -
Viruses
Porcine Reproductive and Respiratory Syndrome Virus NSP8 Suppresses NF-κB Signaling by Hijacking Host UBE2K and IKKα. [Abstract]2026 May 18;18(5):567. PMID: 42198770 -
MedScience
Targeting circSFPQ_008/SFPQ/BRCA1 axis for overcoming platinum resistance in ovarian cancer. [Abstract]2026 Mar 31. PMID: 41917322 -
Exp Cell Res
Role of CIRP in glioma Progression: Inhibition of ferroptosis via UBR5-Mediated ACSL4 degradation. [Abstract]2026 Apr 15;457(2):114942. PMID: 41687914 -
Vet Res
Salvianolic acid A inhibits PRRSV replication via binding to Keap1 to activate the MKRN1-Nrf2-NQO1 pathway. [Abstract]2025 Sep 25;56(1):182. PMID: 40999490 -
Exp Cell Res
2025 Sep 1;452(1):114744. PMID: 40921293 -
Viruses
DNAJ Homolog Subfamily C Member 11 Stabilizes SARS-CoV-2 NSP3 to Promote Double-Membrane Vesicle Formation. [Abstract]2025 Jul 22;17(8):1025. PMID: 40872740 -
Vet Res
The CRM1-dependent NES257-266 motif in the matrix protein: another factor influencing Newcastle disease virus propagation and virulence. [Abstract]2025 Jul 1;56(1):126. PMID: 40598613 -
Vet Res
LGALS3BP/90K suppresses porcine reproductive and respiratory syndrome virus replication by enhancing GP3 degradation and stimulating innate immunity. [Abstract]2025 Jun 20;56(1):121. PMID: 40542445 -
Exp Cell Res
2025 May 28:114613. PMID: 40447212 -
J Neuroimmune Pharmacol
HucMSCs-Derived Extracellular Vesicles Deliver RPS27A Protein to Manipulate the MDM2-P53 Axis and Ameliorate Neurological Dysfunction in Parkinson's Disease. [Abstract]2025 May 8;20(1):52. PMID: 40338442 -
Vet Res
Chicken interferon-induced transmembrane proteins inhibit Newcastle disease virus infection by affecting viral entry and W protein expression. [Abstract]2025 May 21;56(1):104. PMID: 40399912 -
Vet Res
Neospora caninum hijacks host PFKFB3-driven glycolysis to facilitate intracellular propagation of parasites. [Abstract]2025 Apr 30;56(1):94. PMID: 40307939 -
Med Oncol
Impaired cyclin D3 protein degradation contributes to trastuzumab resistance in HER2 positive breast cancer. [Abstract]2024 Nov 2;41(12):305. PMID: 39487929 -
Viruses
Autophagy Deregulation in HIV-1-Infected Cells Increases Extracellular Vesicle Release and Contributes to TLR3 Activation. [Abstract]2024 Apr 20;16(4):643. PMID: 38675983 -
Exp Cell Res
Inhibition of RhoGEF/RhoA alleviates regorafenib resistance and cancer stemness via Hippo signaling pathway in hepatocellular carcinoma. [Abstract]2024 Mar 1;436(1):113956. PMID: 38341081 -
Exp Cell Res
Squalene epoxidase promotes breast cancer progression by regulating CCNB1 protein stability. [Abstract]2023 Dec 1;433(1):113805. PMID: 37839786 -
Viruses
Oxygen-Sensing Protein Cysteamine Dioxygenase from Mandarin Fish Involved in the Arg/N-Degron Pathway and Siniperca chuatsi Rhabdovirus Infection. [Abstract]2023 Jul 28;15(8):1644. PMID: 37631990 -
Exp Cell Res
RIPK2 promotes the progression of colon cancer by regulating BIRC3-mediated ubiquitination of IKBKG. [Abstract]2023 Aug 1;429(1):113644. PMID: 37211186 -
Exp Cell Res
METTL14/YTHDF1 axis-modified UCHL5 aggravates atherosclerosis by activating the NLRP3 inflammasome. [Abstract]2023 Jun 15;427(2):113587. PMID: 37044315 -
Vet Res
Host E3 ligase Hrd1 ubiquitinates and degrades H protein of canine distemper virus to inhibit viral replication. [Abstract]2023 Apr 2;54(1):30. PMID: 37009870 -
Exp Cell Res
ORP8 inhibits renal cell carcinoma progression by accelerating Stathmin1 degradation and microtubule polymerization. [Abstract]2023 Apr 11;427(1):113601. PMID: 37054771 -
Med Oncol
Combined time-restricted feeding and cisplatin enhance the anti-tumor effects in cisplatin-resistant and -sensitive lung cancer cells. [Abstract]2022 Dec 28;40(1):63. PMID: 36576605 -
Vet Res
Porcine reproductive and respiratory syndrome virus non-structural protein 4 cleaves guanylate-binding protein 1 via its cysteine proteinase activity to antagonize GBP1 antiviral effect. [Abstract]2022 Jul 8;53(1):55. PMID: 35804432 -
Metab Brain Dis
Ginkgolide B inactivates the NLRP3 inflammasome by promoting autophagic degradation to improve learning and memory impairment in Alzheimer's disease. [Abstract]2022 Feb;37(2):329-341. PMID: 35050445 -
Food Chem Toxicol
Ubiquitinated gasdermin D mediates arsenic-induced pyroptosis and hepatic insulin resistance in rat liver. [Abstract]2022 Feb:160:112771. PMID: 34920032 -
Exp Cell Res
MiR-125b attenuates retinal pigment epithelium oxidative damage via targeting Nrf2/HIF-1α signal pathway. [Abstract]2022 Jan 1;410(1):112955. PMID: 34875217 -
Exp Cell Res
FAK-targeting PROTAC demonstrates enhanced antitumor activity against KRAS mutant non-small cell lung cancer. [Abstract]2021 Nov 15;408(2):112868. PMID: 34648846 -
Exp Cell Res
GRIM-19 inhibits proliferation and induces apoptosis in a p53-dependent manner in colorectal cancer cells through the SIRT7/PCAF/MDM2 axis. [Abstract]2021 Oct 1;407(1):112799. PMID: 34461110 -
Mol Med Rep
2021 Sep;24(3):629. PMID: 34278473 -
Exp Cell Res
Mitoferrin 2 deficiency prevents mitochondrial iron overload-induced endothelial injury and alleviates atherosclerosis. [Abstract]2021 May 1;402(1):112552. PMID: 33711329 -
Microb Pathog
Outer membrane protein A inhibits the degradation of caspase-1 to regulate NLRP3 inflammasome activation and exacerbate the Acinetobacter baumannii pulmonary inflammation. [Abstract]2021 Apr:153:104788. PMID: 33571624 -
Med Oncol
Proteasome inhibitors attenuates mitoxantrone-triggered immunogenic cell death in prostate cancer cells. [Abstract]2020 Nov 19;37(12):116. PMID: 33215275 -
Food Chem Toxicol
Impaired ferritinophagy flux induced by high fat diet mediates hepatic insulin resistance via endoplasmic reticulum stress. [Abstract]2020 Jun;140:111329. PMID: 32283200 -
Viruses
Feline Infectious Peritonitis Virus Nsp5 Inhibits Type I Interferon Production by Cleaving NEMO at Multiple Sites. [Abstract]2019 Dec 30;12(1):43. PMID: 31905881 -
Viruses
2019 Nov 30;11(12):1112. PMID: 31801284 -
Cell Cycle
MAGED4 promotes hepatocellular carcinoma progression via activation of JAK2/STAT3 pathway by stabilizing TRIM21. [Abstract]2026 Dec;25(1):1-15. PMID: 42272063 -
Acta Biochim Biophys Sin (Shanghai)
Metabolic reprogramming promotes AR-V7 splicing via SRSF2 lactylation in castration-resistant prostate cancer. [Abstract]2026 Apr 30;Vol.(1):fpage-lpage. PMID: 42178282 -
Andrology
Ubiquitin-mediated immunoglobulin-binding protein 1 degradation promotes autophagy and sperm capacitation in vitro. [Abstract]2025 Jul 2. PMID: 40600667 -
Toxicol Appl Pharmacol
Dl-3-n-butylphthalide attenuates acute myocardial infarction by inhibiting the binding of Nrf2/Keap1. [Abstract]2025 May 31:502:117424. PMID: 40456322 -
J Immunol
Zebrafish fkbp5 attenuates antiviral innate immunity by autophagic degradation of transcription factor irf7. [Abstract]2025 May 20:vkaf089. PMID: 40391431 -
J Immunol
MARCH8 Mediates K27-Linked Polyubiquitination of IL-7 Receptor α to Negatively Regulate IL-7-Triggered T Cell Homeostasis. [Abstract]2024 Nov 15;213(10):1467-1478. PMID: 39311660 -
Am J Physiol Renal Physiol
Membranous translocation of murine double minute 2 promotes the increased renal tubular immunogenicity in ischemia-reperfusion-induced acute kidney injury. [Abstract]2024 Aug 1;327(2):F290-F303. PMID: 38867673 -
Biologics
STAT5B Suppresses Ferroptosis by Promoting DCAF13 Transcription to Regulate p53/xCT Pathway to Promote Mantle Cell Lymphoma Progression. [Abstract]2024 Jul 4:18:181-193. PMID: 38979130 -
J Hepatocell Carcinoma
TRIM55 Promotes Proliferation of Hepatocellular Carcinoma Through Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling. [Abstract]2023 Aug 3:10:1281-1293. PMID: 37554583 -
Toxicol Appl Pharmacol
Inhibition of CDK9 exhibits anticancer activity in hepatocellular carcinoma cells via targeting ribonucleotide reductase. [Abstract]2023 Jul 15:471:116568. PMID: 37245555 -
J Neurosci Res
Intrahippocampal injection of IL-1β upregulates Siah1-mediated degradation of synaptophysin by activation of the ERK signaling in male rat. [Abstract]2023 Jun;101(6):930-951. PMID: 36720002 -
J Immunol
Duck MARCH8 Negatively Regulates the RLR Signaling Pathway through K29-Linked Polyubiquitination of MAVS. [Abstract]2023 Mar 15;210(6):786-794. PMID: 36715497 -
Pathol Int
Salt-like transcription factor 4 promotes laryngeal cancer progression through transcriptional activation of ubiquitin-specific protease 21 to stabilize Yin Yang 1. [Abstract]2023 Mar;73(3):109-119. PMID: 36285444 -
BMC Cancer
NOX4-derived ROS-induced overexpression of FOXM1 regulates aerobic glycolysis in glioblastoma. [Abstract]2021 Nov 5;21(1):1181. PMID: 34740322 -
BMC Cancer
Bortezomib potentiates antitumor activity of mitoxantrone through dampening Wnt/β-catenin signal pathway in prostate cancer cells. [Abstract]2021 Oct 13;21(1):1101. PMID: 34645397 -
Front Physiol
Deacetylation of HSC70-4 Promotes Bombyx mori Nucleopolyhedrovirus Proliferation via Proteasome-Mediated Nuclear Import. [Abstract]2021 Feb 19;12:609674. PMID: 33679433 -
Toxicol Appl Pharmacol
The involvement of lipid raft pathway in suppression of TGFβ-mediated metastasis by tolfenamic acid in hepatocellular carcinoma cells. [Abstract]2019 Oct 1:380:114696. PMID: 31381904 -
PLoS Negl Trop Dis
Identification of anti-flaviviral drugs with mosquitocidal and anti-Zika virus activity in Aedes aegypti. [Abstract]2019 Aug 20;13(8):e0007681. PMID: 31430351 -
Cell Cycle
Chronic restraint stress disturbs meiotic resumption through APC/C-mediated cyclin B1 excessive degradation in mouse oocytes. [Abstract]2018;17(13):1591-1601. PMID: 29911914
MG-132 purchased from MedChemExpress. Usage Cited in: Cell Cycle. 2018;17(13):1591-1601. [Abstract]
The protein level of CCNB1 in different groups is analyzed by Western blot; MG132 significantly increases the protein level of CCNB1 in oocytes from CRS group mice. Western blotting showing the reduced expression of securin is rescued by MG132 in CRS group mouse oocytes.
-
Appl Biochem Biotechnol
Paris Saponin VII Inhibits Ferroptosis through USP7/SLC7A11 to Alleviate Metabolic-associated Fatty Liver Disease in Rats. [Abstract]2026 Jul;198(7):5045-5066. PMID: 41941048 -
Chem Biol Drug Des
Icaritin Inhibits Malignant Progression and Enhances Ferroptosis and Bortezomib Sensitivity by Suppressing HSP90AA1 Expression in Multiple Myeloma. [Abstract]2026 Apr;107(4):e70284. PMID: 41973828 -
Appl Biochem Biotechnol
NCBP2 Regulates PGAM5-Mediated Mitophagy Via KIF23 Alternative Splicing To Promote Cervical Cancer ProgressionRun Title: NCBP2 Promotes Cervical Cancer Via Mitophagy. [Abstract]2026 Mar 24. PMID: 41874817 -
Cancer Res Commun
Mutant Isocitrate Dehydrogenase 1 Sensitizes Intrahepatic Cholangiocarcinoma Cells to MDM2 Inhibitors. [Abstract]2026 Mar 1;6(3):616-629. PMID: 41747217 -
Appl Biochem Biotechnol
USP7 Stabilizes USF1 to Aggravate ox-LDL-Induced Endothelial Injury Through the MYD88/NF-κB Pathway in Atherosclerosis. [Abstract]2025 Jul 18. PMID: 40679551 -
Chem Biol Drug Des
Artesunate Enhances Sensitivity of Renal Cancer Cells to Sunitnib by Mediating Tripartite Motif Containing 24-Induced Ubiquitination of Paired Box 6. [Abstract]2025 May;105(5):e70116. PMID: 40346910 -
Biochim Biophys Acta Mol Cell Biol Lipids
2025 Apr 26:159618. PMID: 40294697 -
Appl Biochem Biotechnol
2025 Jun;197(6):3871-3889. PMID: 40080374 -
Chem Biol Drug Des
Alantolactone facilitates ferroptosis in non-small cell lung cancer through promoting FTH1 ubiquitination and degradation. [Abstract]2024 Aug;104(2):e14560. PMID: 39175059 -
Chem Asian J
Selective Protein Degradation through Tetrazine Ligation of Genetically Incorporated Unnatural Amino Acids. [Abstract]2024 Sep 2:e202400824. PMID: 39221720 -
Front Oncol
MOF negatively regulates estrogen receptor α signaling via CUL4B-mediated protein degradation in breast cancer. [Abstract]2022 Sep 23;12:868866. PMID: 36212422 -
Stem Cells Int
FAIM Enhances the Efficacy of Mesenchymal Stem Cell Transplantation by Inhibiting JNK-Induced c-FLIP Ubiquitination and Degradation. [Abstract]2022 Sep 30:2022:3705637. PMID: 36248256 -
Appl Biochem Biotechnol
2022 Apr;194(4):1621-1635. PMID: 34826090 -
Front Oncol
2021 Feb 23;11:615568. PMID: 33708629 -
IUBMB Life
OTUD1 Relieves Coxsackievirus-Induced Ferroptosis and Inflammation in Myocardial Cells by Stabilizing NRF2 and Inhibiting NF-κB Signaling. [Abstract]2026 Mar;78(3):e70094. PMID: 41853919 -
Pathol Res Pract
SIRT3 promotes oxaliplatin sensitivity in hepatocellular carcinoma by promoting ferroptosis through endoplasmic reticulum stress response. [Abstract]2026 May:281:156400. PMID: 41775211 -
Mol Carcinog
AOC3 Loss Promotes Imatinib Resistance in GIST by Stabilizing HK2 and Enhancing H3K18la-Driven Myc Transcription. [Abstract]2026 Apr;65(4):407-421. PMID: 41570175 -
Pathol Res Pract
RNF6 activates JNK/c-JUN pathway in ovarian cancer by promoting K48-linked NME4 ubiquitination. [Abstract]2026 Mar:279:156366. PMID: 41616518 -
Pathol Res Pract
KLF11 interacts with MDM2 to stabilize E2F1 and promotes DNA damage repair to induce radioresistance in esophageal cancer cells. [Abstract]2026 Apr:280:156375. PMID: 41655531 -
Mol Carcinog
USP2 Promotes Nasopharyngeal Carcinoma Progression by Activating TRAF2/NF-κB Signaling and Stabilizing MMP2. [Abstract]2025 Oct 27. PMID: 41144793 -
Pathol Res Pract
FBXW7 promotes osteoarthritis injury by regulating SLC7A11 ubiquitination degradation and chondrocyte ferroptosis. [Abstract]2026 Jan:277:156297. PMID: 41274067 -
Mol Carcinog
ZNF480 Accelerates Chemotherapy Resistance in Breast Cancer by Competing With TRIM28 and Stabilizing LSD1 to Upregulate the AKT-GSK3β-Snail Pathway. [Abstract]2025 Jan;64(1):192-208. PMID: 39503216 -
Mol Carcinog
2024 Sep;63(9):1750-1767. PMID: 38860604 -
Mol Carcinog
CDK10 suppresses metastasis of lung adenocarcinoma through inhibition of the ETS2/c-Raf/p-MEK/p-ERK signaling loop. [Abstract]2024 Jan;63(1):61-74. PMID: 37737453 -
J Pharm Pharmacol
2023 Jun 5;75(6):784-805. PMID: 36971498 -
Clin Exp Metastasis
PITX1 suppresses osteosarcoma metastasis through exosomal LINC00662-mediated M2 macrophage polarization. [Abstract]2023 Feb;40(1):79-93. PMID: 36334221 -
J Cancer
EGLN1 induces tumorigenesis and radioresistance in nasopharyngeal carcinoma by promoting ubiquitination of p53 in a hydroxylase-dependent manner. [Abstract]2022 Mar 28;13(7):2061-2073. PMID: 35517429 -
Int J Med Sci
RIP1-dependent Apoptosis and Differentiation Regulated by Skp2 and Akt/GSK3β in Acute Myeloid Leukemia. [Abstract]2022 Mar 6;19(3):525-536. PMID: 35370472 -
Int J Med Sci
ZFP91 promotes cell proliferation and inhibits cell apoptosis in AML via inhibiting the proteasome-dependent degradation of RIP1. [Abstract]2022 Jan 1;19(2):274-285. PMID: 35165513 -
Hum Mol Genet
E3 ligase Smurf1 protects against misfolded SOD1 in neuronal cells by promoting its K63 ubiquitylation and aggresome formation. [Abstract]2022 Jun 22;31(12):2035-2048. PMID: 35022748 -
Environ Toxicol
RNF168 suppresses the cancer stem cell-like traits of nonsmall cell lung cancer cells by mediating RhoC ubiquitination. [Abstract]2022 Mar;37(3):603-611. PMID: 34873829 -
-
Hum Exp Toxicol
2021 Nov;40(11):1985-1997. PMID: 34002651 -
Int J Med Sci
Inhibition of USP1 induces apoptosis via ID1/AKT pathway in B-cell acute lymphoblastic leukemia cells. [Abstract]2021 Jan 1;18(1):245-255. PMID: 33390793 -
Int J Med Sci
Cancer Cell enters reversible quiescence through Intracellular Acidification to resist Paclitaxel Cytotoxicity. [Abstract]2020 Jun 29;17(11):1652-1664. PMID: 32669967 -
J Inorg Biochem
2017 Oct:175:92-100. PMID: 28743050
MG-132 purchased from MedChemExpress. Usage Cited in: J Inorg Biochem. 2017 Oct:175:92-100. [Abstract]
TPEN-triggered PML-RARα degradation in NB4 cells is reversed by MG-132 treatment. NB4 cells are treated with 5 μM TPEN with or without the presence of 1 μM MG-132 for the indicated durations (0–12 h) and then lysed. The lysates are analyzed for PML-RARα and RARα protein levels by western blotting.
-
Cancer Med
2026 Jun;15(6):e71772. PMID: 42204437 -
Hum Cell
Long non-coding RNA FEZF1-AS1 suppresses ferroptosis in multiple myeloma cells through KIAA1429-mediated m6A modification. [Abstract]2025 Oct 14;38(6):178. PMID: 41085851 -
Naunyn Schmiedebergs Arch Pharmacol
5-Methoxyflavone inhibits the proliferation of lung adenocarcinoma cells through PI3K/AKT/GSK3β/β-catenin/Cyclin D1 signaling and attenuates chemoresistance and PD-L1 expression. [Abstract]2025 Oct 31. PMID: 41168435 -
Cell Biol Int
Total Flavonoids of Hedyotis Diffusa Willd Suppresses Prostate Cancer Progression by Promoting AR Ubiquitination and Degradation via the PIAS4/STAT3 Pathway. [Abstract]2025 Aug 27. PMID: 40862474 -
Cell Biol Int
2025 Mar 24. PMID: 40126008 -
J Alzheimers Dis
Icariin improves learning and memory function by enhancing HRD1-mediated ubiquitination of amyloid precursor protein in APP/PS1 mice. [Abstract]2025 Jan 15:13872877241303949. PMID: 39814545 -
Front Biosci (Landmark Ed)
HP1 Promotes the Centromeric Localization of ATRX and Protects Cohesion by Interfering Wapl Activity in Mitosis. [Abstract]2025 Jan 21;30(1):26426. PMID: 39862081 -
Funct Integr Genomics
The role of lipoprotein‑associated phospholipase A2 in inflammatory response and macrophage infiltration in sepsis and the regulatory mechanisms. [Abstract]2024 Sep 30;24(5):178. PMID: 39343830 -
Glycoconj J
2024 Oct;41(4-5):229-240. PMID: 39356381 -
Kaohsiung J Med Sci
CMTM5 influences Hippo/YAP axis to promote ferroptosis in glioma through regulating WWP2-mediated LATS2 ubiquitination. [Abstract]2024 Oct;40(10):890-902. PMID: 39166861 -
Immunol Res
β-Indole-3-acetic acid attenuated collagen-induced arthritis through reducing the ubiquitination of Foxp3 via the AhR-TAZ-Tip60 pathway. [Abstract]2024 Aug;72(4):741-753. PMID: 38630408 -
Kaohsiung J Med Sci
Molecular mechanism of WWP1-mediated ubiquitination modification affecting proliferation and invasion/migration of liver cancer cells. [Abstract]2024 Mar;40(3):255-268. PMID: 37997542 -
Kaohsiung J Med Sci
The role of KDM4A-mediated histone methylation on temozolomide resistance in glioma cells through the HUWE1/ROCK2 axis. [Abstract]2024 Feb;40(2):161-174. PMID: 37873881 -
Cell Biol Int
ASPM promotes migration and invasion of anaplastic thyroid carcinoma by stabilizing KIF11. [Abstract]2023 Jul;47(7):1209-1221. PMID: 36883909 -
Cancer Med
KBTBD7 promotes non-small cell lung carcinoma progression by enhancing ubiquitin-dependent degradation of PTEN. [Abstract]2022 May 2. PMID: 35499228 -
Clin Oral Investig
The gain-of-function FAM83H mutation caused hypocalcification amelogenesis imperfecta in a Chinese family. [Abstract]2021 May;25(5):2915-2923. PMID: 33009625 -
J Alzheimers Dis
Heme Oxygenase 1 Inhibits Adult Neural Stem Cells Proliferation and Survival via Modulation of Wnt/β-Catenin Signaling. [Abstract]2020;76(2):623-641. PMID: 32568195 -
J Alzheimers Dis
2020;76(2):491-504. PMID: 32538849 -
Ren Fail
Silencing of USP22 promotes FGF11 degradation to attenuates renal fibrosis in diabetic kidney disease. [Abstract]2026 Dec;48(1):2668134. PMID: 42269715 -
Biol Reprod
O-GlcNAcylation of p66Shc drives senescence associated secretory phenotype via mitochondrial DNA release in gestational diabetes mellitus†. [Abstract]2026 May 11:ioag090. PMID: 42113624 -
Mol Immunol
High fat diet promotes asthma by inhibiting the differentiation of regulatory T cells via E3 ubiquitin ligase ITCH. [Abstract]2026 Apr:192:32-44. PMID: 41791173 -
Biol Reprod
Rictor stability mediated by USP9X regulates embryo implantation by participating in lipid metabolism of endometrium. [Abstract]2025 Apr 14:ioaf088. PMID: 40226881 -
J Tradit Complement Med
Salvianic acid A promotes osteogenic differentiation of bone marrow mesenchymal stem cells in senile osteoporosis through bromodomain-containing protein 4/Ariadne RBR E3 ubiquitin-protein ligase 1/Rubicon axis. [Abstract]2025 Feb 7;15(4):434-445. PMID: 40677544 -
Mol Pharmacol
Role of HNF4A-AS1/HNRNPC-mediated HNF4A ubiquitination protection against ritonavir-induced hepatotoxicity. [Abstract]2025 Mar;107(3):100021. PMID: 40037142 -
J Tradit Complement Med
Curcumol promotes ferroptosis of colon cancer by targeting the ubiquitination and degradation of GPX4. [Abstract]2024 Aug 21;15(2):170-181. PMID: 40060150 -
Arch Biochem Biophys
2023 Jul 1:742:109640. PMID: 37207933 -
Arch Biochem Biophys
ApoM suppresses kidney renal clear cell carcinoma growth and metastasis via the Hippo-YAP signaling pathway. [Abstract]2023 Jul 15:743:109642. PMID: 37211224 -
J Innate Immun
Cathelicidins Induce Toll-Interacting Protein Synthesis to Prevent Apoptosis in Colonic Epithelium. [Abstract]2023;15(1):204-221. PMID: 36116427 -
Arch Biochem Biophys
Chemical degrader enhances the treatment of androgen receptor-positive triple-negative breast cancer. [Abstract]2022 May 30;721:109194. PMID: 35337811 -
Arch Biochem Biophys
ESR1 inhibits ionizing radiation-induced ferroptosis in breast cancer cells via the NEDD4L/CD71 pathway. [Abstract]2022 Aug 15:725:109299. PMID: 35613689 -
FEBS Lett
Autophagic degradation of claudin-5 mediated by its binding to a Clostridium perfringens enterotoxin fragment modulates endothelial barrier permeability. [Abstract]2022 Apr;596(7):924-937. PMID: 35156707 -
FEBS Lett
ABRO1 stabilizes the deubiquitinase BRCC3 through inhibiting its degradation mediated by the E3 ubiquitin ligase WWP2. [Abstract]2021 Jan;595(2):169-182. PMID: 33107021 -
FEBS Lett
Voltage-gated sodium channels β3 subunit promotes tumorigenesis in hepatocellular carcinoma by facilitating p53 degradation. [Abstract]2020 Feb;594(3):497-508. PMID: 31626714 -
Mol Immunol
Persistent IKKα phosphorylation induced apoptosis in UVB and Poly I:C co-treated HaCaT cells plausibly through pro-apoptotic p73 and abrogation of IκBα. [Abstract]2018 Dec:104:69-78. PMID: 30445257
MG-132 purchased from MedChemExpress. Usage Cited in: Mol Immunol. 2018 Dec:104:69-78. [Abstract]
Western analysis of proteins expression with treatment of IKK-16 or MG-132.
-
Discov Oncol
Mitochondrial pyruvate carrier inhibits tumor growth by Bmi1 ubiquitination in renal cell carcinoma progression. [Abstract]2025 Jul 2;16(1):1253. PMID: 40601174 -
Free Radic Res
Down-regulation of Selenoprotein K impairs the proliferation and differentiation of chicken skeletal muscle satellite cells by inhibiting the Nrf2 antioxidant signaling pathway. [Abstract]2025 Mar;59(3):215-225. PMID: 39981965 -
Carcinogenesis
USP49 promotes adenocarcinoma of the esophagogastric junction malignant progression via activating SHCBP1-β-catenin-GPX4 axis. [Abstract]2024 Sep 5:bgae060. PMID: 39234990 -
J Anim Sci
Glucose inhibits the inflammatory response in goose fatty liver by increasing the ubiquitination level of PKA. [Abstract]2024 Aug 19:skae239. PMID: 39158360 -
Am J Cancer Res
SPATA20 deficiency enhances the metastatic and angiogenic potential of cancer cells by promoting HIF-1α synthesis. [Abstract]2024 Feb 15;14(2):727-743. PMID: 38455399 -
Oral Dis
USP14 promotes the cancer stem-like cell properties of OSCC via promoting SOX2 deubiquitination. [Abstract]2024 Oct;30(7):4255-4265. PMID: 38376172 -
Am J Cancer Res
UBE2S targets RPL26 for ubiquitination and degradation to promote non-small cell lung cancer progression via regulating c-Myc. [Abstract]2023 Aug 15;13(8):3705-3720. PMID: 37693154 -
Discov Oncol
Activating the Hippo pathway by nevadensin overcomes Yap-drived resistance to sorafenib in hepatocellular carcinoma. [Abstract]2023 May 27;14(1):83. PMID: 37243813 -
Insects
BmCBP Catalyzes the Acetylation of BmApoLp-II Protein and Regulates Its Stability in Silkworm, Bombyx mori. [Abstract]2023 Mar 23;14(4):309. PMID: 37103124 -
Am J Cancer Res
TNKS inhibitors potentiate proliferative inhibition of BET inhibitors via reducing β-Catenin in colorectal cancer cells. [Abstract]2022 Mar 15;12(3):1069-1087. PMID: 35411247 -
Am J Cancer Res
YY1-mediated reticulocalbin-2 upregulation promotes the hepatocellular carcinoma progression via activating MYC signaling. [Abstract]2021 May 15;11(5):2238-2251. PMID: 34094681 -
J Pharmacol Sci
Momordin Ic induces G0/1 phase arrest and apoptosis in colon cancer cells by suppressing SENP1/c-MYC signaling pathway. [Abstract]2021 Aug;146(4):249-258. PMID: 34049792 -
Am J Cancer Res
2020 Oct 1;10(10):3440-3457. PMID: 33163282 -
Front Genet
Identification and functional analysis of a novel CSNK2A1 frameshift variant in stillbirth. [Abstract]2025 Oct 27:16:1692704. PMID: 41216289 -
J Appl Toxicol
2025 Aug 11. PMID: 40789488 -
J Orthop Surg Res
TRIM55 suppresses inflammatory response after spinal cord injury by accelerating the ubiquitination and degradation of TLR4. [Abstract]2025 May 26;20(1):517. PMID: 40420098 -
J Biochem Mol Toxicol
UBE2T mediates SORBS3 ubiquitination to enhance IL-6/STAT3 signaling and promote lung adenocarcinoma progression. [Abstract]2024 Jun;38(6):e23743. PMID: 38816989 -
J Cancer Res Clin Oncol
LncRNA HOXC-AS3 accelerates malignant proliferation of cervical cancer cells via stabilizing KDM5B. [Abstract]2024 Jun 6;150(6):294. PMID: 38842683 -
Neuroscience
2024 May 10:549:101-109. PMID: 38734303 -
Neuroscience
NEDD4 like E3 ubiquitin protein ligase represses astrocyte activation and aggravates neuroinflammation in mice with depression via paired box 6 ubiquitination. [Abstract]2023 Oct 15:530:144-157. PMID: 37661017 -
BMC Pulm Med
The function role of ubiquitin proteasome pathway in the ER stress-induced AECII apoptosis during hyperoxia exposure. [Abstract]2021 Nov 22;21(1):379. PMID: 34809635 -
Int J Biochem Cell Biol
Resveratrol induces depletion of TRAF6 and suppresses prostate cancer cell proliferation and migration. [Abstract]2020 Jan;118:105644. PMID: 31712163 -
Vet Microbiol
ASFV early protein p30 suppresses antiviral type I IFN induction by targeting TRIM21 and RIG-I like receptor signaling adaptor MAVS. [Abstract]2026 Aug:319:111066. PMID: 42119254 -
Vet Microbiol
Porcine reproductive and respiratory syndrome virus nsp2 protects viral RNA-dependent RNA polymerase from autophagic degradation. [Abstract]2026 May:316:110993. PMID: 41861694 -
Vet Microbiol
SEC10 suppresses KLF15-mediated transcriptional activation of JAK1 and promotes BoHV-1 replication. [Abstract]2026 May:316:111004. PMID: 41903488 -
Immun Inflamm Dis
Yiqi Daozhi Formula Reduces the M1 Polarization of Macrophages in Mice With Postoperative Ileus Through Mediating Glycolysis Metabolism. [Abstract]2026 Feb;14(2):e70353. PMID: 41684127 -
Virus Res
PCBP2 inhibits antiviral innate immune responses via the MAVS-mediated signaling pathway in severe fever with thrombocytopenia syndrome. [Abstract]2026 Mar:365:199699. PMID: 41638535 -
Vet Microbiol
Mechanistic study of PEDV NSP3-mediated regulation of host innate immune responses via ubiquitin removal and UPR pathway modulation. [Abstract]2026 Feb:313:110875. PMID: 41512599 -
Vet Microbiol
ENTR1 stabilizes MAVS by inhibiting NIX-mediated mitophagy to restrict BPIV3 and VSV replication. [Abstract]2025 Dec 31:313:110865. PMID: 41494271 -
Vet Microbiol
Sec6 suppresses BoHV-1-triggered innate immunity through NDP52-mediated autophagic degradation of STING. [Abstract]2025 Dec 10:312:110836. PMID: 41406560 -
Vet Microbiol
2025 Nov 10:312:110791. PMID: 41223816 -
Vet Microbiol
2025 Sep 6:310:110721. PMID: 40925072 -
Vet Microbiol
Sec6 suppresses BEFV-triggered type I IFN responses by promoting P62-mediated MAVS degradation. [Abstract]2025 Sep:308:110658. PMID: 40780029 -
Invest New Drugs
Synergistic effects of the curcumin analog HO-3867 and olaparib in transforming fallopian tube epithelial cells. [Abstract]2025 Aug 4. PMID: 40760233 -
Vet Microbiol
Porcine reproductive and respiratory syndrome virus nsp2-related proteins induce host translational arrest by specifically impairing the mTOR signaling cascade. [Abstract]2025 May 13:306:110562. PMID: 40367705 -
Vet Microbiol
Long noncoding RNA USP30-AS1 promotes influenza A virus replication by enhancing PHB1 function. [Abstract]2025 Apr:303:110444. PMID: 40020267 -
Vet Microbiol
VAPA suppresses BEFV and VSV-induced type I IFNs signaling response by targeting JAK1 for NEDD4-mediated ubiquitin-proteasome degradation. [Abstract]2025 May:304:110456. PMID: 40080976 -
Vet Microbiol
Glaesserella parasuis serotype 5 promotes pyroptosis via degrading Caveolin-1 in 3D4/21 cells. [Abstract]2025 Jan 13:302:110393. PMID: 39823716 -
Toxicol In Vitro
TCDD inhibits the proliferation of C17.2 cells through the activation of the c-Cbl/β-catenin signaling pathway. [Abstract]2025 Jan 27:106014. PMID: 39880321 -
Vet Microbiol
STAT6 promotes innate immunity against BEFV and VSV by inhibiting STUB1 and NIX-mediated MAVS degradation. [Abstract]2024 Nov:298:110290. PMID: 39471658 -
Vet Microbiol
Cellular RNA-binding proteins LARP4 and PABPC1 synergistically facilitate viral translation of coronavirus PEDV. [Abstract]2024 Aug 15:298:110219. PMID: 39182469 -
Toxicol In Vitro
Transcription Factor yin-Yang 1 augments nucleoporin 93 oncogene activity and modulates bladder Cancer malignancy. [Abstract]2024 Jun 8:105875. PMID: 38857852 -
Vet Microbiol
Porcine reproductive and respiratory syndrome virus infection inhibits NF-κB signaling pathway through cleavage of IKKβ by Nsp4. [Abstract]2023 Jul:282:109767. PMID: 37141805 -
Anal Cell Pathol
Effect of COP1 in Promoting the Tumorigenesis of Gastric Cancer by Down-Regulation of CDH18 via PI3K/AKT Signal Pathway. [Abstract]2023 Mar 28:2023:5617875. PMID: 37025097 -
Vet Microbiol
GRAMD4 regulates PEDV-induced cell apoptosis inhibiting virus replication via the endoplasmic reticulum stress pathway. [Abstract]2023 Apr:279:109666. PMID: 36738512 -
Virus Res
Pseudorabies virus glycoprotein gE suppresses interferon-β production via CREB-binding protein degradation. [Abstract]2021 Jan 2;291:198220. PMID: 33152381 -
Toxicol In Vitro
YAN, a novel microtubule inhibitor, inhibits P-gp and MRP1 function and induces mitotic slippage followed by apoptosis in multidrug-resistant A549/Taxol cells. [Abstract]2020 Dec;69:104971. PMID: 32805372 -
Vet Microbiol
Cholesterol 25-Hydroxylase inhibits bovine parainfluenza virus type 3 replication through enzyme activity-dependent and -independent ways. [Abstract]2019 Dec;239:108456. PMID: 31767082 -
Exp Eye Res
Homeostasis of SLC4A11 protein is mediated by endoplasmic reticulum-associated degradation. [Abstract]2019 Nov;188:107782. PMID: 31491427 -
Brain Res
Dehydrocorybulbine blocks the Lyn-mediated MAPK pathway to promote anti-inflammatory polarization of microglia in mice after sevoflurane anesthesia. [Abstract]2026 Mar 1:1874:150163. PMID: 41529779 -
PLoS One
SAT1 promotes the progression of OA by regulating TRIM33-mediated p53 acetylation to enhance ferroptosis. [Abstract]2025 Oct 8;20(10):e0332761. PMID: 41060973 -
PLoS One
2025 Jan 7;20(1):e0316912. PMID: 39775346 -
PLoS One
Hsa-miR-22-3p inhibits liver cancer cell EMT and cell migration/ invasion by indirectly regulating SPRY2. [Abstract]2023 Feb 7;18(2):e0281536. PMID: 36749775 -
-
Cancer Manag Res
Phosphorylated MAPK14 Promotes the Proliferation and Migration of Bladder Cancer Cells by Maintaining RUNX2 Protein Abundance. [Abstract]2020 Nov 6;12:11371-11382. PMID: 33204153 -
Tissue Cell
SENP1 drives glycolytic reprogramming to promote malignant progression of gastric cancer via deSUMOylation of HIF-1α. [Abstract]2026 Jun 17:103:103703. PMID: 42378852 -
Tissue Cell
Paeonol inhibits the progression of endometrial cancer by affecting TRIM26-mediated LDHA ubiquitination modification. [Abstract]2026 Jun:100:103359. PMID: 41691946 -
J Steroid Biochem Mol Biol
E3 ubiquitin ligase PELI1 promotes ferroptosis in granulosa cells in PCOS by degrading Fth1. [Abstract]2026 Jan 29:259:106948. PMID: 41620040 -
Tissue Cell
Oroxindin promotes angiogenesis in pressure ulcers through activating PI3K/AKT signaling pathway by PTEN suppression. [Abstract]2025 Dec 21:99:103291. PMID: 41475085 -
Theriogenology
Regulation of autophagy-Ferroptosis crosstalk by the SLC7A11-GPX4 axis during sperm capacitation. [Abstract]2025 Dec 24:254:117795. PMID: 41483535 -
Reprod Sci
E2F8 Transcriptionally Activates DTL to Promote Endometrial Cancer Progression Via the MAPK Pathway. [Abstract]2025 Dec 29. PMID: 41461624 -
Tissue Cell
PRMT1 promotes H2O2 induced cardiomyocytes cell via mediating arginine methylation of P53. [Abstract]2025 Nov 27:99:103253. PMID: 41349350 -
Clin Exp Pharmacol Physiol
2025 Nov;52(11):e70077. PMID: 40960006 -
Mol Biotechnol
NRF1 Transcriptionally Regulates USP1-Mediated Deubiquitination of AURKA to Facilitate Osteosarcoma Progression. [Abstract]2025 Feb 7. PMID: 39915374 -
J Steroid Biochem Mol Biol
Loss of DDB2 in type II diabetes mellitus induces dysregulated ubiquitination of KMT2A in lipid metabolism disorders. [Abstract]2025 Jan 9:106673. PMID: 39798620 -
J Steroid Biochem Mol Biol
OBHSA, a novel selective estrogen receptor degrader, overcomes tamoxifen resistance through cell cycle arrest and unfolded protein response-mediated apoptosis in breast cancer. [Abstract]2024 Aug 13:106599. PMID: 39147211 -
Clin Transl Oncol
NEDD4L represses prostate cancer cell proliferation via modulating PHF8 through the ubiquitin-proteasome pathway. [Abstract]2023 Jan;25(1):243-255. PMID: 36136271 -
Prostate
Diptoindonesin G antagonizes AR signaling and enhances the efficacy of antiandrogen therapy in prostate cancer. [Abstract]2022 Jun;82(8):917-932. PMID: 35322879 -
J Cardiovasc Transl Res
SIRT6 Protects Against Myocardial Ischemia-Reperfusion Injury by Attenuating Aging-Related CHMP2B Accumulation. [Abstract]2022 Aug;15(4):740-753. PMID: 35235147 -
Immunol Invest
TRIM31: A Novel Guardian Against Periodontal Inflammation via Modulation of NLRP3 Inflammasome and Macrophage Polarization. [Abstract]2026 Jun 22:1-21. PMID: 42329222 -
Purinergic Signal
Proteasomal-dependent endothelial P2Y6 receptor downregulation as an adaptive mechanism limiting monocyte adhesion during intestinal schistosomiasis. [Abstract]2026 Mar 24;22(2):31. PMID: 41874831 -
Toxicon
Toosendanin sensitizes hepatocyte ferroptosis via dual inhibition of Nrf2 O-GlcNAcylation and USP7-driven deubiquitination. [Abstract]2026 Apr 1:273:109018. PMID: 41628670 -
Gene
2025 Nov 20:972:149817. PMID: 41075950 -
Virology
Effects of synonymous codons with optimization / deoptimization in nucleoprotein (NP) gene of influenza A virus on interaction between NP and tripartite motif protein 25 (TRIM25). [Abstract]2025 Sep:610:110626. PMID: 40669436 -
Gene
Pathogenicity analysis of three SCA14-associated missense mutations in PRKCG gene of Chinese patients with ataxia. [Abstract]2025 Apr 10:149483. PMID: 40221062 -
Gene
Clinical and functional characterization of rare compound heterozygous mutations in the SERPINC1 gene causing severe thrombophilia. [Abstract]2024 Mar 1:897:148085. PMID: 38104950 -
Ann Hematol
CCDC50, an essential driver involved in tumorigenesis, is a potential severity marker of diffuse large B cell lymphoma. [Abstract]2023 Nov;102(11):3153-3165. PMID: 37684379 -
Am J Reprod Immunol
Lipoxin A4 depresses inflammation and promotes autophagy via AhR/mTOR/AKT pathway to suppress endometriosis. [Abstract]2023 Mar;89(3):e13659. PMID: 36412044 -
Eur J Neurosci
Repeated sevoflurane exposures inhibit neurogenesis by inducing the upregulation of glutamate transporter 1 in astrocytes. [Abstract]2023 Jan;57(2):217-232. PMID: 36440503 -
Gene
Selenoprotein S regulates tumorigenesis of clear cell renal cell carcinoma through AKT/ GSK3β/NF-κB signaling pathway. [Abstract]2022 Jul 20;832:146559. PMID: 35569765 -
Vet Sci
2025 May 19;12(5):490. PMID: 40431583 -
Thorac Cancer
SLC34A2 promotes cell proliferation by activating STX17-mediated autophagy in esophageal squamous cell carcinoma. [Abstract]2024 May 8. PMID: 38720472 -
Exp Ther Med
2024 Apr 17;27(6):255. PMID: 38682111 -
Exp Ther Med
Proteasome inhibitor MG132 enhances the sensitivity of human OSCC cells to cisplatin via a ROS/DNA damage/p53 axis. [Abstract]2023 Mar 30;25(5):224. PMID: 37123203 -
J Oral Pathol Med
2023 May;52(5):448-455. PMID: 36935549 -
J Recept Signal Transduct Res
CBLC inhibits the proliferation and metastasis of breast cancer cells via ubiquitination and degradation of CTTN. [Abstract]2022 Dec;42(6):588-598. PMID: 36043996 -
FEBS Open Bio
2021 Feb;11(2):456-467. PMID: 33350608 -
Exp Ther Med
Sophocarpine attenuates septic liver injury through suppression of the NLRP3 inflammasome via autophagy-mediated degradation. [Abstract]2020 Dec;20(6):249. PMID: 33178347 -
Insect Mol Biol
The effect of acetylation on the protein stability of BmApoLp-III in the silkworm, Bombyx mori. [Abstract]2020 Feb;29(1):104-111. PMID: 31390480 -
Cell Div
2026 May 18;21(1):15. PMID: 42151974 -
Biochemistry (Mosc)
A Conjugate of Aminoadamantane and Tetrahydro-γ-Carboline Inhibits Accumulation of Mutant α-Synuclein A53T in the Cellular Model of Proteinopathy. [Abstract]2026 May;91(5):789-799. PMID: 42219390 -
-
Biochem Biophys Res Commun
SBF-1 suppresses colorectal cancer cell growth via modulating cholesterol metabolic reprogramming. [Abstract]2025 Nov 25:794:153046. PMID: 41317708 -
J Gene Med
TRIM34-Mediated Ubiquitination and Degradation of HIF-1A Regulates Glycolysis in Endothelial Cells, Inhibits Angiogenesis, and Relieves the Progression of Lung Fibrosis. [Abstract]2025 Aug;27(8):e70032. PMID: 40836270 -
J Mol Histol
METTL5-mediated m6A modification of UBE3C promotes osteosarcoma progression by suppressing ferroptosis via inducing AHNAK ubiquitination. [Abstract]2025 Jul 23;56(4):235. PMID: 40696164 -
J Mol Histol
The effect of USP17 knockdown on autophagic ferroptosis in gastric cancer by regulating the BNIP3-NCOA4-FTH1 axis. [Abstract]2025 Jul 31;56(4):245. PMID: 40742478 -
Biochem Biophys Res Commun
Papain-like protease of SARS-CoV-2 inhibits dsRNA-induced type I interferon response partly by cleaving TBK1. [Abstract]2025 Jun 21:777:152244. PMID: 40570639 -
Biochem Biophys Res Commun
Development of a versatile system for evaluating the target protein degradation activity of novel ubiquitin ligases utilizing existing PROTACs. [Abstract]2025 Jan 20:749:151370. PMID: 39864384 -
Bioorg Med Chem Lett
Cyclic vinyl sulfones activate NRF2 to protect from oxidative stress-induced programmed necrosis. [Abstract]2024 Dec 5:130058. PMID: 39644937 -
Biochem Biophys Res Commun
2024 May 14:708:149798. PMID: 38518721 -
Oncol Lett
Heparanase inhibitor OGT 2115 induces prostate cancer cell apoptosis via the downregulation of MCL‑1. [Abstract]2024 Jan 5;27(2):83. PMID: 38249815 -
Biochem Biophys Res Commun
Puerarin reduces cell damage from cerebral ischemia-reperfusion by inhibiting ferroptosis. [Abstract]2024 Jan 22:693:149324. PMID: 38101001 -
Biochem Biophys Res Commun
Exosomal lncRNA HOTAIR induces PDL1+ B cells to impede anti-tumor immunity in colorectal cancer. [Abstract]2023 Feb 12:644:112-121. PMID: 36640665 -
Biochem Biophys Res Commun
Fibroblast growth factor receptor inhibitor erdafitinib promotes Mcl-1 degradation and synergistically induces apoptosis with Bcl-xL/Bcl-2 inhibitor in urothelial cancer cells. [Abstract]2022 Nov 5:628:76-83. PMID: 36084554 -
Biochem Biophys Res Commun
2022 Feb 19:593:122-128. PMID: 35063767 -
Biochem Biophys Res Commun
2020 Feb 18;S0006-291X(20)30325-9. PMID: 32085898 -
Biochem Biophys Res Commun
β-catenin stimulates Tcf7l1 degradation through recruitment of casein kinase 2 in mouse embryonic stem cells. [Abstract]2020 Apr 2;524(2):280-287. PMID: 31987502 -
Biochem Biophys Res Commun
Proteasome inhibition promotes mono-ubiquitination and nuclear translocation of mature (52 kDa) PINK1. [Abstract]2019 Sep 17;517(2):376-382. PMID: 31362890 -
Biochem Biophys Res Commun
VHL regulates NEK1 via both HIF-2α pathway and ubiquitin-proteasome pathway in renal cancer cell. [Abstract]2019 Feb 12;509(3):797-802. PMID: 30635121 -
Oncol Lett
Never-in-mitosis A-related kinase 8, a novel target of von-Hippel-Lindau tumor suppressor protein, promotes gastric cancer cell proliferation. [Abstract]2018 Nov;16(5):5900-5906. PMID: 30333866
MG-132 purchased from MedChemExpress. Usage Cited in: Oncol Lett. 2018 Nov;16(5):5900-5906. [Abstract]
Treatment with the 26S proteasome inhibitor, MG 132 (10 µM), rescues the downregulation of NEK 8 in the pVHL overexpressing SGC 7901 cells.
-
Biochem Biophys Res Commun
NHERF1 and NHERF2 regulation of SR-B1 stability via ubiquitination and proteasome degradation. [Abstract]2017 Sep 2;490(4):1168-1175. PMID: 28669731
MG-132 purchased from MedChemExpress. Usage Cited in: Biochem Biophys Res Commun. 2017 Sep 2;490(4):1168-1175. [Abstract]
Treatment of CHO-K1 cells with proteasome inhibitor, MG-132 results in elevated SR-B1 protein levels. The cells with MG-132, a potent proteasome inhibitor that inhibit ubiquitin/proteasome-dependent protein degradation, and MG-132 treatment significantly enhances cellular SR-B1 protein level.
-
Biochem Biophys Res Commun
Inflammatory mediator bradykinin increases population of sensory neurons expressing functional T-type Ca(2+) channels. [Abstract]2016 Apr 29;473(2):396-402. PMID: 26944020 -
J Diabetes Metab Disord
miR-148b attenuates ox-LDL-induced phenotypic switching of vascular smooth muscle cells by suppressing KLF4 expression and promoting its ubiquitination. [Abstract]2026 May 25;25(1):142. PMID: 42205318 -
Genet Res (Camb)
A Cuproptosis-Related lncRNA Signature Predicts Prognosis and Shapes the Immune Landscape in Primary Lower-Grade Glioma. [Abstract]2025 Dec 8:2025:3061843. PMID: 41438616 -
Biochem Cell Biol
TRAF7 inhibits proliferation and migration of esophageal squamous cell carcinoma by ubiquitination-mediated degradation of SOX12. [Abstract]2025 Jul 7. PMID: 40623321 -
Arch Dermatol Res
Adipose stem cell‑derived exosomes promote high glucose-induced wound healing by regulating the TRIM32/STING axis. [Abstract]2024 Jun 1;316(6):323. PMID: 38822901 -
FASEB Bioadv
2024 Sep 9;6(11):555-564. PMID: 39512837 -
BMC Med Genomics
Truncated FRMD7 proteins in congenital Nystagmus: novel frameshift mutations and proteasomal pathway implications. [Abstract]2024 Jan 26;17(1):36. PMID: 38279119 -
J Gastrointest Oncol
N-myc downstream-regulated gene 2 promotes the protein stability of estrogen receptor beta via inhibition of ubiquitin-protein ligase E3A to suppress colorectal cancer. [Abstract]2020 Dec;11(6):1200-1213. PMID: 33456993 -
J Thorac Dis
Yifei Sanjie Formula in improving the response to PD-1 blockade by lung cancer through the attenuation of the USP7-NR1H4-bile acid metabolism axis. [Abstract]2026 Mar 31;18(3):243. PMID: 41988276 -
J Thorac Dis
Circular RNA circFTO promotes pressure overload-induced cardiac hypertrophy by encoding a novel protein FTO-36aa. [Abstract]2025 Aug 31;17(8):6127-6150. PMID: 40950872 -
Arch Insect Biochem Physiol
The acetylation modification regulates the stability of Bm30K-15 protein and its mechanism in silkworm, Bombyx mori. [Abstract]2021 Jul;107(3):e21823. PMID: 34075635 -
Biol Open
2026 Jan 1;15(1):bio062179. PMID: 41384385 -
Cell J
2023 Feb 1;25(2):118-125. PMID: 36840458 -
Transl Cancer Res
Complement and coagulation cascades are associated with prognosis and the immune microenvironment of lower-grade glioma. [Abstract]2024 Jan 31;13(1):112-136. PMID: 38410234 -
Psychogeriatrics
Role of the OTUB1/IRF7/NOX4 axis in oxidative stress injury and inflammatory responses in mice with Parkinson's disease. [Abstract]2023 Jan;23(1):32-44. PMID: 36332656 -
Transl Cancer Res
Withaferin A suppresses skin tumor promotion by inhibiting proteasome-dependent isocitrate dehydrogenase 1 degradation. [Abstract]2019 Oct;8(6):2449-2460. PMID: 35116997 -
-
Am J Transl Res
TRIM62 promotes osteoarthritis progression by facilitating GPX4 ubiquitination and chondrocyte ferroptosis. [Abstract]2026 May 15;18(5):4474-4491. PMID: 42325784 -
Biochem Genet
2026 Feb 21. PMID: 41721959 -
Biochem Genet
FBXW7 Inhibited M2 Macrophage Polarization in Endometrial Cancer by Reducing CCL2 Secretion Through Ubiquitination of MYBL2 Subtitle: The Role of FBXW7 on M2 Macrophage Polarization in EC. [Abstract]2026 Jan 3. PMID: 41484508 -
Biochem Genet
TRIM8 Promotes Proliferation, Invasion, and Migration of Cervical Cancer Cells by Ubiquitinating and Degrading SOCS1. [Abstract]2025 Aug;63(4):3206-3219. PMID: 38918306 -
Biochem Genet
ZMIZ1 Regulates Proliferation, Autophagy and Apoptosis of Colon Cancer Cells by Mediating Ubiquitin-Proteasome Degradation of SIRT1. [Abstract]2024 Aug;62(4):3245-3259. PMID: 38214831 -
Neurol Res
USP7 alleviates neuronal inflammation and apoptosis in spinal cord injury via deubiquitinating NRF1/KLF7 axis. [Abstract]2024 Jul 15:1-10. PMID: 39007840 -
J Cardiothorac Surg
Protective role of FBXL19 in Streptococcus pneumoniae-induced lung injury in pneumonia immature mice. [Abstract]2023 Mar 24;18(1):92. PMID: 36964598 -
-
Biosci Biotechnol Biochem
Synergistic effect of cerium chloride and calcium chloride alters calcium signaling in keratinocytes to promote epidermal differentiation. [Abstract]2024 Nov 22;88(12):1432-1441. PMID: 39333009 -
Can J Physiol Pharmacol
Chloroquine attenuates lipopolysaccharide-induced inflammatory responses through upregulation of USP25. [Abstract]2017 May;95(5):481-491. PMID: 28134560 -
Protein Pept Lett
Irisin Mitigates Myocardial Hypoxia/Reoxygenation Injury by Preserving Mitochondrial Redox Homeostasis via the UCP2-SOD2 Axis. [Abstract]2026 Mar 2. PMID: 41787993 -
-
-
Autophagy Rep
Glucose concentration of neuronal media formulations influences PINK1-dependent mitophagy in human iNeurons. [Abstract]2026 Jun 12;5(1):2685472. PMID: 42317396 -
-
-
-
-
-
-
-
-
bioRxiv
2026 May 18:2026.05.16.725645. PMID: 42239248 -
-
-
bioRxiv
2026 May 14:2026.05.12.724395. PMID: 42182270 -
-
-
-
-
-
-
-
-
-
-
-
-
bioRxiv
Ischemia-Induced Post-Translational Modifications of GLT-1 Mediate Aberrant Trafficking and Impaired Glutamate Uptake. [Abstract]2026 Mar 17:2026.03.13.711603. PMID: 41890068 -
-
-
-
-
-
-
-
-
-
-
-
-
-
bioRxiv
Conformation-specific Antibody Deciphers K27-linked Ubiquitination in Chaperone-Mediated Proteostasis. [Abstract]2025 Dec 18:2025.12.18.695067. PMID: 41446272 -
-
-
-
-
-
-
-
-
-
-
-
-
bioRxiv
Development of Degraders and 2-pyridinecarboxyaldehyde (2-PCA) as a recruitment Ligand for FBXO22. [Abstract]2025 Aug 20:2025.08.19.671158. PMID: 40894587 -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
bioRxiv
2024 Dec 5:2024.12.05.627000. PMID: 39677682 -
-
bioRxiv
All-trans retinoic acid-mediated ADAR1 degradation synergizes with PD-1 blockade to suppress pancreatic cancer. [Abstract]2024 Oct 23:2024.10.20.619300. PMID: 39484589 -
bioRxiv
2024 Sep 27:2024.09.25.615094. PMID: 39386645 -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
bioRxiv
2025 Apr 28:2024.04.18.590103. PMID: 38659924 -
-
-
-
-
-
-
-
-
bioRxiv
Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer. [Abstract]2023 Sep 28:2023.09.28.559973. PMID: 37808840 -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
J Oncol
Ubiquitin-Specific Peptidase 8 Modulates Cell Proliferation and Induces Cell Cycle Arrest and Apoptosis in Breast Cancer by Stabilizing Estrogen Receptor Alpha. [Abstract]2023 Jan 4:2023:8483325. PMID: 36644233 -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Ann Transl Med
Cimetidine promotes STUB1-mediated degradation of tumoral FOXP3 by activating PI3K-Akt pathway in gastric cancer. [Abstract]2020 Oct;8(20):1304. PMID: 33209884 -
-
-
-
-
-
MG-132 purchased from MedChemExpress. Usage Cited in: Université de Montréal. Octobre 2017.
Unsynchronized control and ARF6 cells are treated with DMSO or MG132 (10 μM) for 1h or 4h, lysed and total ubiquitinated proteins are determined using western blot (n=3).
-
Oncotarget
Loss of PIG3 increases HIF-1α level by promoting protein synthesis via mTOR pathway in renal cell carcinoma cells. [Abstract]2016 May 10;7(19):27176-84. PMID: 27029070
Lösungsmittel & Löslichkeit
DMSO : ≥ 50 mg/mL (105.13 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
* "≥" means soluble, but saturation unknown.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 1.67 mg/mL (3.51 mM); Clear solution
This protocol yields a clear solution of ≥ 1.67 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (16.7 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: 1.67 mg/mL (3.51 mM); Suspended solution; Need ultrasonic
This protocol yields a suspended solution of 1.67 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (16.7 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Reinheit & Dokumentation
-
Data Sheet (285 KB)
-
SDS (396 KB)
- English - EN (396 KB)
- Français - FR (396 KB)
- Deutsch - DE (396 KB)
- Norwegian - NO (396 KB)
- Español - ES (396 KB)
- Swedish - SV (396 KB)
- Italian - IT (396 KB)
- Korean - KR (396 KB)
- Portuguese - PT (396 KB)
-
Handling Instructions (2659 KB)
Verweise
[1]. Harhouri K, et al. MG132-induced progerin clearance is mediated by autophagy activation and splicing regulation. EMBO Mol Med. 2017 Sep;9(9):1294-1313. [Content Brief]
[2]. Fan WH, et al. Proteasome inhibitor MG-132 induces C6 glioma cell apoptosis via oxidative stress. Acta Pharmacol Sin. 2011 May;32(5):619-25. [Content Brief]
[3]. Tsubuki S, et al. Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine. J Biochem. 1996 Mar;119(3):572-6. [Content Brief]
[4]. Fiedler MA, et al. Inhibition of TNF-alpha-induced NF-kappaB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132. Am J Respir Cell Mol Biol. 1998 Aug;19(2):259-68. [Content Brief]
[5]. MacLaren AP, et al. p53-dependent apoptosis induced by proteasome inhibition in mammary epithelial cells. Cell Death Differ. 2001 Mar;8(3):210-8. [Content Brief]
[6]. Han YH, et al. The effect of MG132, a proteasome inhibitor on HeLa cells in relation to cell growth, reactive oxygen species and GSH. Oncol Rep. 2009 Jul;22(1):215-21. [Content Brief]
[7]. Dang L, et al. Proteasome inhibitor MG132 inhibits the proliferation and promotes the cisplatin-inducedapoptosis of human esophageal squamous cell carcinoma cells. Int J Mol Med. 2014 May;33(5):1083-8. [Content Brief]
[8]. Matsumoto Y, et al. Enhanced efficacy against cervical carcinomas through polymeric micelles physically incorporating theproteasome inhibitor MG132. Cancer Sci. 2016 Jun;107(6):773-81. [Content Brief]
[9]. Bonuccelli G, et al. Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins. Am J Pathol. 2003 Oct;163(4):1663-75. [Content Brief]
[10]. Sun F, et al. Proteasome inhibitor MG-132 induces dopaminergic degeneration in cell culture and animal models. Neurotoxicology. 2006 Sep;27(5):807-15. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.1025 mL | 10.5126 mL | 21.0252 mL | 52.5630 mL |
| 5 mM | 0.4205 mL | 2.1025 mL | 4.2050 mL | 10.5126 mL | |
| 10 mM | 0.2103 mL | 1.0513 mL | 2.1025 mL | 5.2563 mL | |
| 15 mM | 0.1402 mL | 0.7008 mL | 1.4017 mL | 3.5042 mL | |
| 20 mM | 0.1051 mL | 0.5256 mL | 1.0513 mL | 2.6281 mL | |
| 25 mM | 0.0841 mL | 0.4205 mL | 0.8410 mL | 2.1025 mL | |
| 30 mM | 0.0701 mL | 0.3504 mL | 0.7008 mL | 1.7521 mL | |
| 40 mM | 0.0526 mL | 0.2628 mL | 0.5256 mL | 1.3141 mL | |
| 50 mM | 0.0421 mL | 0.2103 mL | 0.4205 mL | 1.0513 mL | |
| 60 mM | 0.0350 mL | 0.1752 mL | 0.3504 mL | 0.8760 mL | |
| 80 mM | 0.0263 mL | 0.1314 mL | 0.2628 mL | 0.6570 mL | |
| 100 mM | 0.0210 mL | 0.1051 mL | 0.2103 mL | 0.5256 mL |